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Summary 
This PhD thesis describes work undertaken to develop efficient silver(I) catalysts 
for the intramolecular reactions of alkynes with nitrogen and oxygen containing 
nucleophiles for the synthesis of heterocycles. The introductory chapter provides 
an overview of recent advances in silver-catalyzed heterofunctionalization 
reactions of alkynes, with a focus on reactions involving C-N and C-O bond 
formations. A summary of the catalytic applications of silver(I) NHC catalysts in 
the literature, which will be explored in Chapter 4, is also provided. 
 
Chapter 2 begins with the screening of silver salts as catalysts for the 
intramolecular hydroamination of alkynes with trichloroacetimidates. A strong 
counteranion effect on selectivity was observed. The impact of employing silver(I) 
complexes with variety of P- and  N- donor ligands on catalytic activity was also 
explored, where pyridine-ligated silver salts showed superior activity and 
selectivity. Reaction optimization was undertaken, and 1-bromoalkyne substrates 
were effectively cyclized with catalytic loadings as low as 1 mol%. 
 
In Chapter 3, the application of the pyridine-ligated silver salts developed in 
Chapter 2 as catalysts for the cycloisomerization of propargyl amides is described. 
A broader substrate scope was observed compared to the previously reported 
AgSbF6 catalyst and a mechanism for the reaction is proposed based on 
ii 
 
experimental observations. In Chapter 4, the synthesis and characterization of a 
new class of silver(I) NHC carboxylate complexes are presented. The activity 
towards the cycloisomerization of propargyl amides was investigated, and they 
showed complementary reactivities compared to the pyridine-ligated silver 
catalysts in Chapter 3. In Chapter 5, an overall conclusion and future work are 
discussed. 
 
The last Chapter contains experimental procedures and characterization data of all 
the compounds synthesized during the course of this project. 
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Chapter 1 Introduction 
 
1.1 The Role of Silver Salts in Gold Catalysis 
Over the last decade, gold compounds have been extensively studied due to 
their superior catalytic activity in various organic transformations. 1  In 
particular, cationic gold(I) complexes bearing N-heterocyclic (NHC) carbene 
or phosphine ancillary ligands have shown remarkable reactivity in various 
organic transformations compared to classic “neutral” gold salts. 2 , 3  Their 
superior catalytic efficiency is apparent in several processes, such as the 
electrophilic activation of alkynes towards nucleophiles, where good 
chemoselectivities and yields can be obtained with low catalytic loadings of 
0.1 to 1 mol%. On the other hand, the use of neutral gold salts often requires a 
higher loading (1−10%) and, in some cases, elevated temperatures to achieve 
similar conversions.4 
 
Currently, the preparation of these cationic species is achieved predominantly 
by the treatment of gold(I) and gold(III) chloride salts or complexes with the 
corresponding silver salt, which effectively introduces a new, weakly 
coordinated and thus labile anion on the gold center. Silver salts have often 
been viewed as innocent anion exchange agents for the generation of cationic 
gold catalysts, as long as the silver salts cannot catalyze the reaction. 
Furthermore, it has also been assumed that the silver chloride byproduct 
formed as a result of the anion metathesis reaction precipitates out of solution 
quantitatively, and a filtration step will remove it completely from the reaction 
mixture.   
2 
 
 
 
Scheme 1.1. Digold catalyst resting state in the intramolecular hydroarylation 
of allenes catalyzed by [(Ph3P)Au(NTf2)] 
 
 
Fig. 1.1. Proposed mixed Au-Ag intermediate 1.4 formed in the intramolecular 
hydroarylation of allenes catalyzed by [(Ph3P)AuCl]/AgNTf2 
 
However, the role of silver in gold-catalyzed reactions has recently been 
questioned. Known as the “silver effect” in gold catalysis, experimental 
evidence have shown a distinct influence of silver on gold-catalyzed reactions.  
In 2009, Gagné and co-workers reported the observation of a digold catalyst 
resting state 1.3 in the catalytic intramolecular hydroarylation of allene 1.1 to 
give 1.2 (Scheme 1.1).5 However, when the catalyst was generated in situ from 
a 1:5 mixture of Ph3PAuCl/AgNTf2 (5 mol%/25 mol%), the reaction 
proceeded just as efficiently, although a different catalyst resting state was 
3 
 
observed.6 It was formulated as the mixed Au–Ag species 1.4 (Fig. 1.1), based 
on 1H and 31P NMR spectroscopic data. It was also found that 1.3 could be 
converted to 1.4 in the presence of 3 equivalents of AgNTf2, hinting at the 
possibility of Ag(I) ions intercepting Au(I) catalytic intermediates in the 
reaction mixture, with a possible impact on reaction kinetics. Indeed, at a 
catalytic loading of 5 mol% of [(Ph3P)Au(NTf2)], the rate of reaction was 
significantly decreased when a three-fold excess of AgNTf2 was added to the 
reaction mixture, showing that  the mixed-metal dinuclear species may have 
their own unique reactivity. 
 
 
Scheme 1.2. Hydration of propargyl esters 
 
Shi and co-workers also obtained conflicting results with those previously 
reported by Sahoo et al. 7  with regards to the ability of cationic gold(I) 
catalysts [(Ph3P)Au]X to promote the hydration of propargyl esters
8 (Scheme 
1.2). They found that when an additional step involving filtration of the 
[(Ph3P)AuCl]/AgX (X = TfO
-, SbF6
-, BF4
-) catalytic mixture through Celite 
was taken prior to addition of the substrate, the catalytic reaction did not 
proceed. However, if the mixture of [(Ph3P)AuCl]/AgX was used directly, the 
reaction proceeded in good yields. Analysis of the catalytic mixtures after 
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Celite filtration by X-ray photoelectron spectroscopy (XPS) revealed the 
absence of any silver, implying that in certain cases, a combination of both 
gold and silver was essential to make catalysis possible. Further evidence for 
the formation of different species in solution in the presence of silver ions was 
provided by 31P NMR.  
 
 
Scheme 1.3. Preparation of the IPr**AuCl–AgSbF6 intermediate 
 
Having successfully prepared an extremely bulky N-heterocyclic carbene 
ligand, IPr**, and its corresponding gold(I) chloride complex (1.5), Straub and 
co-workers took advantage of the steric shielding of the IPr** ligand to probe 
the structure of cationic gold(I) intermediates generated from chloride 
abstraction by silver salts.9 A solution of complex 1.5 in DCE was added to 
AgSbF6, and the mixture was filtered through Celite was carried out to remove 
the AgCl. Removal of the solvent in vacuo yielded a colorless solid, which 
was crystallized from CD2Cl2. Single crystal X-ray diffraction studies of 
crystals grown from the filtrate revealed the formation of a silver(I)-
5 
 
coordinated gold(I) chloride complex with a triangular Ag–Cl–Au fragment 
(Scheme 1.3, compounds 1.6b and 1.6c). This result shows that silver cation-
gold chloride adducts which are soluble in organic solvents may form during 
the chloride abstraction step, which can result in the retention of small 
amounts of silver in solution even after filtration through Celite – a  procedure 
previously thought to remove all traces of silver ions in solution. More 
importantly, these adducts may account for the observed differences in activity 
and selectivity of catalyst reaction mixtures generated by the different 
protocols. 
 
Scheme 1.4. Preparation of [{Au(JohnPhos)}2(-Cl)Ag][SbF6] 
 
The interference of silver(I) in gold(I) catalysis was also recently 
demonstrated by the isolation of a chloride-bridged trimetallic dication with a 
bimetallic gold/silver core (1.8) generated from a mixture of the neutral 
complex [(JohnPhos)AuCl] (1.7) and AgSbF6, followed by a quick filtration 
through Celite (Scheme 1.4).10 It was also found that the precipitation of AgCl 
is a slow process: Little to no AgCl precipitates when the filtration is done 
immediately; approximately half is removed if filtration is done within 5 
minutes; and a trace (1-3%) remains even after stirring for 20 h. The solid 
state structure of 1.8 gives a snapshot of the early stages of halide abstraction 
and possibly provides clues to the mechanism by which silver can be 
6 
 
reincorporated into catalyst structures. It is possible that the formation of 1.8 is 
driven by the instability of the initially formed [(JohnPhos)Au]SbF6, which is 
stabilized by coordination to remaining [(JohnPhos)AuCl] to give the 
binuclear structure in 1.8. 
 
 
 
 
Fig. 1.2. Gold complexes that do not require activation by silver salts 
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Fig. 1.2. cont’d Gold complexes that do not require activation by silver salts. 
 
Driven by the ambiguous role of silver ions in gold catalysis, there is a 
growing trend towards the development of alternative routes for ‘silver-free’ 
gold catalysis. As a result, several cationic Au(I) complexes have been 
prepared (Fig. 1.2) that are stabilized by an inner sphere counteranion11,12 (1.9 
and 1.10), solvent molecule 13 , 14  (1.11a,b and 1.12), benzonitrile ligands 15 
(1.13, 1.14, 1.15a-c), oxonium center16,17 (1.16) or triazole ligand18 (1.17a,b), 
and do not require activation by silver salts. They have also demonstrated 
good catalytic efficiency towards organic transformations. However, the 
preparation of these complexes still require the use of a silver salt, and more 
economically viable methods that would completely eliminate the use of silver 
salts in both the synthesis and activation steps are needed.  
 
 
Scheme 1.5. Activation of a phosphine gold(I) methyl complex by a strong 
acid 
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To date, only three such alternative methods have been developed, and they 
each have their limitations and disadvantages. The first strategy involves the 
protonation of phosphine Au(I) methyl complexes [R3P-Au-Me] with strong 
acids such as methanesulfonic acid,19 to liberate methane and the cationic 
complex (Scheme 1.5). The resulting cationic catalysts are robust and stable to 
air and moisture, and show good activities towards the intermolecular addition 
of alcohols to alkynes. However, the harsh acidic conditions required are 
incompatible with organic transformations that involve acid-sensitive 
substrates.   
 
Scheme 1.6. Activation of a carbene gold(I) chloride complexes by a silylium 
salt 
 
The second method involves using alternative halide abstracting reagents. 
Bertrand and co-workers have used the silylium salt [(Tol)SiEt3]
+[B(C6F5)4]
- 
(Tol = toluene) 20 , 21   to obtain the cationic gold(I) complex of the cyclic 
(alkyl)(amino)carbene (CAAC) ligand (Scheme 1.6).22 The resulting cationic 
complex is indefinitely stable in solution and in the solid state, and shows 
good activity towards the cross-coupling of enamines and alkynes. The only 
disadvantage is the non-trivial synthesis of the silylium reagent.  
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Scheme 1.7. Intramolecular hydroalkylation of ene-	-ketoamides catalyzed by 
[(Ph3P)AuCl]/Cu(OTf)2 
 
Bezzenine and Gandon have also recently reported that Lewis acids such as 
the triflate salts of Cu(I), Cu(II), Zn(II), In(III) and Bi(III), and trimethylsilyl 
triflate can act as activators.23,24,25 The use of Cu(OTf)2 as an activator was 
compatible with the use of chiral phosphine, phosphite and NHC complexes of 
gold(I) and various reaction media, including water.24 Surprisingly robust 
catalytic species can result, which outperform gold(I)/silver(I) combinations.23 
For instance, in the intramolecular hydroalkylation of ene-	-ketoamides, 
complete conversion of substrate 1.18 occurred at high reaction temperatures 
and low catalytic loadings (Scheme 1.7), while only 28% conversion was 
achieved with AgOTf  as the activator under identical conditions. However, 
the success of the Au(I)/Cu(II) catalytic system is highly dependent on the 
reaction being catalyzed; in certain instances silver salts are still better.24 
Moreover, the exact role of Cu(OTf)2 in the reaction is still unknown, although 
the authors propose that it acts as a halide scavenger and undergoes slow anion 
metathesis with chloride of the gold(I) complex, delivering small amounts of 
cationic gold(I) catalytic species at a time, thus preventing fast decay of these 
highly reactive species. There is also the possibility of cooperative Au(I)/Cu(II) 
catalysis, which has not been ruled out. However, a disadvantage is the need to 
employ five- to ten-fold excess of the Lewis acid activator compared to silver 
salts, which were usually used in equal amounts or two-fold excess.  
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Scheme 1.8. Synthesis of [(IPr)Au(OH)] (1.23) 
 
The third method involves the use of the “golden synthon” [(IPr)Au(OH)] 
(1.23) developed by the group of Nolan, which is an excellent precursor to 
several organogold compounds due to the presence of a basic hydroxide ligand 
(Scheme 1.8).26 The synthesis of 1.2326 is simple and high yielding, and does 
not require an inert atmosphere.  
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 Scheme 1.9. Activation of [(IPr)Au(OH)] (1.23) by reaction with acids 
 
Complex 1.23 is basic in nature, having a pKa value between 29 and 31. Thus, 
it can be activated by protonolysis with acids (Scheme 1.9). The reaction of 
1.23 with trifluoromethanesulfonimide (HNTf2) enabled access to complex 
1.10 via a silver-free synthetic route in excellent yield. The solvent-stabilized 
cationic Au(I) complexes [(IPr)Au(solv)][BF4] (solv = Et2O (1.24), MeCN 
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(1.12)) can also be generated in situ by the reaction of 1.23 with HBF4
OEt2, 
and have shown good activities in the 3,3’-rearrangement of allylic acetates 
and Beckmann-type rearrangement reaction of aldoximes. 27  If an aqueous 
solution of HBF4 is used, the -hydroxy-bridged dinuclear species 
[{Au(IPr)}2(-OH)][X] (X = BF4, NTf2, OTf, SbF6, FABA) 1.25 are  formed. 
The stability of these complexes in aqueous media has been exploited in gold-
catalyzed reactions involving water, such as the hydration of nitriles and 
alkynes. 28  Although 1.23 provides an elegant silver-free approach to the 
synthesis of [(IPr)Au]+, it is not a general strategy that can be easily extended 
to other ligands than IPr. At this point, the stability of Au(I) hydroxide 
complexes of other ancillary ligands such as phosphines, or even similar NHC 
ligands are yet unknown. Thus, if enantioselective gold catalysis is the aim 
and chiral ligands are required, activation by silver salts might still be the best 
method to generate the catalytically active cationic gold species. 
 
1.2 Silver-Catalyzed Heterocyclization Reactions of Alkynes 
While homogeneous gold catalysis has emerged as one of the most powerful 
tools in organic synthesis in the last decade, the use of silver catalysts in 
organic synthesis is also well-documented.29 However, the utility of silver in 
the field of chemical catalysis has largely been overshadowed by the success 
of gold, and it has mainly assumed the role of a co-catalyst/halide scavenger in 
gold-catalyzed transformations. However, the recent revelations of the non-
innocent role of silver in gold catalysis have had an impact on the 
interpretation of the results of gold-catalyzed reactions. Indeed, the silver salt 
employed for the generation of cationic gold species may sometimes act as a 
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catalyst in its own right. Indeed, as we will discuss in this section, silver salts 
are active catalysts for the addition of nucleophiles of alkynes, and also 
sometimes exhibit different reactivity patterns from gold catalysts. 
 
The study of heterocycles constitutes one of the largest areas of research in 
organic chemistry, due to their immense importance in biological systems and 
in industry, where they are frequently found as key structural units in 
pharmaceuticals and agrochemicals. Much effort has thus been devoted to 
developing new and efficient methods for their synthesis, including the 
application of metal-catalyzed processes. 30  The metal-catalyzed 
heterocyclization of alkynes provides an efficient and atom-economical route 
for the assembly of heterocycles. 
 
 
Scheme 1.10. General mechanism of a silver(I)-catalyzed intramolecular 
hydroamination reaction 
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Silver(I) species, which are good -Lewis acids,31 form favorable interactions 
with unsaturated systems such as alkynes. The generally accepted mechanism 
for these transformations is illustrated using the intramolecular 
hydroamination reaction as an example in Scheme 1.10. This involves the 
initial interaction of the alkyne (1.26) with the -acidic silver catalyst, which 
reduces the electron density of the triple bond, rendering it electrophilic and 
susceptible to nucleophilic attack by the heteroatom to generate an 
organosilver intermediate, which then undergoes protodemetallation to give 
the heterocyclic product. It is important to note that the issue of 
regioselectivity can arise in the cyclization step, as the nucleophile can add to 
either carbon atom of the alkyne to give the exo- or endo-cyclized product 
1.27a and 1.27b, respectively. The heteroaddition usually proceeds in an anti 
manner, such that only the Z-diastereoisomer of the exo-cyclized product 
1.27a is obtained.  
 
In the following sections, silver(I)-catalyzed reactions of O- and N- 
nucleophiles with alkynes will be presented, based on literature 
reviews32,33,34,35 and recent publications. The next section will be divided into 
two parts; the first devoted to the reactions involving oxygen nucleophiles, and 
the second to those with nitrogen nucleophiles. Mechanisms of these reactions 
will only be discussed only if they are significantly different from the general 
mechanism presented in Scheme 1.10, or if the cyclization step precedes 
another transformation, for instance, in tandem reactions. If the same reaction 
has been reported with gold catalysts, the differences between the two 
catalytic systems will be highlighted. 
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1.2.1 Oxygen nucleophiles 
The various functional groups that can acts as oxygen nucleophiles are 
summarized in Fig. 1.3. These include alcohols, carboxylic acids, carbonates, 
and phosphates that contain sp3-hybridized oxygen atoms; and aldehydes, 
ketones, amides and pyrimidine nucleobases that contain sp2-hybridized 
oxygen atoms. 
 
 
Fig. 1.3 Functional groups containing nucleophilic oxygen atoms 
 
1.2.1.1 Alcohols 
 
Scheme 1.11. Cyclization of acetylenic alcohol 1.28 to the functionalized 2-
methylene oxolane 1.29 
 
The first example of a silver-catalyzed intramolecular cyclization of alcohols 
was reported in 1987 by Pale and Chuche.36 The acetylenic epoxy alcohol 1.28 
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was effectively cyclized to the functionalized 2-methylene oxolane 1.29 in the 
presence of silver carbonate (Scheme 1.11). Subsequently, it was found that 
only silver salts having a basic counteranion, such as acetate, oxide and 
carbonate, were effective towards the transformation. In contrast, silver nitrate 
was inactive, while the more electrophilic silver tetrafluoroborate only led to 
decomposition. The reaction also proceeded well in most solvents, except 
protic solvents, which cause degradation of the product. The cyclization 
process was also regiospecific for the 5-exo-dig product. However, it was 
found that linear acetylynic alcohols without the epoxy group did not react, 
suggesting that the cyclization was highly dependent on the substrate, 
requiring that the hydroxyl and acetylenic units to be held in close proximity. 
Silylated alkynes also reacted poorly, unless a stoichiometric amount of 
catalyst was employed.37 
  
 
Scheme 1.12. Cyclization of acetylenic alcohols 1.30 with ether groups in the 
propargylic position (MOM = methoxymethyl, TBDPS = tert-
butyldiphenylsilyl) 
 
Ether groups at the propargylic position were found to lead to a dramatic 
acceleration of the cyclization rate (Scheme 1.12), possibly by altering the 
adjacent π-system through hyperconjugation. No reaction took place in their 
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absence or if they were replaced by an electron-withdrawing group such as 
acetate.38 
 
 
Scheme 1.13. Gold(I) chloride catalyzed cyclization of acetylenic alcohols 
1.30 
 
It was later found that gold(I) chloride could also catalyze the reaction at 10 
mol% catalytic loading in the presence of potassium carbonate (Scheme 
1.13).39 Neither gold(III) chloride nor the triphenylphosphine gold(I) complex 
[(Ph3P)AuCl] were suitable catalysts. Similar to the silver-catalyzed reaction, 
oxygenated substituents in the propargylic position were required for good 
yields. Internal alkyne substrates where R1 = Ph and Br also cyclized in good 
yields, but no reaction was observed when R1 = TMS.   
 
 
Scheme 1.14. Cyclization of 	-methylene acetylenic alcohols 1.32 to furans 
1.33  
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The related 	-methylene acetylenic alcohols 1.32 also undergo 5-endo-dig 
cyclization and aromatization to the corresponding furans 1.33 in the presence 
of silver nitrate adsorbed on silica (Scheme 1.14).40 Other silver salts such as 
AgOTf, AgBF4 and AgTFA also afforded the products in good yields, but 
AgNO3 adsorbed on silica has the added advantage of recyclability. Non-polar 
solvents such as hexane were superior, as they increased the affinity of the 
polar alcohol towards the silica gel surface. 
 
 
Scheme 1.15. Cyclization of gem-difluoropropargyl substituted acetylenic 
alcohols 
 
The cyclization of gem-difluoropropargyl substituted acetylenic alcohols 1.34 
using AgNO3 enabled the formation of fluorinated furan derivatives.
41 
Interestingly, gold(I) and gold(III) catalysts resulted in unsatisfactory yields 
and were unable to activate the electronically deficient triple bond. The 
reaction presumably proceeds via 5-endo-dig cyclization to the difluoro-4,5-
dihydrofuran 1.35, which aromatizes spontaneously to the more stable 4,5-
dihydrofuran 1.36 after elution through silica gel. Both electron-withdrawing 
and electron donating aliphatic and aromatic groups are tolerated at R2, but 
internal alkynes resulted in low to moderate yields. 
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Scheme 1.16. Oxacyclization of homopropargylic diols to bicyclic ketals 
 
 
Scheme 1.17. Different reactivities of silver and gold catalysts towards the 
cyclization of homopropargylic diol 1.37 
 
Although the formation of five-membered rings seems to be preferred in most 
of the silver-catalyzed cyclization of acetylenic alcohols, conveniently chosen 
substrates can lead to six-membered heterocycles, as shown in Scheme 1.16.42 
AgOTf catalyzes the oxacyclization of homopropargylic diols 1.37, providing 
convenient access to bicyclic ketals 1.38 bearing a functionalizable side chain. 
In comparison, cationic gold(I) and gold(III) catalysts generated in situ in the 
presence of AgOTf, however, resulted in low yields of the bicyclic ketals 1.38 
in DCE. Addition of one equivalent of water to the reaction mixture, however, 
furnished the carbocyclized product 1.39 exclusively (Scheme 1.17). This 
observed difference in chemoselectivity was attributed to the higher Lewis 
acidity of gold(I) and gold(III) cations which resulted in activation of the 
alkyne towards nucleophilic attack by the softer alkene nucleophile. This is an 
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example of where the stronger -Lewis acidity of gold complexes can be 
detrimental and result in undesired byproducts. In fact, this difference in - 
and -Lewis acidity between silver(I) and gold(I) has recently been 
recognized and harnessed in the development of new cascade reactions.43 
 
 
Scheme 1.18. Cyclization of 2-azetidinone-tethered alkynols. (Diox = (S)-2,2-
dimethyl-1,3-dioxolan-4-yl, Tol = 4-MeC6H4 
 
The differences in reactivity between Ag(I) and Au(III) is reinforced in the 
study by Alcaide and co-workers44, who described the AgOAc and AuCl3-
mediated cyclization of 2-azetidinone-tethered alkynols to give different 
tetrahydrofuran-based β-lactams (Scheme 1.18). The reaction required a 
stoichiometric amount of AgOAc under basic conditions, while the reaction 
using AuCl3 was carried out with a 5 mol% catalytic loading under acidic 
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conditions. Due to the higher Lewis acidity of AuCl3 and the presence of the 
Brønsted acidic PTSA, intramolecular hydroalkoxylation, followed by 
hydration of the resulting alkene, was always observed with the Au(III) 
catalytic system.  
 
 
Scheme 1.19. Comparison of silver and gold catalysts in the cyclization of o-
alkynoylphenols to aurones 
 
o-Alkynoylphenols 1.40 may be cyclized to the corresponding aurones 1.41 in 
the presence of catalytic amounts of AgNO3 in methanol (Scheme 1.19). The 
reaction proceeds with good regioselectivity towards the 5-exo-dig cyclized 
aurone products, as only traces of the 6-endo-dig cyclized flavones 1.42 were 
detected.45 In the corresponding gold-catalyzed reaction reported several years 
later,46 the aurone products were obtained in good yields and regioselectivities 
at a lower catalytic loading of 10 mol%. However, the addition of 10 mol% of 
K2CO3 was essential to deprotonate the phenol before it can participate as a 
nucleophile in the reaction. Other more soluble and Lewis acidic gold catalysts 
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such as (Ph3P)AuCl, (Ph3P)AuCl/AgSbF6 and AuCl3 were less effective than 
AuCl, resulting mainly in degradation products.  
 
1.2.1.2 Carboxylic Acids 
 
Scheme 1.20. Silver nitrate-mediated cyclization of acetylenic acids 
 
The silver-mediated cyclization of acetylenic acids was first reported in 1958 
by Castañer and Pascual (Scheme 1.20). 47  They observed that 
phenylpropargylidene malonic acid (1.43, R = Ph) could be converted to γ-
benzylidene--carboxybutenolide (1.44, R = Ph) in the presence of 
stoichiometric amounts of silver nitrate at room temperature. Although 
aromatic propargylidene malonic acids afforded exclusively the butenolides 
1.44, their alkyl analogues (R = Me, nBu) resulted in mixtures of butenolides 
1.44 and -pyrones 1.45 in a variable ratio.48  
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R Ratio of 1.47/1.48 
nHex 86/14 
Cy 90/10 
tBu 98/2 
Ph 100/0 
 
 
R Ratio 1.50/1.51 
nHex 96/4 
Cy 97/3 
tBu 98/2 
Ph 98/2 
 
Scheme 1.21. Cyclization of ,	-unsaturated acetylenic acids to furanones 
and pyranones using silver catalysts 
 
Interest in the five-membered furanone-derivatives arising from their 
biological activities has stimulated research in the development of efficient 
methods to prepare these compounds. An example is the silver-catalyzed 
cyclization of ,	-unsaturated acetylenic acids 1.46 and 1.49 (Scheme 1.21), 
which could potentially afford both the five-membered furanones 1.47 and 
1.50 or six-membered pyranones 1.48 and 1.51.  Although factors affecting 
the pyranone/furanone ratio have not been clearly established, it is known that 
the ratio between the two products is strongly dependent on the substrate 
structure, the nature of silver salt employed, and the solvent.49 Depending on 
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the substrate, the selectivity towards the five-membered furanone product may 
be increased by using either AgI or Ag in DMF at high dilutions,50 or Ag2CO3 
in DMF.51 
 
 
Scheme 1.22. Cyclization of ,	-unsaturated acetylenic acids to furanones 
and pyranones using gold(I) chloride 
 
The cyclization of 1.46 has also been attempted with AuCl (Scheme 1.22).52 
Although a direct comparison of the selectivities and yields with the silver-
catalyzed reaction is not possible due to the different substrate scope examined, 
it appears that the use of AuCl does not offer much advantage over the use of 
silver salts. Similar to the silver-catalyzed reaction, 10 mol% of catalyst was 
also required; and in addition, a basic additive such as K2CO3 was also 
essential.  
 
 
Scheme 1.23. Cyclization of saturated acetylenic acids to enol lactones using 
silver carbonate 
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Scheme 1.24. Silver-catalyzed synthesis of -spirobutyrolactone derivatives 
 
For the cyclization of saturated acetylenic acids 1.52, the use of Ag2CO3 as a 
catalyst in aromatic solvents has proven to be most effective37 (Scheme 1.23). 
The presence of oxygen-containing propargylic substituents also favored the 
cyclization.39 The protocol can also be extended to the synthesis of -
spirobutyrolactone derivatives 1.55 (Scheme 1.24). 53  Gold catalysts were 
recently employed for the same reaction. Using a gold(III) N-heterocyclic 
carbene (NHC) complex, 4-pentynoic acid (1.52, R1, R2, R3 = H) was cyclized 
to the corresponding enol lactone 1.53 in quantitative yield (Scheme 1.25), as 
was previously obtained with Ag2CO3.
54 A lower catalytic loading of 2.5 mol% 
was sufficient for the gold-catalyzed reaction, and the reaction could be 
effected at room temperature. In comparison, the use of AuCl3 and AuCl salts 
only resulted in yields of 90% and 70% respectively under the same conditions, 
which highlights the ability of the NHC ligand to improve the reactivity of the 
gold catalyst. 
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Scheme 1.25. Cyclization of saturated acetylenic acids to enol lactones using a 
gold(III) NHC catalyst. 
 
1.2.1.3 Carbonates 
 
Scheme 1.26. Synthesis of cyclic carbonates 1.58 and vinylene carbonates 
1.59 
 
In addition to acetylenic alcohols and carboxylic acids, acetylenic carbonates 
can also be used in heterocyclization reactions. In the presence of 10 mol% of 
silver acetate and 1 equivalent of DBU, acetylenic carbonates 1.57, produced 
in situ by the incorporation reaction of carbon dioxide with tertiary 
propargylic alcohols 1.56, afford the corresponding cyclic carbonates 1.58 in 
quantitative yields (Scheme 1.26).55,56 Most of the silver salts were efficient in 
promoting this reaction. It is worth noting that gold was inactive for the 
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reaction, while copper salts only produced trace amounts of the cyclic 
carbonate. When a secondary propargylic alcohol 1.56 (R2 = H) was used, 
reducing the amount of DBU could result in the sole formation of vinylene 
carbonates 1.59, the more stable isomerized product of the cyclic carbonate 
1.58 (R2 = H).57 
 
 
Scheme 1.27. Enantioselective carbon dioxide incorporation into 
bispropargylic alcohols, followed by silver-catalyzed cyclization 
 
As an extension of this work, the combined catalyst system of AgOAc with a 
chiral Schiff base ligand (L*) achieved the asymmetric carbon dioxide 
incorporation into bis-propargylic alcohols 1.60 with desymmetrization to 
afford the corresponding cyclic carbonates 1.61 in good yields and 
enantiomeric excesses (Scheme 1.27).58 However, long reaction times were 
required. DBU was not necessary for the reaction, as it results in a racemic 
product if added to the reaction mixture, presumably by blocking coordination 
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of the chiral ligand to the silver catalyst. 1H NMR spectroscopic analysis 
suggested that the silver acetate and chiral ligand would form a corresponding 
2:1 complex.  
 
1.2.1.4 Phosphates 
 
Scheme 1.28. Cyclization of acetylenic phosphonic acids to 2-pyrones 
 
The cyclization of acetylenic phosphonic acids 1.62 to 2-pyrones 1.63 
(Scheme 1.28) was reported for the first time in 2005, 59  with high 
regioselectivity and good yields in the presence of catalytic amounts of 
Ag2CO3. AgNO3 gave comparable yields, but AgI was ineffective. 
 
1.2.1.5 Aldehydes, Ketones and Amides 
 
Scheme 1.29. Gold(I)- and silver(I)-catalyzed cyclization of ortho-alkynyl 
formylquinoline in the presence of methanol 
 
  
29 
 
Table 1.1. Comparison of the furoquinoline (1.65) to pyranquinoline (1.66) 
product ratio in the cyclization of ortho-alkynyl formylquinoline by various 
gold and silver catalysts 
Entry Catalyst Ratio 1.65/1.66 
1 AuCl3 no conversion 
2 [(Ph3P)AuCl] 0/100 
3 [(Ph3P)AuCl]/AgSbF6 0/100 
4 AgSbF6 0/100 
5 AgPF6 0/100 
6 AgOTf 0/100 
7 AgNO3 0/100 
8 Ag2SO4 5/95 
9 AgF 5/95 
10 AgOCN 40/60 
11 AgOAc 48/52 
12 Ag2CO3 100/0 
13 Ag2O 100/0 
14 AgO 100/0 
 
The oxygen atoms of the carbonyl group in aldehydes and ketones can act as 
nucleophiles, forming cationic intermediates that can be trapped by protic 
nucleophiles such as alcohols, thus formally constituting an O-H addition to 
the alkyne. For instance, Belmont et al. have reported a comparative study of 
gold(I) and silver(I) catalysts in the cyclization of ortho-alkynyl 
formylquinolines 1.64 in the presence of methanol to give furoquinolines 1.65 
or pyranquinolines 1.66 (Scheme 1.29).60 It was observed that AuCl3 did not 
catalyze the reaction (entry 1), while [(Ph3P)AuCl] resulted in a poor 
conversion of 25% to the pyranoquinoline 1.66 (entry 2). The more reactive 
[(Ph3P)Au][SbF6] generated in situ by using AgSbF6 provided 1.66 with a 
high conversion of >95% (entry 3). Screening of silver salts in the same 
reaction (entries 4 to 14) revealed an interesting correlation of the pKa of the 
counteranion used with the regioselectivity, where the selectivity towards the 
5-exo-dig product 1.65 increased with increasing pKa of the counteranion.  
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Scheme 1.30. Proposed mechanistic pathways for the cyclization of ortho-
alkynyl formylquinoline 
 
The observed counteranion effect was rationalized according to the Lewis 
acidity and oxidizing ability of the compounds, which resulted in two different 
modes of activation of the substrate. AgSbF6, AgPF6, AgOTf, AgNO3, AgF 
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and Ag2SO4 (Scheme 1.30, path A), known for their ability to form -
complexes with alkynes, activate the alkyne towards nucleophilic attack by the 
carbonyl group, forming the zwitterionic complex 1.67 which is attacked by 
MeOH to give the intermediate 1.68. Protodemetallation occurs to release 
product 1.66 and regenerate the catalyst.  Ag2CO3, Ag2O, and AgO (Scheme 
1.30, path B), on the other hand, tend to interact mainly with the aldehyde 
functionality due to their higher oxidative abilities. Nucleophilic attack of 
MeOH at the aldehyde function results in the formation of the acetyl 
derivative 1.69, which then cyclized to give intermediate 1.70. 
Protodemetallation then occurs to give the product 1.65 and regenerate the 
catalyst. The remaining two compounds, AgOCN and AgOAc (Table 1.1, 
entry 10 and 11) exhibit poor regioselectivities due to hybrid activation of both 
the alkyne and aldehyde functionalities in the substrate.  
 
 
Scheme 1.31. Silver-catalyzed cyclization of alkynones in the presence of 
alcohols 
 
In a similar fashion, the silver(I)-catalyzed reaction of alkynones 1.71 with 
alcohols has been used as a tool for the synthesis of 1-allenyl isochromenes 
1.73 (Scheme 1.31). 61  The reaction most probably proceeds through a 
benzopyrylium cation 1.72 formed by the nucleophilic attack of the carbonyl 
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oxygen to the silver-coordinated alkyne. The subsequent addition of an 
alcohol molecule led to the formation of the allene system. Notably, the use of 
AuCl3 as a catalyst did not afford any of the desired products. Notably, a 
counteranion effect of the silver salts was observed; AgSbF6 gave the highest 
yields for the transformation, while AgClO4, AgBF4, and AgPF6 were not as 
effective. Ag2SO4 did not promote the reaction at all. 
 
 
Scheme 1.32. Cyclization of N-propargyl amides 
 
The silver-catalyzed cyclization of N-propargyl amides 1.74 to 5-
methyleneoxazolines 1.75 was reported by Harmata et al. in 2008 (Scheme 
1.32). 62  Unlike the aldehyde and ketone examples described above, the 
addition of a protic nucleophile was not necessary, as the amide moiety 
provides the proton necessary for protodemetallation and regeneration of the 
catalyst. N-propargyl amide substrates with gem-dialkyl substitution at the 
propargylic position cyclized in excellent yields, presumably due to the 
Thorpe-Ingold effect.63 Sterically hindered and electron-withdrawing alkyl and 
aryl groups were also tolerated at the position beside the carbonyl carbon. 
However, only one substrate without the gem-dimethyl substitution was 
reported, and the effect of substitution at the terminal positon of the alkyne 
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was not investigated. We have thus studied this reaction in greater detail, and 
the results will be reported in Chapters 3 and 4. 
 
1.2.1.6 Pyrimidines 
 
Scheme 1.33. Silver-catalyzed synthesis of furanopyrimidine nucleosides 
 
Another example of the versatility of silver salts as catalysts is in the synthesis 
of substituted furanopyrimidine nucleosides.64,65 Upon treatment of 5-alkynyl 
uracil derivatives 1.76 with a catalytic amount of AgNO3, substituted 
furanopyrimidine nucleosides 1.77 were obtained in quantitative yields 
(Scheme 1.33). This represents an improvement over the previously reported 
protocol which involves a stoichiometric amount of CuI in triethylamine/ 
methanol at reflux,66 as higher yields were obtained under milder reaction 
conditions. 
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1.2.2 Nitrogen Nucleophiles 
A diverse range of functional groups can act as nitrogen nucleophiles, as 
illustrated in Fig. 1.4. Other than differences in hybridization of the nitrogen 
atom (sp3 or sp2), some of these functional groups also contain more than one 
nitrogen atom. 
 
 
Fig. 1.4 Functional groups containing nucleophilic nitrogen atoms 
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1.2.2.1 Amines 
 
 
Catalyst Solvent Temp. Yield 
AgBF4 CH2Cl2 40 C 69 
[Ag(Triphos)]BF4 toluene 111 C 75 
AuCl3 MeCN 82 C 71 
AuCl3/Triphos 
(1:1 molar ratio) 
CH2Cl2 40 C 49 
 
Scheme 1.34. Intramolecular hydroamination of 6-aminohex-1-yne using 
silver(I) and gold(III) catalysts 
 
In a study encompassing a screening of twenty group 8 to 12 transition metal 
catalysts, Müller and co-workers found that AgBF4 and the silver complex, 
[Ag(Triphos)]BF4, are active catalysts for the intramolecular hydroamination 
of 6-aminohex-1-yne 1.78. 67  The reaction proceeds via the enamine 
intermediate 1.79, which undergoes a 1,3-hydrogen shift to give the more 
stable cyclic imine product 1.80 (Scheme 1.34). Au(III) catalysts could also 
catalyze the reaction, while the Au(I) complex [(Ph3P)AuCl], did not give any 
conversion. The result is significant as this is the first report of a structurally 
well-characterized silver(I) complex being applied in the heterocyclization 
reactions of alkynes, as only simple silver salts have been used previously. 
General trends in the effect of counteranions on the same reaction were also 
revealed in a later study. 68  The highest rates were observed when anions 
derived from sulfonic acids are used (-OTs, -OTf), medium rates were 
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observed for CF3CO2
-, NO3
- and the non-coordinating ions (ClO4
-, BF4
-, PF6
-); 
whereas very low rates are observed for the more basic anions (CH3CO2
-, 
PhCO2
-, and CO3
2-).  
 
 
Catalyst Yield / % 
AgOTf 55 
[Ag(phen)]OTf 95 
NaAuCl4 46 
 
Scheme 1.35. Intramolecular hydroamination reaction of 5-phenyl-4-pentyn-
1-amine using silver and gold catalysts 
 
More recently, Helquist and co-workers have demonstrated that the silver(I) 
phenanthroline complex is an efficient catalyst for the intramolecular 
hydroamination of 5-phenyl-4-pentyn-1-amine 1.81 (Scheme 1.35).69 Other 
silver and gold catalysts screened under the same conditions furnished the 
cyclic imine 1.82 as the sole product, albeit in lower yields. The higher yields 
obtained with [Ag(phen)]OTf compared to AgOTf showed the ability of the 
phenanthroline ligand to stabilize the catalytically active metal center during 
the reaction. The [Ag(phen)]OTf complex also has the added advantage of 
being stable towards air and moisture compared to silver salts, which tend to 
be hygroscopic.  
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Scheme 1.36. Intramolecular hydroamination reaction of 4-pentyn-1-amine  
 
Inspired by the ability P- and N-donor ligands to improve the stability and 
catalytic efficiency of silver in hydroamination reactions, Messerle and co-
workers investigated a series Ag(I) complexes prepared in situ from AgOTf 
and a series of bidentate N,N-, P,N- and P,P-donor ligands as catalysts towards 
the intramolecular hydroamination of 4-pentyn-1-amine 1.84.70 The best result 
was obtained with the pyrazole-phosphine ligand shown in Scheme 1.36. 
 
 
Scheme 1.37. Synthesis of 2,5-disubstituted pyrrolines 
 
Enantiomerically pure 2,5-disubstituted pyrrolines 1.87 can be prepared from  
enantiopure propargyl glycines 1.86 by a Ag-catalyzed intramolecular 
hydroamination reaction (Scheme 1.37).71 AgOTf was found to be the best 
catalyst compared to other group 11 metal salts such as NaAuCl4 and 
Cu(OTf)2. 
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Scheme 1.38. Silver-promoted oxidative cyclization of homopropargylamines 
 
Knölker and coworkers has also reported the synthesis of pyrroles via the 
cyclization of homopropargylamines 1.88. 72   The reaction involves an 
oxidative cyclization process, which necessitates stoichiometric amounts of 
silver salt to be used. The proposed mechanism is represented in Scheme 1.38. 
The coordination of the alkyne to the silver cation activates the alkyne group 
of 1.88 towards intramolecular nucleophilic attack of the amine leading to 
intermediate 1.90. Protonation of 1.90 affords the iminium ion 1.91, which on 
subsequent 	-hydride elimination generates the pyrrylium ion 1.92 and 
metallic silver. Finally, deportonation of 1.92 provides pyrrole 1.89.  
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Scheme 1.39. Synthesis of functionalized pyrroles 
 
As an interesting extension of the work by Knölker, Dovey et al., the synthesis 
of functionalized pyrroles 1.94 was described in two steps: the propargylation 
of secondary enaminones 1.93, followed by an AgNO3 catalyzed 
intramolecular hydroamination (Scheme 1.39).73 The hydroamination step can 
be accelerated by microwave irridation, resulting in a drastic reduction in 
reaction times from 16-20 h to 1 min. The reaction was also extended to the 
synthesis of the bridgehead pyrroles 1.96 from 1.95.74  
 
 
Scheme 1.40. Cyclization of alkynylaminophosphonates 
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Alkynylaminophosphonates 1.97, analogues of amino acids, can also be 
cyclized in the presence of silver triflate to obtain 1,2-dihydroisoquinolines 
1.98 in high yields (Scheme 1.40).75 
 
1.2.2.2 Amides 
  
Scheme 1.41. Cyclization of 4-propargyl azetidinones 
 
The first example of silver-mediated addition of amides to alkynes was 
reported by Liebeskind and Prasad in 1988,76 which involves the cyclization of 
4-propargyl azetidinones 1.99 (Scheme 1.41). However, a stoichiometric 
amount of AgNO3 was required, the reaction time was long, and only 
substrates bearing Me and Ph groups at the alkyne could be cyclized. 
 
 
Scheme 1.42. Cyclization of alkynyl amides 
 
A decade later, Nagasaka et al. reported another example of the cyclization of 
alkynyl amides 1.101 (Scheme 1.42).77 In this case, strong basic conditions 
41 
 
were required for the deprotonation of the amide, and the reaction conditions 
were quite harsh. 
 
1.2.2.3 Carbamates 
 
Scheme 1.43. Cyclization of O-propargyl carbamates with silver isocyanate 
 
The nitrogen atom of O-propargyl carbamates 1.103 can also act as 
nucleophiles, providing convenient access to 4-methylene-2-oxazolidinones 
1.104. The transformation has been reported to be catalyzed by Ag(I) 
isocyanate, but the reaction was only demonstrated with a somewhat limited 
substrate scope of three examples (Scheme 1.43).78 A later report showed that 
with 5 mol% AuCl and 5 mol% of either Et3N or KO
tBu as base, internal 
alkyne substrates can also be cyclized in good to moderate yields.79 
 
1.2.2.4 Sulfonamides 
 
Scheme 1.44. Cyclization of benzenesulfonamides 
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Benzenesulfonamides 1.105 can also be cyclized by silver salts, giving 1,1-
dioxo-2H-1,2-benzothiazines 1.106 (Scheme 1.44) selectively.80 Silver salts 
(AgNO3, AgF, AgSbF6) were better than copper salts (CuI and CuCl) as 
catalysts for this reaction. The addition of triethylamine to the reaction mixture 
also resulted in an acceleration of the reaction, and this was attributed to the 
ability of triethylamine to form hydrogen bonds with the sulfonamide group 
(SNH




NEt3), enhancing its nucleophilicity. The reaction proceeded in 
with good chemoselectivity without any of the O-cyclization product; and also 
with good regioselectivity, as none of the isomeric five-membered ring 
product was detected. A plausible explanation for the regioselectivity is that 
the longer S-N bond length favored endo ring closure due to the lower 
geometric constraint. The broad generality of this approach was also evident 
from the variety of electron-donating and electron withdrawing alkyl and aryl 
groups on the alkyne that were tolerated under the reaction conditions. 
 
 
Scheme 1.45. Silver and gold-catalyzed intramolecular hydroamination of 1-
(2-(sulfonylamino)phenyl)prop-2-yn-1-ols 
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Chan et al. have also reported that AgOAc catalyzes the intramolecular 
hydroamination of 1-(2-(sulfonylamino)phenyl)prop-2-yn-1-ols 1.107 to 
afford (Z)-2-methylene-1-sulfonylindolin-3-ols 1.108 in excellent yields under 
mild reaction conditions and with low catalytic loadings.81 The reaction also 
proceeded with good regioselectivity, as no side products arising from 6-endo-
dig cyclization were detected. It is interesting to note that the reaction 
produces only the 5-exo-dig cyclized product when silver catalysts are 
employed. When cationic gold catalysts were used, the 5-exo-dig cyclized 
product 1.108 further underwent an intramolecular Friedel-Crafts alkylation 
when R1 and R2 = Ar to afford the indenyl-fused indoles 1.109.82 
 
 
Scheme 1.46. Tandem cyclization/alkynylation reaction of 1-((2-
tosylamino)aryl)but-2-yne-1,4-diols 
 
With the structurally similar 1-((2-tosylamino)aryl)but-2-yne-1,4-diols 1.110, 
tandem cyclization/alkynylation can occur under silver catalysis to afford the 
2-alkynyl indoles 1.111 (Scheme 1.46).83 The proposed mechanism for the 
transformation is shown in Scheme 1.47. 
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Scheme 1.47. Proposed mechanism for the tandem cyclization/alkynylation 
reaction of 1-((2-tosylamino)aryl)but-2-yne-1,4-diols 
 
1.2.2.5 Imines 
 
Scheme 1.48. Synthesis of isoquinolines via cyclization of iminoalkynes 
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In reactions similar to those of o-alkynyl benzaldehydes (Scheme 1.29), 
imines derived from these substituted benzaldehydes can also be cyclized in 
the presence of silver salts (Scheme 1.48).84 In the presence of AgNO3, the 
attack of the imino nitrogen atom on the activated alkyne triple bond of 1.112 
results in the formation of an isoquinolinium intermediate 1.114. Cleavage of 
the C-N bond affords a tert-butyl carbocation, which supplies the proton for 
regeneration of the catalyst and release of the isoquinoline product 1.113.   
 
 
Scheme 1.49. Synthesis of 1,2-dihydroisoquinoline derivatives 
 
In a similar manner, Yamamoto et al. have reported the synthesis of 
functionalized 1,2-dihydroisoquinoline derivatives 1.116 through trapping of 
the iminium intermediate 1.117 produced in the cyclization step by various 
pro-nucleophiles, such as MeNO2, EtNO2, CH2(COMe)2, CH2(CO2Me)2, 
CH2(CN)2, acetone, MeCN and even alkynes (Scheme 1.49).
85 Cu(OTf)2 can 
also catalyze the reaction, but with slightly lower yields. AuCl, however, was 
ineffective. 
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Scheme 1.50. Synthesis of pyrroles from imines 
 
AgOTf catalyzes the intramolecular reaction between imines 1.118 (formed in 
situ from condensation of ketone and amine) and alkynes to yield 
functionalized pyrroles 1.119 (Scheme 1.50).86 The reaction was tolerant of 
various substituents on the amine (i.e. n-pentyl, allyl, benzyl, p-
methoxybenzyl, phenyl, p-methoxyphenyl, p-toluenesulfonyl) and cyclic 
ketones were also possible substrates. Comparisons were also made with the 
AuCl/AgOTf/PPh3 catalytic system where 5 mol% of each component was 
used. The AgOTf-catalyzed reactions were faster and similar yields were 
obtained with both catalysts, except in reactions that require higher 
temperatures. Higher yields were obtained with the AuCl/AgOTf/PPh3 
combination in those cases, possibly due to the higher thermal stability of the 
catalyst. Attempts to characterize the active catalytic species in the 
AuCl/AgOTf/PPh3 catalytic system were largely unsuccessful. 
 
1.2.2.6 Hydrazones and Hydrazides 
 
Scheme 1.51. Cyclization of propargyl N-sulfonylhydrazones 
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The cyclization of propargyl N-sulfonylhydrazones 1.120 allows the efficient 
and regioselective synthesis of 1,3- and 1,5-disubstituted and 1,3,5-pyrazoles 
1.121. 87  Silver salts (AgSbF6, AgBF4, AgOTf, AgPF6, AgClO4) were 
generally effective at promoting the reaction, although AgSbF6 gave the 
highest yields. The gold complex [Au(PPh3)2]SbF6 was inactive. The sulfonyl 
group (tosylate and mesylate) on the hydrazone was essential for the reaction 
to occur, and it migrates from N to C during the reaction. Based on crossover 
experiments and deuterium labeling studies, a plausible mechanism was 
proposed, as outlined in Scheme 1.52. Coordination of the alkyne to silver 
activates it towards nucleophilic attack by the hydrazone, and gives rise to 
intermediate 1.122. Deprotonation and cleavage of the N-Ts bond results in 
the formation of the ion pair 1.123.  An attack of the tosyl anion to the 
electron-deficient imine carbon followed by protodemetallation gives the 
product 1.121 and regenerates the silver catalyst. 
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Scheme 1.52. Plausible mechanism for the cyclization of propargyl N-
sulfonylhydrazones 
 
 
Scheme 1.53. Silver triflate catalyzed tandem reaction of N’-(2-
alkynylbenzylidene)hydrazide with alkynes 
 
Wu et al. have developed an efficient tandem reaction of N’-(2-
alkynylbenzylidene)hydrazide 1.125 with alkynes catalyzed by AgOTf, which 
generated the highly functionalized fused 1,2-dihydroisoquinolines 1.126 in 
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good to excellent yields.88 The proposed mechanism for the transformation 
involves activation of the alkyne in substrate 1.125 by AgOTf, followed by 
nucleophilic attack by the hydrazide to form the isoquinolium intermediate 
1.127.  Nucleophilic attack by the acetylide ion formed in situ from a mixture 
of alkyne and DBU on 1.127 afforded the corresponding product 1.128, which 
then undergoes intramolecular 5-endo cyclization, leading to 1.129, followed 
by aromatization to generate the product 1.126. 
 
1.2.2.7 Nitrogen-containing heterocycles 
 
Scheme 1.54. Synthesis of N-fused heteroaromatic compounds 
 
In a similar way to imine nucleophiles, sp2 nitrogen atoms embedded in 
aromatic compounds also reacted with alkynes to give N-fused heteroaromatic 
compounds via an intramolecular cyclization reaction catalyzed by AgBF4 
(Scheme 1.54).89 Moderate yields of 40-60% were obtained. Electron-donating 
groups on the benzene ring accelerate the reaction, while electron-withdrawing 
groups slow down the reaction. AgTFA, on the other hand, only resulted in 
low conversions. This could have been due to the deprotonation of the 
terminal alkyne proton by the weakly basic trifluoroacetate anion, and the 
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formation of the corresponding silver acetylide which could not take part in 
the cyclization reaction. In comparison, the Au(I) complexes [(Ph3P)AuCl] 
and KAu(CN)2 were inactive as catalysts for the reaction, while the Au(I) 
bis(tetrahydrothiopyran) salt [Au(C5H10S)2]BF4 showed a similar reaction rate 
to AgBF4. However, the formation of a gold mirror was also observed – an 
indication of the reduction of the Au(I) ion by the dihydropyrimidine cyclized 
product. No reduction to Ag(0) was observed in the silver-catalyzed reactions, 
which was attributed to the slightly lower reduction potential of Ag(I) 
compared to Au(I). 
 
Scheme 1.55. Synthesis of fused tricyclic benzimidazoles 
 
A similar strategy was reported for the preparation of fused tricyclic 
benzimidazoles using silver salts (Scheme 1.55).90 Among the eight silver salts 
screened, AgOTf showed the highest efficiency. Water could be used as the 
solvent and microwave irradiation enabled higher yields in shorter reaction 
times.  Complete selectivity towards the 6-exo-dig product 1.133 was always 
obtained, except when X = O and when R2 is an aromatic group. In these cases, 
almost equal amounts of the 7-endo-dig product were also observed, possibly 
due to the – conjugative effect between the alkyne and the aryl groups, 
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which results in a similar propensity of the benzimidazole nitrogen attacking 
either carbon of the acetylene bond. 
 
 
Scheme 1.56. Synthesis of fused pyrrole-containing heterocycles 
 
Gevorgyan et al. developed a mild and base-free protocol for the synthesis of 
fused pyrrole-containing heterocycles 1.141 which involves the silver-
catalyzed 5-endo-dig cyclization of propargyl-containing pyridines 1.140 
(Scheme 1.56).91 An initial screening of catalysts showed that AgBF4 and 
AgPF6 led to nearly quantitative yields of the product in 30 min, while copper 
and gold catalysts were also efficient, although the yields obtained were 
slightly lower (See Table 1.2). The reaction also showed a broad substrate 
scope, as several substituents were tolerated at the propargyl position and at 
the alkyne, and their corresponding products were obtained in good yields of 
64-95% yield. 
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Table 1.2. Initial screening of catalysts for the cyclization of 1.140 
Entry Catalyst Time / h Yield / % 
1 AgBF4 0.5 >99 
2 AgPF6 0.5 >99 
3 AgSbF6 0.5 52 
4 CuI 3 77 
5 CuCl 0.5 83 
6 AuI 3 95 
7 AuCl3 0.5 71 
 
 
Scheme 1.57.  Cyclization of alkynyl pyridin-2-amines 
 
Similarly, silver salts also catalyze the cyclization of alkynyl pyridin-2-amines 
to give imidazo[1,2-a]pyridines (Scheme 1.57).92 However, higher catalytic 
loadings (10 mol%), and harsher reaction conditions were required for the 
transformation. Extra caution had to be taken to keep oxygen out of the 
reaction mixture to minimize the formation of the side products 1.144 and 
1.145. AgOTf was the best catalyst for the reaction, and it was found that 
methyl substituents on the pyridine ring resulted in short reaction times, while 
bromo- or chloro- substituents slowed down the reaction significantly. Other 
heterocyclic ring systems, such as imidazole or pyrazine also underwent 
smooth cyclization to the corresponding azo-fuzed heterocycles.  
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Scheme 1.58. Cyclization of the internal alkyne substrate 1.146 
 
Interestingly, with the internal alkyne substrate 1.146 (Scheme 1.58), the 
expected product resulting from 5-exo-dig cyclization was not observed. 
Instead, the corresponding triflate salt 1.147 resulting from 6-endo-dig 
cyclization, was obtained in poor yield. However, when a stoichiometric 
amount of AgOTf was used, product 1.147 could be isolated in 92% yield 
after a short reaction time of 30 minutes. 
 
 
Scheme 1.59. Cyclization of 9-propargyladenine 
 
Verma and co-workers observed an unexpected silver-mediated cyclization of 
9-propargyladenine 1.149 (Scheme 1.59) when they attempted to prepare the 
corresponding silver(I) complex. 93  The product was the cationic tricyclic 
purine derivative 1.150. 
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1.2.2.8 Guanidine derivatives 
 
Scheme 1.60. Cyclic guanidines as precursors to 2-aminoimidazoles 
 
Eycken and co-workers envisaged that the cyclic guanidines 1.152, prepared 
via cyclization of propargyl guanidines 1.151, would be suitable precursors for 
the preparation of 2-aminoimidazoles 1.153 (Scheme 1.60).94 The screening of 
several Lewis acid catalysts led to the discovery of AgNO3 as the most 
efficient catalyst for the transformation, leading to near quantitative 
conversions in acetonitrile at room temperature after 20 minutes. Comparable 
results were obtained with AgOTf, while other catalysts, such as AuCl3, CuCl, 
CuBr, and Cu(OTf)2 were inefficient. 
 
 
Scheme 1.61. Cyclization of di-Boc-protected propargylguanidine under 
acidic conditions 
 
Looper et al. later found that silver salts catalyze the same transformation 
under acidic conditions with good selectivity for the 5-exo-dig cyclized 
product 1.152 (Scheme 1.61).95 Au(III) salts were less efficient, and tended to 
afford the 6-endo-dig cyclized product 1.154, while Cu(OTf) resulted in the 
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formation both cyclization products and 1.155, which results from a [1,3]-
prototropic shift and isomerization of the alkyne. By varying the propargylic 
substituent and the alkyne substituent, it was found that selectivity towards the 
5-exo-dig product was the greatest when the electronic differences between the 
two substituents are large. 
 
1.2.2.9 Isourea derivatives 
 
Scheme 1.62. Cyclization of acetylenic isoureas 
 
The structurally similar acetylenic isoureas 1.156 afforded oxazolidines 1.157 
(n = 0) or oxazines 1.157 (n = 1) when treated with silver triflate (Scheme 
1.62).96 The reaction proceeded at room temperature with 2-5 mol% of AgOTf 
with the O--acetylenic isoureas 1.156 (n = 0); however, higher catalytic 
loadings of 25-30 mol% and higher reaction temperatures were required for 
the O-	-acetylenic isoureas 1.156 (n = 1). Yields and reaction times were not 
reported in this publication. 
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1.2.2.10. Urea Derivatives 
 
Scheme 1.63. Synthesis of 2-imidazolones 1.161 and tetrasubstituted 3,4-
dihydropyrimidin-2(1H)-ones 1.162 from secondary propargylamines and 
isocyanates 
 
 
Scheme 1.64. Synthesis of imidazolin-4-ones 1.164 and oxazolidin-2-imines 
1.165 from secondary propargylamines and tosylcyanates 
 
Eycken has reported the synthesis of 2-imidazolones 1.161 from secondary 
propargylamines 1.158 and isocyanates 1.159 by a one-pot acylation, followed 
by Ag(I)-catalyzed cycloisomerization, via the propargylic urea intermediate 
1.160 (Scheme 1.63).97 Recently, cationic gold catalysts were employed for 
the reaction, and interestingly, the reaction afforded mainly the 6-endo-
cyclized product 1.162.98 The reaction with tosylcyanates 1.163 also resulted 
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in different products when silver and gold catalysts were employed (Scheme 
1.64) – the AgOTf-catalyzed reaction favors the N-cyclized imidazolin-4-ones 
1.164, while the gold-catalyzed reaction resulted in the O-cyclized oxazolidin-
2-imines 1.165.99 
 
In an attempt to rationalize the differences in behavior between the two 
catalysts, triphenylphosphine was added as a ligand in the AgOTf-catalyzed 
reaction between N-methylpropargyl-amine 1.158 (R1 = Me, R2 = R3 = H) and 
tosyl isocyanate 1.163, with the hope of observing an effect on the selectivity 
brought about by the reduced Lewis acidity of the silver metal center. Indeed, 
an improved stability of the catalyst and a greater selectivity towards the N-
cyclized product was observed. Pearson’s concept of hard and soft acid and 
bases (HSAB) was invoked to explain the chemoselectivity difference 
observed between the silver and gold catalytic systems in the reaction of 
tosylcyanates. The authors thus propose that in the [(Ph3P)AuCl]/AgOTf-
catalyzed process, the triflate counteranion is pushed outside the primary 
coordination sphere, resulting in a completely aurated alkyne triple bond that 
is a hard acid and would preferably react with the harder carbamide oxygen 
nucleophile. In the AgOTf-catalyzed process, however, AgOTf does not 
dissociate completely and exists as a contact ion-pair which would form a 
highly polarized soft -complex with the alkyne triple bond and preferably 
react with the softer amide nitrogen. The differences in regioselectivity 
observed with the alkyl and aryl isocyanates, on the other hand, appear to be 
more susceptible to kinetic and thermodynamic control rather than the choice 
of catalytic system. The higher temperatures and higher catalytic loadings of 
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the AgOTf-catalyzed process indicate that the 5-exo-cyclization could be 
kinetically-favored, while the cationic Au(I) process which occurs under 
milder conditions could be under thermodynamic control. 
 
1.2.2.11 Azides 
 
Scheme 1.65. Cyclization 2-alkynyl benzyl azides 
 
Other than the cyclization of imines (see Schemes 1.48 and 1.49), the 
cyclization 2-alkynyl benzyl azides 1.157 can also provide access to 
substituted isoquinolines 1.158 (Scheme 1.65).100 The reaction proceeds with 
high regioselectivity as only the 6-endo-dig cyclization product was formed. 
Higher yields were also obtained with substrates with electron-withdrawing 
substituents on the phenyl ring. However, this reaction requires high catalyst 
loading (20 mol%), trifluoroacetic acid additive and high temperatures  to 
obtain decent yields.   
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1.2.2.12 Nitrosamines 
 
Scheme 1.66. Cyclization of N-nitrosamines 
 
Building on the success of the AgNO3/silica catalyst in the cyclization of 	-
methylene alkynols to furans (see Scheme 1.14), Knight and co-workers 
applied the same catalyst to the cyclization of N-nitrosamines 1.159 to afford 
pyrazole-N-oxides 1.160 in nearly quantitative yields (Scheme 1.66). 101 
Deoxygenation of the pyrazole-N-oxides with PCl3 gives the corresponding N-
substituted pyrazoles 1.161.   
 
1.3 Catalytic Applications of Silver(I) NHC Complexes 
During the past decades N-heterocyclic carbenes (NHCs) have emerged as a 
versatile class of ligands in coordination chemistry, particularly in the field of 
homogeneous catalysis. The first silver NHC complex was synthesized by 
Arduengo and co-workers in 1993.102 However, it was left to Wang and Lin to 
demonstrate their capability as versatile carbene transfer agents that the 
chemistry of silver NHCs was explored.103 Since then, they have been widely 
employed in transmetallation reactions.104 However, their application catalysis 
remains largely unexplored. In this section, a summary of all the catalytic 
applications of silver NHCs reported to date will be provided, with particular 
emphasis on the important structural features of the NHC ligands that 
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influence the catalytic activity of the resulting silver complex. This would be 
appropriate before a discussion of the structures and reactivity of NHC silver(I) 
acetate complexes provided in Chapter 4. Instead of describing the examples 
in chronological order as previous reviews have done 105,106, the discussion 
will be broadly divided into three sections based on the type of reaction being 
catalyzed.  
 
1.3.1. Reactions Involving Alkenes 
 
Scheme 1.67. General mechanism for the diboration of alkenes 
 
The diboration of alkenes presents two inherent issues of chemoselectivity and 
enantioselectivity that can be tackled with the proper design of metal catalysts. 
As can be seen from the general mechanism107 in Scheme 1.67, a successful 
catalyst must first be able to into the B–B  bond of the diboron reagent in 
order to form the intermediate metal bis(boryl)complex 1.164. Subsequent 
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alkene coordination to form 1.165 and insertion into the M–B bond provides 
intermediates 1.166a and b, which can then undergo reductive elimination to 
generate the desired 1,2-bis(boronate)ester product 1.167. It should be noted 
that intermediates 1.166a and b can also undergo a competitive 	-hydride 
elimination to give the undesired hydroboration products 1.168a and b.  
 
 
Scheme 1.68. Diboration of alkenes using silver(I) chiral NHC complexes 
 
In 2005, Peris and Ferńandez reported that Ag(I) bis(NHC) complexes of the 
menthol-derived ligand 1.163a catalyzed the diboration of alkenes (Scheme 
1.68). 108  They thought that Ag(I) NHC complexes combined requisite 
electronic properties to ensure cleavage of the diborane, while low energy d-
orbitals minimize -backbonding and thus 	-hydride elimination. More 
significantly, it provided the first example of Ag(I) NHC complexes being 
applied in catalytic reactions. Disappointingly, the silver(I) complex of ligand 
1.163a catalyzed the diboration reaction with limited scope, and no 
asymmetric induction was observed, possibly due the lability of the Ag-C 
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bond, and that the chiral center lies far from the metal. Subsequently, other 
chiral NHC ligands 1.163b-d were employed109, but the ees remained low, 
with the highest ee of 9% achieved by the complex of ligand 1.163c, 
presumably due to the higher steric hindrance around the metal center upon 
coordination. In comparison, AgNO3 and Ag(I) phosphine complexes were 
completely inactive under the same reaction conditions.  
 
 
Scheme 1.69. Silver(I) NHC catalyzed 1,3-dipolar cycloaddition of 
azomethine ylides with acrylates 
 
Later, Lassaletta, Ferńandez and co-workers reported that enantioselective 
catalysis by Ag(I) NHC complexes can be achieved using pincer type 
S/C(NHC)/S ligands, where the configuration of the sulfur atom is controlled 
by a neighboring stereogenic centre (Scheme 1.69). 110  Ligand 1.169a 
produced the highest ees of up to 80%. The authors attribute the successful 
chiral induction to the ability of the tridentate pincer ligands to stabilize the 
resulting complexes, and also to the hemilabile behavior of the thioether 
functionalities in the ligand. 
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Scheme 1.70. Silver(I) NHC catalyzed cyclopropanation reaction between 
styrene and phenyldiazoacetate 
 
In a comparative study of the ability of NHC complexes of group 11 metals to 
catalyze the cyclopropanation of olefins, Pérez  and Echavarren  reported that 
the Ag(I)-NHC chloride complexes of IPr and SIPr were able to catalyze the 
cyclopropanation reaction between styrene and phenyldiazoacetate, although 
they were less active than their gold and copper analogues (Scheme 1.70).111 
 
1.3.2. C-C Bond Forming Reactions 
 
Scheme 1.71. Silver(I)-NHC catalyzed Sonogashira coupling reaction 
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The group of Biffis employed Ag(I) complexes of scorpionate-type triscarbene 
ligands and biscarbene ligands in the Sonogashira coupling of phenylacetylene 
and 4-iodoacetophenone (Scheme 1.71). 112  Despite the harsh reaction 
conditions, the yields were generally poor, and even lower than that of AgI 
(yields >90%)113 under similar reaction conditions. 
 
 
Scheme 1.72. Silver(I) NHC catalyzed carbomagnesiation reactions of alkynes 
and enynes with alkyl Grignard reagents 
 
 
Scheme 1.73. Unsuccessful use of a silver(I) bis(NHC) complex in the  
carbostannylation reaction of alkynes 
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Terao and Kambe et al. have also reported that the [(IMes)AgCl] catalyzes the 
carbomagnesiation of terminal alkynes efficiently in the presence of 1,2-
dibromoethane as an oxidant. Compared to AgOTs or combinations of 
AgOTs/phosphine, [(IMes)AgCl] generally gave better yields, except when 
sec-butylmagnesium was used. 114  The reaction could also be extended to 
conjugated enynes, provided an electrophile, such as cyclopentanone, was 
used to trap the intermediate organomagnesium species formed. In the 
somewhat related carbostannylation reaction of alkynes (Scheme 1.73), silver 
salts (AgOTf, AgBF4 and AgSbF6) and the triphenylphosphine complex 
[(Ph3P)AgOTf] were active catalysts, while the cationic Ag(I) bis(NHC) 
complex of IMes could not catalyze the reaction. 
 
 
Scheme 1.74. Silver(I) NHC-catalyzed alkynylation reactions of isatins 
 
66 
 
Liu, Li and co-workers have reported the first silver(I) NHC-catalyzed 
reaction performed in water. 115  Using the reaction of N-benzylisatin with 
phenylacetylene as a model reaction (Scheme 1.74), the activity of seven 
Ag(I)-NHC chloride complexes were screened. Interestingly, they found that 
the NHC ligand employed had a profound effect on the outcome of the 
reaction – complexes of imidazole-derived NHC ligands with aromatic 
substituents on nitrogen (IMes, SIMes, IPr and SIPr) gave excellent yields of 
92-98%, while complexes of the triazole derived NHC ligand 1.173, and 
imidazole-derived NHC ligands with alkyl substituents on nitrogen 1.174 and 
1.175 showed poor activity (0-10% yield). Using the most effective IMes 
complex, the substrate scope was explored. The reaction was found to be 
insensitive to substitution at the alkyne, while the substitution at the N-atom of 
the isatins influenced the reactivity and the product yield strongly. The use of 
water as the solvent was crucial for obtaining good yields, and the reaction 
could also be run in air. The authors propose that excellent activity of the 
catalysts was due to the high stability of the complexes and corresponding 
silver acetylide catalytic intermediates. 
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Scheme 1.75. The first silver(I) NHC catalyzed A3-coupling reaction reported 
by the group of Wang 
 
The three-component coupling of aldehyde, alkyne, and amine (A3-coupling) 
is probably the most widely studied catalytic reaction employing Ag(I)-NHC 
catalysts, first reported by the group of Wang in 2008. 116  They have 
demonstrated that Ag(I)-NHC complexes and polystyrene-supported Ag(I)-
NHC complexes are efficient catalysts for the reaction (Scheme 1.75). In both 
the polystyrene-supported and non-polystyrene supported complexes, the N-
substitution on the NHC ligand was found to influence the catalytic efficiency 
in the order: Bn > Ph > tBu > Me, which approximately correlates with the 
size of the substituents. The polystyrene supported complexes also showed 
slightly higher activities compared to the non-polystyrene supported 
complexes (69-90% vs. 61-80% yield), and can be recycled for over 12 cycles 
without significant leaching. 
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Scheme 1.76. Catalytic activity of polystyrene-supported silver(I) NHC 
complexes synthesized by the group of Cai 
 
The use of polystyrene-supported Ag(I) NHC complexes for the A3 reaction 
was further investigated by Cai et al. (Scheme 1.76).117 Instead of using a 
benzyl linker group to tether the NHC moiety to polystyrene, they used a 
1,2,3-triazole linker group, which was constructed via click chemistry. In 
contrast to the catalysts previously reported by Wang, the activity of this series 
of catalysts was not affected by the N-substitution of the NHC ligands. The 
presence of the potentially coordinating triazole group also appeared to be 
beneficial to the catalytic efficiency of the complexes, as good yields could be 
obtained at reduced catalytic loadings of 0.5 mol%. The catalysts can also be 
recycled for 5 cycles without significant loss in activity. 
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Scheme 1.77. Catalytic activities of well-defined silver(I) NHC complexes 
 
Zou and co-workers prepared chloro-, bromo- and bis(NHC) complexes of the 
ligands 1.178 and 1.179, and unambiguously confirmed their structure in the 
solid state via single crystal X-ray crystallography. 118  Screening for their 
catalytic activity towards the A3 reaction, it was found that complexes of the 
more sterically hindered ligand 1.179 were superior, and the chloride 
complexes showed better yields than the corresponding bromide and bis(NHC) 
complexes (Scheme 1.77). The larger steric hindrance of ligand 1.179 
presumably results in more stable complexes that do not undergo exchange 
readily in solution, while the observation that the chloride complexes were 
more active than their bromide counterpart suggests that the first step of the 
catalytic cycle involves the coordination of the alkyne to the complex, which 
is more favorable with a smaller anion.  
 
However, these complexes were less active than the polystyrene supported 
catalysts reported by Wang et al., as adopting the same reaction conditions 
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reported by Wang (CH2Cl2 at room temperature) in the reaction of 
phenylacetylene, 3-phenylpropionaldehyde and piperidine only furnished trace 
amounts of product. More forcing reaction conditions (dioxane at 100 C) 
were adopted; and although respectable yields of 61-99% were obtained, it 
was found that AgCl also resulted in 80% yield of under the same reaction 
conditions. Complex [(1.179)AgCl] exhibited a near quantitative  yield of 99% 
which surpassed that of AgCl, and it was used for subsequent investigation of 
the substrate scope.   
 
 
Scheme 1.78. Silver(I) NHC halide and acetate complexes as catalysts for the 
A3 reaction reported by Navarro and co-workers 
 
A similar effect of the size of the anionic ligand on silver was also observed 
by Navarro and co-workers. 119 In a comparative study of the complexes of 
silver(I) halide and acetate complexes of IPr and SIPr ligands (Scheme 1.78), 
it was found that the catalytic activity decreased in the order: OAc > Cl > Br 
? I, and differences in activity between the IPr and SIPr complexes were 
minimal; lending support to Zou’s proposal that the initiating step of the 
reaction involves displacement of halide ligand by the alkyne to form a silver 
acetylide intermediate.   
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Scheme 1.79. Di- and polynuclear Ag(I)-NHC complexes synthesized by 
Tang’s group 
 
The three most recent reports by Tang’s group120,121,122 focused more on the 
structural features of the complexes than their catalytic activity, as there is 
little discussion on how the structure of the NHC impacts the catalytic activity 
of the resulting complexes. Nevertheless, in this work, the flexibility and 
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presence of multiple donor functionalities in the NHC ligands resulted in 
multinuclear and polymeric structures. These impose a negative effect on the 
efficiency of the resulting complexes as both higher reaction temperatures and 
catalytic loadings were required (Scheme 1.79). 
 
1.3.3 Nucleophilic Addition Reactions to Alkynes 
 
Scheme 1.80. Synthesis of cyclic carbonates 
 
The synthesis of cyclic carbonates using homogeneous silver catalysts has 
been described previously (Scheme 1.26). Building on the success of Zhang’s 
polystyrene-supported Ag(I) NHC complexes in the A3 reaction, Qi, Jiang and 
co-workers prepared two of the polystyrene catalysts reported by Zhang’s 
group, PS-1.176a and PS-1.176b (see Scheme 1.75), and a new polystyrene-
supported Ag(I) complex of the same NHC ligand bearing an n-butyl group on 
nitrogen, PS-1.176e (see Scheme 1.80). The catalysts were tested for their 
activity towards the cyclization of carbonates, 123  and good yields were 
obtained at low catalytic loadings. The catalyst could also be recycled for up 
to 15 times without decrease in catalytic activity. 
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Scheme 1.81. Formal hydroboration of alkynes 
 
The ability of Ag(I) to catalyze the formation of carbon-boron bonds was 
exemplified by the seminal work of Peris and Ferńandez108 in the diborylation 
of alkenes with bis(catecholato)-diboron (Scheme 1.68). This prompted the 
group of Yoshida to carry out a preliminary screening of Ag(I)-NHC chloride 
complexes of IMes, SIMes and IPr to catalyze the addition of bis(pinacolato)-
diboron to alkynes (Scheme 1.81).124 It was found that a strong base was 
essential for the reaction to proceed in a protic solvent such as methanol. The 
IMes and SIMes complexes showed similar activities, while the reaction did 
not proceed with the complex of the more sterically demanding IPr. Using 
[(IMes)AgCl], the substrate scope was explored. In addition to the high 
regioselectivity towards the 	-product, a variety acyclic and cyclic alkyl 
groups, functional groups such as cyano, halogen, silyl ether, and hydroxyl, 
were tolerated at the alkyne. The non-terminal alkyne, diphenylacetylene, also 
underwent the stereoselective hydroboration to afford (Z)-borylstilbene in 95% 
yield. 
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1.3.4. Nucleophilic addition reactions to aldehydes and imines 
 
Scheme 1.82. Hydrosilylation of benzaldehyde 
 
In 2006, Stradiotto and Wile reported the first application of silver compounds 
in the hydrosilylation of aromatic and aliphatic aldehydes to yield silyl 
ethers.125 They found that AgOTf alone could catalyze the reaction, but the 
addition of appropriate ligands such as monodentate phosphines or NHC could 
result in cleaner reactions and improved yields. Only one example of a NHC 
ligand was used in this work (1.187, Scheme 1.82), and monodentate 
phosphines with non-sterically hindered substituents such as Et3P, were still 
superior.  
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Scheme 1.83. Cyanosilylation of imines by a trisilver cationic cage 
 
Zhang, Duan and co-workers synthesized a novel chiral trisilver cationic cage 
of the ligand 1.188, which had a cylindrical shape with a diameter of 
approximately 1 nm (9.5 Å) (Scheme 1.83). When the complex was applied to 
the asymmetric cyanosilylation of imines, they found that the yields 
diminished with sterically hindered substrates bearing naphthyl groups, 
suggesting that the reactions took place within the cavity of the cylinder. The 
low levels of stereoinduction obtained were attributed to the linear geometry 
around the silver centers and the lack of steric hindrance to constrain the 
spatial geometry of products.126 
 
1.4 Summary and Project Aims 
The gold- and silver-catalyzed cycloisomerization reactions involving attack 
of a heteroatom nucleophile on alkynes is an attractive method for the 
synthesis of heterocycles. In the examples presented above, differences in 
reactivity between gold and silver catalysts are evident, and numerous 
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transformations where gold catalysts have previously proven to be efficient 
can be achieved by silver species, sometimes under slightly different reaction 
conditions. Although the slightly lower Lewis activity of silver(I) catalysts 
compared to gold(I) catalysts may require that higher catalytic loadings and 
harsher reaction conditions in certain instances, this property of silver may be 
harnessed when more than one nucleophilic site is present in the substrate and 
reaction of the weaker nucleophile with the alkyne is preferred; or when 
subsequent reactions of the double bond resulting from the cyclization reaction 
is to be avoided. 
 
Lately, the role of silver salts in cationic gold(I) and gold(III) catalysts has 
also come under scrutiny, and the potential of silver salts to mediate some of 
these transformations, or to exhibit different reactivity patterns in the same 
transformation that complement that of gold catalysts is slowly being 
recognized. Moving beyond their role as halide abstractors in gold catalysis, a 
number of reports where silver catalysts have been employed at low catalytic 
loadings and mild reaction conditions, or even in tandem reactions, have been 
amply demonstrated. However, most of these early studies have primarily 
focused on the use of silver salts rather than silver complexes as catalysts. In 
the few cases where suitable ligands are employed, greater stability and 
efficiency of the catalyst was reported. However, very little is known about the 
active catalytic species in the reaction mixture in these cases. 
 
Previous work in the KKH group 127  has also demonstrated the utility of 
silver(I) catalysts in the enantioselective heterofunctionalization reactions of 
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allenes, which offer a cost-effective alternative to gold-catalyzed reactions. 
Similarly, the objective of this work is to explore the catalytic utility of silver(I) 
salts and complexes in the heterocyclization reactions of alkynes, as a step 
towards the development of silver catalysts that are competitive with existing 
gold(I) complexes. This work began with the screening of simple silver salts 
to establish the counteranion effects on catalytic activity, followed by an 
investigation of the various P- and N-donor and NHC ligands on the catalytic 
activity. Given that there are few examples of silver(I) NHC complexes as 
catalysts for organic transformations, we believe that there is much room for 
exploration of these strong -donor ligands on the catalytic activity of the 
resulting silver complexes. Catalysts which show good activity will be 
optimized by varying the reaction conditions, e.g. the solvent, temperature and 
catalytic loading. Finally, a range of substrates will be synthesized and 
screened to determine the reaction scope and limitations of the catalyst. 
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Chapter 2 Intramolecular Hydroamination Reaction of 
Trichloroacetimidates 
 
In this chapter, the catalytic activity of silver(I) salts and their complexes with 
P- and N-donor ligands towards an intramolecular hydroamination reaction – 
specifically, the addition of trichloroacetimidates to alkynes, will be explored. 
As described in Chapter 1, previously reported examples of intramolecular 
silver(I)-catalyzed hydroamination reactions of alkynes have been limited to 
the addition of amine and amide substrates. It would thus be worthwhile to 
explore the possibility of expanding the scope to include imidates as 
nucleophiles, potentially affording N,O-heterocycles such as oxazoline, 
oxazole and oxazine products.  
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Scheme 2.1. Previous reports of intramolecular hydroamination of alkynes by 
imidate nucleophiles 
 
The intramolecular addition of imidates to alkynes can occur without any 
catalyst via a thermal isomerization process, as shown in Scheme 2.1a.128 Gold 
catalysts were later employed for the reaction, allowing it to proceed under 
milder reaction conditions: Shin and co-workers129 were the first to report the 
use of a cationic phosphine–gold(I) complex to effect the cyclization of 16 
acyclic substrates to exo-methylene substituted oxazolines and oxazines in 
good to excellent yields (Scheme 2.1b). Hashmi et al.130 later reported that 
AuCl3 could also promote the reaction, affording the oxazole products, but 
with a very limited substrate scope, consisting of only two examples (Scheme 
2.1c).  
 
2.1 Initial Screening of Silver Salts 
 
Scheme 2.2. Model reaction for the initial screening of Ag(I) and Cu(I) salts 
 
The ability of various silver and copper salts to promote the intramolecular 
hydroamination reaction of the model substrate 2.1a was first examined. The 
reaction could potentially afford the methylene oxazoline 2.2a or the oxazole 
2.3a (Scheme 2.2). In the initial screening, a mixture of 2.1a and 10 mol% of 
the silver or copper salt was stirred in acetonitrile at room temperature. After 6 
h, TLC analysis showed that 2.1a was completely consumed in certain cases. 
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Removal of the solvent in vacuo and subsequent 1H NMR analyses of the 
crude reaction mixtures in CDCl3 indicated the absence of the alkyne 
resonance peak at 2.55 ppm, and the appearance of triplet of doublet 
resonances at 5.39 and 4.87 ppm, which correspond to the diastereomeric 
alkene protons of 2.2a; and/or a triplet at 2.27 ppm which corresponds to the 
methyl protons in 2.3a. The reactions were then repeated with a known 
amount of an internal standard (1,3,5-methoxybenzene) added to the NMR 
samples of the crude reaction products. The NMR yields of 2.2a and 2.3a can 
thus be calculated by comparing the integrals of the alkene protons of 2.2a and 
the methyl protons of 2.3a relative to the protons of 1,3,5-methoxybenzene. 
The results are tablulated in table 2.1; the corresponding pKa values of the 
conjugate acids of the counteranions of the silver and copper salts were also 
included in the analysis. 
 
Table 2.1. Initial screening of Ag(I) and Cu(I) salts in the cyclization of 2.1aa 
Entry Catalyst 
pKa of 
conjugate 
acid 
Conversionb 
(%) 
Yieldb 
of 2.2a 
(%) 
Yieldb 
of 2.3a 
(%) 
1 AgOAc 4.8131 36 8 
 
2 AgTFA 0.2131 100 76 
 
3 AgNO3 -1.3
132 
   
4 AgOTs -2.8133 91 9 8 
5 AgBF4 -4.9
134 100 
 16 
6 AgSbF6 -13
135 100 28 
 
7 AgOTf -14136 100 18 15 
8 AgPF6 -20
135 49 16 
 
9 Ag2O 15.7
137 
   
10 Ag2CO3 3.9
138 
   
11 Ag2SO4 -3.0
132 
   
12 [Cu(OTf)]2
C6H6 -14
136 100 33 
 
13 TfOH -14136 
   
a Reaction conditions: 2.1a (0.4 mmol), catalyst (0.04 mmol, 10 mol%), 23 C,  MeCN (1 mL). 
b Determined by 1H NMR spectroscopy, using 1,3,5-trimethoxybenzene as internal standard.  
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It was observed that some of the silver salts and copper(I) triflate were active 
for the transformation. However, although full conversion of 2.1a was 
achieved in some cases, the yields of the products remained low, due to 
competitive formation of side products, which were also observed in the 
reaction mixture. Attempts to identify these products were unsuccessful. None 
of the di-silver salts Ag2O, Ag2CO3 and Ag2SO4 were active (entries 9-11) and, 
with the exception of AgOAc, AgPF6 and AgNO3, all other AgX salts and 
[Cu(OTf)]2 afforded quantitative conversion of 2.1a within 6 h at room 
temperature (entries 2, 4-7 and 12). This indicated a strong counteranion effect 
on catalytic activity; in the order CF3CO2
- > > TfO- > SbF6
- > BF4
- > TsO- > 
PF6
- > CH3CO2
-, which did not show any correlation with the pKa values of 
the conjugate acids. Notably, AgTFA gave the highest yield of 2.2a in 76% 
yield after 6 h. To clarify that Brønsted acids were not involved in the reaction, 
a control experiment was performed using 10 mol% of triflic acid (the 
maximum amount of acid that could theoretically be formed in the reaction). 
No conversion of substrate 2.1a was observed (entry 13). 
 
The reaction was also conducted in various common organic solvents, such as 
CH2Cl2, DCE, acetone and THF, and the results are summarized in Table 2.2. 
It was postulated that the differing polarities and donor abilities of these 
solvents will affect the solubility of the catalysts and stability of reactive 
catalytic intermediates during the reaction, which could potentially allow 
cleaner reactions and improved yields of the products. 
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Table 2.2. Solvent study using silver saltsa 
Entry Catalyst Solvent Conversion
b 
(%) 
Yieldb of 
2.2a (%) 
Yieldb of 
2.3a (%) 
1 AgOAc DCE 51 21 
 
2 AgTFA DCE 100 14 15 
3 AgOTs DCE 100 5 26 
4 AgBF4 DCE 100  16 
5 AgSbF6 DCE 100 54  
6 AgOTf DCE 100 
 46 
7 AgPF6 DCE 37 13  
8 AgOTf/PSc DCE 100 80 
 
9 AgOAc acetone 30 9 
 
10 AgTFA acetone 62 22 
 
11 AgOTs acetone 68 28 
 
12 AgBF4 acetone 100 37 5 
13 AgSbF6 acetone 82 37  
14 AgOTf acetone 100 40 
 
15 AgPF6 acetone 27 5  
16 AgOAc CH2Cl2 51 26  
17 AgTFA CH2Cl2 100 10 28 
18 AgOTs CH2Cl2 100  38 
19 AgBF4 CH2Cl2 100 12 22 
20 AgSbF6 CH2Cl2 100 13 35 
21 AgOTf CH2Cl2 100  52 
22 AgPF6 CH2Cl2 40 15  
23 AgOAc THF 46 9 
 
24 AgTFA THF 73 15 
 
25 AgOTs THF 79 28 
 
26 AgBF4 THF 57 16  
27 AgSbF6 THF 77 35  
28 AgOTf THF 96 51 
 
29 AgPF6 THF 26 3  
a Reaction conditions: 2.1a (0.4 mmol), catalyst (0.04 mmol, 10 mol%), 23 C,  solvent (1 
mL). b Determined by 1H NMR spectroscopy, using 1,3,5-trimethoxybenzene as internal 
standard. c PS = proton sponge (5 mol%), 40 C, 3 h. 
 
In chlorinated solvents such as CH2Cl2 and DCE, complete conversion of 2.1a 
was obtained with all the silver salts except AgOAc and AgPF6, while acetone 
and THF afforded lower conversions but allowed the high selectivities towards 
the oxazoline product 2.2a. Interestingly, the use of 10 mol% of AgOTf in 
CH2Cl2 and DCE afforded the aromatic oxazole product 2.3a exclusively in 
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moderate yields (entries 6 and 21), while the formation of the oxazoline 
product 2.2a was favored in acetone and THF.  
 
The irreversible isomerization of methylene oxazolines to oxazoles has been 
reported to occur rapidly under acidic conditions.129 Although it was found 
that TfOH is not catalytically active in the cyclization of 2.1a (Table 2.1, entry 
13), it was found that the aromatization of 2.2a to 2.3a was complete within 5 
h in the presence of 5 mol% of TfOH. Suspecting that trace amounts of the 
Brønsted acid could be generated in situ and be responsible for the 
isomerization of 2.2a to 2.3a, a separate experiment was conducted whereby 5 
mol% of 1,8-bis(dimethylamino)naphthalene (proton sponge) was added to the 
AgOTf-catalyzed cyclization of 2.1a. Indeed, 2.2a was formed exclusively in 
80% yield (entry 8) with minimal side product formation, showing that 
selective formation of the exo-methylene product 2.2a can be attained by Ag-
catalysis, as long as the attendant Brønsted acidity can be suppressed.  
 
2.2 Synthesis and Catalytic Activity of Ag(I) Complexes of P- 
and N-Donor Ligands 
Encouraged by the above results, the effect of ligands on the activity of the 
silver catalysts was assessed, in an attempt to improve the performance of 
these silver(I) catalysts. Well-defined Ag(I) complexes of several P- and N-
donor ligands were first prepared by reaction with AgOTf in the appropriate 
stoichiometric ratio (Scheme 2.2). Complexes 2.4, 139 2.5a140 and 2.769 were 
prepared according to literature procedures, and characterized by comparisons 
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of their NMR data. Complex 2.6 was specifically prepared as a new entity in 
this work. 
 
 
Scheme 2.3. Synthesis of Ag(I) complexes of (a) triphenylphosphine, (b) 
pyridine, (c) 2,2’-bipyridine and (d) 1,10-phenanthroline 
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Fig. 2.1. Molecular structure of complex 2.6, with two structurally distinct 
molecules in the asymmetric unit 
 
Table 2.3. Selected bond lengths (Å) and angles (deg) for complex 2.6 
Ag(1A)-N(1A) 2.362(3) Ag(1B)-N(1B) 2.372(4) 
Ag(1A)-N(12A) 2.300(4) Ag(1B)-N(12B) 2.305(3) 
Ag(1A)-N(21A) 2.393(3) Ag(1B)-N(21B) 2.350(3) 
Ag(1A)-N(32A) 2.264(3) Ag(1B)-N(32B) 2.322(4) 
N(1A)-Ag(1A)-N(12A) 71.0(1) N(1B)-Ag(1B)-N(12B) 70.9(1) 
N(21A)-Ag(1A)-N(32A) 71.2(1) N(21B)-Ag(1B)-N(32B) 71.3(1) 
 
The structure of the bis(pyridine) complex 2.6 has been confirmed by X-ray 
structure analysis, and is depicted in Fig. 2.1, with relevant bond distances and 
angles given in Table 2.3. The asymmetric unit of complex 2.6 consists of two 
distinct [Ag(bpy)2]
+ cations and two triflate anions, with slightly different 
bond distances and angles obtained for each. The Ag(I) ion adopts a distorted 
square planar geometry in the complex, through coordination with two 
chelating 2,2’-bipyridine ligands. The AgN bond lengths fall within the range 
of 2.264(3) and 2.393(3) Å, and the ligand NAgN bite angles range from 
70.93 to 71.34 , typical for complexes of such ligands.141 The two pyridyl 
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rings within each bipyridine ligand are roughly coplanar, with dihedral angles 
in the range of 9.15 to 15.33, while the interplanar dihedral angles between 
pairs of ligands bonded to silver are 33.5 and 23.8. 
 
It is worthy to note that the 2,2’-bipyridyl ligand forms a bis-chelate complex 
with AgOTf, while a mono-chelate complex is formed with the 1,10-
phenanthroline ligand. However, the actual metal-to-ligand ratio of the 1,10-
phenanthroline silver(I) triflate complex remains ambiguous. In the adopted 
literature procedure69 for the synthesis of the complex, a 1:1 metal-to-ligand 
ratio was assumed by analogy to a previously reported [Ag(phen)]NO3 
complex 142 , and no spectroscopic data or elemental analysis results were 
provided. A literature search revealed that Ag(I) has a tendency to form bis-
chelate complexes with 1,10-phenanthroline in the presence of weakly 
coordinating anions such as triflate,141, 143   although different solvents and 
reaction conditions were used for the preparation of the complex. Although 1H 
and 13C NMR experiments on the complex revealed the presence of a single 
species in solution while C, H, and N microanalyses showed that the 
composition of the complex is closer to that of a bis-chelate complex than that 
of a mono-chelate complex.  Attempts to crystallize the complex only afforded 
thin, poor quality needles that were unsuitable for X-ray single crystal 
diffraction. Despite this uncertainty, the complex was included in the catalyst 
screening since it was reported to be an active catalyst in intramolecular 
hydroamination reactions. 
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The isolated silver complexes 2.4-2.7 were evaluated as catalysts in the 
cyclization of the model substrate 2.1a in a number of solvents (MeCN, DCE, 
acetone, CH2Cl2 and THF), and the results are shown in Table 2.4. 
 
Table 2.4. Screening of catalysts for the cyclization of substrate 2.1aa 
Entry Catalyst Solvent Conversion
b 
(%) 
Yieldb of 
2.2 (%) 
Yieldb of 
2.3 (%) 
1 2.4c MeCN 
   
2 2.5 MeCN 100 83 
 
3 2.5 DCE 100 83 
 
4 2.5 acetone 100 87 
 
5 2.5 CH2Cl2 100 83  
6 2.5 THF 100 75 
 
7 2.6 MeCN 32 13 
 
8 2.6 DCE 44 22 
 
9 2.6 acetone 69 46 
 
10 2.6 CH2Cl2 35 17  
11 2.6 THF 49 21 
 
12 2.7c MeCN 
   
a Reaction conditions: 2.1a (0.4 mmol), catalyst (0.04 mmol, 10 mol%), 23 C,  solvent (1 
mL). b Determined by 1H NMR spectroscopy, using 1,3,5-trimethoxybenzene as internal 
standard. c Changing the solvent failed to improve the conversion. 
 
The triphenylphosphine complex 2.4 was found not to be catalytically inactive 
in any of the solvents employed (Table 2.4, entry 1). The failure of complex 
2.4 to catalyze the reaction could be due to the reduced Lewis acidity of the 
metal center that arises from the stronger donating ability of 
triphenylphosphine towards Ag(I) compared to nitrogen-donor ligands. This 
higher affinity of Ag(I) towards phosphorous donors compared to nitrogen 
donors has been exemplified in the structural studies of Ag(I) complexes of 2-
pyridylphosphine ligands, where it was found that coordination to the pyridine 
nitrogen to silver(I) is only involved when chloro or phosphorus coordination 
is insufficient for coordinative saturation.144 
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The Ag(I) bis(pyridine) complex 2.5 afforded 2.2a regioselectively as the sole 
product in all solvents, and in higher yields than that obtained with AgTFA in 
MeCN (Table 2.4 entry 2 vs Table 2.1, entry 2). The solvent did not have a 
significant effect on the yield, although marginally higher yields were 
obtained when the reactions were conducted in acetone (Table 2.4, entries 2-6). 
The complete selectivity for the oxazoline product 2.2a suggests that in 
addition to their ability to stabilize reactive catalytic species, the pyridine 
ligands could also serve as acid scavengers, preventing the isomerization of 
2.2a to 2.3a.  
 
 
Scheme 2.4. (a) Synthesis of [Ag(bpy)]n(ClO4)2n, which exists as one-
dimensional polymer in the solid state; (b) An example of a Pt(II) 2,2-
bipyridine ‘roll-over’ cyclometallated complex 
 
Complex 2.7 is similar to 2.6 in that they both contain bidentate, chelating N-
donor ligands. However, complex 2.6 catalyzed the reaction while complex 
2.7 was inactive (entries 7-12). The observed difference in catalytic activity 
could be attributed to the poor solubility of complex 2.7 in the solvents 
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employed at room temperature, and the greater rigidity of the phenanthroline 
(phen) ligand compared to the bipyridine (bpy) ligand. Despite having a 
saturated square planar coordination sphere, rotation around the central bond 
of the bpy ligands in complex 2.6 can create vacant coordination sites for the 
coordination of incoming substrates. This flexibility of the bpy ligand is 
apparent from its ability to form one-dimensional ligand-bridged polymeric 
arrays141 and ‘roll-over’ cyclometallated complexes by rotation around the 
central bond145 (Scheme 2.3). In comparison, this rotational freedom is not 
possible for the phen ligand. If the structure of a bis-ligated complex is 
assumed, coordination of substrates will not be possible without the 
dissociation of a phen ligand from the metal center, which is less likely to 
occur given its strong chelating ability. 
 
2.3 Reaction Optimization and Substrate Scope 
 
Scheme 2.5. 5- and 6-exo-dig cyclizations of (homo)propargylic 
trichloroacetimidate substrates 2.1 and 2.8 
 
The scope of complex 2.5 was subsequently investigated with a range of 
substrates, and the results were compared with those previously achieved 
using cationic gold complexes (Table 2.5). 
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Table 2.5. Substrate scopea 
Entry R1, R2, R3 Solvent n T 
(C) 
t (h) Prod. Yieldb Yieldc 
(Au 
cat.) 
1 H, H, H acetone 0 23 6 2.2a 87 
(67) 
98 
2 Me, H, H acetone 0 23 6 2.2b 85 
(74) 
 
3 Et, H, H acetone 0 23 6 2.2c >99 
(86) 
 
4 iPr, H, H acetone 0 23 6 2.2d 87 
(82) 
74 
5 Ph, H, H acetone 0 23 6 2.2e 

d 

d 
6 Me, Me, H acetone 0 23 6 2.2f 89 
(79) 
 
7 H, H, Me acetone 0 23 6 2.2g 
  
8 H, H, Ph MeCN 0 60 7 2.2h 29  
9 H, H, 
CH2Br 
acetone 0 23 6 2.2i 
  
10 H, H, 
SiMe3 
MeCN 0 60 7 2.2j 82 
(72) 
 
11 H, H, Br acetone 0 23 6 2.2k 77 
(30) 
 
12 H, H, H acetone 1 23 6 2.9a 93 
(76) 
91 
13 Me, H, H acetone 1 23 6 2.9b 97 
(93) 
 
14 Et, H, H acetone 1 23 6 2.9c 99 
(91) 
 
15 Ph, H, H acetone 1 23 6 2.9d 94 
(90) 
 
16 4-ClC6H4, 
H, H 
acetone 1 23 6 2.9e 96 
(87) 
91 
17 4-CF3C6H4, 
H, H 
acetone 1 23 6 2.9f 73 
(70) 
 
18 H, H, Ph acetone 1 56 7 2.9g 31  
19e H, H, 
SiMe3 
acetone 1 56 8 2.9h 80 
(71) 
 
a Reaction conditions: Substrate (0.4 mmol), 2.5 (0.04 mmol, 10 mol%), solvent (1 mL).  
b Determined by 1H NMR spectroscopy, using 1,3,5-trimethoxybenzene as internal standard. 
Isolated yields after purification by column chromatography are indicated in parentheses.  
c Reported isolated yields according to ref. 129, under the following conditions: 
Au(PAr3)Cl/AgSbF6 (5 mol%), DCE, 0 C then r.t., 10 min to 9 h (Ar = C6F5, C6H5). 
d Mixture of unidentifiable products was obtained.  
e 20 mol% of catalyst used. 
 
All reactions proceeded with good regio- and diastereoselectivity; only the 
exo-cyclized products and (Z)-double bond isomers were observed in all cases, 
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indicating that the anti-addition of the N-H occurs exclusively. The presence 
of alkyl substituents at R1 and/or R2  for both propargyl (n = 0) and 
homopropargyl substrates (n = 1) did not significantly alter the reactivity 
(entries 1-4 and 12-14). However, propargylic substrate 2.1e with a phenyl 
group in the propargylic position, was not a viable substrate, as was the case 
previously observed with the Au(I) cationic catalyst (entry 5). In this case, an 
unidentifiable mixture of products were obtained. In contrast, the 
homopropargylic substrates 2.8d-f with aryl substituents at R1 cyclized in 
good yields (entries 15-17). The failure of 2.1e to undergo clean cyclization 
was attributed to the ability of the trichloroactimidate functionality to act as a 
leaving group in the presence of Lewis acids – a property that has been 
frequently been exploited in the generation of glycosidic linkages in the 
synthesis of oligosaccharides 146  – it is thus postulated that an elimination 
reaction could have occurred with substrate 2.1e in the presence of the silver 
catalyst, resulting in a resonance-stabilized benzylic carbocation as depicted in 
Scheme 2.6. This reactive carbocation may then attacked by nucleophiles 
present in the reaction mixture to give several side products. However, 
attempts to identify these side products to support our hypothesis have been 
unsuccessful.  
 
 
Scheme 2.6. Possible Ag(I)-promoted elimination of the trichloroacetimidate 
functionality in substrate 2.1e 
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One of the limitations of the reported  Au(I) and Au(III) catalysts was their 
inability to cyclize propargylic substrates containing non-terminal alkyne 
groups (n = 0, R3  H), which limits its utility only to the synthesis of 
methylene oxazolines and methyl oxazoles. Remarkably, although substrates 
2.1g and 2.1i containing alkyl groups at the alkyne terminus were inactive 
(entries 7 and 9) with the silver catalyst, good conversions were obtained with 
substrates that have trimethylsilyl and bromo substituents at these positions 
(entries 10 and 11). The phenyl-substituted substrate 2.1h also showed a low 
level of conversion of 29% at an elevated temperature of 60 C (entry 8). 
Similarly, the cyclization of homopropargylic substrates with non-terminal 
alkynes also proceeded in good conversions, albeit at elevated temperatures 
and higher catalytic loadings.  
 
These results constitute the first example of a silver-catalyzed intramolecular 
hydroamination addition of trichloroacetimidates to alkynes, with comparable 
yields being obtained to that of previously reported cationic Au(I) catalysts. 
The fact that internal alkyne substrates can be cyclized to afford vinyl-bromide 
and silane products is particularly encouraging, as this extends the scope of the 
reaction beyond methylene oxazolines, with the potential to afford useful 
oxazoline and oxazole derivatives.    
 
  
93 
 
2.4. Investigation of Ligand Effects in the Cyclization of 
Bromoalkynes 
 
Scheme 2.7. Synthesis of Ag(I) bis(pyridine) triflate complexes 
 
The facile cyclization of internal alkyne substrate 2.1k (Table 2.5, entry 11) to 
afford the (Z)-4-(bromomethylene)-4,5-dihydrooxazole (Z)-2.2k at room 
temperature at 10 mol% catalytic loading attracted particular attention, as 2.2k 
could potentially be subjected to further functionalization via cross-coupling 
of the vinyl bromide moiety, hence affording 4-substituted oxazoline 
derivatives. Hence, it was decided to investigate if the efficiency of the Ag(I) 
bis(pyridine) triflate catalyst 2.5a could be further improved by fine-tuning of 
the ligand properties and counteranion. To this end, analogous complexes of 
pyridine ligands with electron-donating and electron-withdrawing substituents 
at the 4-position were prepared in a similar manner to complex 2.5a (Scheme 
2.7), and their 1:2 AgOTf:pyridine stoichiometry was confirmed by elemental 
analyses. Attempts to prepare the complex of the 4-trifluoromethylpyridine 
ligand failed, as it could not coordinate effectively to silver, due to its much-
reduced Lewis basicity. The solid state structures of these complexes will be 
discussed in Section 2.6.  
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The conversion of the acyclic substrate 2.1k in the presence of 1 mol% of the 
respective catalyst to the bromo-substituted oxazoline 2.2k was monitored in 
situ by 1H NMR spectroscopy  at room temperature (23 C), using acetone-d6 
as the solvent (Scheme 2.8), and the results are shown in Fig. 2.2. The final 
conversions were recorded and are shown in Table 2.6. 
 
 
Scheme 2.8. Comparison of the catalytic activity of bis(pyridine) triflate 
complexes in the cyclization of substrate 2.1k to 2.2k. 
 
 
Fig. 2.2. Percentage Conversion of 2.1k vs. time in the presence of 1 mol% of 
bis(pyridine) triflate complexes. 
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Table 2.6. Screening of various bis(pyridine) triflate catalysts for the 
cyclization of substrate 2.1k 
Entry Catalyst Time Conversion (%) 
1 [Ag(Py)2]OTf (2.5a) 45 min 100 
2 [Ag(Ac-Py)2]OTf (2.10a) 25 min 100 
3 [Ag(MeO-Py)2]OTf (2.11a) 6 h 77 
4 [Ag(4-DMAP)2]OTf (2.12a) 6 h 0 
5 [Ag(Me-Py)2]OTf (2.13a) 2 h 15 min 100 
 
The presence of an electron-withdrawing acetyl group on the pyridine ligand 
in complex 2.10a led to a dramatic enhancement in reaction rate, and complete 
conversion of 2.1k was achieved in only 25 min compared to 2.5a, which 
required 45 minutes (entries 1 and 2). In contrast, the introduction of electron-
donating groups on the pyridine ligand slowed down the reaction. The 
introduction of a methyl substituent on the pyridine ligand in 2.13a led to 
longer reaction times before complete conversion was achieved (entry 5). For 
the methoxy-substituted pyridine complex 2.11a, the reaction was sluggish 
and conversion remained at a modest 77% even after 6 h (entry 3). Finally, the 
4-DMAP complex 2.12a with the most strongly electron-donating ligand was 
completely inactive in this reaction. These observations suggest that the 
electron-withdrawing substituents on the pyridine ligand enhance the Lewis 
acidity of the Ag(I) metal center, resulting in greater binding to the alkyne 
moiety, which activates it towards nucleophilic attack by the imidate 
nucleophile. 
 
Next, counteranion effects in the catalytic system was investigated. A series of 
five additional Ag(I) bis(4-acetylpyridine) complexes, [Ag(Ac-Py)2]Y, where 
Y = ClO4
- (2.10b), BF4- (2.10c), PF6- (2.10d), SbF6- (2.10e) and CF3CO2- 
(2.10f), were prepared. The conversion of 2.1k to 2.2k in the presence of 1 
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mol% of  these complexes in acetone-d6 was monitored in situ by 1H NMR 
spectroscopy over 25 min at room temperature (23 C), and the results are 
presented in Fig. 2.2.  
 
As catalysts 2.10a, c and d, each bearing TfO-, BF4- and PF6- counteranions 
respectively, exhibited similar rates, the catalytic loading was further reduced 
to 0.7 mol% for a better comparison. From Fig. 2.3 and 2.4, it is established 
that the reaction rate increases in the order: CF3CO2
- < SbF6
- < ClO4
- < BF4
-  
TfO- < PF6
-. With the exception of SbF6
-, the reaction rate correlates inversely 
with the basicity of the counteranion, i.e. weakly and non-coordinating 
counteranions generally perform well, while basic counteranions such as 
trifluoroacetate have a detrimental effect on the reaction rate. 
 
 
 
Fig. 2.3. Percentage conversion of 2.1k vs. time in the presence of 1 mol% of 
bis(4-acetylpyridine) catalysts [Ag(Acpy)2]Y 
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Fig. 2.4. Percentage Conversion of 2.1k vs. time in the presence of 0.7 mol% 
of bis(4-acetylpyridine) catalysts [Ag(Acpy)2]Y (Y = TfO-, BF4- and PF6-) 
 
The general trends observed in the donating ability of the pyridine ligands and 
counteranion basicity were also similarly detected in the cyclization of 
substrate 2.9i (Scheme 2.9, Figs. 2.5 and 2.6). Under optimized conditions 
(Scheme 2.10), 2.2k and 2.9i were isolated in excellent yields. 
 
 
Scheme 2.9. Comparison of the catalytic activity of bis(pyridine) triflate 
complexes in the cyclization of substrate 2.8i to 2.9i 
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Fig. 2.5. Percentage Conversion of 2.8i vs. time in the presence of 1 mol% of 
bis(pyridine) triflate complexes 
 
 
 
Fig. 2.6. Percentage Conversion of 2.8i vs. time in the presence of 1 mol% of 
bis(4-acetylpyridine) catalysts [Ag(Acpy)2]Y 
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Scheme 2.10. Cyclization of 2.1k and 2.8i under optimized reaction 
conditions 
 
2.5. Trapping of Organosilver Intermediates with Electrophiles 
 
Scheme 2.11. Possible trapping of vinyl silver intermediates in the reaction 
with N-bromosuccinimide 
 
Encouraged by the ability of our catalyst to deliver the (Z)-bromomethylene 
oxazoline 2.2k and oxazine 2.9i regioselectively, we envisaged that the 
intermediate organosilver species 2.13 may be trapped by an electrophilic 
halogen source such as N-bromosuccinimide (NBS), as shown in Scheme 2.11, 
to deliver the (E)-isomer. An experiment was carried out by conducting the 
cyclization of 2.1a with 1.2 equivalents of NBS and 10 mol% of AgOTf in 
acetone. An initial exothermic reaction was observed, which was accompanied 
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by an immediate change in the color of the reaction mixture from colorless to 
brown. TLC indicated the complete consumption of 2.1a after 6 h, and the 
formation of a new product which was isolated by column chromatography. 
Spectroscopic characterization confirmed the identity of this new product to be 
the expected (E)-bromomethylene oxazoline 2.2k, which was obtained as a 
white crystalline solid in 63% yield. As (E)-2.2k was slightly thermally 
unstable and showed signs of decomposition when stored at room temperature 
overnight, it was postulated that the yield could be improved by avoiding the 
exothermic reaction that occurred during the initial stage of the reaction. To 
this end, the reaction mixture was repeated at 0 C prior to the addition of 
AgOTf, which resulted in a cleaner reaction and an improved yield of 71% of 
2.2k. In comparison, the analogous reaction of the homopropylgylic 2.8a with 
NBS resulted in a significantly lower yield of 25% of (E)-2.9i, due to the 
competitive formation of an equal amount of the unbrominated product 2.9a.  
 
 
Fig. 2.7 Electrophilic fluorinating reagents: (a) Selectfluor and (b) NFSI 
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Scheme 2.12. Formation of halomethylene oxazolines from 
trichloroacetimidates 
 
Attempts were made to extend the reaction to include electrophilic halogen 
sources such as N-chlorosuccinimide (NCS), Selectfluor and N-
fluorobenzenesulfonimide (NFSI) (Fig. 2.7), and the results are summarized in 
Scheme 2.12. Lower yields were obtained with NCS compared to NBS, 
presumably due to its lower reactivity, as the major product was the 
unchlorinated product 2.9a; and disappointingly, none of the expected 
fluoromethylene oxazolines and oxazines were formed using Selectfluor or 
NFSI as the trapping agent. Control experiments conducted under the same 
conditions in the absence of AgOTf showed no conversion in all cases, except 
in the reaction of NBS and 2.1a, where a low yield of 7% of (E)-2.2k was 
obtained. The crystal structures of (E)-2.9i and (E)-2.9j were also obtained 
(Fig. 2.6), delivering unambiguous proof for geometry of the double bond. 
 
 
(E)-2.9i 
 
(E)-2.9j 
Fig. 2.8. Crystal structures of (E)-2.9i and (E)-2.9j.   
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2.6 Structural Analysis of Silver(I) Bis(pyridine) complexes 
 
[Ag(Py)2]PF6 (2.5d) 
 
[Ag(4-DMAP)2]PF6 (2.12d) 
 
[Ag(Ac-Py)2]PF6 (2.10d) 
 
[Ag(MeO-Py)2]PF6 (2.11d) 
 
Fig. 2.9. Molecular structures of complexes 2.5d, 2.10d, 2.11d and 2.12d. 
Hydrogen atoms and PF6
- anions have been omitted for clarity. 
 
The effect of para-substituents of the pyridine ligand has been found to exert a 
profound effect on the catalytic activity of these silver complexes (Section 2.4). 
In order to understand this effect, the solid state structures of  four 
bis(pyridine)silver(I) complexes with the same (PF6-) counteranion, 2.5d, 
2.10d, 2.11d and 2.12d  were obtained and compared (Fig. 2.7). Complexes 
2.10d and 2.11d are new, while the crystal structures of complexes 2.5d147 and 
2.12d 148  have previously been reported. The relevant bond distances and 
angles of the complexes are shown in Table 2.7.  
 
A few prominent structural features of the solid-state structures of these can be 
noted. These include: 1) the coordination of two pyridine ligands to Ag(I) in a 
linear fashion in all four complexes; 2) the additional coordination of 
acetonitrile solvent molecules to Ag(I), as observed in the structures of 
complexes 2.10d and 2.11d, 3) the presence of unsupported argentophilic 
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interactions between two adjacent molecules present in complexes 2.5d and 
2.11d, and 4) the different molecular packing in the solid state that could favor 
 stacking interactions between the pyridine rings. The inclusion of solvent 
in the coordination sphere of Ag(I) in complexes 2.10d and 2.11d but not in 
2.5d and 2.12d could have been brought about by the different solvents used 
for the crystallization of the complexes. Complexes 2.10d and 2.11d were 
crystallized from MeCN/Et2O, while 2.5d was crystallized by vapor diffusion 
of Et2O into a CH2Cl2 solution of the complex. The crystallization solvent for 
2.12d was not stated. This additional coordination of MeCN in addition to two 
pyridyl ligands also results in a larger deviation of the NAgN bond angle 
from 180; 2.10d and 2.11d both have NAgN bond angles of 169, 
compared to 178 and 180 in 2.5d and 2.12d respectively.   
 
Despite the similar coordination environment and geometry of Ag(I) in 
complexes 2.10d and 2.11d, a notable difference between them is the 
argentophilic interaction (Ag–Ag = 3.228 Å) that is present in 2.11d but not in 
2.10d. AgAg distances longer than the Ag–Ag separation in metallic silver 
(2.889 Å), but shorter than the sum of the van der Waals radii (3.44 Å) are 
usually an indication of such interactions.149 However, the distance between 
two adjacent Ag centers in 2.10d (4.513 Å) is too great for Ag


Ag 
interactions to occur. A plausible explanation for this is that the more basic 4-
methoxypyridine ligands reduce the effective positive charge on the Ag metal 
center in 2.11d, allowing two adjacent [AgL2(NCMe)]+ units to approach each 
other more closely and consequently to form Ag···Ag interactions. A slightly 
shorter and stronger Ag···Ag interaction (Ag–Ag = 2.964 Å) is present in 2.5d 
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compared to 2.11d. In 2.11d, the Ag···Ag interaction is further complemented 
by face to face  stacking interactions between the pyridine moieties. In 
2.5d, however, such interactions are absent due to the staggered conformation 
of the two [Ag(Py)2]
+ units relative to each other. 
 
Table 2.7 Selected bond lengths (Å) and angles (deg) for complexes 2.5a-d, 
2.10d, 2.11d and 2.12d 
Complex Ag1N1 Ag1N2 N1Ag1N2 Ag


Ag Ref. 
[Ag(Ac-py)2]PF6 
(2.10d) 2.170(3) 2.173(3) 169.3(1)  
this 
work 
[Ag(MeO-Py)2]PF6 
(2.11d) 2.133(2) 2.134(2) 169.22(9) 3.2279(4) 
this 
work 
[Ag(4-DMAP)2]PF6 
(2.12d) 2.1087  180.0  148 
[Ag(Py)2]PF6  
(2.5d) 2.129(6)  178.1(3) 2.964(2) 147 
[Ag(Py)2]ClO4 
(2.5b) 2.126(4) 2.133(4) 173.83(17) 2.99917(10) 147 
[Ag(Py)2]BF4  
(2.5c) 2.123(3) 2.127(3) 174.81(9) 3.0001(5) 147 
[Ag(Py)2]OTf 
(2.5a) 2.153(2) 2.155(2) 166.67(7) 2.665(2) 140 
 
From Table 2.7, the most noticeable difference between the four complexes is 
that of the AgN bond length, which generally decreases with increasing 
basicity of the pyridine ligand. Complex 2.12d, which has the most basic 4-
dimethylaminopyridine ligand, also has the shortest AgN bond length of 
2.109 Å, while complex 2.10d, with the least basic 4-acetylpyridine ligand, 
has the longest AgN bond length of 2.172 Å. This is commensurate with a 
weaker binding of the least Lewis basic pyridyl ligand to the metal center. The 
additional coordination of the solvent to Ag in 2.10d may also reflect its 
greater Lewis acidity.  
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[Ag(py)2]PF6 (2.5d) 
 
[Ag(py)2]ClO4 (2.5b) 
 
[Ag(py)2]BF4 (2.5c) 
 
[Ag(py)2]OTf (2.5a) 
 
Fig. 2.10. Molecular structures of complexes 2.5a-d. Hydrogen atoms have 
been omitted for clarity. 
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Similarly, a comparison of the solid state structures of four known bis(pyridine) 
complexes, [Ag(py)2]X  where py = pyridine, X = PF6
- (2.5d), ClO4- (2.5b),  
BF4
- (2.5c) and, TfO- (2.5a), allows an investigation of the effect of the 
counteranion on the coordination geometry of these complexes. The ability of 
the counteranion to influence the resulting supramolecular structures of silver 
coordination polymers is well-known in existing literature,150 and the same 
effect is expected to be observed in simple silver(I) pyridine complexes. The 
molecular structures of these complexes are shown in Fig. 2.10, and the bond 
distances and angles gathered from CIF files obtained from the Cambridge 
Structural Database (CSD), are tabulated in Table 2.7. The coordination 
environment around the silver atom in complexes 2.5b, 2.5c and 2.5d which 
have ClO4
-, BF4
-, PF6
-, counteranions, respectively, are largely similar. In each 
case, dimeric structures were observed, consisting of two monomeric 
[Ag(py)2]
+ units held together by unsupported Ag


Ag interactions. Within 
each monomeric unit, the two pyridine ligands are coplanar, the AgN bond 
lengths of the complexes fall within the narrow range of 2.126(4)2.129(6) Å, 
and the NAgN bond lengths do not deviate significantly from 180. The 
strength of the argentophilic interactions present in these complexes is evident 
from the AgAg distances of 2.96–3.00 Å, which are just slightly longer than 
the Ag–Ag separation in metallic silver (2.889 Å).150 The two [Ag(py)2]
+ units 
are staggered with respect to each other with a N–Ag


Ag–N dihedral angle of 
ranging from 90.00 in 2.5b to 94.13 in 2.5c, which probably optimizes the 
AgAg interaction energy at the expense of face to face  stacking 
interactions between the pyridine ligands within the dimer. Nevertheless, 
columns of adjacent dimeric units in 2.5b and 2.5c are oriented in a manner 
107 
 
that allows for ‘head-to-head’  stacking interactions to occur between pairs 
of dimers (centroid-centroid distance = 3.569 Å in 2.5b, and 3.541 Å in 2.5c). 
In 2.5d, however, ‘head to tail’  stacking of the pyridine rings occurs, with 
a longer centroid–centroid distance of 3.734 Å.  
 
In contrast, complex 2.5a, which has a more coordinating TfO- anion, exists as 
a dimer in the solid state, with two [Ag(py)2]
+ units held together by two 
bridging TfO- anions. As a result, the silver atom adopts a T-shaped geometry, 
and is coordinated to two nitrogen atoms of two distinct pyridine ligands and 
one oxygen atom from the TfO- anion. The interaction of the Ag metal center 
with the TfO- anion results in a greater deviation of the NAgN bond angle 
from linearity (166.67), which is accompanied by an increase in the Ag–N 
bond distance to 2.153 Å. The two pyridine ligands bonded to Ag are also not 
coplanar, which reflected by the dihedral angle of 63.97(6). 
 
Although the structures of the complexes in solution might differ from their 
structures in the solid state, the above analysis of the structural characteristics 
has provided useful information regarding the relative strength of the AgN 
bond in the various pyridine complexes. A general decrease in AgN bond 
length was observed with increasing basicity of the pyridine ligands. Shorter 
and stronger AgN bonds reflect a greater donation of electron density from 
the pyridine ligands to Ag(I), which in turn affects its Lewis acidity and ability 
to coordinate to the substrate during the catalytic reaction. This is in 
agreement with experimental observations where Ag(I) complexes of the least 
basic 4-acetylpyridine ligand showed superior activities compared to 
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complexes of other more basic pyridine ligands. In addition, the ability of 
weakly coordinating anions such as triflate to bind to Ag(I) and perturb the 
original linear coordination geometry of Ag(I) to a significant extent supports 
experimental observations that the nature of counteranion of the catalyst can 
affect the outcome of the reaction, and that strongly coordinating anions are 
detrimental to the efficiency of the catalyst. 
 
2.7 Mechanistic Considerations 
 
Scheme 2.13. Possible mechanism for the Ag(I)-catalyzed cyclization of 2.1a  
 
Based on experimental findings and by analogy with the proposed mechanism 
for the intramolecular hydroamination reactions catalyzed by gold, a 
mechanism for the formation cyclization of 2.1a under silver catalysis is 
proposed (Scheme 2.13). In the first step, one of the pyridine ligands on Ag(I) 
dissociates, creating an electrophilic and coordinatively unsaturated Ag(I) 
109 
 
species that coordinates to the alkyne in substrate 2.1a, activating it towards 5-
exo-dig attack by the imidate nitrogen. The ability of one of the pyridine 
ligands to dissociate appears to be crucial, as Ag(I) complexes with chelating 
ligands, such as [Ag(phen)2]OTf, or strongly donating pyridine ligands, such 
as [Ag(4-DMAP)]OTf, were inactive towards the transformation. The anti-
addition of the imidate nucleophile to the alkyne is supported by the 
stereochemistry of the cyclization products of internal alkyne substrates and 
the products of the trapping reactions of the vinyl silver intermediate 2.13 with 
electrophilic halogen sources. The zwitterionic vinyl silver intermediate 2.13 
then undergoes protodemetallation to deliver the oxazoline product 2.2a. The 
protodemetallation step may be assisted by the counteranion or free pyridine 
ligands. The free pyridine ligands can also act as acid scavengers, preventing 
the isomerization of 2.2a to the oxazole 2.3a. 
 
2.8 Conclusion 
In summary, silver salts have been found to be active catalysts for the 
intramolecular hydroamination addition of trichloroacetimidates to alkynes, 
where the nature of the counteranion and solvent affected both the yields and 
selectivity of the reaction. In the cyclization of the model substrate 2.1a, the 
use of AgTFA in MeCN afforded the oxazoline product 2.2a, while AgOTf in 
DCE resulted in the formation of the oxazole 2.3a (Scheme 2.10). The 
formation of 2.3a occurs via the Brønsted acid-catalyzed isomerization of 2.2a, 
due to traces of TfOH produced in situ during the reaction. 
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Scheme 2.14. Counteranion and solvent effects in the cyclization of model 
substrate 2.1a 
 
The silver(I) complexes of N-donor ligands such as 1,10-bipyridine and 
pyridine were also found to be active catalysts for the above transformation. 
Encouragingly, the bis(pyridine)silver(I) triflate complex, [Ag(py)2]OTf, 
showed improved yields in the cyclization of the model substrate, and was 
also able to effect the cyclization of challenging internal alkyne substrates 
previously not possible with gold catalysts.  
 
Further fine-tuning of the ligand electronic properties and counteranion of the 
silver(I) bis(pyridine) catalysts showed that electron-withdrawing substituents 
on the pyridine ligands, and the use of weakly coordinating counteranions led 
to an improvement in the efficiency of the catalyst. The silver(I) bis(4-
acetylpyridine) hexafluorophosphate complex (2.10d) could promote the 
cyclization of propargylic and homopropargylic substrates with bromo-
substitution at the alkyne to afford the corresponding (Z)-methylene 
bromooxazoline and oxazolines in quantitative yields and short reaction times 
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with catalytic loadings as low as 1 mol%, delivering a significant 
improvement to the process catalyzed by silver salts. 
 
The trapping of vinylsilver intermediates in the reaction with NBS and NCS 
was demonstrated as a complementary approach that allows access to the 
opposite (E)-isomers of the halomethylene oxazolines and oxazines in 
moderate yields. It also lends support to the proposed mechanism, where anti-
addition of the imidate nucleophile to the alkyne is believed to occur. 
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Chapter 3 Cyclosiomerization of Propargyl Amides 
 
In the previous chapter, the silver-catalyzed intramolecular addition of 
trichloroacetimidates to alkynes to give 4-methylene oxazolines (2.2) and 
oxazoles (2.3) was described (Scheme 3.1a). In this chapter, the 
cycloisomerization of propargyl amides (3.1), which could potentially afford 
the 5-alkylidene oxazolines (3.2), oxazoles (3.3) and also oxazines (3.4) 
(Scheme 3.1b), will be explored. The reaction involves a formal OH addition 
to the alkyne, in contrast to the NH addition described previously.   
 
 
Scheme 3.1. (a) Intramolecular hydroamination of trichloroacetimidates with 
alkynes described in Chapter 2; (b) Cycloisomerization of propargyl amides 
described in this chapter. 
 
The cycloisomerization of propargyl amides 3.1 was first reported to be 
catalyzed by strong bases such as sodium hydride to give the corresponding 
oxazoles 3.3. 151  The use of transition metal catalysts, which initiate the 
transformation by activation of the alkyne, has allowed the reaction to proceed 
under milder conditions and with greater functional group tolerance. Gold and 
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palladium catalysts, in particular, have proven to be efficient and versatile 
catalysts for the transformation. With Pd(0) and Pd(II) catalysts, 152  the 
cycloisomerization step usually forms part of a tandem reaction sequence, 
preceding reactions that allow further elaboration of the oxazoline products; 
and an example of a Pd(II)-catalyzed cyclization-alkoxycarbonylation reaction 
of propargyl amides is shown in Scheme 3.2.  
 
 
Scheme 3.2. An example of a Pd(II)-catalyzed cyclization-
alkoxycarbonylation reaction of propargyl amides 
 
Table 3.1. Comparison of the reactivity of several catalysts in the 
cycloisomerization of propargyl amides 
 Cat. 
(Loading) 
Reaction 
Cond. 
R1 R2, R3 R4 Prod. 
(Yield) 
Ref 
1 AuCl3 
(2.5-5 
mol%) 
CH2Cl2, 20 
C, 5 min - 
48 h; 
or 
MeCN, 20-
50 C, 2 - 
96 h 
alkyl, aryl, 
heteroaryl 
H, H H 3.3 
(40% -
quant.) 
153
, 
154 
2 [(Ph3P)Au]
X (1-5 
mol%) 
(X = OTs 
or NTf2) 
CH2Cl2, 
r.t., 3 h - 6 
days; 
alkyl, aryl, 
heteroaryl 
H, H H 3.2 
(37-
95%) 
154 
3 [(IPr)AuCl] THF, r.t., aryl, furyl, H, H alkyl 3.2 155 
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(5 mol%), 
AgOTs 
(5 mol%) 
16 h adamantyl and/or 
3.4 
(28-
78%) 
4 [(IPr)AuCl] 
(5 mol%), 
AgOTs 
(5 mol%) 
THF, r.t.-
40 C, 12 h 
- 5 days 
aryl, furyl, 
benzyl, 
tert-butyl 
H, H aryl, 
heteroaryl 
3.2 
and/or 
3.3 
(14-
94%) 
155 
5 W(CO)6  
(20 mol%), 
DABCO 
(1.0 eq.) 
 
1. toluene, 
r.t., 20 h, 
N2,  = 350 
nm 
2. TMAO, 
THF. 
alkyl, aryl H, H H 3.2 
(80-
91%) 
156 
6 W(CO)6  
(20 mol%), 
DABCO 
(1.0 eq.) 
 
1. toluene, 
r.t., 20 h, 
N2,  = 350 
nm 
2. TMAO, 
THF 
alkyl, aryl Me, H H 3.2 and 
3.3 
(20-
73%) 
156 
7 Mo(CO)6 
or W(CO)6 
(20 mol%), 
DABCO 
(1.0 eq.) 
1. toluene, 
r.t., 20 h, 
N2,  =350 
nm 
2. TMAO, 
THF 
alkyl, aryl Me, Me H 3.2 and 
3.4 
(8-
86%) 
156 
8 FeCl3 
(30-50 
mol%) 
DCE, 80 
C, 3 - 8 h, 
alkyl, aryl, 
heteroaryl 
H, H H 3.3 
(65%-
quant.) 
157 
9 ZnI2 
(50 mol%) 
CH2Cl2, 
r.t., 18 min 
- 4 h 
alkyl, aryl, 
indolyl 
Me, Me;  
or 
-(CH2)5- 
H 3.2 
(83-
97%) 
157 
10 ZnI2 
(1.0 eq.) 
CH2Cl2, 
r.t.-45 C, 
3 - 24 h 
alkyl, aryl, 
heteroaryl 
H, H H 3.2 
(62-
94%) 
157 
11 AgSbF6 
(1-5 mol%) 
CH2Cl2, 
r.t., 5 - 10 
min 
alkyl, aryl Me, Me; 
Et, Et;  
or 
-(CH2)5- 
H 3.2 
(89-
98%) 
62 
12 CuI 
(10 mol%) 
DCE, 80 
C, 
overnight 
aryl, 
heteroaryl 
Me, Me;  
or 
-(CH2)5- 
H 3.2 
(76-
93%) 
158 
 
When gold catalysts were employed, the product selectivity was found to be 
dependent upon the oxidation state and the ligand used (Table 3.1, entries 1-4). 
Au(III) chloride153,154 afforded the aromatic oxazole products 3.3 exclusively 
via the methyleneoxazoline intermediate 3.2, which was detected by in situ 
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NMR spectroscopy (entry 1), while Au(I) phosphine catalysts155 gave the 
methylene oxazoline products 3.2 in good yields (entry 2). Notably, the 
reaction scope could also be extended to internal alkynes when a Au(I) N-
heterocyclic carbene (NHC) catalyst was used.155 In these cases, the selectivity 
towards the 5-membered oxazolines/oxazoles (3.2 and 3.3) and 6-membered 
oxazines (3.4) was highly substrate-dependent. With alkyl substituents at the 
alkyne, a mixture of both 3.2 and 3.4 was obtained (entry 3), with increasing 
selectivity towards 3.2 as the size of the alkyl substituent increases. In contrast, 
with aryl substituents at the alkyne, only the 5-membered oxazolines (3.2) and 
oxazoles (3.3) were obtained (entry 4); the formation of 3.3 was only observed 
with certain substrates where the long reaction times required resulted in the 
isomerization of 3.2 to 3.3. 
 
The only drawback associated with the use of Pd and Au catalysts is their high 
cost. As a result, other cheaper alternatives have also been explored. 
Molybdenum(0) and tungsten(0) hexacarbonyl complexes could also catalyze 
the reaction (entries 5-7);156 however, higher catalytic loadings (20 mol%), the 
presence of 1 equivalent of a base (1,4-diazabicyclo[2.2.2]octane, DABCO), 
UV irradiation and an inert atmosphere were required. In addition, an 
oxidative work-up procedure involving trimethylamine N-oxide (TMAO), was 
required. It was also observed that the propargylic substituents (R2 and R3) had 
a large effect on the selectivity of the reaction. 
 
The only other catalyst that can catalyze the selective formation of oxazoles 
3.3 is iron(III) chloride (entry 8). 157 Despite the higher catalytic loading (30-
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50 mol%) and harsher reaction conditions required compared to AuCl3, good 
yields and a broad substrate scope was observed. There is also the added 
advantage of being able to obtain the oxazole products in a one-pot, sequential 
acylation-cyclization reaction starting from propargyl amine, without the need 
to isolate and purify the propargyl amide intermediate. Similarly, this one-pot 
synthetic approach could also be extended to the synthesis of oxazolines 3.2 
using 50 mol% of zinc(II) iodide as a catalyst (entry 9). 157 However, it should 
be noted that the reaction ceases to be catalytic in ZnI2 and harsher reaction 
conditions are required when geminal alkyl groups in the propargylic position 
are absent in the substrate (entry 10).  
 
Similar to ZnI2, the substrate scope of copper
158  and silver salts62 is also 
limited to substrates with propargylic geminal dialkyl substitution. 
Nevertheless, good yields can be achieved with these substrates within 15 
minutes in the presence of only 1-5 mol% of AgSbF6 (entry 11). Copper(I) 
iodide, in comparison, is less efficient compared to AgSbF6, as a higher 
catalyst loading of 10 mol% is required, in addition to higher temperatures and 
longer reaction times. The reaction is also not tolerant of alkyl groups at the 
position beside the carbonyl carbon (R1). 
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3.1. Synthesis of Substrates 
 
Scheme 3.3. Possible synthetic routes to propargyl amides 3.1: (a) acylation of 
propargyl amines; (b) nucleophilic substitution of propargyl alcohols by 
primary amides 
 
Two possible routes for the synthesis of the propargyl amide substrates 3.1 
were envisioned. The first would involve the acylation of propargyl amines 
(Scheme 3.3, method a). Internal alkyne substrates with different R1 
substituents can be readily synthesized by this method, as a wide range of 
different acyl chlorides are commercially available. However, it is difficult to 
introduce substitution on both the propargylic (R2 and R3) and alkyne (R4) 
positions using this method because of the limited number of primary 
propargyl amines that are commercially available and the lack of efficient 
methods for their preparation. For example, Hashmi et al. devised a three-step 
synthetic method (Scheme 3.4a) for the synthesis of internal alkyne substrates 
which began with the preparation of the appropriately substituted propargyl 
amine, followed by acylation of the amine as a final step. Though highly 
flexible, the method required the use of inert conditions, low temperatures and 
tedious workup procedures.155   
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Scheme 3.4. Preparation of internal alkyne substrates via (a) the preparation of 
substituted propargyl amines, (b) the nucleophilic substitution reaction of 
propargyl alcohols with primary amides. 
 
During this work, an alternative approach was envisaged (Scheme 3.3, method 
b), involving a nucleophilic substitution reaction of propargyl alcohols with 
primary amides. This might be a more efficient method as propargylic 
alcohols containing substituents at R2, R3 and R4 can be easily prepared by 
addition of the appropriate acetylide nucleophile to aldehydes of ketones 
(Scheme 3.4b). As the only report on the cycloisomerization of non-terminal 
propargyl amides using Au(I) catalysts was focused on the effect of steric and 
electronic influences of R1 and R4 on product selectivity (Table 3.1, entries 3 
and 4), it would be interesting to investigate the influence of substituents at R2 
and R3 of internal alkyne substrates on the regioselectivity of the reaction.155 
The introduction of substituents at these positions could also potentially result 
in an electronic bias at the alkyne moiety, especially if R2, R3 and R4 possess  
marked differences in electronic properties.  
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Numerous transition metal compounds and Lewis acids such as Ru(II) thiolate 
complexes, 159  iron(III) chloride, 160  molybdenum(V) chloride, 161   sodium 
tetrachloroaurate(III) dihydrate, 162   silver(I) triflimide, 163  bismuth(III) 
chloride, 164  bismuth(III) triflate, 165  aluminum(III) triflate 166  and tin(II) 
chloride 167  have been reported to promote the nucleophilic substitution 
reactions of propargylic alcohols with nitrogen nucleophiles such as aryl 
amides, carbamates and sulfonamides. However, these methods present 
drawbacks either in terms of cost, and/or relatively high catalytic loadings of 
5-10 mol%. 
  
In a recent report by Zheng et al.,168 it was reported that the ion exchange resin 
Amberlite (IR-120H) can promote the propargyl substitution reaction with 
various carbon and heteroatom nucleophiles in excellent yields, including an 
example where an amide nucleophile was used. Prior to this work, there were 
no other reported literature examples of Brønsted-acid-catalyzed nucleophilic 
substitution reactions involving propargylic alcohols with less reactive 
nitrogen nucleophiles such as aryl amides, carbamates and sulfonamides. 
However, the possibility of using an aqueous solution of HBF4 has been 
recently demonstrated in the Diez-Gonzalez group at Imperial College London 
to promote the propargyl substitution reactions with oxygen nucleophiles, 
carbamates and sulfonamides in good yields.169 Hence the analogous reaction 
was explored in this work. 
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Scheme 3.5. Propargylic substitution reaction of 1-(4’-methoxyphenyl)-hept-
2-yn-1-ol (3.4l) with benzamide catalyzed by 50 wt% aq. HBF4. 
 
Table 3.2. Optimization of reaction conditions for the HBF4-catalyzed 
propargylic substitution reaction of 3.4l with benzamide 
Entry 
Cat. 
Loading 
(mol%) 
Benzamide 
(Equiv.) Solvent 
Temp. 
(C) 
Time 
(h) 
Yielda 
of 3.1l 
(%) 
Yielda 
of 3.5 
(%) 
1 2 2 acetone 23 6 94 0 
2 2 2 CH2Cl2 23 6 94 0 
3 2 2 MeCN 80 1 75 0 
4 2 1.5 acetone 23 6 20 35 
5 5 2 acetone 23 4 92 0 
6 1 2 acetone 23 24 NDb NDb 
a Isolated yields of product after purification by column chromatography on silica. b Isolated 
yields were not determined, as incomplete conversion of 3.4l was observed by TLC. 
 
The substitution reaction between 3.4l and benzamide (2 equivalents) was 
initially conducted in acetone at ambient temperature,  in the presence of 2 
mol% of aqueous 50 wt% HBF4 (Scheme 3.5). Pleasingly, the desired amide 
3.1l was obtained in an excellent yield of 94% after 6 h (Table 3.2, entry 1). 
Changing the solvent to CH2Cl2 resulted in an identical yield (entry 2); and 
while MeCN allowed the reaction temperature to be elevated to 80 C, 
shortening the reaction time to 1 h, a diminished yield of 75% was obtained 
(entry 3). When the amount of benzamide nucleophile was reduced to 1.5 
equivalents, the formation of an ether side product 3.5 was detected, as a result 
of dimerization of the propargyl alcohol 3.4l. Increasing the amount of HBF4 
to 5 mol% decreased the reaction time to 4 h but failed to improve the yield, 
while decreasing the amount of HBF4 to 1 mol% led to incomplete conversion 
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of 3.4l. Therefore, a catalyst loading of 2 mol% and 2 equivalents of the amide 
nucleophile was optimal. 
 
 
Scheme 3.6. Preparation of propargyl amide substrates via the HBF4-catalyzed 
substitution of propargylic alcohols 
 
Table 3.3. HBF4-catalyzed propargylic substitution reaction of propargylic 
alcohols 
Entry R1 R2 R3 R4 Conditionsa t (h) Product 
Yieldb 
(%) 
1 Ph PMP H Bu 
acetone, 
23 C 
6 3.1l 94 
2 Ph PMP H TMS 
acetone, 
23 C 
6 3.1m 68 
3 Ph PMP H  
acetone, 
23 C 
6 3.1n 89 
4 Ph PMP H Ph 
acetone, 
23 C 
6 3.1p 77 
5 Ph PMP H 
 
acetone, 
23 C 
1 3.1o 7 
6 Ph PMP H 
 
toluene, 
111 C 
1 3.1o 29 
7 Ph PMP H H 
acetone, 
23 C 
6 3.1q 15 
8 Ph PMP H H 
MeCN, 
80 C 
1 3.1q 66 
9 Cy PMP H Bu 
acetone, 
23 C 
24 3.1s 
 
10 Cy PMP H Bu 
MeCN, 
80 C 
12 3.1s 66 
11 Me PMP H Bu 
acetone, 
23 C 
24 
  
12 Me PMP H Bu 
MeCN, 
80 C 
24 
  
13 Ph Ph H H 
acetone, 
23 C 
24 3.1r 
 
14 Ph Ph H H 
MeCN, 
80 C 
12 3.1r 9 
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15 Ph Me Me H 
acetone, 
23 C 
24 
  
a Reaction conditions: amide (10 mmol, 2.0 eq.), propargyl alcohol (5.0 mmol, 1.0 eq.), 50 wt% 
aq. HBF4 (17.6 L, 2 mol%), solvent (5 mL), temperature (C). 
b Isolated yields of product 
after purification by column chromatography on silica. 
 
With these optimal conditions in hand, the preparation of several propargyl 
amides with different substituents at the position beside the carbonyl group 
(R1), the propargyl position (R2, R3) and alkyne (R4) was attempted (Scheme 
3.6 and Table 3.3). The reaction with propargylic alcohols, where R2 = 4-
methoxyphenyl and R4 = alkyl, aromatic and trimethylsilyl substituents, all 
proceeded smoothly in good to excellent yields (entries 1-4), with the 
exception of the propargyl alcohol substrate where R4 = cyclohexenyl (entry 
5). In this case, heating in toluene at reflux afforded only a slight improvement 
in yield from 7% to 29% (entry 5 vs. 6). The -conjugated system present in 
this system could have caused regioselectivity issues that led to the formation 
of undesired side products. Similarly, the reaction of the propargyl alcohol 
with a terminal alkyne group (R4 = H) afforded the corresponding amide 
product in a poor yield of 15% when acetone was used as the reaction solvent 
(entry 7). However, the yield could be raised to 66% by changing the solvent 
to MeCN and shortening the reaction time by elevating the reaction 
temperature to 80 C (entry 8). 
 
 
Scheme 3.7. Resonance forms of amides 
 
123 
 
The reaction was also extended to include alkyl amides such as 
cyclohexylamide (entries 9 and 10), although the reaction with acetamide was 
did not furnish any product (entries 11 and 12). This is attributed to greater 
interaction of the nitrogen lone pairs with the carbonyl group (Scheme 3.7) 
compared to cyclohexylamide and benzamide, resulting in a reduced 
nucleophilicity for this reactant.  
 
The presence of an electron-rich aromatic ring at the propargyl position (R2) 
seems to be necessary for the substitution reaction to take place. This is 
indicative of a SN1 reaction that occurs via a propargylic cation intermediate. 
When the 4-methoxyphenyl substituent at R2 was replaced with a phenyl 
substituent, none of the desired amide product was formed in acetone at room 
temperature (entry 1 vs. 13). Even under harsher reaction conditions of reflux 
in acetonitrile, the amide product was only obtained in 9% yield after 12 h 
(entry 14). In addition, no reaction occurred when the aromatic propargylic 
substituent was replaced by methyl groups (entry 15). In this case, nearly all of 
the starting materials could be recovered.    
 
It was also noted that tandem  propargylation and cycloisomerization reactions 
between propargyl alcohols and aryl amides to oxazoles can be achieved in 
‘one-pot’ using certain dual catalyst combinations such as Ru(II,III)/Au(III)170 
and Ru(III)/Zn(III) 171 , stoichiometric amounts of p-toluenesulfonic acid,172 
and ytterbium(III) triflate.173 This is very attractive as it bypasses the need to 
isolate the acyclic amide substrate. With this in mind, the propargyl alcohol 
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3.4l was subjected to two equivalents of benzamide in the presence of 10 mol% 
of AgOTf or [Ag(Py)2]OTf  (2.5a) in toluene at 60 C for 16 h (Scheme 3.8). 
 
 
Scheme 3.8. Propargylic substitution reaction of 1-(4’-methoxyphenyl)-hept-
2-yn-1-ol (3.4l) with benzamide in the presence of AgOTf and [Ag(py)2]OTf 
(2.5a) 
 
It was found that AgOTf promoted the complete conversion of the propargyl 
alcohol 3.4l to the corresponding amide 3.1l, but did not catalyze the 
cycloisomerization of 3.1l to the corresponding oxazoline or oxazole. The 
bis(pyridine) complex 2.5a, on the other hand, could not catalyze the 
propargylic substitution reaction, and most of 3.4l remained largely unreacted. 
 
3.2 Initial Screening of Silver(I) and Copper(I) Salts 
 
Scheme 3.9. Model reaction for the initial screening of Ag(I) and Cu(I) salts 
 
N-Benzoyl propargyl amide 3.1a was initially selected as the model substrate 
to assess the catalytic activity of several silver and copper salts and to 
determine the optimum reaction conditions for the cycloisomerization reaction 
(Scheme 3.9). 3.1a was chosen as it lacks substituents at the propargylic 
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position, and the results will not be biased by the operation of the Thorpe-
Ingold effect. In these experiments, a mixture of 3.1a and 10 mol% of the 
silver or copper salt was stirred in CH2Cl2 at room temperature. After 6 h, the 
internal standard (1,3,5-methoxybenzene) was added, and the solvent was 
removed in vacuo. 1H NMR analyses of the crude reaction mixtures in CDCl3 
showed the appearance of multiplet resonances at 4.82 and 4.36 ppm, which 
correspond to the diastereomeric alkene protons of 3.2a. No other peaks were 
observed in the 1-3 ppm region, other than the triplet resonance at 2.28 ppm 
corresponding to the alkyne proton of 3.1a, indicating that the oxazole product 
3.3a was not formed. The NMR yields of 3.2a were calculated by comparing 
the integrals of the alkene protons of 3.2a with the proton signal of 1,3,5-
methoxybenzene, and the results are reported in Table 3.4. 
 
Table 3.4. Initial screening of Ag(I) and Cu(I) salts in the cycloisomerization 
of 3.1aa 
Entry Catalyst 
pKa of 
conjugate 
acid 
t (h) Conversion
b 
(%) 
Yieldb 
of 2.2a 
(%) 
1 AgOAc 4.8131 6 
  
2 AgTFA 0.2131 6 72 60 
3 AgClO4 -1.6
174 6 94 15 
4 AgOTs -2.8133 6 
 trace 
5 AgBF4 -4.9
134 6 
 trace 
6 AgSbF6 -13
135 6 56 40 
7c AgSbF6 -13
135 10 min 
 7 
8c AgSbF6 -13
135 24 h 
 25 
9 AgOTf -14136 6 46 29 
10 AgPF6 -20
135 6 61 56 
11 [Cu(OTf)]2
C6H6 -14
136 24 h 
  
12 [Cu(MeCN)4]PF6 -20
135 24 h 12 5 
13 TfOH -14136 6 h 
  
a Reaction conditions: substrate 3.1a (0.4 mmol), catalyst (0.04 mmol, 10 mol%), 23 C,  
CH2Cl2 (1 mL). 
b Determined by 1H NMR spectroscopy, using 1,3,5-trimethoxybenzene as 
internal standard. c 5 mol% catalytic loading, MeNO2 used as solvent. 
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Although the conversions and yields obtained were generally modest, only the 
unaromatized oxazoline product 3.2a was obtained in all cases. A 
counteranion effect on catalytic activity was also observed, which again did 
not correlate with the pKa values of the conjugate acids. AgTFA gave the 
highest yield of 3.2a in 60% yield after 6 h (entry 2), and the copper(I) 
tetrakis(acetonitrile) hexafluorophosphate complex, [Cu(MeCN)4]PF6, only 
resulted in a low level of conversion after 24 h (entry 12). A control 
experiment revealed that triflic acid could not catalyze the reaction (entry 13).  
 
Harmata et al. have previously reported that 3.2a was obtained in 91% yield 
within 10 min when 5 mol% of AgSbF6 in MeNO2 was used. However, in our 
hands, only 7% yield of 3.2a was obtained under identical conditions (entry 7). 
Prolonging the reaction time to 24 h only resulted in 25% yield (entry 8). 
Indeed, further correspondence with Prof. Hamata revealed that the reported 
example is irreproducible, and an errata has subsequently been issued.175 
 
3.3 Screening of Ag(I) Bis(pyridine) Complexes 
Having established the performance of simple silver salts in the 
cycloisomerization of the model substrate 3.1a, the effect of adding ligands 
was explored.  To provide a direct comparison to the previous work described 
in Chapter 2, the bis(pyridine) Ag(I) triflate complexes 2.5a and 2.10-2.13a, 
were assessed for their catalytic activity towards the cycloisomerization of the 
model substrate 3.1a. The results are summarized in Table 3.5. 
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Table 3.5. Screening of Ag(I) bis(pyridine) complexes in the 
cycloisomerization of 3.1aa 
Entry Catalyst Solvent t (h) Conv
b 
(%) 
Yieldb 
of 2.2a 
(%) 
1 [Ag(py)2]OTf  
(2.5a) 
CH2Cl2 6 29 8 
2 [Ag(4-Ac-Py)2]OTf  
(2.10a) 
CH2Cl2 6 47 26 
3 [Ag(4-MeO-Py)2]OTf 
(2.11a) 
CH2Cl2 6 94 85 
4 [Ag(4-DMAP)2]OTf 
(2.12a) 
CH2Cl2 6 23 5 
5 [Ag(4-Me-Py)2]OTf 
(2.13a) 
CH2Cl2 6 75 59 
6 [Ag(4-MeO-Py)2]ClO4 
(2.11b) 
CH2Cl2 6 100 98 
7 [Ag(4-MeO-Py)2]BF4 
(2.11c) 
CH2Cl2 6 100 >99 
8 [Ag(4-MeO-Py)2]PF6 
(2.11d) 
CH2Cl2 6 100 >99 
9 [Ag(4-MeO-Py)2]SbF6 
(2.11e) 
CH2Cl2 6 100 >99 
10 [Ag(4-MeO-Py)2]CF3CO2 
(2.11f) 
CH2Cl2 6 49 31 
11c 2.11c CH2Cl2 24 100 93 
12c 2.11d CH2Cl2 24 98 96 
13c 2.11e CH2Cl2 24 100 95 
14 2.11d acetone 6 41 22 
15 2.11d THF 6 61 50 
16 2.11d DCE 6 100 99 
17 2.11d MeCN 6 39 20 
18 2.11d MeOH 6 24 8 
a Reaction conditions: substrate 3.1a (0.4 mmol), catalyst (0.04 mmol, 10 mol%), 23 C,  
CH2Cl2 (1 mL). 
b Determined by 1H NMR spectroscopy, using 1,3,5-trimethoxybenzene as 
internal standard. c 5 mol% of catalyst used. 
 
The parent bis(pyridine)silver(I) triflate complex, 2.5a, only gave a 
disappointing yield of 8% after 6 h (entry 1), lower than that obtained with 
AgTFA as the catalyst (Table 3.4, entry 2). Screening of four other silver(I) 
complexes of different pyridyl ligands, 2.10-2.13a, showed that the efficiency 
of the catalyst increased in the order: 4-DMAP < py < 4-Ac-py < 4-Me-py < 
4-MeO-Py. With all five complexes, some catalyst deactivation was apparent 
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from the formation of insoluble white precipitates during the reaction. This 
deactivation occurred to varying extents depending on the pyridine ligand, 
being the most severe with the DMAP complex 2.10a. With the exception of 
complexes 2.10a and 2.12a, bearing 4-acetylpyridine and 4-
dimethylaminopyridine ligands respectively (entries 2 and 4), a general 
increase in catalyst efficiency was brought about by more electron-donating 
pyridine ligands. This result is highly significant, as the trend is opposite to 
that observed in the hydroamination reaction described in the previous Chapter 
(section 2.4). This implies that a different rate-limiting step operates in the 
OH addition, compared to the NH addition.  
 
In the previous work on hydroamination reactions, the activation of the alkyne 
by -coordination was proposed to be the rate-limiting step, on the basis that 
the reaction is accelerated by electron-poor pyridyl ligands (Section 2.4). For 
the cyclisation of 3.1a, the opposite trend was observed. This led us to 
postulate that the protodemetallation to be the rate-limiting step (vide infra). 
 
Having determined that the bis(4-methoxypyridine) Ag(I) triflate complex 
2.11a gave the highest conversions and yields among the series of silver(I) 
complexes, the effect of the counteranion on the catalytic activity was 
investigated. At 10 mol% catalytic loading, the bis(4-methoxypyridine) Ag(I) 
complexes with the non-coordinating counteranions PF6
-, BF4
-, SbF6
- and 
ClO4
- produced near quantitative yields (entries 6-9), while those of the 
slightly coordinating TfO- and CF3CO2
- counteranions resulted in significantly 
lower yields (entries 3 and 10). A reduction of the catalytic loading to 5 mol% 
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revealed that the complex with the PF6
- counteranion (2.11d) was the best 
catalyst for the reaction (entries 11-13). A solvent screen (entries 8 and 14-18) 
showed that chlorinated solvents CH2Cl2 and DCE were the best solvents for 
the reaction. CH2Cl2 was used as the solvent for further investigation of the 
substrate scope, as it is less toxic and has a lower boiling point compared to 
DCE, facilitating its removal from the product. 
 
3.4 Substrate Scope 
The optimized reaction conditions were used to investigate the scope and 
limitations of the Ag(I) bis(4-methoxypyridine) hexafluorophosphate complex 
2.11d (Table 3.6). The propargyl amide substrates 3.1a-q and 3.1s were 
subjected to 10 mol% of 2.11d in CH2Cl2 at room temperature, and NMR 
yields were obtained in a similar manner to that described in Section 3.2: by 
calculating the relative integral ratios of the alkene protons in the product 
relative to those of 1,3,5-trimethoxybenzene. With more reactive substrates 
such as 3.1i and 3.1q, the catalytic loading was reduced; while an increase in 
catalytic loading to 15 mol% was necessary with the internal alkyne substrates 
3.1l, m and o which showed low conversions at 10 mol% catalytic loading.  
For substrates that showed conversions to the desired products, the reaction 
was repeated on a 2.0 mmol preparative scale and the products were isolated 
and characterized after purification by column chromatography or preparative 
TLC. Due to the volatility of the products, only the NMR yields in CD2Cl2 
were reported for substrates 3.1b and 3.1c. 
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With the exception of substrate 3.1m, the reactions proceeded with complete 
regioselectivity towards the 5-membered methylene oxazline products. 
Substrates bearing alkyl and aryl substituents at the amide (R1) were well 
tolerated, leading to the corresponding heterocycles in good to excellent yields 
(entries 1-3). The presence of a crotonyl group in substrate 3.1d did not affect 
the yield (entry 4); however, the presence of a vinyl group resulted in 
decomposition of the catalyst (entry 5). In comparison, substrates with 
electron-withdrawing substituents at the amide position resulted in poorer 
yields (entries 7 and 8), presumably due to the reduced nucleophilicity of the 
carbonyl oxygen atom. The difficulty in promoting the cycloisomerization of 
such substrates was also observed using the Au(I) catalysts,154 where higher 
catalytic loadings and prolonged reaction times up of to 2 days, were required. 
As expected, the introduction of gem-dimethyl or electron-donating 
substituents at the propargylic position (R2/R3) resulted in faster reaction times 
and satisfying yields of between 90-96% (entries 9 and 10).  
 
Substrates 3.1j and 3.1k with two propargylic moieties delivered the double 
cycloisomerized products only in moderate yields (entries 10 and 11). 
Complete conversion of 3.1j was obtained after 24 h, but the yield of 3.2j was 
compromised by the formation of other unknown side products. This problem 
was not encountered with the Au(I) catalyst, [(Ph3P)Au]OTs, where 5 mol% 
of catalyst under identical reaction conditions afforded 3.2j in 80% isolated 
yield.154 
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Even more interestingly, substrates with alkyl and phenyl substituents at the 
alkyne (R4) underwent cycloisomerization smoothly with good regioselectivity 
to give the corresponding five-membered alkylidene oxazoline products 
exclusively (entries 13-17). However, when the phenyl substituent at the 
amide position (R1) was replaced with a cyclohexyl substituent, a complex 
mixture of products was obtained (entries 13 vs. 18), showing the greater 
sensitivity of internal alkyne substrates to substitution at this position 
compared to the terminal alkyne substrates.  
 
It was mentioned in the beginning of this Chapter that the use of Au(I) 
catalysts furnished a mixture of both the five-membered and six-membered 
oxazoline and oxazines with substrates that possess alkyl substituents at the 
alkyne (refer to Table 3.1). This issue of 5-exo/6-endo regioselectivity, 
however, does not arise with our bis(pyridine) Ag(I) catalyst. However, both 
the E- and Z- isomers of the oxazoline products were obtained (entries 13-15). 
The selectivity towards the Z-isomer is greater when the alkyl substituent at 
the alkyne is large, possibly due to the greater instability of the E-isomer as a 
result of steric hindrance with the 4-methoxyphenyl substituent. These results 
contrast with those obtained in the previous Chapter, where anti addition of 
the imidate nucleophile to the alkyne occurs, resulting in complete 
diastereoselectivity towards the Z-isomer. This again highlights the differences 
in the mechanism brought about by a change in the nucleophile. 
 
The only exception was with substrate 3.1p, when the alkyne is substituted by 
a phenyl group. In this case, the reaction proceeded with complete 
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regioselectivity and diastereoselectivity towards the Z-isomer of the five-
membered methylene oxazoline product (entry 16). This result was also 
obtained with the Au(I) catalyst, [(IPr)AuCl]/AgOTs.154 The Z-configuration 
of the product, 3.2p, was confirmed by its solid state structure (Fig. 3.1) and 
nOe observed by 1H spectroscopy. A long-rage allylic 4J coupling can be 
observed between the alkenyl and methine protons, which could be used to 
identify Z-isomers in the other product mixtures. With the exception of 3.2p 
and the Z-isomer of 3.2o, the cycloisomerization products of the internal 
alkyne substrates decomposed during purification by column chromatography. 
For this reason, only their NMR yields are reported in Table 3.6.  
  
 
 
Fig. 3.1. Structural confirmation of (Z)-3.2p 
 
The most surprising result was obtained with substrate 3.1m, bearing a 
trimethylsilyl (TMS) substituent at the terminal position of the alkyne. In this 
particular case, two products 3.2q and 3.4m were obtained in a 1:3.8 ratio 
(entry 17). The former arises from the desilylation of the either the substrate 
prior to cycloisomerization, or the product; and the latter was obtained from 
the 6-endo-dig cyclization. The switch in regioselectivity can be attributed to 
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the electronic influence of the TMS substituent, which withdraws electron 
density from the alkyne -bond via interaction of the alkyne p orbital with 
the Si-C * orbital. Being closer to the TMS substituent, the carbon atom of 
the alkyne closest to the TMS substituent is more electrophilic, and was 
preferentially attacked by the O-nucleophile, resulting in the observed oxazine 
product.  
13
4 
 Ta
bl
e 
3.
6.
 S
ub
st
ra
te
 S
co
pe
a   
En
tr
y 
Su
bs
tr
at
e 
C
at
. L
oa
di
ng
 
Ti
m
e 
Pr
od
uc
t 
Y
ie
ld
b 
1 
 
3.
1a
 
10
 m
ol
%
 
24
 h
 
 
3.
2a
 
>
99
 (
94
) 
2c
 
 
 
3.
1b
 
10
 m
ol
%
 
24
 h
 
 
 
3.
2b
 
74
 
3c
 
 
 
3.
1c
 
10
 m
ol
%
 
24
 h
 
 
 
3.
2c
 
90
 
4 
 
 
3.
1d
 
10
 m
ol
%
 
24
 h
 
 
 
3.
2d
 
91
 (
84
) 
13
5 
 
5 
 
3.
1e
 
10
 m
ol
%
 
24
 h
 
 
3.
2e
 

 
6 
 
3.
1f
 
10
 m
ol
%
 
24
 h
 
 
3.
2f
 

 
7 
 
3.
1g
 
10
 m
ol
%
 
24
 h
 
 
3.
2g
 

 
8 
 
3.
1h
 
10
 m
ol
%
 
24
 h
 
 
3.
2h
 
10
 
9 
 
3.
1i
 
1 
m
ol
%
 
1 
h 
 
3.
2i
 
>
99
 (
96
) 
13
6 
 
10
 
 
 
3.
1q
 
5 
m
ol
%
 
30
 m
in
 
 
 
3.
2q
 
97
 (
90
) 
11
 
 
3.
1j
 
10
 m
ol
%
 
24
 h
 
 
3.
2j
 
34
 (
28
) 
12
 
 
3.
1k
 
10
 m
ol
%
 
24
 h
 
 
3.
2k
 
45
 (
42
) 
13
7 
 
13
 
 
3.
1l
 
15
 m
ol
%
 
24
 h
 
 
3.
2l
 
74
 
(E
:Z
 =
 1
:2
.7
) 
14
 
 
3.
1n
 
10
 m
ol
%
 
10
 h
 
 
 
3.
2n
 
86
 
(E
:Z
 =
 1
:1
.1
) 
15
 
 
3.
1o
 
15
 m
ol
%
 
24
 h
 
 
3.
2o
 
95
 (
49
) 
(E
:Z
 =
 1
:2
.8
) 
13
8 
 
16
 
 
3.
1p
 
10
 m
ol
%
 
10
 h
 
 
3.
2p
 
96
 (
82
) 
17
 
 
3.
1m
 
15
 m
ol
%
 
24
 h
 
 
3.
4m
 
 
an
d  
3.
4m
: 7
6 
3.
2q
: 2
1 
 
13
9 
 
 
3.
2q
 
18
 
 
3.
1s
 
10
 m
ol
%
 
24
 h
 
 
3.
2s
 

 
a  R
ea
ct
io
n 
co
nd
it
io
ns
: s
ub
st
ra
te
 3
.1
 (
0.
4 
m
m
ol
),
 c
at
al
ys
t 2
.1
1d
 (
1-
15
 m
ol
%
),
 C
H
2C
l 2
 (
1 
m
L
),
 2
3 

C
.  
b  
D
et
er
m
in
ed
 b
y 
1 H
 N
M
R
 s
pe
ct
ro
sc
op
y,
 u
si
ng
 1
,3
,5
-t
ri
m
et
ho
xy
be
nz
en
e 
as
 i
nt
er
na
l 
st
an
da
rd
. I
so
la
te
d 
yi
el
ds
 a
ft
er
 p
ur
if
ic
at
io
n 
by
 c
ol
um
n 
ch
ro
m
at
og
ra
ph
y 
or
 p
re
pa
ra
ti
ve
 T
L
C
 
ar
e 
in
di
ca
te
d 
in
 p
ar
en
th
es
es
. 
c  R
ea
ct
io
n 
ca
rr
ie
d 
ou
t i
n 
C
D
2C
l 2
. 
 
140 
 
 
3.5. Trapping of Organosilver(I)  Intermediates with 
Electrophiles 
 
Scheme 3.10. Trapping of organosilver intermediates with N-
halosuccinimides 
 
Table 3.7. Synthesis of halomethyleneoxazolines 3.7 by trapping of 
organosilver intermediates 
Entry Substrate R1 R2 R3 NXS Product Yield of 3.7 
1 
3.1a Ph H H 
NBS 3.7a 84 
2 NBSa 3.7a 8 
3 NIS 3.7b 56 
4 NISa 3.7b 28 
5 3.1c tBu H H NBS 3.7c 64 6 NBSa 3.7c 

b 
7 3.1d  H H NBS 3.7d 61 
8 NBSa 3.7d 

b 
9 
3.1i Ph Me Me 
NBS 3.7e 98 
10 NBSa 3.7e 90 
11 NISa 3.7f 96 
12 3.1q Ph PMP H NBS 3.7g 98 
13 NBSa 3.7g 25 
a Reaction carried out in the absence of AgOTf catalyst. b Degradation products observed. 
 
In a similar manner to that previously described in Chapter 2, the cyclization 
of five propargyl amide substrates were performed in the presence of 1.2 
equivalents of the N-halosuccinimides (NBS, NIS or NCS) and 10 mol% of 
AgOTf in acetone (Scheme 3.10, Table 3.7). Where reactions were observed, 
only the unaromatized oxazolines 3.7 were obtained regiospecifically; good to 
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excellent yields of the desired (E)-bromomethyleneoxazoline products were 
obtained with NBS, while the (E)-iodomethyleneoxazoline products could 
only be obtained with substrates 3.1a and 3.1i, resulting in decomposition of 
the substrate in other cases. The solid state structure of 3.7d was also obtained 
(Fig. 3.2), providing unambiguous evidence for the E-geometry about the 
double bond. NCS was not an effective electrophile in this reaction with all the 
substrates tested.  
 
 
Fig. 3.2. Solid-state structure of 3.7d (50% thermal ellipsoids), showing the E-
geometry. 
 
In the absence of AgOTf, only low yields of the halomethyleneoxazoline 
products were obtained. The only exception was substrate 3.1i, whereby NBS 
and NIS alone could promote the electrophilic cyclization as a result of the 
presence of a prominent Thorpe-Ingold effect.  
 
These results are significant, as previous attempts to intercept the vinylgold(I) 
catalytic intermediates with N-halosuccinimides in the analogous gold(I) 
catalyzed reactions have not been successful.154 Instead of the expected 
halomethyleneoxazolines 3.7, only the halomethyloxazoles 3.8 were obtained 
in low yields via the reaction of the methyleneoxazolines with 
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halosuccinimide. Moreover, these observations provide interesting clues to the 
reaction mechanism, which will be discussed in the next section. 
 
3.6 Mechanistic Considerations 
 
Scheme 3.11. Proposed mechanism 
 
On the basis of our experimental findings, a general mechanism for the 
cycloisomerization reaction is proposed in Scheme 3.11. The stereospecific 
addition of the oxygen nucleophile to the alkyne in the proposed mechanism is 
supported by the sole formation of the Z-halomethylene oxazolines as 
described in the previous section, which also implies that the mixture of E- 
and Z-isomers observed with internal alkyne substrates (Table 3.6, entries 13-
15) could be due to competitive processes occurring in subsequent steps. 
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The fact that AgOTf performed poorly as a catalyst in the cycloisomerization 
reaction of 3.1a (Table 3.4, entry 9) but resulted in 84% yield of the 
bromomethylene oxazoline product 3.7a within 1 hour in the presence of NBS 
(Table 3.7, entry 1) provides support for the hypothesis that the rate-
determining step in the silver-catalyzed cycloisomerization reaction may be 
the final protodemetallation step. This final step involves the breaking of the 
AgC bond in the putative vinylsilver intermediate 3.9 in the presence of a 
proton, and is crucial for achieving catalytic turnover. NBS could have 
supplied a high concentration of electrophilic Br+ ions that assisted the 
demetallation process, resulting in a significant increase in reaction rate. The 
profound effect exerted by substituents on the pyridine ligand in the 
bis(pyridine) silver(I) complexes on catalytic activity has led us to propose the 
involvement of the pyridine ligands  in proton transfer steps of the catalytic 
cycle. It might be possible that strongly basic pyridine ligands such as DMAP 
hamper the protodemetallation step; while weakly basic pyridine ligands such 
as 4-acetylpyridine are ineffective proton transfer agents.  
 
At this point, however, we cannot rule out two possible alternative 
mechanisms that can also explain the mixture of E- and Z-isomers observed 
with internal alkyne substrates (Scheme 3.12): 1) the stereoselective syn 
addition of the carbonyl oxygen nucleophile across the alkyne, to give (E)-3.2, 
which then isomerizes slowly to the thermodynamically more stable (Z)-
isomer as the reaction proceeds (Scheme 3.12a), and; 2) the silver- and base 
assisted isomerization of the propargyl amide to an allenic intermediate, which 
then undergoes 5-endo-dig cyclization to  affords both the E- and Z-isomers of 
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the methyleneoxazoline 3.2. This latter pathway is through to be less likely 
due to the observed Thorpe-Ingold effect observed earlier in the study of 
substrate scope. 
 
Scheme 3.12. Alternative mechanistic pathways that explain the formation of 
of E- and Z-methylene oxazolines 3.2 
 
3.7 Conclusion 
Two synthetic procedures were used to prepare the propargyl amide substrates 
for the cycloisomerization reactions. The first and most commonly used 
method involves the reaction of acyl chlorides with propargyl amines. This 
method is convenient for the synthesis of substrates with different substituents 
at the position beside the carbonyl group. The second method involves a 
newly-developed HBF4-catalyzed nucleophilic substitution of propargyl 
alcohols with primary amides, which is advantageous if substituents are to be 
introduced at the propargylic position or at the alkyne.  
 
Initial catalyst screening was performed using 3.1 as the model substrate. The 
use of silver salts in the cycloisomerization reaction generally gave poor yields. 
The best result was obtained with the use of 10 mol% of AgTFA in CH2Cl2 
that gave the highest yield of 60% after 6 h at room temperature. Bis(pyridine) 
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complexes could also catalyze the reaction; however, the nature of the ligand 
and the counteranion had a considerable influence on the catalytic activity. A 
general increase in efficiency of the catalyst was observed in the presence of 
more electron-donating pyridine ligands and non-coordinating counteranions. 
The Ag(I) bis(4-methoxypyridine) hexafluorophosphate complex showed a 
broad tolerance towards substituents at several positions including the amide 
(R1), propargylic (R2/R3) and at the alkyne (R4). Despite the higher catalytic 
loading of 10 mol%, comparable yields to those obtained with cationic Au(I) 
catalysts could be obtained in certain cases. Significant differences in 
stereoselectivity were revealed between the gold and silver catalysts in the 
cycloisomerization of internal alkyne substrates, suggesting that the Ag(I)-
catalyzed reaction might proceed via a different mechanism from that of 
previously reported Au(I)-catalyzed reactions. 
 
In addition, the trapping of vinylsilver intermediates in the reaction with 
electrophilic halogen sources such as NBS and NIS has also been successful, 
affording the (E)-bromo- and iodo-substituted oxazolines in good yield and 
regioselectivity. This allows for future possibility of the further 
functionalization of the oxazoline products, for the construction of more 
complex and synthetically useful compounds. 
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Chapter 4 Silver(I) N-Heterocyclic Carbene 
Carboxylate Complexes: Synthesis, Structure and 
Catalysis 
 
4.1 General Introduction on Silver(I) N-Heterocyclic Carbene 
Carboxylate Complexes 
The silver(I) ion is known for its coordinative flexibility,176 affinity for both 
hard and soft donor atoms,177,178 ability to form short Ag


Ag contacts179 and 
ligand-unsupported Ag


Ag interactions.180 Concurrently, due to their various 
coordination modes to metal ions and their ability to act as both hydrogen-
bonding acceptors and donors,181 carboxylate ligands have frequently been 
employed in the design and construction of supramolecular architectures, 
which find applications in new functional materials for ion and molecular 
recognition, ion-exchange, and catalysis.182 Hence, the combination of silver(I) 
with carboxylate ligands183,184or polydentate ligands containing carboxylate 
and other functionalities185 for the formation of coordination polymers and 
metal-organic frameworks constitutes an active area of research. 
 
Silver(I) acetate compounds containing N-heterocyclic carbene (NHC) ligands 
have found applications in  medicinal chemistry, 186 , 187 , 188  electrochromic 
materials,189 and as synthons that allow access to  other Ag(I) NHC complexes 
of the type [(NHC)AgX] (where X = halide, N3, SPh, SePh) by reaction with 
silylated nucleophiles SiMe3X.
190,191,192 
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The first silver(I) NHC carboxylate complex 4.2 (Fig. 4.3, vide infra) was 
reported as a CVD- and spin-on glass (SOM) precursor in 2002 by Chung.193 
Later, in 2006, Young reported the synthesis of the silver(I) acetate complex 
containing an NHC ligand derived from caffeine (complex 4.1a, Fig. 4.1) 
which showed good antimicrobial activity against numerous resistant 
respiratory pathogens from the lungs of cystic fibrosis patients.194 Later, the 
anticancer activity of silver(I) acetate complexes containing NHC ligands 
derived from 4,5-dichloro-1H-imidazole (complexes 4.13, 4.14 and 4.15, Fig. 
4.3) was also discovered.195 Subsequent reports on the synthesis of silver(I) 
NHC acetate complexes have largely been focused on exploring their 
biological capabilities and improving their efficacy through fine-tuning of the 
substituent pattern on the NHC ligand. The syntheses, structures and 
applications of silver(I) NHC complexes containing halides as either 
coordinating or non-coordinating counteranions have been covered 
extensively in several reviews.196 In contrast, no systematic analysis of the 
structural and spectroscopic features of silver(I) NHC acetate complexes has 
been undertaken. Furthermore, with the only exception of the benzoate 
complex 4.2 (shown in Fig. 4.10), all the reported complexes contain only 
acetate as a carboxylate ligands, and the catalytic activity of such complexes 
has been largely unexplored: To date, there is only one example of silver(I) 
NHC carboxylate complexes being employed as catalysts.197 
 
This chapter will begin with the structural analysis and spectroscopic 
properties of silver(I) NHC carboxylate complexes reported in the literature, 
followed by a discussion on the methods to prepare these complexes. Notable 
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structural features of this class of complexes and trends in bonding and 
structure will be highlighted, which will allow a better understanding of our 
approach in developing catalytically active NHC silver(I) complexes for 
heterocyclization reactions of alkynes. Finally, the synthesis and 
characterization of new silver(I) NHC carboxylate complexes and their 
catalytic application towards the cycloisomerization of propargyl amides will 
be discussed. 
 
4.1.1 Solid State Structures 
All Ag(I) NHC carboxylate complexes published to date contain monodentate 
NHC ligands, and all but one (complex 4.20) contain acetate as the anionic 
ligand. The discussion of their structures in the solid state will be divided into 
three parts based on the type of heterocycle the NHC ligand is derived from: 1) 
xanthine, 2) imidazole and 3) benzimidazole. Within each family of NHC 
ligands, the complexes differ by the nature of substituents on the heterocyclic 
backbone, and the substituents in the N atoms. The effect of this change in 
substitution on the Ag-Ccarbene and Ag-Ocarboxylate bond lengths, and the 
geometry around Ag(I) will be described. In addition, general trends and 
comparisons with the cationic bis(NHC) complexes and (NHC)AgX (X = 
halide) complexes will be discussed. 
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4.1.1.1 Xanthine-derived NHCs 
 
Fig. 4.1. Ag(I) NHC carboxylate complexes with xanthine-derived NHCs. 
 
 
4.1a 
 
4.1b 
 
4.1c 
 
4.1d 
Fig. 4.2. Molecular structure of complexes 4.1a-d. Hydrogen atoms have been 
omitted for clarity. 
 
Table 4.1. Selected bond lengths (Å) and angles (deg) for complexes 4.1a-d 
Complex Ag1-C1 Ag1-O1 C1-Ag1-O1 Ag


Ag Ref 
4.1a 2.067(3) 2.1198(19) 168.19(9) 
 194 
4.1b 2.072(4) 2.118(3) 175.9(1) 3.199 198 
4.1c 2.068(2) 2.112(2) 174.78(9) 
 199 
4.1d 2.022(7) 2.064(5) 178.2(2) 
 200 
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There are 4 reported examples of silver acetate complexes containing 
xanthine-derived NHC ligands (Fig. 4.1). All complexes are mononuclear, 
with a two-coordinate silver atom bound to the NHC and a monodentate 
acetate ligand. Selected bond lengths and angles are given in Table 4.1, and 
their molecular structures are shown in Fig. 4.2. Complexes 4.1b and 4.1c 
incorporate hydrophilic hydroxyl groups tethered to the xanthine ring to 
improve their solubility in water, while complex 4.1d contains a methyl 
benzoate group in order to improve its ability to bind to certain targeting 
groups that might aid in the delivery of the compound to bacteria cells in vivo. 
The C1-Ag-O1 angle of 168.19(9) in complex 4.1a deviates significantly 
from linearity due a weak interaction of 2.949 Å between the carbonyl of the 
acetate ligand and the metal center, as shown in Fig. 4.2. Complex 4.1d, on the 
other hand, shows a C1-Ag-O1 angle close to linearity of 178.2(2). It also has 
the shortest Ag1-C1 and Ag1-O1 bond lengths in the series of 2.022(7) Å and 
2.064(5) Å respectively.   
 
Xanthine-derived NHCs are known to have good -accepting ability,201 and 
this property is expected to be enhanced in the NHC ligand of complex 4.1d 
due to the presence of the electron-withdrawing methyl benzoate substituent. 
This results in the observed stronger and shorter Ag1-C1 bond. However, the 
expected lengthening of the trans Ag1-O1 bond was not observed. Instead, the 
Ag1-O1 bond was shortened, possibly due to the -donating acetate ligand 
which interacts synergistically with the backbonding of the Ag to the NHC 
ligand in a “push-pull” effect. The Ag1-O1 bond length and C1-Ag1-O1 angle 
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in complexes 4.1b and 4.1c are similar, although 4.1b possesses a longer Ag-C 
bond and a short Ag


Ag contact of 3.199 Å. 
 
4.1.1.2 Imidazole-derived NHCs 
 
 
 
Fig. 4.3. Ag(I) NHC carboxylate complexes with imidazole-derived NHCs. 
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Fig. 4.3. cont’d Ag(I) NHC carboxylate complexes with imidazole-derived 
NHCs. 
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Fig. 4.3. cont’d Ag(I) NHC carboxylate complexes with imidazole-derived 
NHCs. 
 
Perhaps unsurprisingly, silver(I) complexes of imidazole-derived NHC ligands 
constitute the largest class in this series, exhibiting the greatest diversity in 
their coordination chemistry. There are a total of 57 reported examples, which 
can be broadly divided into three main structural variations (Fig. 4.3). A 
compilation of all relevant bond distances and angles for these structures is 
given in Table A1 of Appendix 1. The first and most common variation 
involves the N-substituents on the NHC ligand, with most complexes bearing 
para-substituted benzyl groups, which were chosen to improve the 
lipophilicity of the resulting complexes and their ability to penetrate the cell 
membrane of microorganisms. 
 
4.5a 
 
4.5d 
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4.5c 
Fig. 4.4. Effect of N-substituents: molecular structures of 4.5a, c and d. 
Hydrogen atoms have been omitted for clarity. 
 
The first comparisons are made with the series of substituted complexes 4.5a-e. 
When the methyl substituents on complex 4.3 were replaced by benzyl groups 
in 4.5a, only small changes were observed in the Ag1-C1 and Ag1-O1 bond 
lengths. The benzyl ring substituents in 4.5a are not co-planar with the 
imidazole rings, but approximately perpendicular in their arrangement. They 
are also disposed syn to each other. However, when the hydrogen atoms in the 
4-position of the benzyl rings are replaced with electron-withdrawing cyano 
and ester groups in 4.5c and 4.5d respectively, the benzyl substituents are 
orientated away from each other, one above the plane of the imidazole ring 
and the other below in an anti arrangement (See Fig. 4.4). In addition, an 
increase in the Ag1-C1 and Ag1-O1 bond lengths was also observed, due to 
the reduced -donating ability of the carbene carbon in the presence of more 
electron-withdrawing substituents on the nitrogen atoms. Complex 4.5c also 
displays short Ag


Ag contacts of 3.0050(5) Å, resulting in a C1-Ag1-O1 
angle of 163.4(1) which deviates significantly from linearity. In 4.5d, the 
coordination mode of the acetate ligand also changes from monodentate to an 
asymmetric bidentate mode. 
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Fig. 4.5. Molecular structure of complex 4.7a, chosen as a lead compound for 
biological studies. Hydrogen atoms have been omitted for clarity. 
 
A series of complexes (4.7-4.11) were prepared by Tacke and co-
workers,202,204,205 and the effects of varying the substituents in the 4-position of 
the phenyl rings on the NHC backbone and on the benzyl substituents on 
nitrogen was studied. Of these, complex 4.7a (Fig. 4.5) was chosen as a lead 
compound for further optimization to enhance the antibacterial and cytotoxic 
activity of the resulting silver complexes.202 Notably, complex 4.7a has the 
longest Ag1-C1 bond length, and the Ag1-O1 bond length is at the upper limit 
for the range of Ag1-O1 bond lengths for monodentate acetate ligands in this 
series [2.101(1)-2.164(1) Å]. A short Ag


Ag distance of 2.9107(2) Å was 
also observed, together with a significant deviation from linear geometry of 
163.40(6) Å around the silver atom. Comparing complexes 4.7a, d, and e, 
which differ in the para-substituent of the benzyl groups on nitrogen, the Ag1-
C1 bond length was found to decrease in the presence of electron-withdrawing 
substituents, which is opposite to the trend observed for complexes 4.5a, c and 
d mentioned above.  
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4.2 
 
4.13a 
 
 
4.4 
Fig. 4.6. Effect of substitution on C4/C5: molecular structures of 4.2, 4.4 and 
4.13a showing their spatial arrangement and view from the side. Hydrogen 
atoms have been omitted for clarity. 
 
Table 4.2. Comparison of bond lengths (Å) and bond angles (deg) of 
complexes 4.2, 4.4 and 4.13a. 
 4.2 4.4 4.13a 
Ag1-C1 2.064(5) 2.030(8) 2.061(6) 
Ag1-O1 2.117(3) 2.154(5) 2.129(5) 
C1-Ag1-O1 176.0(2) 168.9(3) 167.3(2) 
Ref. 203 203 203, 195 
 
The substituents on the backbone (C4 and C5 carbons) of the NHC can also be 
varied, and these include para-substituted phenyl substituents and chlorine 
substituents. The chloro-substituted complex 4.13a was found to have greater 
stability in water and NaCl solution compared to 4.2 and 4.4, which was 
attributed to the -electron inductive effect and -donating ability of Cl atoms, 
leading to a reduction of the -donor capability and electron density of the 
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carbene carbon, making it less susceptible to protonolysis in an aqueous 
environment. The conjugated methyl ester group in 4.4, which is both σ-
withdrawing and -withdrawing, however, did not contribute to stability of the 
complex. This could be due to free rotation of the methyl ester in solution 
which breaks the conjugation with the electronic framework of the imidazole 
ring.203 A closer examination of the solid state structures of the three 
complexes reveals that in the presence of electron-withdrawing substituents on 
the NHC backbone, the Ag1-C1 bond shortens, Ag1-O1 bond lengthens and 
the acetate ligand tends towards a bidentate coordination mode. In complex 
4.4, the weak interaction (2.945 Å) between the carbonyl of the acetate ligand 
and silver results in a bent C1-Ag2-O1 angle of 167.3(2), which is similar to 
that in 4.13a. Another interesting difference between the three complexes is 
the twist of the acetate ligand relative to the plane of the NHC ring, apparent 
from their side view (Fig. 4.6). Complex 4.13a is completely planar, while 
only a slight twist is observed in 4.2 and in 4.4 (approximately 45). 
 
 
4.14c 
 
4.7d 
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Fig. 4.7. Effect of substitution on C4/C5: molecular structures of 4.14c and 
4.7d. Hydrogen atoms have been omitted for clarity. 
 
Table 4.3. Comparison of bond lengths (Å) and bond angles (deg) of 
complexes 4.5c, 4.7d and 4.14c. 
 4.5c 4.7d 4.14c 
Ag-C1 2.077(5) 2.060(2) 2.062(2) 
Ag-O1 2.165(3) 2.101(1) 2.118(2) 
C1-Ag-O1 163.4(1) 178.76(8) 174.89(7) 
Ref. 204 205 203 
 
Next, the molecular structures of complexes 4.5c, 4.7d and 4.14c, containing 
the same N-substituents but with hydrogen, chlorine, and phenyl groups on the 
4- and 5- positions of the imidazole ring respectively, are compared (Fig. 4.4 
and 4.7). It appears that the -withdrawing 4,5-bisphenyl substitution in 
complex 4.7d has the largest effect on the Ag-C bond length, even more 
pronounced than that of the -withdrawing 4,5-dichloro substitution in 4.14c. 
The a shorter and stronger Ag1-C1 bond compared to 4.5c could be suggestive 
of -backbonding interactions between Ag(I) and the carbene p-orbital, a 
feature that is greatly enhanced by -acidic substituents on the NHC.206  
 
In an attempt to understand how modifications of the phenyl rings on the 
backbone of complex 4.7d could affect the structure and bonding, complexes 
4.7d, 4.8d and 4.9d were compared. However, no direct correlation between 
bond length and the -withdrawing ability could be established, possibly due 
to the fact that the phenyl substituents on the backbone are twisted relative to 
the plane of the imidazole ring, prohibiting -overlap and resulting in the 
substituents on the phenyl ring, imposing little electronic effect on the NHC 
ligand. The crystal structure of 4.8d was also disordered, with two species 
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differing in the coordination mode of acetate to silver, further hampering 
attempts to draw conclusions based on structure and -backbonding ability of 
the NHC ligands. 
 
Complex 4.18, with bis(bithiophene) groups in the NHC backbone,189 
displayed the longest Ag-O bond length of 2.196(5) Å. The Ag-C bond length 
of 2.084(6) Å was also longer than most complexes in this class. As expected 
from the relatively weak Ag-C and Ag-O bonds, complex 4.18 is unstable in 
solution, decomposing over the course of a few days. 
 
Another structural variation is the introduction of unsymmetrical NHC ligands 
(uNHCs) as ligands in metal-catalyzed reactions. Although they show similar 
structural parameters to symmetrical NHCs, further fine tuning of the 
reactivity and selectivity of their corresponding metal complexes can be 
achieved.207 Likewise, in anticipation that replacing one benzyl substitutent on 
the lead compound 4.7a with a methyl group would increase its solubility in 
DMSO and increase the viable dose of the complex in vitro, the 
unsymmetrical complexes 4.12a-d were prepared. Modifications to the NHC 
backbone (see complexes 4.15 and 4.17) and the incorporation of various 
combinations of different N-substituents (see complexes 4.6 and 4.16) were 
also investigated. Unsurprisingly, only small differences in the structural 
parameters were observed compared to the corresponding symmetrical 
complexes. 
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At this point it will be useful to quantify differences in the size of the NHC 
ligands in the symmetrical and unsymmetrical complexes. The percent buried 
volume (%Vbur), 208 , 209  defined as the percentage of the total volume of a 
sphere centered upon the metal atom that is occupied by the ligand, was used 
to evaluate this. Using the SambVca210 application, the %Vbur was calculated 
using the exact Ag-C bond lengths from the X-ray data of complexes 4.5d, 
4.12c, 4.15b and 4.14c. These values, together with their respective bond 
lengths and angles are shown in Table 4.4, and their molecular structures are 
shown in Fig. 4.8. As expected, only small differences in the %Vbur were 
observed between the symmetrical and unsymmetrical complexes, showing 
that the difference in steric bulk of a benzyl substituent on nitrogen is similar 
to that of a methyl substituent, and the influence of the substituents on 
nitrogen on the %Vbur value is only limited to a close area around the nitrogen.  
 
 
4.12c 
 
4.5d 
 
4.15b 
 
4.14c 
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Fig. 4.8. Comparing symmetrical and unsymmetrical complexes: molecular 
structures of 4.5d, 4.12c, 4.15b and 4.14c. Hydrogen atoms have been omitted 
for clarity. 
 
Table 4.4. Comparison of bond lengths (Å), bond angles (deg) and %Vbur of 
complexes 4.5d, 4.12c, 4.15b and 4.14c. 
 4.12c 4.5d 4.15b 4.14c 
Ag1-C1 2.067(3) 2.067(2) 2.069(4) 2.062(2) 
Ag1-O1 2.137(2) 2.156(1) 2.140(3) 2.118(2) 
C1-Ag1-O1 176.10(9) 171.80(7) 173.86(14) 174.89(7) 
%Vbur 28.0 29.5 28.5 28.5 
Ref. 203 211 202 204 
 
The acetate ligand mostly adopts the monodentate coordination mode for this 
class of complexes, although the symmetric and asymmetric bidentate modes 
were observed in a few complexes, namely 4.5e, 4.13a, 4.14a, 4.15d and 4.16, 
and their solid-state structures are shown in Fig. 4.9. One common feature of 
all these complexes is the presence of electron-withdrawing groups either on 
the NHC backbone or wingtip substituents. Complex 4.5e, the only complex 
with a symmetric chelating acetate ligand, has an unexceptional Ag1-C1 bond 
length of 2.065 Å. The Ag1-O1 bond length, however, is significantly longer 
than that in complexes with monodentate acetate ligands (which have Ag1-O1 
bond lengths in the range of 2.101(1)-2.196(5) Å). According to the theory by 
Hocking and Hambley,212,213 a carboxylate C2-O1 bond length larger than 
1.2505 Å indicates a high covalent character of the metal oxygen bond in the 
complex, while a C2-O1 bond shorter than 1.2505 Å indicates a largely ionic 
interaction. An analysis of the C2-O1 bond lengths of the complexes in Table 
4.5 reveal a high covalent character in the Ag1-O1 bond, with the exception of 
complex 4.14a. This is consistent with the observed Ag-O1 bond length of 
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2.278(4) Å in 4.14a, the longest among the complexes with asymmetric 
chelating acetate ligands.  
 
4.5e 
 
4.13a 
 
4.14a 
 
4.16 
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4.15d 
Fig. 4.9. Complexes with bidentate acetate ligands: molecular structures of 
4.5e, 4.13a, 4.14a, 4.15d and 4.16. Hydrogen atoms have been omitted for 
clarity. 
 
Table 4.5. Comparison of bond lengths (Å) and bond angles (deg) of 
complexes 4.5e, 4.13a, 4.14a, 4.15d and 4.16. 
Symmetric 
bidentate mode 
Asymmetric bidentate mode 
 4.5e  4.13a 4.14a 4.15d 4.16 
Ag1-C1 2.065 Ag1-C1 2.030(8) 2.064(4) 2.040(9) 2.053(8) 
Ag1-O1 2.438 
Ag1-O1 2.154(5) 2.278(4) 2.173(6) 2.138(5) 
Ag1-O2 2.715(5) 2.503(5) 2.687(8) 2.713(7) 
C2-O1 1.257 
C2-O1 1.274(9) 1.238(7) 1.27(1) 1.27(1) 
C2-O2 1.24(1) 1.225(7) 1.25(1) 1.255(7) 
O1-Ag-
O2 
53.7 
O1-Ag-
O2 
52.1(2) 53.4(1) 53.2(3) 52.8(2) 
Ag


Ag - - 3.1412 3.2267 
Ref. 214 Ref. 195, 203 215 214 199 
 
4.1.1.3 Benzimidazole-derived NHCs 
 
Fig. 4.10. Ag(I) NHC carboxylate complexes with benzimidazole-derived 
NHCs. 
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Fig. 4.10. cont’d Ag(I) NHC carboxylate complexes with benzimidazole-
derived NHCs. 
 
The annelation of a benzene ring to imidazole results in a new class of 
benzimidazole NHC ligands, which possess stronger -acidity and a greater 
propensity for -backbonding upon coordination to a metal. The silver(I) 
carboxylate complexes of this class of ligand are depicted in Fig. 4.10, and 
selected bond lengths and angles are given in Table A1 of Appendix 1. As a 
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consequence of the synergistic bonding between -acceptor NHCs and the 
metal, more robust metal-NHC bonds may result – a desirable feature in 
numerous applications of these metal complexes. The additional benzene ring 
also allows for further functionalization and tuning of electronic properties by 
substitution with methyl groups or electron-withdrawing chlorine atoms, for 
instance, in complexes 4.27 and 4.28. 
 
An inspection of the solid state structures of 4.23a-d and 4.27a-b appears to 
highlight the presence of a trans effect, where an elongation of the Ag-O bond 
is observed with the shortening of the Ag-C bond – a phenomenon not 
observed in the previously discussed xanthine and imidazole-type NHCs. The 
presence of electron-withdrawing groups on the wingtip substituents of the 
NHC decreases the Ag-C bond length, and this was accompanied by an 
increase in Ag-O bond length. A comparison of complexes 4.23a and 4.27a, 
which differ in the substitution of two hydrogen atoms on the benzene ring by 
electron-donating methyl groups, result in a change in the coordination mode 
of the acetate ligand from bidentate to monodentate, and an increase in Ag-C 
bond length. The effect of the addition of two methyl groups on the benzene 
ring of the NHC is also evident from the observed decrease in Ag-C bond 
length from 2.072(6) to 2.052(3) Å and the corresponding increase in Ag-O 
bond length from 2.085(5) to 2.113(2) Å when comparing complexes 4.23b 
and 4.27b. This is commensurate with an increased -accepting ability of the 
NHC ligand in 4.27b, leading to a stronger Ag-C bond.  
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Fig. 4.11. Molecular structure of complex 4.22 featuring a three-coordinate 
silver atom. Hydrogen atoms have been omitted for clarity. 
 
Complex 4.22 has a unique structure with a three-coordinate silver atom (see 
Fig. 4.11), binding to two NHC ligands and one monodentate acetate ligand in 
a trigonal planar geometry. Only small deviations away from ideal trigonal 
planar geometry that result from the steric requirements of the iPr substituents 
are observed. The planes of the NHC rings are twisted with respect to the 
coordination plane of silver, and the C-Ag-C angle is 146.3. In comparison to 
complex 4.21, the Ag-O bond length in 4.22 is markedly longer (2.568(2) Å vs. 
2.120(7) Å).  
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Fig. 4.12. Molecular structure of complex 4.24 showing the unsymmetrical 
bridging mode of the acetate ligand. Hydrogen atoms have been omitted for 
clarity. 
 
An unsymmetrical bridging mode of the acetate ligand is observed in complex 
4.24 (See Fig. 4.12), which exists as a dimer in the solid state. One oxygen 
atom of the acetate ligand connects strongly to one silver (2.1206 Å) and 
weakly (2.612(2) Å) to another, resulting in a binuclear species around an 
inversion center (Fig. 11). The AgAg distance is 3.814 Å and the C1-Ag1-
O1A  angle is 170.1. 
 
4.1.2 13C NMR Spectroscopy 
The most diagnostic feature of 13C NMR spectrum of the silver(I) NHC 
carboxylate complexes is the downfield resonance signal of the carbene donor 
atom, which appears in the range from 150.4 to 207.8 ppm. The chemical 
shifts and coupling constants for this carbene carbon reported for all the 
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complexes are given in Table A1 of Appendix 1. Downfield shifts of the 
carbene carbon signal are generally observed in the presence of electron-
withdrawing substituents on the both the nitrogen atoms and backbone of the 
NHC. A change from an unsaturated to saturated backbone of the NHC 
(compare complexes 4.19 and 4.20) results in a downfield shift of the carbene 
signal. Notably, only complexes 4.19 and 4.20 display a pair of doublets for 
the carbene carbon signal that arises from coupling to 107Ag and 109Ag (which 
are magnetically active with spin ½ and a relative abundance of 52% and 48% 
respectively).216  
 
 
Scheme 4.1. Fluxional behavior of silver NHC complexes. 
 
This coupling to silver is an indication of relatively strong Ag-C bonds, which 
can only be observed in cases where there is none or only a slow exchange of 
the carbene moiety between silver atoms on the NMR timescale. The absence 
of coupling to silver is due to the fluxional behavior. A plausible mechanism 
for the exchange has been proposed by Lin 217  (Scheme 4.1), and factors 
affecting this dynamic behavior, such as the steric bulk of the ligand, type of 
halide ion present and solvent polarity have been studied.218,219 Complexes 
4.18 and 4.22 showed the lack of an observable resonance for the carbene 
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carbon, suggesting the presence of dynamic behavior or the poor relaxation of 
the quaternary carbene carbon.196c  
 
4.1.3 Comparison with Analogous Cationic bis(NHC) 
Complexes and (NHC)AgX (X = halide) Complexes 
 
 
 
Fig. 4.13. (NHC)AgX (X = Cl or Br) complexes 4.29-4.34. 
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Fig. 4.14. Cationic bis(NHC) complexes 4.35-4.42. 
 
Given that the carbene carbon resonance is shifted upfield with increasing 
Lewis acidity of the metal center,220,221 it might be possible to estimate the 
relative donor strengths of carboxylate, halide and NHC ligands towards Ag(I) 
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by comparing the carbene carbon chemical shift value of silver(I) NHC acetate 
complexes with their halide and cationic bis(NHC) congeners. The structures 
of these analogous complexes are depicted in Fig. 4.13 and 4.14, and their 
relevant spectroscopic and structural data obtained from literature references, 
are compiled in Table A2 of Appendix 1. More strongly donating co-ligands 
will enhance the electron density on the silver atom, reduce its Lewis acidity 
and shift the carbene carbon resonance downfield. From Table 4.6, it can be 
seen that the carbene carbon resonance of the acetate complexes generally 
appear upfield compared to their corresponding halide and bis(NHC) 
analogues. This implies that carboxylate ligands are weaker donors to silver 
compared to halides and NHC ligands, which is unsurprising, as silver is 
known to have good affinity towards halide ions. 
Table 4.6. Comparison of 13C Ccarbene of (NHC)Ag(O2CR), (NHC)AgX (X = 
Cl or Br) and bis(NHC) complexes 
(NHC)Ag(O2CR) 
complexd Ccarbene 
(NHC)AgX 
complexd Ccarbene 
bis(NHC) 
complexd Ccarbene 
4.1a 186.2b 
  4.35 186.7b 
4.3 178.6b 
  4.36 181.0b 
4.5a 177.0a 4.29 151.2a 
  
4.19 184.3a 4.30 184.6a 4.37 183.6a 
4.20 207.8a 4.31 207.7a 4.38 205.8c 
4.13a 176.1b 
  4.39 181.3b 
4.12a 179.9a 4.33 180.7a 4.40 179.9b 
4.2 173.0c 
  4.41 177.6b 
4.21 179.4a 4.34 185.4a 
  
a CDCl3. 
b DMSO-d6. 
c CD2Cl2. 
d See Table A2 in Appendix 1 for references. 
 
Table 4.7. Comparison of Ag-C bond lengths (Å) of (NHC)Ag(O2CR), 
(NHC)AgX (X = Cl or Br) and bis(NHC) complexes 
(NHC)Ag(O2CR) 
complexb Ag-C 
(NHC)AgX 
complexb Ag-C 
bis(NHC) 
complexb Ag-C 
4.1a 2.067(3) 
  4.35 2.068 
4.3 2.064(5) 
  4.36 2.086 
4.5a 2.065(1) 4.29 2.091(2) 
  
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a4.19 2.064(5) 4.30 2.056(7) 4.37 2.129 
a4.20 2.059(7) 4.31 2.081(9) 
  
4.18 2.084(6) 4.32 2.087(4) 
  
4.13a 2.030(8) 
  4.39 2.082 
4.21 2.070(6) 4.34 2.094(3) 
  
4.23a 2.059(3) 
  4.42 2.089(3) 
a Ag-C bond lengths are obtained from complexes synthesized in this work. As more than one 
molecule is present in the asymmetric unit, the averaged bond length is used. b See Table A2 
in Appendix 1 for references. 
 
Table 4.7 provides a comparison of the Ag-C bond lengths of silver(I) NHC 
acetate complexes with their halide and cationic bis(NHC) congeners. The Ag-
C bond lengths for the carboxylate complexes are shorter than those of the 
corresponding halide and cationic bis(NHC) complexes. 
 
4.1.4 General Trends 
As silver adopts a two-coordinate linear geometry in majority of the 
complexes with the carboxylate ligand binding in a monodentate manner, it is 
apparent that this coordination mode is highly preferred for complexes of this 
type. However, it is worth noting that electron-withdrawing groups on the 
NHC results in an increased tendency for the carboxylate ligand to bind in a 
chelating mode (see section 4.1.1.2). Large deviations from linear geometry 
around the metal center can result from weak interactions of the silver atom 
with the carbonyl oxygen atom of the carboxylate ligand (as observed in 
complex 4.1a in Fig. 4.2), or with the carbonyl oxygen atom of the 
carboxylate ligand in the adjacent complex in the crystal structure (complex 
4.24 in Fig. 4.12). As can be seen from Table A1 in Appendix 1, the presence 
of argentophilic interactions arising from closed shell d10-d10 interactions222 in 
the solid state also tend to result in large deviations from linear geometry. This 
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has also been observed in cationic bis(NHC) complexes of 1,3-
dialkylimidazol-2-ylidene ligands.223  
 
It is evident from the discussion above, that the Ag-C bond length is not a 
good indicator of the strength of the Ag-C bond, which is the result of an 
interplay between the electron-donating and -acceptor ability of the NHC 
ligand bonded to silver. Indeed, -backbonding from NHC ligands to group 11 
metals can contribute to as much as 30% of the overall orbital interaction 
energy based on experimental observations224 and DFT calculations.225 Other 
factors affecting the Ag-C bond length are the co-ligand trans to the NHC, and 
the presence of argentophilic interactions in the solid state. 
 
When - and -electron-withdrawing groups are present on the NHC ligand, it 
is difficult to deconvolute their -withdrawing and -backbonding effects. 
This is because NHCs are stabilized by a push-pull effect (Fig. 4.15), as a 
result of: 1) the electron-withdrawing nitrogen atoms inductively stabilizing 
the -nonbonding orbital of the carbene by increasing its s-character; and 2) 
the donation of electron density from the nitrogen lone pairs into the vacant 
carbene p-orbital, increasing its energy. These two effects increases the -p 
gap and stabilizes the singlet carbene over the more reactive triplet state.226 
Electron-withdrawing substituents can therefore reduce the -donating ability 
of the NHC, but increase its -accepting ability, both of which have opposite 
effects on Ag-C bond length. The absence of a trans effect in most of the 
complexes also does not allow comparisons of the electron donating abilities 
of the NHC.  
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Fig. 4.15 (a) Frontier orbitals of the NHC; (b) electron-withdrawing nitrogen 
atoms stabilizing the -nonbonding orbital of the NHC; (c) the donation of 
electron density from the nitrogen into the carbene p-orbital. 
 
The chemical shift values of the carbene carbon in the 13C NMR also did not 
allow the unambiguous determination of the different donor abilities of NHCs 
in the complexes. The generally accepted rule is that a more strongly donating 
NHC would result in a more downfield shifted resonance peak of the carbene 
carbon. The fact that only complexes 4.19 and 4.20 with bulky 2,6-
diisopropylphenyl substituents on the NHC displayed coupling to silver 
indicates that the rate of ligand exchange processes is slowed down by steric 
hindrance in the NHC. This was also observed for the chloride analogues of 
these complexes.227 Generally, such fluxional complexes are undesirable as 
catalysts, as they may rapidly decompose. Thus, steric parameters of the NHC 
ligand were an important consideration in the design of our catalyst. 
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4.1.5 Synthetic Routes to Ag(I) NHC Carboxylate Complexes 
Two methods have been used to prepare Ag(I) NHC carboxylate complexes: 1) 
the reaction of the free NHC with silver carboxylate and 2) in situ 
deprotonation of imidazolium salts with silver carboxylate (Scheme 4.2). In 
this work, complexes 4.2 (Fig. 4.3), 4.21 and 4.22 (Fig. 4.10) were prepared 
using the first method. The reaction took place at room temperature in solvents 
such as THF and toluene, and reaction times were short (1-3 h).  
 
Scheme 4.2. Synthetic routes to Ag(I) NHC carboxylate complexes: (a) Free 
NHC route; (b) Deprotonation with silver carboxylate. 
 
The second method involves the reaction of silver carboxylate with the 
imidazolium salt in solvents such as dichloromethane, methanol and ethanol, 
depending on the solubility of the imidazolium salt used. Reaction times can 
range from 30 min to 4 days at room temperature, depending on the acidity of 
the imidazolium salt. The reaction mixture can also be refluxed to speed up the 
reaction. Imidazolium salts with electron-withdrawing substituents, especially 
on the backbone, give faster reaction rates. A major disadvantage of this 
method  is the waste associated with using an added equivalent of silver 
carboxylate. This method is also not applicable for the synthesis of less basic 
carboxylate salts. 
 
As the first method requires dry solvents, inert conditions and strong bases for 
the generation of the free carbene species, the second method is generally 
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preferred and is also the more widely used method for the preparation of Ag-
NHC complexes. 
 
4.2 Results and Discussion 
As observed in the previous chapter, more electron-donating pyridine ligands 
promote the silver-catalyzed cycloisomerization of propargyl amides more 
efficiently. This encouraged us to explore the use of strong -donating NHC 
ligands with the aim of achieving even greater catalytic activity.  
 
We began by preparing the chloride and the cationic bis(NHC) complexes of 
the commercially available N,N’-bis(2,6-diisopropylphenyl)imidazol-2-ylidine 
(IPr) ligand, [(IPr)AgCl]228 and [Ag(IPr)2]PF6,
229 and carried out a preliminary 
screening of their catalytic activity towards the cyclization of our model 
substrate (see section 4.3). Disappointingly, neither of these complexes 
exhibited any catalytic activity. This was attributed to the kinetic stability of 
these complexes, which disfavors the dissociation of either the neutral or 
anionic ligand to allow the coordination and activation of the alkyne. In light 
of this, the chloride complex of the slightly less hindered N,N’-bis(2,4,6-
trimethylphenyl)imidazol-2-ylidine (SIMes), [(SIMes)AgCl]43 was prepared. 
This was also found to be catalytically inactive, which was attributed to the 
poor Lewis acidity of the metal center in the presence of strongly electron 
donating ligands. This led us to consider silver-NHC complexes containing 
more labile anionic ligands. Carboxylate ligands were attractive as they are 
known to bind less strongly to d10 metals191 and a number of silver NHC 
acetate complexes have been successfully prepared.186,187,188 In the next 
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section, the synthesis of these complexes using previously reported methods 
and a newly developed method using a mild base will be described. 
 
4.2.1 Synthesis of New Ag(I) NHC Carboxylate Complexes 
4.2.1.1 In situ deprotonation of imidazolium salts with silver(I) acetate 
[(IPr)AgOAc] (4.19) was successfully prepared according to a literature 
procedure,190 which involves the reaction of the imidazolium chloride salt 
IPr
HCl with two equivalents of silver(I) acetate in CH2Cl2 at room 
temperature for 2 hours. However, attempts to prepare the SIMes complex by 
the same method failed, yielding mainly the cationic bis(NHC) product, 
[Ag(SIMes)2]X (X = Cl or OAc) and only small amounts of the desired 
[(SIMes)AgOAc]. Increasing the reaction time led to the formation of more 
[Ag(SIMes)2]X, implying that [(SIMes)AgOAc] could be formed initially, but 
slowly converted to the thermodynamically more stable bis(NHC) complex 
under the reaction conditions. This is not surprising, given that Ag-O bonds 
are weaker than Ag-C bonds. This problem was, however, not encountered 
with the more sterically hindered IPr ligand, as the coordination of two bulky 
IPr ligands on silver is kinetically disfavoured. 
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4.2.1.2 Reaction of free NHCs with silver(I) acetate and silver(I) 
trifluoroacetate 
 
Scheme 4.3. Synthesis of 4.43. 
 
Attempts were made to prepare [(SIMes)AgOAc] by the reaction of free 
SIMes generated in situ with a suspension of silver acetate in THF. However, 
none of the desired complex was formed despite stirring the mixture overnight, 
and silver acetate remained largely unreacted. Suspecting this might arise from 
the poor solubility of silver acetate, the reaction was attempted with the more 
soluble silver trifluoroacetate (Scheme 4.3). Upon stirring overnight, a brown 
solution was obtained. The solvents were removed in vacuo and the resulting 
oily residue triturated with hexane to give an off-white solid. A 1H NMR of 
the product in CDCl3 showed the absence of the imidazolium proton peak at 
9.40 ppm, and the peaks observed in the 13C NMR spectrum were slightly 
different from those the imidazolium salt, although the signal of the carbene 
carbon was not observed. X-ray quality single crystals of the compound were 
obtained by cooling a saturated MeOH:Et2O (1:1) solution of the compound at 
-20 C overnight. The resolved structure shows that the resulting complex is 
an unexpected tetramer, formulated as Ag4(SIMes)2(CF3CO2)4 (4.43). The 
structure of this complex will be discussed in greater detail in section 4.2.2. 
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4.2.1.3 Mild base method 
Due to the shortage of literature methods for the preparation of silver(I) NHC 
carboxylate complexes, the development of a general and operationally simple 
method for the synthesis of such complexes would be highly desirable. Earlier 
work by Nolan 230 , 231  and Gimeno232  have shown that NHC complexes of 
group 11 metals of the type [(NHC)MX] (X = halide) can be prepared 
efficiently by employing a mild base such as K2CO3 to deprotonate the 
imidazolium salt in the presence of a suitable metal source. It was envisaged 
that silver(I) carboxylate complexes could also be accessible if an imidazolium 
salt with a weakly coordinating anion such as BF4
- was used in the presence of 
the desired silver carboxylate. Initially, a mixture of the IPr
HBF4 salt with 
silver acetate was stirred in CH2Cl2 at room temperature for 15 min, followed 
by the addition of 10 equivalents of K2CO3. This led to the formation of the 
expected [(IPr)AgOAc] complex and concomitant formation of the homoleptic 
bis(NHC) complex [Ag(IPr)2][X] (X = BF4 or RCO2) after 1 h. The base was 
increased to 20 equivalents in an attempt to reduce the competitive 
deprotonation of IPr
HBF4 by AgOAc or [(IPr)AgOAc] to give the bis(NHC) 
complex. Gratifyingly, this was effective in suppressing the formation of the 
bis(NHC) complex, and the method was subsequently extended to the 
preparation of other Ag(I) NHC acetate complexes of SIPr, IAd and IPent (Fig. 
4.16), as well as benzoate complexes as shown in Scheme 4.4. After 
recrystallization, the complexes were obtained as air- and moisture-stable 
white crystalline solids in moderate to good yields (45-70%). Notably, none of 
the homoleptic complex was formed where IAd and IPent were used. In 
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comparison, IPr and SIPr Ag(I) complexes of the 4-substituted benzoate 
ligands were always obtained as a mixture of the neutral [(L)AgX] complex 
and the cationic bis(NHC) complex. Attempted purification of these 
complexes by recrystallization was unsuccessful, due to the greater solubility 
of the desired acetate complex compared to the bis(NHC) complex in most 
organic solvents. 
 
 
Fig. 4.16. Abbreviations of NHC ligands used in this study 
 
 
Scheme 4.4. Synthesis of [(NHC)Ag(RCO2)] complexes 
 
4.2.2 Spectral Characteristics 
The 1H NMR spectra of complexes 4.19, 4.20, 4.44 and 4.45 show the absence 
of the low-field resonance around 9-10 ppm, indicating the removal of the C2 
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imidazolium proton. At the same time, the 13C signal for the carbenic carbon 
of complexes 4.19, 4.20 and 4.44 appear as two distinct doublets shifted 
downfield from that of the parent imidazolium salt, ranging between 173.5 to 
207.9 ppm, consistent with coupling to 107Ag and 109Ag (Table 4.8).233 The 
observed coupling indicates relatively strong Ag-C bonds, as a result of no or 
slow exchange of the carbene ligand between silver atoms on the NMR 
timescale.234 The values of 1J(109Ag-13C) and 1J(107Ag-13C) are consistent with 
the gyromagnetic ratio (109Ag)/(107Ag) = 1.15. However, the IAd complexes 
4.45a and 4.45b are relatively unstable in solution and their decomposition is 
evident from the appearance of additional peaks in the 13C spectra that 
increase in intensity over time. Thus no 13C NMR of pure 4.45a and 4.45b 
could be obtained. 
 
Table 4.8. 13C chemical shifts (ppm) of the carbenic carbon (C2) of 
complexes 4.19, 4.20, 4.44 and 4.45, recorded in CDCl3 
Complex 
(C2) 1J(107,109Ag-C) 
[(IPr)AgOAc] (4.19a) 184.5 249, 288 
[(IPr)AgOBz] (4.19b) 184.4 251, 290 
[(IPr)Ag(4-MeC6H4CO2)] (4.19c) 184.5 250, 289 
[(IPr)Ag(4-ClC6H4CO2)] (4.19d) 184.1 252, 291 
[(IPr)AgCl]228 184.6 253, 271 
[(SIPr)AgOAc] (4.20a) 207.9 234, 271 
[(SIPr)AgOBz] (4.20b) 207.9 235, 271 
[(SIPr)Ag(4-MeC6H4CO2)] (4.20c) 207.9 235, 271 
[(SIPr)Ag(4-ClC6H4CO2)] (4.20d) 207.6 236, 273 
[(SIPr)AgCl]228 207.7a 219, 253 
[(IPent)AgOAc] (4.44a) 184.3 250, 288 
[(IPent)AgOBz] (4.44b) 184.2 250, 289 
[(IPent)Ag(4-ClC6H4CO2)] (4.44d) 183.9 252, 291 
[(IAd)AgOAc] (4.45a) 173.7 251, 289 
[(IAd)AgOBz] (4.45b) 173.5 256, 290 
[(IAd)AgCl]228 173.8a 
 (broad singlet) 
a NMR spectrum was obtained in CD2Cl2. 
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Interestingly, the chemical shifts of the carbenic carbon of complexes are 
scarcely influenced by the nature of the carboxylate co-ligand, although there 
is a slight increase in the coupling constant with decreasing basicity of the 
carboxylate ligand. Overall, the chemical shift values of the carbenic carbon, 
and hence the electron-donating ability of the NHC ligands decrease in the 
order: SIPr > IPr > IPent > IAd. The same trend was also observed in the 
analogous chloride complexes.228  
 
ESI-MS analysis of the IPr, SIPr and IPent complexes 4.19, 4.20 and 4.44 
afforded the [Ag(NHC)(MeCN)]+ fragment as the major peak when MeCN 
was used as the carrier solvent, highlighting the stability of this cationic 
species in solution. The [Ag(NHC)2]
+ fragment, often observed in other 
reports as a result of ligand scrambling,198c was not observed in all cases, 
which supports the non-fluxional behavior of these complexes, as suggested 
by NMR. The IAd complexes 4.45a and 4.45b, however, displayed only the 
[NHC+H]+ peak, commensurate with previous observations of their instability 
in solution.  
 
Table 4.9. Carboxyl stretching vibrations and  values (cm-1) of complexes 
4.19, 4.20, 4.44 and 4.45, compared with unligated silver carboxylate salts 
Complex 
asym(COO) sym(COO)  
4.19a 1588.3 1326.1 262.2 
4.19b 1611.7 1346.2 265.5 
4.19c 1602.7 1359.2 243.5 
4.19d 1605.9 1364.6 241.3 
4.20a 1587.2 1326.1 261.1 
4.20b 1613.8 1346.8 267.0 
4.20c 1603.6 1360.2 243.4 
4.20d 1606.6 1365.9 240.7 
4.44a 1599.9 1375.8 224.1 
4.44b 1606.7 1364.5 242.2 
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4.44d 1607.5 1369.6 237.9 
4.45a 1595.0 1372.2 222.8 
4.45b 1597.8 1368.3 229.5 
AgOAc 1509.1 1380.3 128.8 
AgOBz 1512.8 1379.3 133.5 
Ag(4-MeC6H4CO2) 1510.3 1379.3 131.0 
Ag(4-ClC6H4CO2) 1508.8 1371.5 137.3 
 
The solid-state IR frequencies for the asymmetric stretch, asym(COO), the 
symmetric stretch, sym(COO), and the  value
235  ( = asym(COO)  
sym(COO)) of the carboxylate group of complexes 4.19, 4.20, 4.44 and 4.45 
are shown in Table 4.9. The (COO) bands were identified by comparisons 
with spectra of the NHC imidazolium salt precursor and other closely related 
compounds such as [(NHC)AgCl]. The calculated  values  = asym(COO) 
 sym(COO) of all the complexes are greater than 200 cm
-1, and are 
characteristic of a monodentate 236 , 237  or asymmetric bidentate 238  mode of 
carboxylate coordination, in line with their solid state structures (vide infra). 
The  values of the complexes are also significantly larger than the 
corresponding silver carboxylates as a result of an increase in asym(COO) and 
decrease in sym(COO) on coordination of the NHC ligand, which led to an 
overall increase in . Although  was inversely correlated with the basicity 
of the carboxylate ligand for the silver carboxylates, no clear correlation was 
observed in complexes 4.19, 4.20, 4.44 and 4.45. Instead,  increases in the 
order: RCO2 = 4-ClC6H4CO2 < 4-MeC6H4CO2 < MeCO2 < PhCO2. 
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4.2.3 Solid-State Structures 
4.2.3.1 Solid-state structure of complex 4.43 
Complex 4.43 crystallizes as a tetranuclear silver complex of the formula 
Ag4(SIMes)2(O2CCF3)4. The complex may be viewed as an aggregated 2:1 
adduct of [(SIMes)Ag(O2CCF3)] and [Ag2(2-O,O’-CF3CO2)2], held together 
by bridging bidentate trifluoroacetate ligands and Ag


Ag interactions. The 
asymmetric unit of complex 4.43 contains 12 silver atoms, 12 trifluoroacetate 
units, and 6 SIMes ligands. Considered in this fashion, the asymmetric unit 
contains three independent clusters. However, two of the clusters are complete, 
while the third cluster comprises of two distinct half clusters situated across 
centers of symmetry. Fig. 4.17 shows the complete clusters 4.43A and 4.43B, 
while Fig. 4.18 shows the Ci-symmetric clusters 4.43C and 4.43D. The four 
clusters differ slightly in the distance between the silver atoms of the 
[(SIMes)Ag(O2CCF3)] and [Ag2(2-O,O’-CF3CO2)2] core.  
 
4.43A 
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4.43B 
Fig. 4.17. Complete Ag4(SIMes)2(O2CCF3)4 clusters 4.43A and 4.43B in the 
asymmetric unit of complex 4.43. 
  
 
4.43C 
 
4.43D 
Fig. 4.18. Ci-symmetric Ag4(SIMes)2(O2CCF3)4 clusters 4.43C and 4.43D in 
the asymmetric unit of complex 4.43. 
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Clusters 4.43A and 4.43C consisting of a zig-zag Ag4 chain, where four silver 
atoms are held together by short Ag


Ag contacts. The distances between the 
terminal silver atoms and those of the [Ag2(2-O,O’-CF3CO2)2] core are in the 
range 3.114 - 3.168 Å, shorter than that in clusters 4.44B and 4.44D (3.411 - 
3.531 Å). The distances between the two atoms within the [Ag2(2-O,O’-
CF3CO2)2] core are also much shorter, ranging from  2.865 to 2.915 Å.  
 
The terminal Ag atoms in all four clusters are coordinated to one SIMes NHC 
ligand and one oxygen atom of the trifluoroacetate ligand in a linear fashion, 
with C-Ag-O angles between 168.88 and 170.63. The Ag-C bond distances 
are rather short (2.050 - 2.066 Å) compared to those of Ag-NHC complexes in 
the literature.198c The Ag-O bond distances between the terminal Ag atoms and 
the oxygen atoms of the trifluoroacetate ligands (2.085 - 2.107 Å) are also 
shorter than those in the [Ag2(2-O,O’-CF3CO2)2] core (2.207 - 2.244 Å). 
 
4.2.3.2 Solid state structures of complexes 4.19, 4.20, 4.44 and 4.45 
Suitable X-ray diffraction quality crystals of complexes 4.19, 4.20, 4.44 and 
4.45 were grown from CH2Cl2/hexane at 0 C, and their molecular structures 
are shown in Figures 4.19, 4.20 and 4.21. The crystallographic details are 
summarized in Appendix 2, and selected bond lengths and angles are listed in 
Tables 4.10, 4.11 and 4.12. With the exception of the IAd complexes 4.45a 
and 4.45b, the Ag-C and Ag-O bond lengths of all the complexes are in the 
range of previously reported silver(I) NHC carboxylate complexes. No 
argentophilic interactions were observed in all the complexes. 
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4.19c 4.19d 
 
4.20b 
 
4.20c 
 
4.20d 
 
4.44a 
4.44d 
 
4.45a 
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4.45b 
 
Fig. 4.19. Molecular structure of complexes 4.19c,d, 4.20b-d, 4.44a,d and 
4.45a,b. Non-essential hydrogen atoms are omitted for clarity. 
 
Table 4.10. Selected bond lengths (Å) and angles (deg) of complexes 4.19c,d, 
4.20b-d, 4.44a,d and 4.45a,b 
 Ag1-C1 Ag1-O1 
C1-Ag1-
O1 
C2-O1 C2-O2 
% covalent 
charactera 
4.19c 2.063(3) 2.114(2) 175.51(8) 1.268(3) 1.225(4) 22 
4.19d 2.059(3) 2.121(2) 175.26(9) 1.263(3) 1.229(4) 16 
4.20b 2.069(3) 2.131(2) 170.2(1) 1.277(5) 1.234(5) 32 
4.20c 2.060(3) 2.101(2) 171.83(9) 1.253(3) 1.222(3) 4 
4.20d 2.059(2) 2.101(2) 171.85(9) 1.267(3) 1.227(3) 21 
4.44a 2.067(3) 2.111(2) 174.5(1) 1.269(4) 1.217(5) 23 
4.44d 2.064(3) 2.100(2) 165.7(1) 1.255(4) 1.223(4) 7 
4.45a 2.075(4) 2.117(2) 170.1(1) 1.254(4) 1.234(4) 5 
4.45b 2.103(3) 2.123(2) 175.2(1) 1.269(4) 1.231(4) 23 
aCalculated using the formula: {640(C2-O1) – 800}/{2.4(C2-O1) – 2.5264} 
 
Differences in Ag-C bond lengths are observable between complexes bearing 
the same carboxylate ligand but different NHC ligands. The Ag-C bond length 
generally increases in the order: SIPr < IPr < IPent < IAd, and the differences 
are most prominent when comparing acetate complexes 4.19a, 4.20a, 4.44a 
and 4.45a. In this case the Ag-C bond length appears to reflect the strength of 
the Ag-C bond and hence the electron-donating ability of the NHC, thus 
allowing us to infer that the donating abilities of the NHC ligands decrease in 
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the order: SIPr > IPr > IPent > IAd, which is in agreement with that previously 
deduced from 13C NMR data.  
 
The Ag-O bond lengths do not correlate with the basicity of the carboxylate 
ligands and the steric size of the NHC ligand. The differences in Ag-O bond 
lengths between the complexes do not appear to reflect the trans influence of 
the NHC ligands. Nevertheless, the length of Ag-C and Ag-O bonds can 
provide clues about the stability of these complexes. The Ag-C and Ag-O 
bond lengths of the IAd complexes 4.45a and 4.45b are significantly longer 
than those the other complexes, further corroborating their instability in 
solution. Complex 4.18 (see Fig. 4.3) which also has relatively long Ag-C and 
Ag-O bond lengths of 2.084(6) Å and 2.196(5) Å respectively, exhibits the 
same instability in solution.189  
 
The percentage covalent character of the Ag-O bond was estimated on the 
basis of the theory by Hocking and Hambley.212, 213 However, contrary to our 
expectations, the covalency of the Ag-O bond was found to correlate poorly to 
the Ag-O bond length, suggesting that other factors, such as crystal packing 
effects or the different steric parameters of the NHC ligands might affect the 
Ag-O bond length. 
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4.19a 4.44b 
 
4.19b 
Fig. 4.20. Molecular structures of complexes 4.19a, 4.19b and 4.44b, showing 
two molecules in the asymmetric unit. Non-essential hydrogen atoms have 
been omitted for clarity. 
 
Table 4.11. Selected bond lengths (Å) and angles (deg) of complexes 4.19a, 
4.19b and 4.44b, which have two molecules in the asymmetric unit. 
Ag1B 
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 4.19a 4.19b 4.44b 
Ag(1A)-C(1A) 2.064(4) 2.071(2) 2.059(3) 
Ag(1A)-O(1A) 2.112(3) 2.098(2) 2.100(3) 
O(1A)-Ag(1A)-O(2A) 176.8(1) 174.85(7) 164.0(1) 
C(2A)-O(1A) 1.257(6) 1.273(3) 1.243(6) 
C(2A)-O(2A) 1.230(7) 1.233(2) 1.209(5) 
Ag(1B)-C(1B) 2.064(5) 2.059(2) 2.069(3) 
Ag(1B)-O(1B) 2.113(3) 2.094(2) 2.089(3) 
O(1B)-Ag(1B)-O(2B) 177.6(2) 177.80(7) 166.2(1) 
C(2B)-O(1B) 1.253(6) 1.252(3) 1.264(6) 
C(2B)-O(2B) 1.227(7) 1.226(2) 1.219(4) 
% covalent charactera 7 16 4 
aCalculated using the formula: {640(C2-O1) – 800}/{2.4(C2-O1) – 2.5264}, and averaged for 
the two molecules in the asymmetric unit.  
 
 
Fig. 4.21. Solid state structure of (SIPr)Ag(O2CCH3) (4.20a) showing four 
molecules in the asymmetric unit. Non-essential hydrogen atoms have been 
omitted for clarity. 
 
Complex 4.20a is unique as it is the only complex where the carboxylate 
ligand exhibits an asymmetric chelating mode. It consists of 4 distinct 
molecules in the asymmetric unit (Fig. 4.21) that show only slight differences 
in their bond lengths and angles (Table 4.12). The Ag1-C1 bond lengths fall 
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within the range of previously reported isostructural complexes (see Table A1 
of Appendix 1). However, unlike the previously reported complexes, the 
difference between the Ag1-O1 and Ag1-O2 bond lengths is smaller and the 
C2-O1 bond lengths are also smaller than 1.2505 Å, indicating a largely ionic 
interaction between the carboxylate ligand and Ag(I) in the complex.212, 213 It 
is also worthy of note that the Ag-O distances in 4.20a are the longest in our 
series of synthesized complexes. 
 
Table 4.12. Selected bond lengths (Å) and angles (deg) of complex 4.20a 
Ag(1A)-C(1A) 2.059(7) Ag(1C)-C(1C) 2.058(7) 
Ag(1A)-O(1A) 2.151(6) Ag(1C)-O(1C) 2.326(7) 
Ag(1A)-O(2A) 2.590(8) Ag(1C)-O(2C) 2.420(7) 
C(2A)-O(1A) 1.18(1) C(2C)-O(1C) 1.22(1) 
C(2A)-O(2A) 1.24(1) C(2C)-O(2C) 1.18(1) 
O(1A)-Ag(1A)-O(2A) 52.4(3) O(1C)-Ag(1C)-O(2C) 52.5(3) 
Ag(1B)-C(1B) 2.060(7) Ag(1D)-C(1D) 2.059(7) 
Ag(1B)-O(1B) 2.338(7) Ag(1D)-O(1D) 2.300(7) 
Ag(1B)-O(2B) 2.415(8) Ag(1D)-O(2D) 2.445(6) 
C(2B)-O(1B) 1.24(1) C(2D)-O(1D) 1.25(1) 
C(2B)-O(2B) 1.23(1) C(2D)-O(2D) 1.24(1) 
O(1B)-Ag(1B)-O(2B) 54.1(3) O(1D)-Ag(1D)-O(2D) 54.6(2) 
 
Table 4.13. Steric Parameter (%Vbur) Calculated for NHCs of complexes 4.19, 
4.20, 4.44 and 4.45 
Complex %Vbura %Vburb 
[(IPr)AgOAc] (4.19a)c 43.0, 45.8 41.7, 44.6 
[(IPr)AgOBz] (4.19b)c 45.0, 47.2 43.6, 46.1 
[(IPr)Ag(4-MeC6H4CO2)] (4.19c) 42.7 41.5 
[(IPr)Ag(4-ClC6H4CO2)] (4.19d) 42.6 41.5 
[(IPr)AgCl] 46.5 
 
[(SIPr)AgOAc] (4.20a)c 46.0 – 47.5 45.1 – 46.3 
[(SIPr)AgOBz] (4.20b) 47.2 45.9 
[(SIPr)Ag(4-MeC6H4CO2)] (4.20c) 44.6 43.4 
[(SIPr)Ag(4-ClC6H4CO2)] (4.20d) 44.5 43.4 
[(SIPr)AgCl] 45.5 
 
[(IPent)AgOAc] (4.44a) 49.6 48.5 
[(IPent)AgOBz] (4.44b)c 50.3, 53.0 49.1, 52.1 
[(IPent)Ag(4-ClC6H4CO2)] (4.44d) 54.6 53.6 
[(IAd)AgOAc] (4.45a) 40.5 39.3 
193 
 
[(IAd)AgOBz] (4.45b) 38.5 37.0 
[(IAd)AgCl] 40.2 
 
a Calculations were performed using a Ag1-C1 value of 2.00 Å, a sphere radius of 3.5 Å, 
Bondi radii scaled by 1.17, and mesh spacing of 0.05. H atoms were excluded. b Calculations 
were performed using the experimentally determined bond length for the Ag1-C1 bond.  
c Asymmetric unit contains more than one independent molecule. 
 
To evaluate the steric environment of the NHC ligands around the metal center, 
the percentage buried volume (%Vbur) of the complexes was calculated using 
SambVca.210 Using Ag-C bond lengths obtained from crystallographic data, 
the calculated %Vbur of the complexes range from 37.0 to 53.6% (Table 4.13). 
IPent is the bulkiest ligand in the series, followed by SIPr, IPr and IAd. 
However, in the analogous silver(I) chloride complexes, IPr is only marginally 
larger than SIPr.208 The trend could be reversed in this case because of the 
torsion and greater rigidity in the saturated NHC backbone of SIPr, which 
increases the proximity of the aromatic rings to silver. The fact that the %Vbur 
values of the IPr complexes fall within a larger range (41.5 - 46.1) compared 
to SIPr (43.4 - 46.3) supports this.  
 
Only small differences between %Vbur values of complexes with the same 
NHC ligand but different carboxylate ligands are observed. This is because 
alkyl and aryl substituents on the carboxylate ligands reside away from the 
immediate coordination environment of silver, and hence can be considered to 
exhibit a similar steric profile. The differences in %Vbur values can be 
attributed to differences in Ag-C bond length, or simply, to crystal packing 
effects in the solid state. It is also important to note that the %Vbur values are 
calculated from solid state structures and might not be an accurate 
representation of the coordination environment of the Ag atom in solution. 
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Nonetheless, the range of %Vbur values observed reflect the ability of these 
ligands to adapt to the ancillary ligand environment by rearrangement of the 
N-aryl substituents. The bulkiest ligand in the series, IPent, seems particularly 
apt at this, as the range of %Vbur values observed for its complexes span 5.1 
units, from 48.5 to 53.6. This bulky yet flexible property of the IPent ligand 
has implications in the catalytic activity of the resulting silver complexes, 
which will be discussed in the following section. 
 
4.3 Catalysis 
The catalytic properties of complexes 4.19a,b, 4.20a-c, 4.44a,d and 4.45a,b 
for the cycloisomerization of propargyl amides was investigated. Hashmi et al. 
have previously reported the application of cationic Au(I) NHC complexes,155 
[(NHC)Au]OTs, in the cycloisomerization of non-terminal propargyl amides. 
Varying the substituents on both the N atoms and backbone of the NHC did 
not affect the efficiency of the resulting catalyst, which was instead greatly 
affected by the solvent of the reaction. Quantitative conversions could be 
obtained in THF in most cases. In contrast, the Au(I) triphenylphosphine 
complex, [(Ph3P)Au]OTs resulted in a lower conversion of 92% under 
identical reaction conditions. 
 
The conversion of the model substrate 3.1a to the oxazoline 3.2a was 
monitored in situ by 1H NMR spectroscopy over 10 h in the presence of 10 
mol% of the Ag(I) NHC carboxylate complexes at room temperature (23 C). 
The results are shown in Scheme 4.5. The conversions recorded after 24 h are 
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shown in Table 4.14, where the results obtained with other silver complexes 
are also produced for comparison. 
 
Scheme 4.5. Comparison of the catalytic activity of complexes 4.19a,b, 4.20a-
c, 4.44a,d and 4.45a,b for the cycloisomerization of 3.1a 
 
 
 
Effective catalysis was only observed with complexes containing both NHC 
and carboxylate ligands (entries 1-5 vs 11-14). The efficiency of the catalyst is 
clearly affected by both the NHC ligand and the carboxylate co-ligand. The 
reaction rate increased in the order IPr < SIPr < IPent, which is most evident 
when comparing acetate complexes 4.19a, 4.20a and 4.44a. There also 
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appears to be a correlation of the reaction rate with the basicity of the 
carboxylate ligands. Carboxylate ligands with lower basicity display a faster 
reaction rate, as shown by the increase in reaction rate as the carboxylate 
ligand is varied from acetate to 4-methylbenzoate to benzoate in the SIPr 
complexes 4.20a-c. The dramatic increase in reaction rate observed with 
complex 4.44d, which has an IPent ligand and the least basic 4-chlorobenzoate 
co-ligand, also supports this. In this particular case, complete conversion of 
substrate 3.1a to the product was observed within 6 h. In contrast, the IAd 
complexes 4.45a and 4.45b did not give any conversions due to catalyst 
decomposition. The corresponding SIMes and IPr chloride and cationic 
bis(NHC) complexes as well as the silver carboxylate salts were also inactive, 
emphasizing the importance of both the NHC and carboxylate ligands for 
catalytic activity. 
 
Table 4.14. Catalyst screening for the cycloisomerization of 3.1a 
Entry Catalyst Time Conversion 
1 [(IPr)AgOAc] (4.19a) 24 h 75 
2 [(IPr)AgOBz] (4.19b) 24 h 91 
3 [(SIPr)AgOAc] (4.20a) 24 h 85 
4 [(SIPr)AgOBz] (4.20b) 24 h 83 
5 [(SIPr)Ag(4-MeC6H4CO2)] (4.20c) 24 h 93 
6 [(IPent)AgOAc] (4.44a) 24 h 93 
7 [(IPent)Ag(4-ClC6H4CO2)] (4.44d) 6 h 100 
8 [(IAd)AgOAc] (4.45a) 24 h 
 
9 [(IAd)AgOBz] (4.45b) 24 h 
 
10 [(IPr)AgCl] 24 h 
 
11 [Ag(IPr)2]PF6 24 h  
12 [(SIMes)AgCl] 24 h 
 
13 AgOAc 24 h 
 
14 Ag(4-ClC6H4CO2) 24 h  
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Considering that the electronic properties of IPr, SIPr and IPent are very 
similar, the differences activity of the catalysts can be largely attributed to the 
steric properties of the NHC ligand. IPent239,240 may be regarded as a member 
of the family of bulky NHCs with “flexible sterics”. Due to the ability of such 
ligands to adjust their steric bulk to incoming substrates while enabling the 
stabilization of low-valent active catalytic intermediates, metal complexes 
containing these ligands have shown excellent catalytic activity.241,242,243,244 
The superior activity of complex 4.44d could thus be either due to the ability 
of IPent to provide steric shielding of the reactive metal center, hence slowing 
or preventing catalyst decomposition. In fact, in the case of the IPr complexes 
4.19a and 4.19b, the formation of the bis(NHC) complex [Ag(IPr)2]X as a 
result of ligand scrambling reactions was identified as one of the routes of 
catalyst deactivation. The steric bulk on IPent, however, makes this route of 
catalyst deactivation highly unfavourable.  
 
The correlation of the basicity of the carboxylic acids with the reaction rate 
could also suggest the dissociation of the carboxylate ligand and an formation 
of an active cationic [Ag(NHC)]+ catalytic species either by a dissociative or 
associative ligand exchange with the substrate. These ligand exchange process 
with the substrate would be more facile in the presence of carboxylate ligands 
with lower basicity, as they would form weaker bonds with silver. Once 
dissociated, these anions also afford stronger conjugate acids, which can 
facilitate the protodemetallation step. This, coupled with the steric pressure 
exerted by the trans IPent ligand, could account for excellent activity of 
complex 4.44d.  
198 
 
 
Table 4.15. Optimization of reaction conditions for catalyst 4.44d 
Entry Cat. loading Solvent Time Conversion Yield
a 
1 10 mol% CH2Cl2 6 h 100 95 
2 5 mol% CH2Cl2 18 h 100 95 
2 5 mol% chloroform 18 h 100 93 
3 5 mol% THF 18 h 88 80 
4 5 mol% acetone 18 h 80 75 
5 5 mol% MeCN 18 h 89 81 
6 5 mol% MeNO2 18 h 100 82 
7 5 mol% MeOH 18 h 100 89 
a Determined by 1H NMR spectroscopy, using 1,3,5-trimethoxybenzene as internal standard. 
 
Based on the preliminary results, complex 4.44d was chosen as the best 
catalyst and the catalyst loading, solvent and reaction time were subsequently 
optimized. Complete conversion of substrate was also obtained on reduction 
of the catalyst loading from 10 mol% to 5mol%, albeit with a three-fold 
increase in reaction time form 6 h to 18 h. Moderate yields were obtained in 
both protic and aprotic solvents, although chlorinated solvents such as CH2Cl2 
and chloroform were superior. Thus, CH2Cl2 was chosen as the solvent due to 
its lower boiling point and toxicity.  
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With the optimized reaction conditions in hand, the cycloisomerization of 
several other propargyl amide substrates were carried out (Table 4.16). The 
results showed that complex 4.44d is highly complementary to the substrate 
scope of [Ag(MeO-Py)2]PF6 (2.11d) described in the previous Chapter. At 5 
mol% catalytic loading, a wider range of substituents were tolerated at the 
amide. For example, the double cyclization of substrate 3.1k proceeded 
smoothly to afford the double cycloisomerized product 3.2k in quantitative 
yield (entry 11). In contrast, only 45% yield was obtained with 10 mol% of 
[Ag(MeO-Py)2]PF6 as catalyst. Substrates 3.1e and 3.1g, which only resulted 
in catalyst decomposition when [Ag(MeO-Py)2]PF6 was employed, could be 
successfully transformed into the corresponding products in 71% and 37% 
yields respectively using 4.44d as catalyst (entries 3 and 5). However, with 
substrate 3.1k, which also has two propargyl amide groups linked by a one 
carbon atom spacer, gave an incomplete conversion (entry 10), possibly due to 
its ability to form a chelate with the catalyst via the two carbonyl oxygen 
atoms, thus deactivating it. Notably, only small substituents at the propargylic 
position are tolerated, as substrate 3.1i cyclized quickly compared to substrates 
3.1q and 3.1n. The larger p-methoxybenzyl substituent in these substrates 
could hinder the approach of the catalyst (bearing the large IPent ligand) to the 
alkyne, resulting in slower reaction rates. For the non-terminal alkyne 
substrate 3.1n, a mixture of E/Z-double bond isomers was obtained.  
 
In light of experimental observations, a plausible mechanism shown in 
Scheme 4.6 is proposed. The active cationic silver species [(NHC)Ag]+ is first 
generated either by associative or dissociative ligand exchange with the 
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substrate. Activation of the alkyne substrate upon coordination to silver occurs, 
followed by nucleophilic attack by the carbonyl oxygen atom of the amide. 
Protodemetallation of the resulting vinyl silver intermediate affords the 
oxazoline product and regenerates the catalyst. The anti-addition of the 
oxygen nucleophile to the -coordinated alkyne, followed by a stereospecific 
protodemetallation step proposed in our mechanism would only result in the 
formation of the Z-alkene product with non-terminal alkyne substrates (R4  
H). However, a mixture of E and Z isomers were obtained with substrate 3.1n. 
Further investigations are needed to determine if this is the result of 
isomerization of the vinyl silver intermediate or the final oxazoline product.    
    
Scheme 4.6. Proposed Mechanism 
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4.5 Conclusion 
The review of the structural features and 13C NMR spectroscopic properties of 
silver(I) NHC carboxylate complexes in the beginning of this chapter shows 
that there is a strong preference for two-coordinate linear geometry, although 
electron-withdrawing groups on the NHC can increase the tendency for the 
carboxylate to bind in a bidentate manner. Argentophilic interactions also 
cause deviations from the ideal linear geometry in the solid state. A 
comparison of the carbene 13C NMR resonance of the analogous halide 
complexes confirmed our hypothesis that carboxylate ligands are weaker 
donors compared to halides. All the complexes except those with NHCs that 
have large substituents on nitrogen show a lack of coupling of the carbene 
carbon with 107,109Ag in their 13C NMR spectra, an indication of their fluxional 
behavior in solution. Lastly, no direct correlation of Ag-C bond length and 13C 
NMR chemical shift values of the carbene carbon with electronic differences 
between the NHC ligands was observed.  
 
We have also reported the synthesis and structural characterization of a series 
of silver(I) carboxylate complexes supported by NHC ligands by a new route 
involving the deprotonation of the HBF4 salt of the NHC precursors with 
K2CO3 in the presence of silver carboxylates. The complexes proved to be 
highly active in the cycloisomerization of propargyl amides, with a substrate 
scope complementary to that of the bis(4-methoxypyridine) silver(I) 
hexafluorophosphate complex (2.11d) described in the previous chapter. Large 
but flexible NHC ligands such as IPent, and carboxylate co-ligands on silver(I) 
with lower basicity improve catalyst efficiency. A plausible mechanism for the 
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reaction is also proposed, but further investigation is needed to confirm the 
identity of the active catalytic species and the rate-limiting step of the reaction. 
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Chapter 5 Conclusion and Future Work 
 
5.1 Conclusion 
This thesis describes the development of Ag(I) catalysts for intramolecular 
NH and (formal) OH addition to alkynes, allowing the preparation of N,O-
heterocycles. Two examples of such reactions, namely, the hydroamination of 
trichloroacetimidates, and the cycloisomerization of propargyl amides were 
explored (Scheme 5.1). 
 
 
Scheme 5.1. (a) Hydroamination of trichloroacetimidates (b) 
Cycloisomerization of propargyl amides. 
 
Initial experiments using silver salts showed that they were active catalysts for 
these reactions, although only moderate yields could be obtained. The 
reactivity was also highly dependent on the counteranion and solvent 
employed (Table 5.1, entries 1 and 2). The use of AgTFA in MeCN at room 
temperature afforded the methylene oxazoline product 2.2a exclusively, while 
changing the counteranion to triflate and the solvent to DCE resulted in a 
207 
 
selectivity switch towards the oxazole product 2.3a. In the cycloisomerization 
of the propargyl amide substrate 3.1a, AgTFA again proved to be the best 
catalyst, furnishing the methylene oxazoline product 3.2a as the sole product 
in 60% yield (entry 3). 
 
Further studies on ligand effects revealed that bis(pyridine) silver(I) 
complexes showed enhanced catalytic activities with a broad substrate scope. 
In the case of the cyclization of the (homo)propargyl trichloroacetimidates 2.1 
and 2.8, excellent yields of the methylene oxazoline and oxazine products, 2.2 
and 2.9 respectively, were obtained when R1 = H (entries 4 and 5). The 
internal alkyne substrates (R1 = Ph, TMS) also cyclized smoothly, albeit under 
harsher reaction conditions and an increase in catalytic loading (entries 6 and 
7). Similarly, the cyclization of the propargyl amide substrates 3.1 proceeded 
with complete regioselectivity towards the methylene oxazoline product 3.2 
when R1 = H (entry 8). With the internal alkyne substrates where R1 = alkyl, 
however, a mixture of both the E- and Z- isomers of 3.2 were obtained; and 
when R1 = TMS, a change in regioselectivity towards the oxazine 3.4 was 
observed (entry 9).  
 
The success of the bis(pyridine) silver(I) complexes is evident from the fact 
that they form the first examples of Ag-catalysts that can achieve comparable 
yields to that achieved with gold catalysts in these reactions. They also present 
an added economic advantage as they can be prepared easily in good yields 
from silver salts and pyridine ligands, which are cheaper than gold salts. 
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Encouraged by the positive ligand effects on the catalytic activity, the catalytic 
activity of silver(I) N-heterocyclic carbene (NHC) carboxylate complexes 
towards the cyclization of the propargyl amide substrates 3.1 was also 
investigated (entry 10). Interestingly, complementary reactivity was observed 
compared to the bis(pyridine) Ag(I) catalyst. Substrates that reacted poorly 
with the bis(pyridine) Ag(I) catalyst, such as those with electron-poor R4 
substituents, underwent smooth cyclization with the Ag(I) NHC catalyst in 
good yields. In contrast, substrates with propargyl substituents (R2 and R3) that 
cyclized easily with the bis(pyridine) Ag(I) catalyst reacted sluggishly in the 
presence of the Ag(I) NHC catalyst. 
 
 
Scheme 5.2. Synthesis of halomethylene oxazolines  
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The scope of these reactions has also been extended to the synthesis of 
halomethylene oxazolines. These reactions occur in a highly stereospecific 
manner, yielding either the Z-isomer (Scheme 5.2a) or the E-isomer (Scheme 
5.2b and c) exclusively.  
 
5.2 Future Work 
Future work will include exploring the potential of the bis(pyridine) Ag(I) 
complexes and Ag(I) NHC carboxylate complexes developed in this work in 
more challenging transformations, such as in intermolecular hydroamination 
of alkenes. The ability of AgOTf to catalyze the hydroamination of alkenes 
with sulfonamides and p-nitroaniline has been reported, 245  albeit in lower 
yields and a limited substrate scope compared to gold catalysts. It would be 
thus interesting to explore if possibility that the addition of suitable ligands to 
Ag would allow an improvement in the efficiency of the Ag catalyst. 
 
Experiments to provide evidence for the proposed mechanisms for the N-H 
and O-H addition examined in this work should be performed, which will 
provide a better understanding of the role of the pyridine ligands in the 
mechanism, and the observed regioselectivity and diastereoselectivity of the 
reaction. This will also offer fundamental insight to the unique catalytic 
activity of silver compared to gold, as well the complementary activity 
observed between pyridyl and NHC ligands.  
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Scheme 5.3. Proposed synthetic route to 1,3-diamino alcohols from the 4-
bromomethylene oxazine 2.9i 
 
Lastly, further functionalization of the bromo and iodomethylene oxazoline 
products shown in Scheme 5.3 can be carried out. For instance, cross-coupling 
reactions of the vinyl halide moiety in compound 2.9i via Suzuki and Stille 
reactions can be explored. This provides an alternative synthetic route to 4-
benzylidene oxazines (R = aryl) (5.1), as the cyclization of the phenyl 
substituted internal alkyne substrate in the presence of the bis(pyridiyl) Ag(I) 
catalyst only afforded low yields. Asymmetric hydrogenation of the alkene in 
5.1, followed by the hydrolysis of the trichloroactimidate moiety may then 
provide chiral 1,3-amino alcohols, which are not only commonly found in 
natural products and pharmaceuticals 246  but also are useful synthons for 
organic syntheses.247  
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Chapter 6 Experimental 
 
Materials were obtained from commercial suppliers and used without 
purification. We are grateful to Prof. Steven P. Nolan (University of St 
Andrews) for the gift of the imidazolium salts, IAd
HBF4 and IPent
HBF4. 
Unless otherwise stated, all reactions were carried out in air and using 
technical solvents. Solvents were dried by passing through the columns of 
molecular sieves in a solvent purification system (Innovative Technology Inc.). 
All reactions involving air-sensitive reagents were performed using standard 
Schlenk techniques and oven dried glassware. All reactions involving silver 
compounds were performed in the dark by covering the reaction vessels with 
aluminum foil. Catalytic reactions were carried out in Radley tubes in a 
Radley’s 12-place reaction carousel, or in screw-cap vials. Column 
chromatography was performed on silica gel (Kieselgel 60) or neutral alumina. 
Preparative TLC was performed on 20cm  20 cm glass plates with a 1.5 mm 
thick layer of silica gel 60 F254 (Analtech).  
 
Unless otherwise stated, 1H, 13C, 31P and 19F spectra were recorded at 25 °C on 
Bruker Avance™ spectrometers operating at 400 MHz, 101 MHz, 162 MHz 
and 376 MHz respectively. Residual protic solvents were used as an internal 
standard and 13C resonances were referenced to the deuterated carbon. 
Chemical shifts () are reported in ppm, and J values in Hz. Multiplicity is 
abbreviated to s (singlet), br s (broad singlet), d (doublet), t (triplet), q 
(quartet), sept (septet), and multiplet (m). Where required, 2D NMR (COSY, 
DEPT, NOESY and HMQC) experiments were used to distinguish and assign 
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1H and 13C peaks. Infrared spectra were recorded using a Perkin Elmer 100 
series FT-IR spectrometer, equipped with an ATR accessory. Melting points 
were recorded using an Electrothermal Gallenhamp apparatus, and were 
uncorrected. Single crystal X-ray diffraction was performed by Dr. Andrew J. 
P. White (Imperial College London) using an Agilent Xcalibur diffractometer. 
Mass spectra (MS) were recorded by the Mass Spectrometry Service (Dr. Lisa 
Haigh) at Imperial College London on Micromass Autospec Premier, 
Micromass LCT Premier, or VG Platform II spectrometers using EI, CI or ESI 
techniques. Elemental analyses were performed by the Analytical Services at 
London Metropolitan University. 
 
6.1 Compounds used in Chapter 2 
General procedure for the synthesis of the propargylic 
trichloroacetimidates (2.1a-j) (Procedure A): 
A solution of propargylic alcohol (1.0 eq.) and trichloroacetonitrile (1.2 eq.) in 
CH2Cl2 (2.5 mL per mmol of propargylic alcohol) was cooled to 0 C in an ice 
bath and DBU (0.1 eq.) was added dropwise. The reaction mixture was 
allowed to stir at 0 C (for t1 min), then warmed to room temperature and 
stirred (for another t2 min). The solvent was removed in vacuo, and the residue 
was purified by column chromatography on silica gel.  
 
Prop-2-ynyl 2,2,2-trichloroacetimidate (2.1a).129 
t1 = 60, t2 = 30. Prepared from propargyl alcohol (1.16 mL, 20 
mmol) by procedure A, obtained as a colorless oil after 
purification by column chromatography (petroleum ether/ethyl acetate, 8:1). 
214 
 
Yield: 3.11 g (78%). 1H NMR (CDCl3):  = 8.50 (br s, 1H, NH), 4.91 (d, J = 
2.4, 2H, CH2), 2.55 (t, J = 2.4, 1H, CH). 13C NMR (CDCl3):  = 161.8 
(C=NH), 90.7 (CCl3), 77.1 (CCH), 75.1 (CCH), 56.6 (CH2). MS [CI]: m/z 
(%) = 198 (100) [M-H]+. 
 
1-Methylprop-2-ynyl 2,2,2-trichloroacetimidate (2.1b).129 
t1 = 60, t2 = 60. Prepared from 3-butyn-2-ol (1.57 mL, 20 mmol) 
by procedure A, obtained as a colorless oil after purification by 
column chromatography (petroleum ether/ethyl acetate, 10:1). 
Yield: 3.43 g (80%). 1H NMR (CDCl3):  = 8.48 (br s, 1H, NH), 5.54 (dq, J = 
6.7, 2.1, 1H, OCH), 2.52 (d, J = 2.1, 1H, CH), 1.64 (d, J = 6.7, 3H, CH3). 13C 
NMR (CDCl3):  = 161.4 (C=NH), 91.1 (CCl3), 81.4 (CCH), 73.6 (CCH), 
64.9 (OCH), 20.8 (CH3). MS [CI]: m/z (%) = 214 (100) [M+H]+. 
 
1-Ethylprop-2-ynyl 2,2,2-trichloroacetimidate (2.1c). 
t1 = 60, t2 = 120. Prepared from 1.00 g (11.9 mmol) of 1-pentyn-
3-ol by procedure A, obtained as a colorless oil after purification 
by column chromatography (petroleum ether/ethyl acetate, 8:1). 
Yield: 1.42 g (52%). 1H NMR (CDCl3):  = 8.46 (br s, 1H, NH), 5.39 (td, J = 
6.4, 2.2, 1H, OCH), 2.52 (d, J = 2.2, 1H, CH), 2.00 – 1.93 (m, 2H, CH2CH3), 
1.10 (t, J = 7.4, 3H, CH3). 13C NMR (CDCl3):  = 161.6 (C=NH), 91.2 (CCl3), 
80.3 (CCH), 74.1 (CCH), 69.8 (OCH), 27.8 (CH2CH3), 9.3 (CH2CH3). MS 
[CI]: m/z (%) = 228 (100) [M+H]+. 
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Synthesis of 1-Methyl-4-pentyn-3-ol.248 
A solution of isobutyraldehyde (0.91 mL, 10 mmol, 1.0 eq.) in 
dry THF (25 mL) and added to a solution of ethynylmagnesium 
bromide in THF (0.5 M in THF, 30 mL, 15 mmol) at 0 °C, with stirring. After 
3 h, the reaction mixture was quenched by addition of saturated aq. NH4Cl 
solution (50 mL) at 0 C. Volatiles were removed under reduced pressure, and 
Et2O (50 mL) was added. The organic layer was separated, washed with brine 
(50 mL) and dried over Na2SO4. The solvent was removed in vacuo, to furnish 
1-methyl-4-pentyn-3-ol as an orange oil, which was used in the next step 
without further purification. 1H NMR (CDCl3):  = 4.20 (dd, J = 5.8, 2.1, 1H, 
CHOH), 2.48 (d, J = 2.1, 1H, CH), 1.96  1.86 (m, 1H, CH(CH3)2), 1.80 (br 
s, 1H, OH), 1.04 (dd, J = 7.8, 6.8, 6H, CH3). 
 
1-(1-Methylethyl)-prop-2-ynyl 2,2,2-trichloroacetimidate (2.1d). 
t1 = 60, t2 = 120. Prepared from 0.60 g (6.11 mmol) of 1-methyl-
4-pentyn-3-ol by procedure A, obtained as a light yellow oil after 
purification by column chromatography (petroleum ether/ethyl 
acetate, 8:1). Yield: 0.75 g (50%). 1H NMR (CDCl3):  = 8.45 (s, 1H, NH), 
5.26 (dd, J = 5.6, 2.2, 1H, OCH), 2.50 (d, J = 2.2, 1H, CH), 2.25  2.13 (m, 
1H, CH(CH3)2), 1.10 (dd, J = 9.3, 6.7, 6H, CH3). 13C NMR (CDCl3):  = 161.7 
(C=NH), 91.3 (CCl3), 79.2 (CCH), 74.7 (CCH), 73.6 (OCH), 32.4 
(CH(CH3)2), 17.9 (CH3), 17.7 (CH3). MS [CI]: m/z (%) = 242 (28) [M+H]+. 
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1-Phenylprop-2-ynyl 2,2,2-trichloroacetimidate (2.1e).129 
t1 = 60, t2 = 300. Prepared from 1-phenyl-2-propyn-1-ol (2.43 
mL, 20 mmol) by procedure A, obtained as a white solid after 
purification by column chromatography (petroleum ether/ethyl 
acetate, 10:1). Yield: 1.45 g (26%). 1H NMR (CDCl3):  = 8.62 (br s, 1H, NH), 
7.69  7.61 (m, 2H, CH-aromatic), 7.49  7.41 (m, 3H, CH-aromatic), 6.58 (d, 
J = 2.2, 1H, OCH), 2.76 (d, J = 2.3, 1H, CH). 13C NMR (CDCl3):  = 161.3 
(C=NH), 135.0 (CH-aromatic), 129.2 (CH-aromatic), 128.7 (CH-aromatic), 
127.5 (CH-aromatic), 91.0 (CCl3), 79.6 (CCH), 76.2 (CCH), 69.9 (OCH). 
MS [CI]: m/z (%) = 133 (100), 116 (85), 264 (23). 
 
1,1-Dimethylprop-2-ynyl 2,2,2-trichloroacetimidate (2.1f).129 
t1 = 60, t2 = 300. Prepared from 2-methyl-3-butyn-2-ol (1.94 mL, 
20 mmol) by procedure A, obtained as a colorless oil after 
purification by column chromatography (petroleum ether/ethyl 
acetate, 10:1). Yield: 1.22 g (27%). 1H NMR (CDCl3):  = 8.56 (br s, 1H, NH), 
2.61 (s, 1H, CH), 1.81 (s, 6H, CH3). 13C NMR (CDCl3):  = 159.8 (C=NH), 
91.9 (CCl3), 83.9 (CCH), 75.3 (CCH), 73.3 (C(CH3)2), 28.6 (CH3). MS [CI]: 
m/z (%) = 228 (100) [M+H]+. 
 
But-2-ynyl 2,2,2-Trichloroacetimidate (2.1g). 
t1 = 60, t2 = 30. Prepared from 2-butyn-1-ol (1.50 mL, 20 
mmol) by procedure A, obtained as a colorless oil after 
purification by column chromatography (petroleum ether/ethyl acetate, 10:1). 
Yield: 3.20 g (75%). 1H NMR (CDCl3):  = 8.44 (br s, 1H, NH), 4.90 (q, J = 
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2.3, 2H, OCH2), 1.91 (t, J = 2.3, 3H, CH3). 13C NMR (CDCl3):  = 162.06 
(C=NH), 90.99 (CCl3), 84.08 (CCCH3), 72.56 (CCCH3), 57.59 (OCH2), 
3.81 (CH3). MS [CI]: m/z (%) = 214 (100) [M+H]+. 
 
3-Phenylprop-2-ynyl 2,2,2-Trichloroacetimidate (2.1h). 
t1 = 60, t2 = 90.  Prepared from 3-phenyl-2-propyn-1-ol 
(1.0 mL, 8.0 mmol) by procedure A, obtained as a 
colorless oil after purification by column 
chromatography (petroleum ether/ethyl acetate, 8:1). Yield: 1.72g (78%). 1H 
NMR (CDCl3):  = 8.51 (br s, 1H, NH), 7.49 (dd, J = 7.5, 2.2, 2H, CH-
aromatic), 7.37 – 7.29 (m, 3H, CH-aromatic), 5.15 (s, 2H, OCH2). 13C NMR 
(CDCl3):  = 161.98 (C=NH), 131.98 (CH-aromatic), 128.87 (CH-aromatic), 
128.33 (CH-aromatic), 122.10 (CH-aromatic), 90.95 (CCl3), 87.23 (CCC6H5), 
82.29 (CCC6H5), 57.58 (OCH2). MS [CI]: m/z (%) = 229 (100), 133 (86), 
246 (62). (M+ not observed) 
 
4-Tosyloxy-2-butyn-1-ol.  
This compound was prepared by a modified method of a 
previously published procedure.249 A mixture of triethylamine (2.0 mL, 14.4 
mmol, 1.6 eq.), trimethylamine hydrochloride (0.086 g, 0.9 mmol, 0.1 eq.) and 
p-toluenesulfonyl chloride (1.72 g, 9.0 mmol, 1.0 eq.) in MeCN (20 mL) was 
added dropwise over 1 h to a solution of 2-butyne-1,4-diol (3.87 g, 45 mmol, 5 
eq.) in MeCN (30 mL) at 0 C. The reaction mixture was warmed to room 
temperature and quenched with water (75 mL) and ethyl acetate (75 mL). The 
aqueous layer was extracted with another 50 mL of ethyl acetate. The 
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combined organic layers were washed with saturated aqueous NH4Cl solution 
(40 mL) and brine (40 mL), and dried over Na2SO4. The solvent was removed 
in vacuo, leaving behind a dark brown oil. The crude product was purified by 
column chromatography on silica, using petroleum ether/ethyl acetate, 3:7 
then 1:1 as eluting solvent. 1.14 g (53%) of 4-tosyloxy-2-butyn-1-ol was 
obtained as an orange oil. 1H NMR (CDCl3):  = 7.84 (d, J = 8.3, 2H, CH-
aromatic), 7.39 (d, J = 8.3, 2H, CH-aromatic), 4.76 (t, J = 1.7, 2H, TsOCH2), 
4.19 (t, J = 1.7, 2H, CH2OH), 2.48 (s, 3H, CH3), 2.07 (s, 1H, CH2OH). 
 
1-Bromo-2-butyn-4-ol.249 
To a stirred solution of 4-tosyloxy-2-butyn-1-ol (1.14 g, 
4.74 mmol, 1.0 eq.) in acetone (8.0 mL) was added LiBr (0.82 g, 9.49 mmol, 
2.0 eq.) which caused a minor exotherm in the mixture. Stirring was continued 
at room temperature for 1 h and then diluted with Et2O (35 mL) and H2O (17 
mL). The organic layer was washed with brine (5 mL) and dried over MgSO4. 
The solvent was removed in vacuo, and the resulting brown oil (0.63 g, 89%) 
was used without further purification. 1H NMR (CDCl3):  = 4.35 (t, J = 2.0, 
2H, CH2OH), 3.97 (t, J = 2.0, 2H, CH2Br), 2.20 (s, 1H, CH2OH). 13C NMR 
(CDCl3):  = 85.0 (CCH2OH), 80.8 (CCH2Br), 51.1 (CH2OH), 14.3 
(CH2Br). 
 
Synthesis of 4-Bromo-but-2-ynyl 2,2,2-trichloroacetimidate (2.1i). 
t1 = 60, t2 = 120.  Prepared from 1-bromo-2-butyn-4-ol 
(0.87 g, 5.84 mmol) by procedure A, obtained as a 
colorless oil after purification by column chromatography (petroleum 
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ether/ethyl acetate, 5:1). Yield: 1.14 g (67%). 1H NMR (CDCl3):  = 8.51 (br s, 
1H, NH), 5.00 (t, J = 2.1, 2H, OCH2), 3.99 (t, J = 2.1, 2H, CH2Br). 13C NMR 
(CDCl3):  = 161.8 (C=NH), 90.7 (CCl3), 82.4 (CCCH2Br), 80.0 
(CCCH2Br), 56.8 (OCH2), 13.8 (CH2Br). MS [CI]: m/z (%) = 294 (100) 
[M+H]+. 
 
3-(Trimethylsilyl)prop-2-ynyl 2,2,2-trichloroacetimidate (2.1j). 
t1 = 60, t2 = 60. Prepared from 3-
(trimethylsilyl)propargyl alcohol (1.00 g, 7.8 mmol) by 
procedure A, obtained as a colorless oil after purification 
by column chromatography (petroleum ether/ethyl acetate, 8:1). Yield: 1.97 g 
(93%). 1H NMR (CDCl3):  = 8.45 (br s, 1H, NH), 4.91 (s, 2H, OCH2), 0.19 (s, 
9H, CH3). 13C NMR (CDCl3):  = 161.9 (C=NH), 98.2 (CCl3), 93.0 (CCSi), 
90.9 (CCSi), 54.7 (OCH2), -0.3 (Si(CH3)3). MS [CI]: m/z (%) = 272 (100) 
[M+H]+. 
 
Synthesis of 3-Bromoprop-2-ynyl 2,2,2-trichloroacetimidate (2.1k). 
A mixture of propargyl alcohol (1.16 mL, 20 mmol, 1.0 eq.), 
N-bromosuccinimide (3.92 g, 22 mmol, 1.1 eq.) and silver 
nitrate (0.34 g, 2.0 mmol, 0.1 eq.) in acetone (50 mL) was 
stirred at room temperature for 2 h. The solvent was removed in vacuo and the 
residue dissolved in water (50 mL). The resulting solution was extracted with 
Et2O (2  50 mL), and the combined organic extracts washed with brine (20 
mL), dried over Na2SO4, filtered and concentrated to afford the 
bromopropargylic alcohol as a colorless oil. CH2Cl2 (50 mL) and 
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trichloroacetonitrile (2.4 mL, 24 mmol, 1.2 eq.) were added, and the solution 
was cooled to 0 C in an ice bath. DBU (0.3 mL, 2.0 mmol, 0.1 eq.) was then 
added dropwise. The reaction mixture was allowed to stir at 0 C for 1 h, then 
warmed to room temperature and stirred for another 3 h. The solvent was 
removed in vacuo, and the resulting brown oil chromatographed on silica 
using petroleum ether/ethyl acetate (8:1) as eluting solvent, to furnish 2.1k as 
a light yellow oil. Yield: 3.34 g (60%). 1H NMR (CDCl3):  = 8.49 (br s, 1H, 
NH), 4.93 (s, 2H, OCH2). 13C NMR (CDCl3):  = 161.8 (C=NH), 90.7 (CCl3), 
73.5 (CCBr), 57.5 (CCBr), 48.2 (OCH2). MS [CI]: m/z (%) = 280 (83) 
[M+H]+. 
 
General procedure for the preparation of homopropargyl 
trichloroacetimidates (2.8a-c) (Procedure B): 
A solution of the appropriate homopropargyl alcohol (20 mmol, 1.0 eq.) and 
trichloroacetonitrile (24 mmol, 1.2 eq.) in CH2Cl2 (50 mL) was cooled to 0 C 
in an ice bath and DBU (2 mmol, 0.1 eq.) was added dropwise. The reaction 
mixture was allowed to stir at 0 C (for t1 min), then warmed to room 
temperature and stirred (for another t2 min). The solvent was removed in 
vacuo, and the residue chromatographed on silica.  
 
But-3-ynyl 2,2,2-trichloroacetimidate (2.8a). 
This compound was previously reported129 but no experimental 
details and spectroscopic data were given. t1 = 60, t2 = 60. 
Prepared from 3-butyn-1-ol (1.51 mL, 20 mmol) by procedure B, obtained as a 
colorless oil after purification by column chromatography (petroleum 
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ether/ethyl acetate, 10:1). Yield: 3.28 g (76%). 1H NMR (CDCl3):  = 8.35 (br 
s, 1H, NH), 4.40 (t, J = 7.0, 2H, OCH2), 2.68 (td, J = 7.0, 2.7, 2H, CH2C), 
2.01 (t, J = 2.7, 1H, CH). 13C NMR (CDCl3):  = 162.5 (C=NH), 91.2 (CCl3), 
79.6 (CCH), 70.1 (CCH), 66.8 (OCH2), 18.5 (CH2CC). MS [CI]: m/z (%) 
= 214 (100) [M+H]+. 
 
1-Methyl-but-3-ynyl 2,2,2-trichloroacetimidate (2.8b). 
t1 = 60, t2 = 360. Prepared from 4-pentyn-2-ol (1.90 mL, 20 
mmol) by procedure B, obtained as a colorless oil after 
purification by column chromatography (petroleum ether/ethyl 
acetate, 5:1). Yield: 3.71 g (81%). 1H NMR (CDCl3):  = 8.31 (br s, 1H, NH), 
5.17  5.09 (m, 1H, OCH), 2.68  2.54 (m, 2H, CH2C), 2.02 (t, J = 2.7, 1H, 
CH), 1.47 (d, J = 6.3, 3H, CH3). 13C NMR (CDCl3):  = 161.9 (C=NH), 91.6 
(CCl3), 79.5 (CCH), 73.6 (CCH), 70.6 (OCH), 24.9 (CH2CC), 18.3 (CH3). 
MS [CI]: m/z (%) = 228 (100) [M+H]+. 
 
1-Ethyl-but-3-ynyl 2,2,2-trichloroacetimidate (2.8c). 
t1 = 60, t2 = 60. Prepared from 5-hexyn-3-ol (1.00 g, 10.2 mmol) 
by procedure B, obtained as a colorless oil after purification by 
column chromatography (petroleum ether/ethyl acetate, 5:1). 
Yield: 2.37 g (96%). 1H NMR (CDCl3):  = 8.32 (br s, 1H, NH), 5.02  4.96 
(m, 1H, OCH), 2.64  2.62 (m, 2H, CH2C), 2.00 (t, J = 2.7, 1H, CH), 1.91  
1.86 (m, 2H, CH2CH3), 1.01 (t, J = 7.5, 3H, CH2CH3). 13C NMR (CDCl3):  = 
162.3 (C=NH), 91.7 (CCl3), 79.5 (CCH), 78.0 (CCH), 70.5 (OCH), 25.7 
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(CH2CC), 22.5 (CH2CH3), 9.4 (CH2CH3). MS [CI]: m/z (%) = 242 (100) 
[M+H]+. 
 
General procedure for the preparation of homopropargyl alcohols 
(Procedure C): 
Propargylmagnesium bromide was prepared by a modified literature 
procedure:250 A mixture of Mg turnings (1.94 g, 80 mmol) and HgCl2 (75 mg) 
was suspended in dry Et2O (20 mL) and stirred at room temperature for 30 
min. 1.0 mL of propargyl bromide solution (80% in toluene, 6.72 mmol) was 
added in one portion to initiate the reaction (indicated by a slight exotherm). 
The reaction mixture was cooled to 0 C in an ice bath, and another 5.0 mL of 
propargyl bromide solution (80% in toluene, 33.6 mmol) was added dropwise 
over 30 min. Stirring was continued for another 45 min at 0 C, after which 
the solution was decanted into a solution of the corresponding aldehyde (20 
mmol) in Et2O (15 mL) at 0 C. The ice bath was removed, and reaction 
mixture stirred overnight at room temperature. The reaction was quenched by 
the addition of 40 mL of saturated aq. NH4Cl at 0 C. The aqueous layer was 
extracted with 3  40 mL of Et2O, and the combined organic extracts washed 
with brine (75 mL), dried over Na2SO4, filtered and concentrated in vacuo. 
The crude homopropargyl alcohols were obtained as orange oils, which were 
used in the next steps without further purification. 
 
General procedure for the synthesis of the homopropargyl 
trichloroacetimidates (2.8d-f) (Procedure D): 
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A solution of the requisite homopropargyl alcohol (either obtained from 
commercial sources or prepared by procedure C) (10 mmol, 1.0 eq.) and 
trichloroacetonitrile (12 mmol, 1.2 eq.) in CH2Cl2 (25 mL) was cooled to 0 C 
in an ice bath and DBU (1 mmol, 0.1 eq.) was added dropwise. The reaction 
mixture was allowed to stir at 0 C for 15 min, then warmed to room 
temperature and stirred for further 4 h. The solvent was removed in vacuo, and 
the residue chromatographed on silica.  
 
1-Phenyl-but-3-ynyl 2,2,2-trichloroacetimidate (2.8d). 
Prepared by procedure D. After purification by column 
chromatography (petroleum ether/ethyl acetate, 6:1), 1.88 g 
(65%) of 2.8d was obtained as a white crystalline solid. 1H 
NMR (CDCl3):  = 8.39 (br s, 1H, NH), 7.49  7.46 (m, 2H, 
CH-aromatic), 7.41  7.32 (m, 3H, CH-aromatic), 5.99 (t, J = 6.6, 1H, OCH), 
2.97  2.79 (m, 2H, CH2C), 2.00 (t, J = 2.7, 1H, CH). 13C NMR (CDCl3):  
= 161.4 (C=NH), 138.5 (CH-aromatic), 128.5 (CH-aromatic), 126.3 (CH-
aromatic), 91.4 (CH-aromatic), 79.2 (CCH), 78.3 (CCH), 70.9 (OCH), 26.6 
(CH2CC). (CCl3 was too broad to be detected). MS [CI]: m/z (%) = 257 (100), 
274 (94), 145 (86) (M+ not observed). 
 
1-(4-Chlorophenyl)-but-3-ynyl 2,2,2-trichloroacetimidate (2.8e). 
Prepared by procedure D. After purification by column 
chromatography (petroleum ether/ethyl acetate, 10:1), 1.36 g 
(42%) of 2.8e was obtained as an orange oil. This compound 
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was previously reported129 but no experimental details and spectroscopic data 
were given. 1H NMR (CDCl3):  = 8.40 (br s, 1H, NH), 7.42  7.34 (m, 4H, 
CH-aromatic), 5.94 (t, J = 6.6, 1H, OCH), 3.94  2.77 (m, 2H, CH2C), 2.00 (t, 
J = 2.6, 1H, CH). 13C NMR (CDCl3):  = 161.3 (C=NH), 136.9 (CH-
aromatic), 134.4 (CH-aromatic), 128.7 (CH-aromatic), 127.9 (CH-aromatic), 
91.2 (CCH), 78.8 (CCH), 71.2 (OCH), 26.4 (CH2CC). (CCl3 was too 
broad to be detected). MS [CI]: m/z (%) = 181 (100), 164 (31), 364 (26) (M+ 
not observed). 
 
1-(4-Trifluoromethylphenyl)-but-3-ynyl 2,2,2-trichloroacetimidate (2.8f). 
Prepared by procedure D. After purification by column 
chromatography (petroleum ether/ethyl acetate, 10:1), 1.56 
g (44%) of 2.8f was obtained as an orange oil. 1H NMR 
(CDCl3):  = 8.43 (br s, 1H, NH), 7.66  7.58 (m, 4H, CH-
aromatic), 6.01 (t, J = 6.4, 1H, OCH), 2.97  2.80 (m, 2H, CH2C), 2.01 (t, J 
= 2.7, 1H, CH). 13C NMR (CDCl3):  = 161.2 (C=NH), 142.3 (CH-aromatic), 
130.6 (q, J = 32.4, CF3), 126.7 (CH-aromatic), 125.5 (CH-aromatic), 125.5 
(CH-aromatic), 122.6 (CCl3), 91.1 (CCH), 78.5 (CCH), 71.5 (OCH), 26.4 
(CH2CC). MS [CI]: m/z (%) = 371 (100), 215 (34). (M+ not observed) 
 
Synthesis of 4-Phenyl-3-butyn-1-ol.251 
A mixture of bis(triphenylphosphine)palladium(II) 
dichloride (0.15 g, 0.2 mmol, 0.02 eq.), copper(I) iodide 
(19 mg, 0.01 mmol, 0.01 eq.), iodobenzene (1.1 mL, 10 mmol, 1.0 eq.) and 3-
butyn-1-ol (0.9 mL, 12 mmol, 1.2 eq.) was dissolved in dry Et3N (60 mL) and 
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refluxed for 2.5 h. The resultant dark brown solution was quenched with 22.5 
mL of an ethyl acetate/water mixture (1:1.25). The aqueous and organic 
phases were separated, and the organic layer was washed with water (50 mL) 
and then brine (50 mL), dried over anhydrous Na2SO4, filtered and 
concentrated in vacuo. The resulting orange oil was and purified by column 
chromatography (petroleum ether/ethyl acetate, 1:2) on silica gel to afford 
0.86 g (59%) of 4-phenyl-3-butyn-1-ol as a light yellow oil. 1H NMR (CDCl3): 
 = 7.48  7.40 (m, 2H, CH-aromatic), 7.36  7.27 (m, 3H, CH-aromatic), 
3.84 (t, J = 6.3, 2H, CH2OH), 2.72 (t, J = 6.3, 2H, CCH2), 1.82 (br s, 1H, 
OH). 
 
Synthesis of 4-Phenyl-but-3-ynyl 2,2,2-trichloroacetimidate (2.8g). 
Prepared on a 5.88 mmol scale by procedure D. After 
purification by column chromatography (petroleum 
ether/ethyl acetate, 6:1), 1.59 g (93%) of 2.8g was obtained as a light yellow 
crystalline solid. 1H NMR (CDCl3):  = 8.37 (br s, 1H, NH), 7.41  7.37 (m, 
3H, CH-aromatic), 7.30  7.28 (m, 2H, CH-aromatic), 4.49 (t, J = 7.0, 2H, 
OCH2), 2.92 (t, J = 7.0, 2H, CH2C). 13C NMR (CDCl3):  = 162.6 (C=NH), 
131.6 (CH-aromatic), 128.0 (CH-aromatic), 123.4 (CH-aromatic), 91.3 (CH-
aromatic), 85.0 (CCC6H5), 82.2 (CCC6H5), 67.1 (OCH2), 19.5 (CH2CC). 
(CCl3 was too broad to be detected). MS [CI]: m/z (%) = 290 (33) [M+H]+. 
 
Synthesis of 4-(Trimethylsilyl)but-3-yn-1-ol.251, 252 
n-BuLi (1.6 M in hexane, 27.5 mL, 44 mmol, 2.2 eq.) 
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was added dropwise to a solution of 3-butyn-1-ol (1.5 mL, 20 mmol, 1.0 eq.) 
in dry THF (25 mL) at -78 °C. After stirring for 1 h, the yellow suspension 
was allowed to warm to room temperature, before cooling down again to -
78 °C, whereupon trimethylchlorosilane (5.6 mL, 44 mmol, 2.2 eq.) was added 
dropwise. The cooling bath was removed, and the reaction mixture was stirred 
overnight at room temperature. The reaction was quenched by the dropwise 
addition of 5M H2SO4 (10 mL) at 0 °C, stirring for 1 h to ensure complete 
hydrolysis of the TMS-ether. The aqueous layer was then separated and 
extracted with Et2O (2  10 mL). The combined organic layers was washed 
with water (10 mL) and brine (10 mL), dried over MgSO4, filtrated and 
concentrated under reduced pressure to give 1.89 g (66%) of 4-
(trimethylsilyl)but-3-yn-1-ol as a light yellow oil, which was used for the next 
step without further purification. 1H NMR (CDCl3):  = 3.71 (t, J = 6.3, 2H, 
CH2OH), 2.50 (t, J = 6.3, 2H, CH2), 1.74 (s, 1H, OH), 0.16 (s, 9H, Si(CH3)3). 
 
4-(Trimethylsilyl)but-3-ynyl 2,2,2-trichloroacetimidate (2.8h). 
Prepared on a 12.4 mmol scale by procedure D. After 
purification by column chromatography (petroleum 
ether/ethyl acetate, 8:1), 2.90 g (81%) of 2.8h was obtained as a white 
crystalline solid. 1H NMR (CDCl3):  = 8.33 (br s, 1H, NH), 4.38 (t, J = 7.0, 
2H, OCH2), 2.71 (t, J = 7.0, 2H, CH2C), 0.13 (s, 9H, CH3). 13C NMR 
(CDCl3):  = 162.6 (C=NH), 101.8 (CCl3), 91.3 (CCSi), 86.8 (CCSi), 66.9 
(OCH2), 19.9 (CH2CC), -0.02 (Si(CH3)3). MS [CI]: m/z (%) = 286 (100) 
[M+H]+. 
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4-Bromobut-3-ynyl 2,2,2-trichloroacetimidate (2.8i). 
A mixture of 3-butyn-1-ol (0.34 mL, 4.5 mmol, 1.0 eq.), N-
bromosuccinimide (0.88 g, 4.95 mmol, 1.1 eq.) and silver 
nitrate (76.4 mg, 0.45 mmol, 0.1 eq.) in acetone (10 mL) was stirred at room 
temperature for 2 h. The solvent was removed in vacuo and the residue 
dissolved in water (10 mL). The resulting solution was extracted with Et2O (2 
 10 mL), and the combined organic extracts washed with brine (10 mL), 
dried over Na2SO4, filtered and concentrated to afford 4-bromo-but-3-yn-1-ol 
as a colorless oil. CH2Cl2 (10 mL) and trichloroacetonitrile (0.54 mL, 5.4 
mmol, 1.2 eq.) were added, and the solution was cooled to 0 C in an ice bath. 
DBU (67.3 L, 0.45 mmol, 0.1 eq.) was then added dropwise. The reaction 
mixture was allowed to stir at 0 C for 1 h, then warmed to room temperature 
and stirred for another 3 h. The solvent was removed in vacuo, and the 
resulting brown oil chromatographed on silica using petroleum ether/ethyl 
acetate (5:1) as eluting solvent, to furnish 0.83 g (63%) of 2.8i as a colorless 
oil. 1H NMR (CDCl3):  = 8.35 (br s, 1H, NH), 4.38 (t, J = 6.9, 2H, OCH2), 
2.70 (t, J = 6.9, 2H, CH2C). 13C NMR (CDCl3):  = 162.4 (C=NH), 91.1 
(CCl3), 75.5 (CCBr), 66.4 (CCBr), 40.4 (OCH2), 19.6 (CH2CC). HRMS 
(ESI) calcd for C6H5BrCl3NO [M+H]
+: 291.8698;  found 291.8706. 
 
General procedure for the synthesis of Ag(I) bis(pyridine) complexes 
(Procedure E):139 
The silver salt AgX (0.5 mmol, 1.0 eq.) and the appropriate pyridine ligand 
(1.0 mmol, 1.0 eq.) were mixed in MeCN (5 mL) and stirred at room 
temperature overnight. The reaction mixture was filtered through Celite, and 
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the solvent removed from the filtrate in vacuo. The resulting residue was 
washed with diethyl ether to afford the desired complexes as colorless, air- 
and moisture-stable solids. 
 
Bis(pyridine)silver(I) trifluoromethanesulfonate [Ag(Py)2]OTf (2.5a).139 
Prepared by procedure E. Yield: 0.14 g (69%). 1H NMR (CDCl3):  = 8.74  
8.72 (m, 4 H), 7.84  7.82 (m, 2 H), 7.42  7.41 (m, 4H). 13C NMR (CDCl3):  
= 152.0, 138.9, 125.3. Anal. Calc. for C11H10AgF3N2O3S: C, 31.83; H, 2.43; N, 
6.75%. Found: C, 31.83; H, 2.37; N, 6.68%. 
 
Bis(4-acetylpyridine)silver(I) trifluoromethanesulfonate [Ag(Ac-Py)2]OTf 
(2.10a). 
Prepared by procedure E. Yield: 0.22 g (90%). 1H NMR (DMSO-d6):  = 8.82 
 8.81 (m, 4H), 7.86  7.84 (m, 4H), 2.63 (s, 6H). 13C NMR (DMSO-d6):  = 
198.5, 151.6, 143.3, 122.0, 27.4. Anal. Calc. for C15H14AgF3N2O5S: C, 36.09; 
H, 2.83; N, 5.61%. Found: C, 36.13; H, 2.75; N, 5.69%. 
 
Bis(4-acetylpyridine)silver(I) perchlorate [Ag(Ac-Py)2]ClO4 (2.10b). 
Prepared by procedure E. Yield: 0.18 g (80%). 1H NMR (DMSO-d6):  = 8.82 
 8.80 (m, 4H), 7.83  7.82 (m, 4H), 2.63 (s, 6H). 13C NMR (DMSO-d6):  = 
197.9, 151.3, 142.9, 121.7, 26.9. Anal. Calc. for C14H14AgClN2O6: C, 37.40; 
H, 3.14; N, 6.23%. Found: C, 37.54; H, 3.06; N, 6.35%. 
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Bis(4-acetylpyridine)silver(I) tetrafluoroborate [Ag(Ac-Py)2]BF4 (2.10c). 
Prepared by procedure E. Yield: 0.17 g (78%). 1H NMR (DMSO-d6):  = 8.82 
 8.81 (m, 4H), 7.84  7.82 (m, 4H), 2.63 (s, 6H). 13C NMR (DMSO-d6):  = 
197.9, 151.3, 142.9, 121.7, 26.9. Anal. Calc. for C14H14AgBF4N2O2: C, 38.48; 
H, 3.23; N, 6.41%. Found: C, 38.60; H, 3.17; N, 6.49%. 
 
Bis(4-acetylpyridine)silver(I) hexafluorophosphate [Ag(Ac-Py)2]PF6 
(2.10d). 
Prepared by procedure E. Yield: 0.19 g (77%). 1H NMR (DMSO-d6):  = 8.82 
 8.81 (m, 4H), 7.85  7.82 (m, 4H), 2.63 (s, 6H). 13C NMR (DMSO-d6):  = 
198.0, 151.1, 142.8, 121.6, 26.9. Anal. Calc. for C14H14AgF6N2O2P: C, 33.96; 
H, 2.85; N, 5.66%. Found: C, 34.03; H, 2.67; N, 5.70%. 
 
Bis(4-acetylpyridine)silver(I) hexafluoroantimonate [Ag(Ac-Py)2]SbF6 
(2.10e). 
Prepared by procedure E. Yield: 0.26 g (89%). 1H NMR (DMSO-d6):  = 8.82 
 8.81 (m, 4H), 7.86  7.83 (m, 4H), 2.63 (s, 6H). 13C NMR (DMSO-d6):  = 
197.9, 151.2, 143.0, 121.8, 26.9. Anal. Calc. for C14H14AgF6N2O2Sb: C, 28.70; 
H, 2.41; N, 4.78%. Found: C, 28.88; H, 2.47; N, 4.82%. 
 
Bis(4-acetylpyridine)silver(I) trifluoroacetate [Ag(Ac-Py)2]CF3CO2 (2.10f). 
Prepared by procedure E. Yield: 0.20 g (86%). 1H NMR (CDCl3):  = 8.81  
8.79 (m, 4H), 7.81  7.77 (m, 4H), 2.64 (s, 6H). 13C NMR (CDCl3):  = 196.4, 
152.2, 143.6, 122.2, 26.6. Anal. Calc. for C16H14AgF3N2O4: C, 41.49; H, 3.05; 
N, 6.05%. Found: C, 41.60; H, 2.98; N, 6.04%. 
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Bis(4-methoxypyridine)silver(I) trifluoromethanesulfonate [Ag(MeO-
Py)2]OTf (2.11a). 
Prepared by procedure E. Yield: 0.21 g (88%). 1H NMR (CDCl3):  = 8.54  
8.51 (m, 4H), 6.88  6.83 (m, 4H), 3.87 (s, 6H). 13C NMR (CDCl3):  = 166.9, 
153.3, 111.0, 55.7. Anal. Calc. for C13H14AgF3N2O5S: C, 32.86; H, 2.97; N, 
5.90%. Found: C, 32.77; H, 2.97; N, 5.90%. 
 
Bis(4-dimethylaminopyridine)silver(I) trifluoromethanesulfonate [Ag(4-
DMAP)2]OTf (2.12). 
Yield: 0.24 g (96%). 1H NMR (CDCl3):  = 8.21  8.20 (m, 4H), 6.54  6.52 
(m, 4H), 3.04 (s, 12H). 13C NMR (CDCl3):  = 154.8, 150.9, 107.0, 39.1. Anal. 
Calc. for C15H20AgF3N4O3S: C, 35.94; H, 4.02; N, 11.18%. Found: C, 36.04; 
H, 3.97; N, 11.08%. 
 
Bis(4-methylpyridine)silver(I) trifluoromethanesulfonate [Ag(Me-
Py)2]OTf (2.13). 
Yield: 0.14 g (65%). 1H NMR (CDCl3):  = 8.55  8.54 (m, 4H), 7.26  7.20 
(m, 4H), 2.38 (s, 6H). 13C NMR (CDCl3):  = 151.4, 150.8, 125.9, 21.3. Anal. 
Calc. for C13H14AgF3N2O3S: C, 35.23; H, 3.18; N, 6.32%. Found: C, 35.16; H, 
3.19; N, 6.21%. 
 
(Triphenylphosphine)silver(I) trifluoromethanesulfonate [(Ph3P)Ag(OTf)] 
(2.4).139 
Silver(I) trifluoromethanesulfonate (0.26 g, 1.0 mmol, 1.0 eq.) and 
triphenylphosphine (0.26 g, 1.0 mmol. 1.0 eq.). and CH2Cl2 (10 mL) were 
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added to a 25 mL round-bottomed flask and the reaction mixture stirred for 12 
h at room temperature. The clear solution was concentrated to half of its 
original volume under reduced pressure and ca. 4 mL of pentane was added. 
The solution was cooled to -20°C to yield 0.38 g (73%) of 2.4 as a white, 
crystalline solid. 1H NMR (CDCl3):  = 7.49 – 7.39 (m, 15H). 
13C NMR 
(CDCl3):  = 133.9, 133.8, 131.2, 129.2, 129.1. 
31P NMR (CDCl3):  = 16.31. 
Anal. Calc. for C19H15AgF3O3PS: C, 43.95; H, 2.91%. Found: C, 43.96; H, 
2.93%. 
 
Synthesis of [Ag(bpy)2]OTf (2.6). 
Silver(I) trifluoromethanesulfonate (0.13 g, 0.5 mmol, 1.0 eq.) was added to a 
solution of 2,2’-bipyridine (0.16 g, 1.0 mmol, 2.0 eq.) in MeCN (5 mL). The 
reaction mixture was stirred at room temperature overnight, and the solvent 
was removed in vacuo to give a light yellow crystalline solid. X-ray 
diffraction quality single crystals were obtained by recrystallization from 
CH2Cl2/n-hexane at room temperature overnight. Yield: 0.17 g (60%). Light 
yellow solid.  1H NMR (CDCl3):  = 8.61  8.59 (m, 2H), 8.38 – 8.30 (m, 2H), 
8.09 (td, J = 7.9, 1.8, 2H), 7.59  7.55 (m, 2H). 13C NMR (CDCl3):  = 151.8, 
150.8, 139.4, 125.8, 122.9. Anal. Calc. for C21H16AgF3N4O3S: C, 44.30; H, 
2.83; N, 9.84%. Found: C, 44.37; H, 2.82; N, 9.98%. 
 
Synthesis of [Ag(phen)]OTf (2.7).69 
A solution of silver(I) trifluoromethanesulfonate (0.29 g, 1.11 mmol, 1.0 eq.) 
in 7 mL of water was added a solution of 1,10-phenanthroline (0.20 g, 1.11 
mmol, 1.0 eq.) in 7 mL of methanol. The reaction mixture was stirred for 15 
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min. The pale yellow precipitate was filtered off, washed with methanol and 
dried in vacuo. Yield: 0.28 g (58%). 1H NMR (DMSO-d6):  = 9.17  9.14 (m, 
2H), 8.79  8.75 (m, 2H), 8.21 (d, J = 5.4, 2H), 8.02  7.98 (m, 2H). 13C NMR 
(DMSO-d6):  = 151.9, 142.4, 138.9, 129.5, 127.7, 125.4.  
 
General catalytic procedure for the Ag(I)-catalyzed conversion of 2.1 to 
2.2 or 2.8 to 2.9 (Procedure F): 
Substrate 2.1 or 2.8 (4.0 mmol, 1.0 eq.) was dissolved in acetone (2.5 mL per 
mmol of substrate) at room temperature and [Ag(Py)2]OTf (166.0 mg, 0.4 
mmol, 0.1 eq.) was added. After 6 h, the reaction mixture was filtered, and the 
filtrate concentrated in vacuo. The residue was purified by column 
chromatography on silica. 
 
4-Methylene-2-(trichloromethyl)-4,5-dihydrooxazole (2.2a).129, 130  
Prepared from 2.1a (0.80 g) by procedure F, isolated as a yellow 
oil after purification by column chromatography (petroleum 
ether/ethyl acetate, 8:1). Yield: 0.54 g (67%). 1H NMR (CDCl3):  = 5.39 (td, 
J = 3.3, 1.6, 1H, =CH), 5.23 (t, J = 3.1, 2H, OCH2), 4.87 (td, J = 3.3, 1.6, 1H, 
=CH). 13C NMR (CDCl3):  = 168.6 (NCO), 153.3 (C=CH2), 102.1 (C=CH2), 
74.4 (OCH2). (CCl3 was too broad to be detected). HRMS (ESI) calcd for 
C5H4Cl3NO [M+H]
+: 199.9437; found 199.9447. 
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5-Methyl-4-methylene-2-(trichloromethyl)-4,5-dihydrooxazole (2.2b).129  
Prepared from 2.1b (0.86 g) by procedure F, Isolated as a yellow 
oil after purification by column chromatography (petroleum 
ether/ethyl acetate, 8:1). Yield: 0.63 g (74%). 1H NMR (CDCl3):  
= 5.46 (qt, J = 6.4, 3.0, 1H, =CH), 5.35 (dd, J = 3.4, 1.5, 1H, OCH), 4.77  
4.76 (m, 1H, =CH), 1.57 (d, J = 6.5, 3H, CH3). 13C NMR (CDCl3):  = 166.9 
(NCO), 158.5 (C=CH2), 101.8 (C=CH2), 83.4 (OCH), 21.4 (CH3). (CCl3 was 
too broad to be detected). HRMS (ESI) calcd for C6H6Cl3NO [M+H]
+: 
213.9593; found 213.9580.  
 
5-Ethyl-4-methylene-2-(trichloromethyl)-4,5-dihydrooxazole (2.2c).  
Prepared from 2.1c (0.91 g) by procedure F, isolated as a yellow 
oil after purification by column chromatography (petroleum 
ether/ethyl acetate, 5:1). Yield: 0.79 g (86%).  1H NMR (CDCl3): 
 = 5.42  5.39 (m, 2H, =CH2), 4.76 (t, J = 2.0, 1H, OCH), 2.05  1.95 (m, 1H, 
CH2CH3), 1.81  1.71 (m, 1H, CH2CH3), 1.01 (t, J = 7.4, 3H, CH3). 13C NMR 
(CDCl3):  = 167.3 (NCO), 156.7 (C=CH2), 102.1 (C=CH2), 87.8 (OCH), 28.5 
(CH2CH3), 7.6 (CH2CH3). (CCl3 was too broad to be detected). MS [CI]: m/z 
(%) = 228 (100) [M+H]+. 
 
5-(1-Methylethyl)-4-methylene-2-(trichloromethyl)-4,5-dihydrooxazole 
(2.2d).129  
Prepared from 2.1d (0.97 g) by procedure F, isolated as a yellow 
oil after purification by column chromatography (petroleum 
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ether/ethyl acetate, 10:1). Yield: 0.80 g (82%). 1H NMR (CDCl3):  = 5.42 (dd, 
J = 3.0, 1.4, 1H, =CH), 5.26 (dd, J = 5.8, 3.0, 1H, =CH), 4.78  4.77 (m, 1H, 
OCH), 2.09  1.98 (m, 1H, CH(CH3)2), 1.11 (d, J = 6.9, 3H, CH3), 0.95 (d, J = 
6.9, 3H, CH3). 13C NMR (CDCl3):  = 167.4 (NCO), 155.9 (C=CH2), 102.6 
(C=CH2), 91.4 (OCH), 33.8 (CH(CH3)2), 18.1 (CH3), 14.8 (CH3). (CCl3 was 
too broad to be detected). HRMS (ESI) calcd for C8H10Cl3NO [M+H]
+: 
241.9906; found 241.9911. 
 
5,5-Dimethyl-4-methylene-2-(trichloromethyl)-4,5-dihydrooxazole (2.2f).  
Prepared from 2.1f (0.91 g) by procedure F, isolated as a yellow 
oil after purification by column chromatography (petroleum 
ether/ethyl acetate, 8:1). Yield: 0.72 g (79%). 1H NMR (CDCl3): 
 = 5.31 (d, J = 1.5, 1H, =CH), 4.71 (d, J = 1.5, 1H, =CH), 1.59 (s, 6H, CH3). 
13C NMR (CDCl3):  = 165.3 (NCO), 162.0 (C=CH2), 100.9 (C=CH2), 91.8 
(C(CH3)2), 27.7 (C(CH3)2). (CCl3 was too broad to be detected). HRMS (ESI) 
calcd for C7H8Cl3NO [M+H]
+: 229.9720; found 229.9730. 
 
(Z)-4-Trimethylsilylmethylene-2-(trichloromethyl)-4,5-dihydrooxazole 
(Z)-2.2j. 
Prepared by procedure F from 2.1j (1.09 g), but with 
[Ag(Py)2]OTf (166.0 mg, 0.4 mmol, 0.2 eq.) in MeCN at 
60 C for 7 h. Isolated as a yellow oil after purification by 
column chromatography (petroleum ether/ethyl acetate, 10:1). Yield: 0.79 g 
(74%).  1H NMR (CDCl3):  = 5.28 (t, J = 2.6, 1H, =CH), 5.14 (d, J = 2.6, 2H, 
CH2), 0.18 (s, 9H, Si(CH3)3). 13C NMR (CDCl3):  = 168.5 (NCO), 159.2 
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(C=CSi), 116.2 (C=CSi), 75.7 (OCH2), -0.2 (Si(CH3)3). (CCl3 was too broad 
to be detected). HRMS (ESI) calcd for C8H12Cl3NOSi [M]
+: 272.9724; found 
272.9844. 
 
(Z)-4-Bromomethylene-2-(trichloromethyl)-4,5-dihydrooxazole (Z)-2.2k. 
Prepared by procedure F from 2.1k (1.12 g), but with and 
[Ag(Ac-Py)2]PF6 (19.8 mg, 0.04 mmol, 0.01 eq.) as catalyst 
and a reaction time of 30 min. Isolated as a white crystalline 
solid after purification by column chromatography (petroleum ether/ethyl 
acetate, 8:1). Yield: 1.06 g (95 %). 1H NMR (CDCl3):  = 5.92 (t, J = 2.8, 1H, 
=CH), 5.24 (d, J = 2.8, 2H, CH2). 13C NMR (CDCl3):  = 169.7 (NCO), 149.8 
(C=CBr), 92.4 (C=CBr), 74.8 (OCH2). (CCl3 was too broad to be detected). 
HRMS (ESI) calcd for C5H3BrCl3NO [M+H]
+: 279.8521; found 279.8533. 
 
2-(Trichloromethyl)-4-methylene-5,6-dihydro-4H-1,3-oxazine (2.9a).129 
Prepared by procedure F from 2.8a (0.86 g), isolated as a light 
yellow oil after purification by column chromatography (petroleum 
ether/ethyl acetate, 5:1). Yield: 0.65 g (76%). 1H NMR (CDCl3):  
= 5.29 (s, 1H, =CH), 4.86 (s, 1H, =CH), 4.47  4.44 (m, 2H, OCH2), 2.64  
2.61 (m, 2H, CH2C=). 13C NMR (CDCl3):  = 153.74 (NCO), 140.99 (NC=C), 
111.47 (NC=C), 67.40 (OCH2), 26.21 (CH2C=). (CCl3 was too broad to be 
detected). HRMS (ESI) calcd for C6H6Cl3NO [M+H]
+: 215.9564; found 
215.9571. 
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2-(Trichloromethyl)-4-methylene-6-methyl-5,6-dihydro-1,3-oxazine (2.9b). 
Prepared by procedure F from 2.8b (0.91 g), Isolated as a yellow 
oil after purification by column chromatography (petroleum 
ether/ethyl acetate, 5:1). Yield: 0.85 g (93%). 1H NMR (CDCl3): 
 = 5.31 (s, 1H =CH), 4.85 (s, 1H, =CH), 4.59  4.51 (m, 1H, OCH), 2.68  
2.63 (m, 1H, CH2C=), 2.35  2.29 (m, 1H, CH2C=), 1.42 (d, J = 6.4, 3H, CH3). 
13C NMR (CDCl3):  = 153.9 (NCO), 141.2 (NC=C), 111.8 (NC=C), 74.4 
(OCH), 33.0 (CH2), 20.0 (CH3). (CCl3 was too broad to be detected). HRMS 
(ESI) calcd for C7H8Cl3NO [M+H]
+: 227.9750; found 227.9752. 
 
2-(Trichloromethyl)-4-methylene-6-ethyl-5,6-dihydro-1,3-oxazine (2.9c). 
Prepared by procedure F from 2.8c (0.97 g), isolated as a light 
yellow oil after purification by column chromatography 
(petroleum ether/ethyl acetate, 5:1). Yield: 0.88 g (91%). 1H 
NMR (CDCl3):  = 5.28 (s, 1H, =CH), 4.84 (s, 1H, =CH), 4.34  4.30 (m, 1H), 
2.64  2.60 (m, 1H, OCH), 2.38 2.32 (m, 1H, CH2C=), 1.79  1.67 (m, 2H, 
CH2CH3), 1.04 (t, J = 7.5, 3H, CH2CH3). 13C NMR (CDCl3):  = 154.0 (NCO), 
141.4 (NC=C), 111.6 (NC=C), 79.3 (OCH), 31.0 (CH2C=), 27.2 (CH2CH3), 
9.1 (CH2CH3). (CCl3 was too broad to be detected). HRMS (ESI) calcd for 
C8H10Cl3NO [M+H]
+: 243.9877; found 243.9888. 
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2-(Trichloromethyl)-4-methylene-6-phenyl-5,6-dihydro-1,3-oxazine 
(2.9d).129 
Prepared by procedure F from 2.8d (1.16 g), isolated as a 
light yellow solid after purification by column 
chromatography (petroleum ether/ethyl acetate, 5:1). Yield: 
1.05 g (90%). 1H NMR (CDCl3):  = 7.45  7.37 (m, 5H, CH-aromatic), 5.38 
 5.34 (m, 2H, =CH2), 4.92 (d, J = 1.7, 1H, OCH), 2.90  2.85 (m, 1H, 
CH2C=), 2.67  2.60 (m, 1H, CH2C=). 13C NMR (CDCl3):  = 154.2 (NCO), 
141.4 (CH-aromatic), 138.2 (CH-aromatic), 128.9 (CH-aromatic), 125.7 (CH-
aromatic), 112.0 (NC=C), 92.0 (NC=C), 79.2 (OCH), 34.1 (CH2C=). (CCl3 
was too broad to be detected). HRMS (ESI) calcd for C12H10Cl3NO [M+H]
+: 
289.9906; found 289.9894. 
 
2-(Trichloromethyl)-4-methylene-6-(4-chlorophenyl)-5,6-dihydro-1,3-
oxazine (2.9e).129  
Prepared by procedure F from 2.8e (1.30 g), isolated as 
an orange oil after purification by column 
chromatography (petroleum ether/ethyl acetate, 8:1). 
Yield: 1.13 g (87%). 1H NMR (CDCl3):  = 7.41  7.39 (m, 2H, CH-aromatic), 
7.38  7.30 (m, 2H, CH-aromatic), 5.39 (d, J = 1.6, 1H, =CH), 5.33 (dd, J = 
10.4, 3.6, 1H, =CH), 4.93 (d, J = 1.6, 1H, OCH), 2.89  2.84 (m, 1H, CH2C=), 
2.59 (m, 1H, CH2C=). 13C NMR (CDCl3):  = 153.9 (NCO), 141.0 (CH-
aromatic), 136.7 (CH-aromatic), 134.8 (CH-aromatic), 129.1 (CH-aromatic), 
127.2 (NC=C), 112.4 (NC=C), 91.9 (CCl3), 78.4 (OCH), 33.9 (CH2C=). 
HRMS (ESI) calcd for C12H9Cl4NO [M+H]
+: 325.9487; found 325.9491. 
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2-(Trichloromethyl)-4-methylene-6-(4-trifluoromethylphenyl)-5,6-
dihydro-1,3-oxazine (2.9f). 
Prepared by procedure F from 2.8f (1.43 g), isolated as 
a yellow oil after purification by column 
chromatography (petroleum ether/ethyl acetate, 8:1). 
Yield: 1.00 g (70%). 1H NMR (CDCl3):  = 7.69 (d, J 
= 8.2, 2H, CH-aromatic), 7.51 (d, J = 8.2, 2H, CH-aromatic), 5.44  5.41 (m, 
2H, =CH2), 4.95 (d, J = 1.7, 1H, OCH), 2.91 (dd, J = 15.2, 3.7, 1H, CH2C=), 
2.65 – 6.57 (m, 1H, CH2C=). 13C NMR (CDCl3):  = 153.7 (NCO), 142.1 
(CH-aromatic), 140.6 (CH-aromatic), 131.0  (q, J = 33.0, CF3), 126.0 (CH-
aromatic), 125.9 (CH-aromatic), 122.5 (NC=C), 112.7 (NC=C), 91.8 (CCl3), 
78.3 (OCH), 33.9 (CH2C=). HRMS (ESI) calcd for C13H9Cl3F3NO [M+H]+: 
357.9780; found 357.9776. 
 
(Z)-2-(Trichloromethyl)-4-(trimethylsilyl)methylene-5,6-dihydro-1,3-
oxazine (Z)-2.9h. 
Prepared by procedure F from 2.8h (1.15 g), but with 
[Ag(Py)2]OTf (0.33 g, 0.8 mmol, 0.2 eq.) in acetone at 
reflux for 8 h. Isolated as a light yellow oil after purification 
by column chromatography (petroleum ether/ethyl acetate, 8:1). Yield: 0.81 g 
(71%). 1H NMR (CDCl3):  = 5.30 (t, J = 1.1, 1H, =CH), 4.44 (t, J = 6.1, 2H, 
OCH2), 2.61 (td, J = 6.1, 1.1, 2H, CH2C=), 0.17 (s, 9H, Si(CH3)3). 13C NMR 
(CDCl3):  = 152.3 (NCO), 146.9 (C=CSi), 127.1 (C=CSi), 92.4 (CCl3), 67.6 
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(OCH2), 28.8 (CH2C=), -0.1 (Si(CH3)3). HRMS (ESI) calcd for C9H14Cl3NOSi 
[M+H]+: 285.9988;  found 285.9994. 
 
(Z)-2-(Trichloromethyl)-4-bromomethylene-5,6-dihydro-1,3-oxazine (Z)-
2.9i. 
Prepared by procedure F from 2.8i (1.17 g), but with [Ag(Ac-
Py)2]PF6 (19.8 mg, 0.04 mmol, 0.01 eq.) as catalyst and a 
reaction time of 1 h. Isolated as a white solid after purification 
by column chromatography (petroleum ether/ethyl acetate, 8:1). Yield: 1.11 g 
(95%). 1H NMR (CDCl3):  6.00 (t, J = 1.2, 1H, =CH), 4.45 (t, J = 6.1, 2H, 
OCH2), 2.63 (td, J = 6.1, 1.2, 2H, CH2C=). 13C NMR (CDCl3):  = 155.3 
(NCO), 136.9 (C=CBr), 102.5 (C=CBr), 91.7 (CCl3), 67.1 (OCH2), 26.4 
(CH2C=). HRMS (ESI) calcd for C6H5BrCl3NO [M+H]+: 291.8698;  found 
291.8706. 
 
General procedure for trapping of organosilver(I) intermediates with 
electrophiles (Procedure G): 
To a solution of 2.1a (0.80 g, 4.0 mmol, 1.0 eq.) or 2.8a (0.86 g, 4.0 mmol, 1.0 
eq.) in acetone (10 mL) was added N-bromosuccinimide (0.85 g, 4.8 mmol, 
1.2 eq.) or N-chlorosuccinimide (0.64 g, 4.8 mmol, 1.2 eq.). The resulting 
mixture was cooled to 0 C before the addition of silver(I) 
trifluoromethanesulfonate (102.7 mg, 0.4 mmol, 10 mol%). The reaction 
mixture was allowed to rise to room temperature, and stirred for another 6 h. 
The solvent was removed in vacuo, and the residue extracted with 20 mL of 
petroleum ether/ethyl acetate (8:1). The resulting solution was concentrated in 
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vacuo and purified by column chromatography on silica, using petroleum 
ether/ethyl acetate (8:1) as eluting solvent.  
 
(E)-4-Bromomethylene-2-(trichloromethyl)-4,5-dihydrooxazole (E)-2.2k. 
Prepared by procedure G. Yield: 0.79 g (71%). White solid. mp 
60  65 C. 1H NMR (CDCl3):  = 6.56 (t, J = 3.5, 1H, =CH), 
5.21 (d, J = 3.5, 2H, OCH2). 13C NMR (CDCl3):  = 169.2 (NCO), 
151.7 (NC=C), 97.5 (NC=C), 75.8 (CH2). (CCl3 was too broad to be detected). 
MS [CI]: m/z (%) = 312 (100), 192 (38), 329 (19). (M+ not observed) 
 
(E)-4-Chloromethylene-2-(trichloromethyl)-4,5-dihydrooxazole (E)-2.2l. 
Prepared by procedure G. Yield: 0.32 g (34%). White solid. mp 
59  60 C. 1H NMR (CDCl3):  = 6.52 (t, J = 3.5, 1H, =CH), 
5.34 (d, J = 3.5, 2H, OCH2). 13C NMR (CDCl3):  = 168.7 
(NCO), 149.8 (NC=C), 109.5 (NC=C), 74.4 (CH2). (CCl3 was too broad to be 
detected). MS [CI]: m/z (%) = 236 (100), 179 (11). 
 
(E)-2-(Trichloromethyl)-4-bromomethylene-5,6-dihydro-1,3-oxazine (E)-
2.9i. 
Prepared by procedure G. Yield: 0.29 g (25%). White solid. 
Single crystals suitable for X-ray diffraction studies were 
obtained from a saturated solution of (E)-2.9i in petroleum 
ether/ethyl acetate (8:1) at -20 C. mp 98  101 C. 1H NMR (CDCl3):  = 
6.64 (d, J = 1.4, 1H, =CHBr), 4.45 (t, J = 6.1, 2H, OCH2), 2.77 (td, J = 6.1, 1.4, 
2H, CH2C=). 13C NMR (CDCl3):  = 153.2 (NCO), 139.0 (C=CBr), 107.5 
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(C=CBr), 91.5 (CCl3), 66.3 (OCH2), 23.5 (CH2C=). MS [CI]: m/z (%) = 294 
(100), 236 (12). 
 
(E)-2-(Trichloromethyl)-4-chloromethylene-5,6-dihydro-1,3-oxazine (E)-
2.9j. 
Prepared by procedure G. Yield: 0.11 g (11%). White solid. 
Single crystals suitable for X-ray diffraction studies were obtained 
from a saturated solution of (E)-2.9j in petroleum ether/ethyl 
acetate (8:1) at -20 C. mp 80  83 C. 1H NMR (CDCl3):  = 6.50 (d, J = 1.8, 
1H, =CHCl), 4.44 (t, J = 6.1, 2H, OCH2), 2.78 (td, J = 6.1, 1.8, 2H, CH2C=). 
13C NMR (CDCl3):  = 153.2 (NCO), 137.2 (C=CHCl), 117.7 (C=CHCl), 91.6 
(CCl3), 66.0 (OCH2), 21.7 (CH2C=). MS [CI]: m/z (%) = 250 (100), 214 (9), 
193 (8). 
 
6.2 Compounds used in Chapter 3 
Ethyl-2-chloro-2-oxoacetate.253 
To oxalyl chloride (1.72 mL, 20 mmol, 2.0 eq.) at 0 °C was 
added ethanol (10 0.58 mL, 10 mmol, 1.0 eq.) dropwise with a 
syringe pump over 1 h. Upon completion of addition, the mixture was allowed 
to warm to room temperature over 2 h. The crude material was distilled (lit. 254 
132  135 C at 760 Torr) under N2 to give the desired product as a colorless 
oil, which was used immediately in the reaction with propargylamine. Yield: 
0.29 g (11%).  
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Ethyl potassium malonate.255 
To a 100 mL round bottomed flask was added diethyl 
malonate (3.0 mL, 20 mmol, 1.0 eq.) and 13 mL of ethanol. 
A solution of potassium hydroxide (1.12 g, 20 mmol, 1.0 eq.) in 13 mL of 
ethanol was added dropwise with stirring. A large amount of white precipitate 
was formed. The suspension was stirred for 2 h at room temperature, and 
allowed to stand overnight. The resulting mixture was refluxed for another 1 h, 
and was filtered hot. The filtrate obtained was cooled to 0 C in the freezer 
overnight, and the resulting colorless crystals were filtered off, washed with 
diethyl ether and dried in vacuo. Yield: 2.40 g (71%). 1H NMR (D2O):  = 
4.18 (q, J = 7.2, 2H, CH2), 3.29 (s, 2H, CH2CH3), 1.26 (t, J = 7.1, 3H, 
CH2CH3). 13C NMR (D2O):  = 174.3 (C=O), 171.5 (C=O), 62.06 (CH2), 
44.67 (CH2CH3), 13.21 (CH2CH3).  
 
2-Ethoxycarbonylacetyl chloride. 
Prepared by a modified literature procedure. 256  Ethyl 
potassium malonate (1.70 g, 10 mmol, 1.0 eq.) was 
suspended in CH2Cl2 (20 mL) at 0 C under a positive pressure of N2. Oxalyl 
chloride (1.0 mL, 12 mmol, 1.2 eq.) was then added dropwise over 5 min 
followed by DMF (3-5 drops). The resulting solution was stirred for 1 h at 
0 °C then at room temperature for 1 h. The resulting mixture was filtered, and 
the solvent removed from the filtrate to give a red oil, which was distilled 
under reduced pressure (b.p. 70 C at 16 Torr)257 to give a colorless oil, which 
was used immediately in the reaction with propargylamine. Yield: 0.62 g 
(41%). 
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General procedure for the synthesis of substrates 3.1a-I (Procedure H): 
To a solution of propargylic amine (10 mmol, 1.0 eq.) in CH2Cl2, 
triethylamine (1.4 mL, 10 mmol, 1.0 eq.) and 4-dimethylaminopyridine (24.4 
mg, 0.2 mmol, 0.02 eq.) were added. The resulting mixture was cooled to 0 C, 
and the acid chloride (10 mmol, 1.0 eq.) was added. The mixture was stirred 
for 30 min at 0 C and 3 h at room temperature. H2O (15 mL) was added, and 
the aqueous layer extracted with another 3  15 mL of CH2Cl2. The combined 
organic extracts were washed with saturated NaHCO3, H2O and brine, dried 
over Na2SO4 and concentrated in vacuo. The crude product was purified by 
column chromatography on silica.  
 
N-(Prop-2-ynyl)benzamide (3.1a).258 
Prepared by procedure H from benzoyl chloride (1.2 mL) 
and propargylamine (0.64 mL), isolated as a white 
crystalline solid after purification by column chromatography (petroleum 
ether/ethyl acetate, 1:1). Yield: 1.51 g (95%). 1H NMR (CDCl3):  = 7.80  
7.77 (m, 2H, CH-aromatic), 7.56 – 7.47 (m, 1H, CH-aromatic), 7.49 – 7.40 (m, 
2H, CH-aromatic), 6.29 (br s, 1H, NH), 4.26 (dd, J = 5.1, 2.5, 2H, CH2CH), 
2.29 (t, J = 2.5, 1H, CH2CH). 13C NMR (CDCl3):  = 167.8 (C=O), 133.9 
(CH-aromatic), 132.0 (CH-aromatic), 128.8 (CH-aromatic), 127.5 (CH-
aromatic), 79.9 (CCH), 71.8 (CCH), 29.9 (CH2CCH). max/cm-1: 3289 
(NH), 1638 (C=O). 
 
  
244 
 
N-(Prop-2-ynyl)acetamide (3.1b).153 
Prepared by procedure H from acetyl chloride (0.71 mL) 
and propargylamine (0.64 mL), isolated as a white solid 
after purification by column chromatography (CH2Cl2/ethyl acetate, 1:1). 
Yield: 0.16 g (16%). 1H NMR (CDCl3):  = 5.87 (br s, 1H, NH), 4.04 (dd, J = 
5.1, 2.5, 2H, CH2CH), 2.23 (t, J = 2.5, 1H, CH2CH), 2.01 (s, 3H, CH3). 13C 
NMR (CDCl3):  = 169.8 (C=O), 79.4 (CCH), 71.6 (CCH), 29.2 
(CH2CCH), 23.0 (CH3). max/cm-1: 3226 (NH), 1632 (C=O). 
 
N-(Prop-2-ynyl)pivalamide (3.1c).259 
Prepared by procedure H from trimethylacetyl chloride (1.2 
mL) and propargylamine (0.64 mL), isolated as a white 
solid after purification by column chromatography (CH2Cl2/ethyl acetate, 9:1). 
Yield: 1.14 g (82%). 1H NMR (CDCl3):  = 5.86 (br s, 1H, NH), 4.02 (dd, J = 
5.0, 2.6, 2H, CH2CH), 2.22 (t, J = 2.6, 1H, CH2CH), 1.19 (s, 9H, C(CH3)3). 
13C NMR (CDCl3):  = 178.0 (C=O), 79.8 (CCH), 71.5 (CCH), 38.6 
(C(CH3)3), 29.3 (CH2CCH), 27.4 (C(CH3)3). max/cm-1: 3263 (NH), 1634 
(C=O). 
 
N-(Prop-2-ynyl)cinnamamide (3.1d).260 
Prepared by procedure H from cinnamoyl chloride 
(1.67 g) and propargylamine (0.64 mL), isolated as a 
white solid after purification by column chromatography (petroleum 
ether/ethyl acetate, 1:1). Yield: 1.02 g (55%). 1H NMR (CDCl3):  = 7.67 (d, J 
= 15.7, 1H, CHCO), 7.49  7.47 (m, 2H, CH-aromatic), 7.39 –7.28 (m, 3H, 
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CH-aromatic), 6.48 (d, J = 15.7, 1H, CH=CHCO), 6.44 (br s, 1H, NH), 4.20 
(dd, J = 5.3, 2.5, 2H, CH2C), 2.25 (t, J = 2.5, 1H, CCH). 13C NMR (CDCl3): 
 = 165.7 (C=O), 141.7 (CHCO), 134.6 (CH-aromatic), 129.8 (CH-aromatic), 
128.8 (CH-aromatic), 127.8 (CH-aromatic), 119.9 (CH=CHCO), 79.5 (CCH), 
71.7 (CCH), 29.4 (CH2CCH). max/cm-1: 3216 (NH), 1609 (C=O). 
 
N-(Prop-2-ynyl)acrylamide (3.1e).261 
Prepared by procedure H from cinnamoyl chloride (0.81 
mL) and propargylamine (0.64 mL), isolated as a white 
solid after purification by column chromatography (CH2Cl2/ethyl acetate, 1:1). 
Yield: 0.55 g (50%). 1H NMR (CDCl3):  = 6.32 (dd, J = 17.0, 1.3, 1H, 
CH2=CH), 6.11 (dd, J = 17.0, 10.3, 1H, CH2=CH), 5.91 (br s, 1H, NH), 5.69 
(dd, J = 10.3, 1.3, 1H, CH2=CH), 4.13 (dd, J = 5.2, 2.6, 2H, CH2CCH), 2.25 
(t, J = 2.6, 1H, CCH). 13C NMR (CDCl3):  = 165.1 (C=O), 130.0 (CH2=CH), 
127.4 (CH2=CH), 79.2 (CCH), 71.8 (CCH), 29.3 (CH2CCH). max/cm-1: 
3251 (NH), 1620 (C=O). 
 
Prop-2-ynylcarbamic acid ethyl ester (3.1f).259 
Prepared by procedure H from ethyl chloroformate (0.96 
mL) and propargylamine (0.64 mL), isolated as a light 
yellow oil after purification by column chromatography (petroleum ether/ethyl 
acetate, 7:3). Yield: 0.72 g (57%). 1H NMR (CDCl3):  = 5.06 (br s, 1H, NH), 
4.11 (q, J = 7.1, 2H, CH2CH3), 3.94 (dd, J = 5.7, 2.5, 2H, CH2CH), 2.22 (t, J 
= 2.5, 1H, CH2CH), 1.21 (t, J = 7.1, 3H, CH2CH3). 13C NMR (CDCl3):  = 
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156.1 (C=O), 79.8 (CCH), 71.3 (CCH), 61.2 (CH2CH3), 30.6 (CH2CCH), 
14.5 (CH2CH3). max/cm-1: 3296 (NH), 1694 (C=O). 
 
Ethyl oxo(prop-2-yn-ylamino)acetate (3.1g).153 
Prepared by procedure H from 2-ethoxycarbonylacetyl 
chloride (1.51 g) and propargylamine (0.64 mL), isolated 
as a white solid after purification by column chromatography 
(CH2Cl2/methanol, 95:5) and trituration with diethyl ether. Yield: 0.67 g 
(43%). 1H NMR (CDCl3):  = 7.29 (br s, 1H, NH), 4.35 (q, J = 7.2, 2H, 
CH2CH3), 4.13 (dd, J = 5.7, 2.6, 2H, CH2CH), 2.29 (t, J = 2.6, 1H, CH2CH), 
1.38 (t, J = 7.2, 3H, CH2CH3). 13C NMR (CDCl3):  = 160.0 (C=O), 156.1 
(C=O), 77.9 (CCH), 72.5 (CCH), 63.4 (CH2CH3), 29.6 (CH2CCH), 13.9 
(CH2CH3). max/cm-1: 3276 (NH), 1736 (C=O), 1679 (C=O). 
 
Ethyl 3-oxo-3-(prop-2-yn-1-ylamino)propanoate (3.1h).154 
Prepared by procedure H from 2-
ethoxycarbonylacetyl chloride (1.51 g) and 
propargylamine (0.64 mL), isolated as an off-white solid after purification by 
column chromatography (CH2Cl2/ethyl acetate, 7:3). Yield: 1.05 g (62%). 
1H 
NMR (CDCl3):  = 7.46 (br s, 1H, NH), 4.21 (q, J = 7.1, 2H, CH2CH3), 4.09 
(dd, J = 5.2, 2.6, 2H, CH2CC), 3.33 (s, 2H, COCH2), 2.24 (t, J = 2.5, 1H, 
CCH), 1.29 (t, J = 7.1, 3H, CH2CH3). 13C NMR (CDCl3):  = 169.4 (CO), 
164.7 (CO), 79.1 (CCH), 71.6 (CCH), 61.7 (CH2CH3), 40.7 (COCH2CO), 
29.1 (CH2CCH), 14.0 (CH2CH3). max/cm-1: 3282 (NH), 1732 (C=O), 1643 
(C=O). 
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N-(α,α-Dimethylpropargyl)-1-benzenecarboxamide (3.1i).156 
Prepared by procedure H from benzoyl chloride (1.2 mL) 
and 2-methyl-3-butyn-2-amine (1.1 mL), isolated as a white 
solid after purification by column chromatography (CH2Cl2/ethyl acetate, 9:1). 
Yield: 1.60 g (85%). 1H NMR (CDCl3):  = 7.79 – 7.71 (m, 2H, CH-aromatic), 
7.53 – 7.45 (m, 1H, CH-aromatic), 7.42 – 7.38 (m, 2H, CH-aromatic), 6.26 (br 
s, 1H NH), 2.38 (s, 1H, CCH), 1.76 (s, 6H, C(CH3)2). 13C NMR (CDCl3):  = 
166.4 (CO), 134.8 (CH-aromatic), 131.4 (CH-aromatic), 128.5 (CH-aromatic), 
126.8 (CH-aromatic), 87.1 (CCH), 69.3 (CCH), 48.0 (C(CH3)2), 29.0 
(C(CH3)2). max/cm-1: 3286 (NH), 1639 (C=O). 
 
5,5-Diethyl-1,3-di(prop-2-yn-1-yl)pyrimidin-2,4,6-(1H,3H,5H)-trione.154 
Propargyl bromide (80 wt% solution in toluene, 7.6 mL, 44 
mmol, 2.2 eq.) and sodium hydroxide (0.88 g, 22 mmol, 1.1 eq.) 
were added to a solution of sodium barbital (4.12 g, 20 mmol, 
1.0 eq.) in 40 mL of ethanol/water (1:1). The resulting mixture 
was stirred at room temperature for 48 h, before all the volatile components 
were removed in vacuo. The residue was extracted with CH2Cl2 (3  50 mL). 
The combined organic layers were dried over MgSO4, and the solvent was 
removed in vacuo to afford a brown oil. 15 mL of ethanol was added, and the 
resulting mixture cooled to 0 C overnight. The colorless crystals that were 
obtained were filtered off and dried in vacuo. Yield: 3.05 g (59%). Colorless 
crystals. 1H NMR (CDCl3):  = 4.70 (d, J = 2.5, 4H, CH2CCH), 2.22 (t, J = 
2.5, 2H, CCH), 2.08 (q, J = 7.4, 4H, CH2CH3), 0.81 (t, J = 7.4, 6H, CH2CH3). 
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13C NMR (CDCl3):  = 170.8 (C=O), 149.3 (C=O), 77.3 (CCH), 71.5 
(CCH), 58.4 (C(CH2CH3)2), 33.5 (CH2CCH), 31.2 (CH2CH3), 9.4 
(CH2CH3). 
 
2,2-Diethyl-N,N’-di(prop-2-yn-1-yl)malonamide (3.1j). 
Prepared by a modified literature procedure.154 5,5-Diethyl-
1,3-di(prop-2-yn-1-yl)pyrimidin-2,4,6-(1H,3H,5H)-trione 
(1.30 g, 5.0 mmol, 1.0 eq.) was suspended in ethanol (10 
mL) and as solution of potassium hydroxide (0.56 g, 10 mmol, 2.0 eq.) in 
ethanol (20 mL) was added. The resulting mixture was stirred for 1 h at room 
temperature, and the solvent removed in vacuo to give a yellow oil. The 
resulting oil was dissolved in 25 mL of 0.5 M HCl, and extracted with CH2Cl2 
(3  25 mL). The combined organic layers were dried over MgSO4, and the 
solvent removed in vacuo. The crude product was purified by column 
chromatography on silica (petroleum ether/ethyl acetate, 7:3 then 1:1) to 
afford the desired product as a white solid. Yield: 0.78 g (67%). 1H NMR 
(CDCl3):  = 7.48 (s, 2H, NH), 4.07 (dd, J = 5.3, 2.6, 4H, CH2CCH), 2.22 (t, 
J = 2.5, 2H, CCH), 1.90 (q, J = 7.4, 4H, CH2CH3), 0.85 (t, J = 7.4, 6H, 
CH2CH3). 13C NMR (CDCl3):  = 172.5 (C=O), 79.0 (CCH), 71.1 (CCH), 
57.8 (C(CH2CH3)2), 30.5 (CH2CCH), 28.9 (CH2CH3), 9.0 (CH2CH3). 
max/cm
-1: 3290 (NH), 1660 (C=O), 1622 (C=O). 
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N1,N3-Di(prop-2-ynyl)isophthalamide (3.1k). 
Prepared by a modified literature 
procedure. 262  A mixture of isophthaloyl 
chloride (2.03 g, 10 mmol, 1.0 eq.), triethylamine (3.0 mL, 22 mmol, 2.2 eq.) 
and propargylamine (1.4 mL, 22 mmol, 2.2 eq.) in 90 mL of CH2Cl2 was 
stirred for 3 days at room temperature. The white precipitate that appeared was 
filtered off and dried in vacuo. The filtrate was diluted with 30 mL of 1.0 M 
HCl solution and extracted with 2  75 mL of CH2Cl2. The combined organic 
extracts were dried over MgSO4 and the solvent removed in vacuo to afford a 
light gray solid, which was combined with the white solid obtained earlier. 
Purification by column chromatography on silica (CH2Cl2/methanol, 95:5) 
afforded the desired product as white needles. Yield: 2.00 g (83%). 1H NMR 
(DMSO-d6):  = 9.05 (t, J = 5.5, 2H, CH-aromatic), 8.33 (t, J = 1.7, 1H, CH-
aromatic), 7.99 (dd, J = 7.6, 1.7, 2H, NH), 7.58 (t, J = 7.7, 1H, CH-aromatic), 
4.07 (dd, J = 5.5, 2.4, 4H, CH2CCH), 3.14 (t, J = 2.4, 2H, CCH). NMR 
(DMSO-d6):  = 165.5 (CH-aromatic), 134.1 (CH-aromatic), 130.1 (CH-
aromatic), 128.6 (CH-aromatic), 126.4 (CH-aromatic), 81.2 (CCH), 73.0 
(CCH), 28.6 (CH2CCH). max/cm-1: 3290 (NH), 1660 (C=O), 1622 (C=O). 
max/cm
-1: 3302 (NH), 3237 (NH), 1642 (C=O). 
  
General procedure for the synthesis of propargyl alcohols (Procedure I):  
To a solution of alkyne (11 mmol, 1.1 eq.) in anhydrous THF (35 mL) at -78 
C under N2 was added 
nBuLi (1.6 M solution in hexanes, 6.6 mL, 10.5 mmol, 
1.05 eq.). After stirring at -78 C for 15 min, aldehyde (10 mmol, 1.0 eq.) was 
added. The reaction mixture was allowed to warm to room temperature and 
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stirred for another 1 h, and quenched with 30 mL of saturated aq. NH4Cl 
solution. The resulting mixture was extracted with CH2Cl2 (3  30 mL). The 
combined organic phases were dried over MgSO4, concentrated in vacuo, and 
the residue purified by column chromatography on silica. 
 
1-(4’-Methoxyphenyl)-hept-2-yn-1-ol.163 
Prepared by procedure I from 1-hexyne (1.3 mL) 
and p-anisaldehyde (1.2 mL), isolated as a yellow 
oil after purification by column chromatography 
(petroleum ether/ethyl acetate, 4:1). Yield: 1.73g (79%). 1H NMR (CDCl3):  
= 7.47 (d, J = 8.7, 2H, CH-aromatic), 6.90 (d, J = 8.7, 2H, CH-aromatic), 5.40 
(d, J = 6.0, 1H, OH), 3.81 (s, 3H, OCH3), 2.47 (d, J = 6.0, 1H, CHOH), 2.28 
(td, J = 7.1, 2.0, 2H, CCCH2), 1.58 – 1.48 (m, 2H, CH2), 1.48 – 1.37 (m, 2H, 
CH2), 0.92 (t, J = 7.2, 3H, CH2CH3). 13C NMR (CDCl3):  = 159.5 (CH-
aromatic), 133.6 (CH-aromatic), 128.0 (CH-aromatic), 113.7 (CH-aromatic), 
87.4 (CCCH2), 80.0 (CCCH2), 64.4 (CHOH), 55.3 (OCH3), 30.7 (CCCH2), 
22.0 (CH2), 18.5 (CH2), 13.6 (CH2CH3). HRMS (ESI) calcd for C14H18O2 [M-
OH]+: 201.12794; found 201.1277. 
 
1-(4’-Methoxyphenyl)-3-(trimethylsilyl)prop-2-yn-1-ol.263 
Prepared by procedure I from 
trimethylsilylacetylene (1.6 mL) and p-
anisaldehyde (1.2 mL), isolated as a colorless oil 
after purification by column chromatography (petroleum ether/ethyl acetate, 
8:1).  1H NMR (CDCl3):  = 7.47 (d, J = 8.7, 2H, CH-aromatic), 7.41 (d, J = 
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8.7, 2H, CH-aromatic), 5.41 (d, J = 5.5, 1H, OH), 3.82 (s, 3H, OCH3), 2.11 (d, 
J = 5.5, 1H, CHOH), 0.20 (s, 9H, Si(CH3)3). 13C NMR (CDCl3):  = 159.7 
(CH-aromatic), 132.6 (CH-aromatic), 128.2 (CH-aromatic), 113.8 (CH-
aromatic), 105.1 (CHCC), 91.3 (CHCC), 64.6 (CHOH), 55.3 (OCH3), -0.18 
(Si(CH3)3). HRMS (ESI) calcd for C13H18O2Si [M-OH]+: 217.1048; found 
217.1058. 
 
 1-(4’-Methoxyphenyl)-3-cyclopropyl-prop-2-yn-1-ol. 
Prepared by procedure I from 
cyclopropylacetylene (0.93 mL) and p-
anisaldehyde (1.2 mL), isolated as a white solid 
after purification by column chromatography (petroleum ether/ethyl acetate, 
3:1) and recrystallization from toluene at -20 C overnight. Yield: 1.74 g 
(86%). mp 43  45 C. 1H NMR (CDCl3):  = 7.44 (d, J = 8.7, 2H, CH-
aromatic), 6.89 (d, J = 8.7, 2H, CH-aromatic), 5.37 (d, J = 5.7, 1H, OH), 3.81 
(s, 3H, OCH3), 2.11 (d, J = 5.7, 1H, CHOH), 1.32 – 1.29 (m, 1H, cyclopropyl 
CH), 0.82 – 0.76 (m, 2H, cyclopropyl CH2) 0.74 – 0.70 (m, 2H, cyclopropyl 
CH2). 13C NMR (CDCl3):  = 159.5 (CH-aromatic), 133.5 (CH-aromatic), 
128.0 (CH-aromatic), 113.8 (CH-aromatic), 90.4 (CHCC), 75.3 (CHCC), 
64.4 (CHOH), 55.3 (OCH3), 8.5 (cyclopropyl CH), -0.15 (cyclopropyl CH2). 
IR (neat): 2199, 1489, 1028, 961, 758, 694 cm–1. HRMS (ESI) calcd for 
C13H14O2 [M-OH]
+: 185.0966; found 185.0956. Anal. Calc. for C13H14O2: C, 
77.20; H, 6.98%. Found: C, 77.29; H, 6.90%. 
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1-(4’-Methoxyphenyl)-3-(1-cyclohexenyl)-prop-2-yn-1-ol. 
Prepared from 1-ethynylcyclohexene (1.3 mL) 
and p-anisaldehyde (1.2 mL), isolated as a white 
solid after purification by column 
chromatography (petroleum ether/ethyl acetate, 3:1) and washing of the 
resulting oily solid with cold diethyl ether. Yield: 1.87 g (77%). mp 102  108 
C. 1H NMR (CDCl3):  = 7.47 (d, J = 8.7, 2H, CH-aromatic), 6.90 (d, J = 8.7, 
2H, CH-aromatic), 6.17  6.15 (m, 1H, CHOH), 5.52 (d, J = 5.6, 1H, OH), 
3.81 (s, 3H, OCH3), 2.17 – 2.08 (m, 5H, cyclohexenyl CH2), 1.65 – 1.58 (m, 
4H, cyclohexenyl CH2). 13C NMR (CDCl3):  =159.6 (CH-aromatic), 135.6 
(CH-aromatic), 133.3 (CH-aromatic), 128.1 (CH-aromatic), 120.0 
(cyclohexenyl C), 113.9 (cyclohexenyl C), 88.4 (CHCC), 86.2 (CHCC), 
64.6 (CHOH), 55.3 (OCH3), 29.1 (cyclohexenyl CH2), 25.6 (cyclohexenyl 
CH2), 22.2 (cyclohexenyl CH2), 21.4 (cyclohexenyl CH2). HRMS (ESI) calcd 
for C16H18O2 [M-OH]
+: 225.1279; found 225.1282. Anal. Calc. for C16H18O2: 
C, 79.31; H, 7.49%. Found: C, 79.42; H, 7.43%. 
 
1-(4’-Methoxyphenyl)-3-phenylprop-2-yn-1-ol.264 
Prepared from phenylacetylene (1.2 mL) and p-
anisaldehyde (1.2 mL), isolated as a white solid 
after purification by column chromatography 
(petroleum ether/ethyl acetate, 3:1). Yield: 2.07 g (87%). 1H NMR (CDCl3):  
= 7.55 (d, J = 6.4, 2H), 7.49  7.47 (m, 2H, CH-aromatic), 7.33 (m, 3H, CH-
aromatic), 6.98 – 6.89 (d, J = 6.4, 2H, CH-aromatic), 5.65 (d, J = 6.0, 1H, 
CHOH), 3.83 (s, 3H, OCH3), 2.30 (d, J = 6.0, 1H, CHOH). 13C NMR (CDCl3): 
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 = 159.7 (CH-aromatic), 133.0 (CH-aromatic), 131.7 (CH-aromatic), 128.5 
(CH-aromatic), 128.3 (CH-aromatic), 128.2 (CH-aromatic), 122.5 (CH-
aromatic), 114.0 (CH-aromatic), 88.9 (CHCC), 86.5 (CHCC), 64.7 (CHOH), 
55.3 (OCH3). HRMS (ESI) calcd for C16H14O2 [M-OH]+: 221.0966; found 
221.0976. 
 
1-(4-Methoxyphenyl)-2-propyn-1-ol.265  
Ethynylmagnesium bromide (0.5 M in THF, 24.0 mL, 
12 mmol, 1.2 eq.) was added to a solution of p-
anisaldehyde (1.2 mL, 10 mmol, 1.0 eq.) in dry THF (20 
mL) at 0 C under N2. The reaction mixture was stirred for 1 h at room 
temperature, then quenched with water (50 mL) and extracted with 50 mL of 
CH2Cl2. The organic layer was dried over Na2SO4, and the solvent was 
removed in vacuo. Purification by column chromatography on silica 
(petroleum ether/ethyl acetate, 3:1) afforded the desired product as a white 
solid. Yield: 1.15 g (71%). 1H NMR (CDCl3):  = 7.46 (d, J = 8.8, 2H, CH-
aromatic), 6.90 (d, J = 8.8, 2H, CH-aromatic), 5.39 (dd, J = 6.4, 2.3, 1H, OH), 
3.80 (s, 3H, OCH3), 2.66 (d, J = 2.3, 1H, CHOH). 13C NMR (CDCl3):  = 
159.7 (CH-aromatic), 132.4 (CH-aromatic), 128.0 (CH-aromatic), 114.0 (CH-
aromatic), 83.7 (CCH), 74.6 (CCH), 63.9 (NHCH), 55.3 (OCH3). HRMS 
(ESI) calcd for C10H10O2 [M-OH]
+: 145.0653; found 145.0645. 
 
General procedure for the synthesis of substrates 3.1l-n, p (Procedure J): 
The propargyl alcohol (5.0 mmol, 1.0 eq.) was dissolved in 5.0 mL of acetone. 
Benzamide (1.21g, 10.0 mmol, 2.0 eq.) and HBF4 (50 wt% aqueous solution, 
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17.6 L, 0.1 mmol, 0.02 eq.) were successively added, and the resulting 
mixture was stirred at room temperature for 6 h. The solvent was removed in 
vacuo and the residue purified by column chromatography on silica. 
 
N-[1-(4-Methoxyphenyl)hept-2-ynyl]benzamide (3.1l). 
Prepared from 1-(4’-methoxyphenyl)-hept-2-yn-1-ol 
(1.09 g) by procedure J, isolated as a white solid after 
purification by column chromatography (petroleum 
ether/ethyl acetate, 3:1). Yield: 1.51 g (94%). mp 98  
100 C. 1H NMR (CDCl3):  = 7.81 – 7.74 (m, 2H, CH-aromatic), 7.55 – 7.46 
(m, 3H, CH-aromatic), 7.46 – 7.39 (m, 2H, CH-aromatic), 6.94 – 6.85 (m, 2H, 
CH-aromatic), 6.52 (d, J = 8.4, 1H, NH), 6.15 (dt, J = 8.4, 2.2, 1H, CHCC), 
3.80 (s, 3H, OCH3), 2.27 (td, J = 7.1, 2.2, 2H, CCCH2), 1.59 – 1.49 (m, 2H, 
CH2), 1.48 – 1.38 (m, 2H, CH2), 0.92 (t, J = 7.2, 3H, CH2CH3). 13C NMR 
(CDCl3):  = 166.0 (CO), 159.3 (CH-aromatic), 134.0 (CH-aromatic), 131.9 
(CH-aromatic), 131.6 (CH-aromatic), 128.5 (CH-aromatic), 128.4 (CH-
aromatic), 127.0 (CH-aromatic), 113.9 (CH-aromatic), 85.6 (CCCH2), 78.0 
(CCCH2), 55.3 (OCH3), 44.8 (CHCC), 30.7 (CCCH2), 22.0 (CH2), 18.5 
(CH2), 13.6 (CH2CH3). HRMS (ESI) calcd for C21H23NO2 [M+H]+: 322.1807; 
found 322.1782. max/cm
-1: 3290 (NH), 1632 (C=O). Anal. Calc. for 
C21H23NO2: C, 78.47; H, 7.21; N, 4.36%. Found: C, 78.36; H, 7.13; N, 4.41%. 
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N-[1-(4-Methoxyphenyl)- 3-(trimethylsilyl)prop-2-ynyl]benzamide (3.1m). 
Prepared from 1-(4’-methoxyphenyl)-3-
(trimethylsilyl)prop-2-yn-1-ol (1.17 g) by procedure J, 
isolated as a white solid after purification by column 
chromatography (petroleum ether/ethyl acetate, 4:1). 
Yield: 1.15 g (68%). mp 167  169 C. 1H NMR (CDCl3):  = 7.81 – 7.76 (m, 
2H, CH-aromatic), 7.54 – 7.47 (m, 3H, CH-aromatic), 7.47 – 7.40 (m, 2H, 
CH-aromatic), 6.93 – 6.86 (m, 2H, CH-aromatic), 6.52 (d, J = 8.5, 1H, NH), 
6.21 (d, J = 8.5, 1H, CHCC), 3.81 (s, 3H, OCH3), 0.21 (s, 9H, Si(CH3)3). 13C 
NMR (CDCl3):  = 166.0 (CO), 159.4 (CH-aromatic), 133.9 (CH-aromatic), 
131.8 (CH-aromatic), 131.0 (CH-aromatic), 128.6 (CH-aromatic), 128.4 (CH-
aromatic), 127.1 (CH-aromatic), 114.0 (CH-aromatic), 103.3 (CCCH2), 89.8 
(CCCH2), 55.3 (OCH3), 45.1 (CHCC), -0.12 (Si(CH3)3). HRMS (ESI) calcd 
for C20H23NO2Si [M+H]
+: 338.1576; found 338.1558. max/cm
-1: 3262 (NH), 
1628 (C=O). Anal. Calc. for C20H23NO2Si: C, 71.18; H, 6.87; N, 4.15%. 
Found: C, 70.92; H, 6.79; N, 4.22%. 
 
N-[1-(4-Methoxyphenyl)-3-cyclopropyl-prop-2-ynyl]benzamide (3.1n). 
Prepared from 1-(4’-methoxyphenyl)-3-cyclopropyl-
prop-2-yn-1-ol (1.01 g) by procedure J, isolated as a 
white solid after purification by column 
chromatography (petroleum ether/ethyl acetate, 2:1). 
Yield: 1.36 g (89%). mp 119  123 C. 1H NMR (CDCl3):  = 7.81 – 7.74 (m, 
2H, CH-aromatic), 7.55 – 7.45 (m, 3H, CH-aromatic), 7.45 – 7.38 (m, 2H, 
CH-aromatic), 6.91 – 6.85 (m, 2H, CH-aromatic), 6.52 (d, J = 8.4, 1H, NH), 
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6.12 (dd, J = 8.4, 1.8, 1H, CHCC), 3.80 (s, 3H, OCH3), 1.33  1.28 (m, 1H, 
cyclopropyl CH), 0.87 – 0.68 (m, 4H, cyclopropyl CH2). 13C NMR (CDCl3):  
= 165.9 (CO), 159.3 (CH-aromatic), 134.0 (CH-aromatic), 131.8 (CH-
aromatic), 131.6 (CH-aromatic), 128.5 (CH-aromatic), 128.3 (CH-aromatic), 
127.0 (CH-aromatic), 113.9 (CH-aromatic), 88.5 (CHCC), 73.3 (CHCC), 
55.3 (OCH3), 44.7 (CHCC), 8.2 (cyclopropyl CH), -0.5 (cyclopropyl CH2). 
HRMS (ESI) calcd for C20H19NO2 [M+H]
+: 306.1494; found 306.1505. 
max/cm
-1: 3235 (NH), 1625 (C=O). Anal. Calc. for C20H19NO2: C, 78.66; H, 
6.27; N, 4.59%. Found: C, 78.49; H, 6.16; N, 4.71%. 
 
N-[1-(4-Methoxyphenyl)-3-phenyl-prop-2-ynyl]benzamide (3.1p). 
Prepared from 1-(4’-methoxyphenyl)-3-phenyl-prop-2-
yn-1-ol (1.19 g) by procedure J, isolated as a white solid 
after purification by column chromatography 
(CH2Cl2/ethyl acetate, 20:1). Yield: 1.30 g (77%). mp 
165  168 C. 1H NMR (CDCl3):  = 7.84  7.77 (m, 2H, CH-aromatic), 7.63 
– 7.56 (m, 2H, CH-aromatic), 7.55 – 7.47 (m, 3H, CH-aromatic), 7.48 – 7.40 
(m, 2H, CH-aromatic), 7.34  7.31 (m, 3H, CH-aromatic), 6.97 – 6.89 (m, 2H, 
CH-aromatic), 6.64 (d, J = 8.4, 1H, NH), 6.42 (d, J = 8.4, 1H, CHCC), 3.82 
(s, 3H, OCH3). 13C NMR (CDCl3):  = 166.1 (CO), 159.5 (CH-aromatic), 
133.8 (CH-aromatic), 131.8 (CH-aromatic), 131.8 (CH-aromatic), 131.2 (CH-
aromatic), 128.6 (CH-aromatic), 128.6 (CH-aromatic), 128.5 (CH-aromatic), 
128.3 (CH-aromatic), 127.1 (CH-aromatic), 122.5 (CH-aromatic), 114.1 (CH-
aromatic), 87.2 (CHCC), 84.9 (CHCC), 55.3 (OCH3), 45.1 (CHCC). 
HRMS (ESI) calcd for C23H19NO2 [M+H]
+: 221.0966; found 221.0976. 
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max/cm
-1: 3255 (NH), 1631 (C=O). Anal. Calc. for C23H19NO2: C, 80.92; H, 
5.61; N, 4.10%. Found: C, 80.81; H, 5.53; N, 4.18%. 
 
General procedure for the synthesis of substrates 3.1q-s (Procedure K): 
The propargyl alcohol (5.0 mmol, 1.0 eq.) was dissolved in 5.0 mL of MeCN. 
The corresponding amide (10.0 mmol, 2.0 eq.) and HBF4 (50 wt% aqueous 
solution, 17.6 L, 0.1 mmol, 0.02 eq.) were successively added, and the 
resulting mixture was heated at 80 C for the specified time. After cooling to 
room temperature, the solvent was removed in vacuo and the residue purified 
by column chromatography on silica.  
 
N-[1-(4-Methoxyphenyl)-prop-2-ynyl]benzamide (3.1q). 
Prepared from 1-(4-methoxyphenyl)-2-propyn-1-ol (0.81 g) 
and benzamide (1.21 g) by procedure K. Reaction time = 1 h. 
Isolated as a white solid after purification by column 
chromatography (petroleum ether/ethyl acetate, 3:1). Yield: 
0.87 g (66%). mp 159  163 C. 1H NMR (CDCl3):  = 7.83 – 7.75 (m, 2H, 
CH-aromatic), 7.55 – 7.47 (m, 3H, CH-aromatic), 7.47 – 7.39 (m, 2H, CH-
aromatic), 6.94 – 6.86 (m, 2H, CH-aromatic), 6.55 (d, J = 8.2, 1H, NH), 6.18 
(dd, J = 8.2, 2.4, 1H, NHCH), 3.81 (s, 3H, OCH3), 2.53 (d, J = 2.4, 1H, 
CCH). 13C NMR (CDCl3):  = 166.1 (CO), 159.6 (CH-aromatic), 133.7 (CH-
aromatic), 131.8 (CH-aromatic), 130.4 (CH-aromatic), 128.6 (CH-aromatic), 
128.4 (CH-aromatic), 127.1 (CH-aromatic), 114.1 (CH-aromatic), 81.9 
(CCH), 73.1 (CCH), 55.3 (OCH3), 44.5 (NHCH). HRMS (ESI) calcd for 
C17H15NO2 [M+H]
+: 266.1181; found 266.1170. max/cm
-1: 3280 (NH), 3255 
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(CH), 1633 (C=O). Anal. Calc. for C17H15NO2: C, 76.96; H, 5.70; N, 5.28%. 
Found: C, 76.99; H, 5.72, N, 5.26%. 
 
N-Benzoyl-1-phenyl-2-propynylamine (3.1r).160 
Prepared from 1-phenyl-2-propyn-1-ol (0.66 g) and 
benzamide (1.21 g) by procedure K. Reaction time = 12 h. 
Isolated as a white solid after purification by column 
chromatography (petroleum ether/ethyl acetate, 3:1). Yield: 0.11 g (9%). mp 
130  133 C. 1H NMR (CDCl3):  = 7.80 (dd, J = 7.3, 1.7, 2H, CH-aromatic), 
7.64 – 7.49 (m, 3H, CH-aromatic), 7.47 – 7.31 (m, 5H, CH-aromatic), 6.57 (d, 
J = 8.5, 1H, NH), 6.25 (dd, J = 8.5, 2.4, 1H, NHCH), 2.55 (d, J = 2.4, 1H, 
CCH). 13C NMR (CDCl3):  = 146.2 (CO), 138.2 (CH-aromatic), 133.6 (CH-
aromatic), 132.0 (CH-aromatic), 128.8 (CH-aromatic), 128.6 (CH-aromatic), 
128.3 (CH-aromatic), 127.1 (CH-aromatic), 81.6 (CCH), 73.3 (CCH), 45.0 
(NHCH). HRMS (ESI) calcd for C16H13NO [M+H]+: 236.1075; found 
236.1083. max/cm
-1: 3280 (NH), 3255 (CH), 1633 (C=O). 
 
N-[1-(4-Methoxyphenyl)hept-2-ynyl]cyclohexane carboxamide (3.1s). 
Prepared from 1-(4’-methoxyphenyl)-3-phenyl-prop-
2-yn-1-ol (1.19 g) and cyclohexane carboxamide 
(1.27 g) by procedure K. Reaction time = 12 h. 
Isolated as a white solid after purification by column 
chromatography (petroleum ether/ethyl acetate, 4:1). Yield: 1.08 g (66%). mp 
109  111 C. 1H NMR (CDCl3):  = 7.43 – 7.37 (m, 2H, CH-aromatic), 6.89 
– 6.83 (m, 2H, CH-aromatic), 5.94 (dd, J = 8.6, 2.3, 1H, CHCC), 5.83 (d, J = 
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8.6, 1H, NH), 3.79 (s, 3H, OCH3), 2.24 (td, J = 7.0, 2.3, 2H, CCCH2), 2.06 
(tt, J = 11.8, 3.5, 1H, cyclohexyl CH), 1.94 – 1.72 (m, 4H, cyclohexyl CH2), 
1.66 (m, 1H, cyclohexyl CH), 1.57 – 1.35 (m, 6H, cyclohexyl CH2, 
CH2CH2CH3), 1.23 (m, 3H, cyclohexyl CH2), 0.91 (t, J = 7.2, 3H, CH2CH3). 
13C NMR (CDCl3):  = 174.5 (CO), 159.1 (CH-aromatic), 132.2 (CH-
aromatic), 128.2 (CH-aromatic), 113.8 (CH-aromatic), 85.2 (CHCC), 78.2 
(CHCC), 55.3 (OCH3), 45.3 (CHCC), 43.9 (cyclohexyl CH), 30.7 
(CCCH2), 29.6 (cyclohexyl CH2), 29.4 (cyclohexyl CH2), 25.7 (cyclohexyl 
CH2), 22.0 (CH2CH2CH3), 18.4 (CH2CH2CH3), 13.6 (CH2CH3). HRMS (ESI) 
calcd for C21H29NO2 [M+H]
+: 328.2277; found 328.2285. max/cm
-1: 3280 
(NH), 3278 (CH), 1634 (C=O). Anal. Calc. for C21H29NO2: C, 77.02; H, 
8.93; N, 4.28%. Found: C, 76.89; H, 8.99; N, 4.25%. 
 
N-[1-(4-Methoxyphenyl)-3-(cyclohex-1-enyl)-prop-2-ynyl]benzamide 
(3.1o). 
1-(4’-methoxyphenyl)-3-(1-cyclohexenyl)-prop-2-
yn-1-ol (1.21 g, 5.0 mmol, 1.0 eq.) was dissolved in 
5.0 mL of toluene. Benzamide (1.21 g, 10.0 mmol, 
2.0 eq.) and HBF4 (50 wt% aqueous solution, 17.6 
L, 0.1 mmol, 0.02 eq.) were successively added, 
and the resulting mixture was refluxed for 1 h. After cooling to room 
temperature, the solvent was removed in vacuo and the residue purified by 
column chromatography on silica (petroleum ether/ethyl acetate, 4:1). Yield: 
0.50 g (29%). mp 146  151 C. 1H NMR (CDCl3):  = 7.79  7.77 (m, 2H), 
7.57 – 7.47 (m, 3H), 7.47 – 7.38 (m, 2H), 6.93 – 6.85 (m, 2H), 6.54 (d, J = 8.5, 
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1H, NH), 6.30 (d, J = 8.5, 1H, CHCC), 6.18 (tt, J = 3.8, 1.8, 1H, 
cyclohexenyl CH), 3.80 (s, 3H, OCH3), 2.23 – 2.04 (m, 4H, cyclohexenyl 
CH2), 1.71 – 1.53 (m, 4H, cyclohexenyl CH2). 13C NMR (CDCl3):  = 166.0 
(CO), 159.3 (CH-aromatic), 135.7 (CH-aromatic), 134.0 (CH-aromatic), 131.7 
(CH-aromatic), 131.6 (CH-aromatic), 128.6 (CH-aromatic), 128.4 (CH-
aromatic), 127.1 (CH-aromatic), 120.1 (cyclohexenyl C), 114.0 (cyclohexenyl 
CH), 87.0 (CHCC), 84.3 (CHCC), 55.3 (OCH3), 45.0 (CHCC), 29.2 
(cyclohexenyl CH2), 25.6 (cyclohexenyl CH2), 22.2 (cyclohexenyl CH2), 21.4 
(cyclohexenyl CH2). HRMS (ESI) calcd for C23H23NO2 [M+H]+: 225.1279; 
found 225.1282. max/cm
-1: 3306 (NH), 1633 (C=O). Anal. Calc. for 
C21H29NO2: C, 79.97; H, 6.71; N, 4.05%. Found: C, 80.03; H, 6.74; N, 4.01%. 
 
Bis(4-methoxypyridine)silver(I) perchlorate [Ag(MeO-Py)2]ClO4 (2.11b). 
Prepared by procedure E. Yield: 0.21 g (78%). 1H NMR (DMSO-d6):  = 8.48 
 8.46 (m, 4H), 7.16  7.14 (m, 4H), 3.88 (m, 6H). 13C NMR (DMSO-d6):  = 
166.2, 152.4, 111.0, 55.7. Anal. Calc. for C12H14AgClN2O6: C, 33.87; H, 3.32; 
N, 6.58%. Found: C, 33.92; H, 3.29; N, 6.64%. 
 
Bis(4-methoxypyridine)silver(I) tetrafluoroborate [Ag(MeO-Py)2]BF4 
(2.11c). 
Prepared by procedure E. Yield: 0.19 g (93%). 1H NMR (DMSO-d6):  = 8.48 
 8.47 (m, 4H), 7.16  7.14 (m, 4H), 3.88 (m, 6H). 13C NMR (DMSO-d6):  = 
166.2, 152.4, 111.0, 55.7. Anal. Calc. for C12H14AgBF4N2O2: C, 34.90; H, 
3.42; N, 6.78%. Found: C, 34.70; H, 3.47; N, 6.75%. 
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Bis(4-methoxypyridine)silver(I) hexafluorophosphate [Ag(MeO-Py)2]PF6 
(2.11d). 
Prepared by procedure E. Yield: 0.21 g (87%). X-ray diffraction quality single 
crystals were grown from MeCN/Et2O at -20 C. 
1H NMR (DMSO-d6):  = 
8.48  8.47 (m, 4H), 7.15  7.14 (m, 4H), 3.88 (m, 6H). 13C NMR (DMSO-d6): 
 = 166.2, 152.4, 111.0, 55.7. Anal. Calc. for C12H14AgF6N2O2P: C, 30.60; H, 
3.00; N, 5.95%. Found: C, 30.51; H, 2.98; N 5.93%. 
 
Bis(4-methoxypyridine)silver(I) hexafluoroantimonate [Ag(MeO-Py)2] 
(2.11e). 
Prepared by procedure E. Yield: 0.22 g (78%). 1H NMR (DMSO-d6):  = 8.47 
 8.46 (m, 4H), 7.13  7.12 (m, 4H), 3.88 (m, 6H). 13C NMR (DMSO-d6):  = 
166.2, 152.3, 111.0, 55.7. Anal. Calc. for C12H14AgF6N2O2Sb: C, 25.65; H, 
2.51; N, 4.99%. Found: C, 26.15; H, 2.61; N, 5.04%. 
 
Bis(4-methoxypyridine)silver(I) trifluoroacetate [Ag(MeO-Py)2]CF3CO2 
(2.11f). 
Prepared by procedure E. Yield: 0.20 g (91%). 1H NMR (CDCl3):  = 8.45  
8.43 (m, 4H), 6.85  6.83 (m, 4H), 3.85 (m, 6H). 13C NMR (CDCl3):  = 166.5, 
152.8, 110.7, 55.4. Anal. Calc. for C13H14AgF3N2O5S: C, 32.86; H, 2.97; N, 
5.90%. Found: C, 38.45; H, 2.82; N, 6.36%. 
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General procedure for the Ag(I)-catalyzed cycloisomerization of 
propargyl amides (Procedure L): 
The propargyl amide substrate (2.0 mmol, 1 eq.) was dissolved in CH2Cl2 (5.0 
mL) at room temperature and [Ag(MeO-Py)2]PF6 (1-15 mol%) was added. 
After the prescribed reaction time, the reaction mixture was filtered, and the 
filtrate concentrated in vacuo. The residue was purified by column 
chromatography (petroleum ether/ethyl acetate). 
 
2-Phenyl-5-methylene-4,5-dihydrooxazole (3.2a).156 
Prepared by procedure L, purified by column chromatography 
(petroleum ether/ethyl acetate, 1:1). Yield: 0.30 g (94%). Yellow 
oil. 1H NMR (CDCl3):  = 8.05 – 7.91 (m, 2H, CH-aromatic), 7.56 – 7.47 (m, 
1H, CH-aromatic), 7.48 – 7.40 (m, 2H, CH-aromatic), 4.82 (q, J = 2.9, 1H, 
=CH), 4.65 (t, J = 2.9, 2H, NCH2), 4.36 (q, J = 2.6, 1H, =CH). 13C NMR 
(CDCl3):  = 163.7 (NCO), 158.8 (C=CH2), 131.8 (CH-aromatic), 128.5 (CH-
aromatic), 128.0 (CH-aromatic), 126.7 (CH-aromatic), 83.7 (=CH2), 57.7 
(NCH2). HRMS (ESI) calcd for C10H9NO [M+H]+: 160.0757; found 160.0751. 
max/cm
-1: 1692 (C=C), 1647 (C=N). 
 
2-Methyl-5-methylene-4,5-dihydrooxazole (3.2b). 
Prepared by procedure L, but too volatile to be isolated. 1H NMR 
(CD2Cl2):  = 4.73  4.71 (m, 1H, =CH), 4.47  4.44 (m, 2H, 
CH2), 4.34  4.33 (m, 1H, =CH), 2.12 (t, J = 1.5, 3H, CH3). 
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2-tert-Butyl-5-methylene-4,5-dihydrooxazole (3.2c).154 
Prepared by procedure L, but too volatile to be isolated. 1H NMR 
(CD2Cl2):  = 4.52 (dt, J = 3.0, 2.4, 1H, =CH), 4.29 (dd, J = 2.4, 
2H, CH2), 4.14 (dt, J = 3.0, 2.4, 1H, =CH), 1.13 (s, 9H, C(CH3)3). 
 
(E)-5-Methylene-2-styryl-4,5-dihydrooxazole  (3.2d).154 
Prepared by procedure L, purified by column 
chromatography (petroleum ether/ethyl acetate, 2:1). Yield: 
0.31 g (84%). White solid. 1H NMR (CDCl3):  = 7.60 – 7.30 
(m, 6H, CH-aromatic, C6H5CH=), 6.63 (d, J = 16.3, 1H, C6H5CH=CH), 4.76 
(q, J = 2.9, 1H, =CH), 4.58 (t, J = 2.8, 2H, NCH2), 4.32 (q, J = 2.7, 1H, =CH). 
13C NMR (CDCl3):  = 163.5 (NCO), 158.5 (C=CH2), 140.8 (C6H5CH=), 
134.9 (CH-aromatic), 129.7 (CH-aromatic), 128.9 (CH-aromatic), 127.6 (CH-
aromatic), 114.1 (C6H5CH=CH), 83.3 (=CH2), 57.7 (NCH2). HRMS (ESI) 
calcd for C12H11NO [M+H]
+: 186.0913; found 186.0916. max/cm
-1: 1687 
(C=C), 1656 (C=N).  
 
Ethyl-(5-methylene-4,5-dihydro-1,3-oxazol-2-yl)acetate (3.2h).154  
Prepared by procedure L. Due to the low yield of this 
compound (ca. 10% by NMR) and difficulties in separation 
from unreacted starting material, this compound was not 
isolated. 1H NMR (CDCl3):  = 4.70 (q, J = 3.0, 1H, =CH), 4.46 (td, J = 2.8, 
1.4, 2H, NCH2), 4.30 (q, J = 2.7, 1H, =CH), 4.22 (q, J = 7.1, 2H, CH2CH3), 
3.43 (s, 2H, COCH2), 1.28 (t, J = 7.1, 3H, CH2CH3). 
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4,4-Dimethyl-5-methylene-2-phenyl-4,5-dihydrooxazole (3.2i).157 
Prepared by procedure L, purified by column chromatography 
(petroleum ether/ethyl acetate, 6:1). Yield: 0.36 g (96%). 
Colorless oil. 1H NMR (CDCl3):  = 8.00  7.98 (m, 2H, CH-aromatic), 7.54 – 
7.47 (m, 1H, CH-aromatic), 7.47 – 7.40 (m, 2H, CH-aromatic), 4.74 (d, J = 
2.8, 1H, =CH), 4.25 (d, J = 2.9, 1H, =CH), 1.45 (s, 6H, C(CH3)2). 13C NMR 
(CDCl3):  = 167.9 (NCO), 159.8 (C=CH2), 131.6 (CH-aromatic), 128.4 (CH-
aromatic), 128.1 (CH-aromatic), 127.0 (CH-aromatic), 82.3 (=CH2), 69.1 
(C(CH3)2), 29.7 (C(CH3)2). HRMS (ESI) calcd for C12H13NO [M+H]+: 
188.1070; found 188.1074. max/cm
-1: 1694 (C=C), 1645 (C=N). 
 
2,2'-Pentane-3,3-diylbis(5-methylene-4,5-dihydro-1,3-oxazole) (3.2j).154 
Prepared by procedure L, purified by column 
chromatography (petroleum ether/ethyl acetate, 6:1). Yield: 
0.13 g (28%). White solid. 1H NMR (CDCl3):  = 4.64 (q, J = 
3.0, 2H, =CH), 4.45 (t, J = 2.9, 4H, NCH2), 4.24 (q, J = 2.6, 2H, =CH), 2.00 (q, 
J = 7.5, 4H, CH2CH3), 0.83 (t, J = 7.5, 6H, CH2CH3). 13C NMR (CDCl3):  = 
166.8 (NCO), 158.6 (C=CH2), 83.8 (=CH2), 57.1 (NCH2), 47.2 (C(CH2CH3)2), 
25.1 (CH2CH3), 8.2 (CH2CH3). HRMS (ESI) calcd for C13H18N2O2 [M+H]+: 
234.1369; found 234.1360. max/cm
-1: 1692 (C=C), 1660 (C=N).  
 
1,3-Bis(5-methylene-4,5-dihydrooxazol-2-yl)benzene (3.2k). 
Prepared by procedure L, purified by column 
chromatography (petroleum ether/ethyl acetate, 2:3). 
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Yield: 0.13 g (42%). White solid. mp 107  109 C. 1H NMR (CDCl3):  = 
8.52 (d, J = 1.8, 1H, CH-aromatic), 8.11 (dd, J = 7.8, 1.8, 2H, CH-aromatic), 
7.51 (t, J = 7.8, 1H, CH-aromatic), 4.83 (q, J = 3.0, 2H, =CH), 4.65 (t, J = 2.9, 
4H, NCH2), 4.37 (q, J = 2.7, 2H, =CH). 13C NMR (CDCl3):  = 162.9 (NCO), 
158.6 (C=CH2), 131.1 (CH-aromatic), 128.8 (CH-aromatic), 127.6 (CH-
aromatic), 127.3 (CH-aromatic), 84.2 (=CH2), 57.8 (NCH2). HRMS (ESI) 
calcd for C14H12N2O2 [M+H]
+: 241.0972; found 241.0976. max/cm
-1: 1693 
(C=C), 1646 (C=N). Anal. Calc. for C14H12N2O2: C, 69.99; H, 5.03; N, 
11.66%. Found: C, 70.07; H, 5.06; N, 11.59%. 
 
(5E)-5-Pentylidene-4-(4-methoxyphenyl)-2-phenyl-4,5-dihydro-1,3-
oxazole (E-3.2l). 
Prepared by procedure L. This compound decomposes on 
silica and was not isolated. 1H NMR (CDCl3):  = 8.01  7.99 
(m, 2H, CH-aromatic), 7.42  7.37 (m, 3H, CH-aromatic), 
7.30  7.27 (m, 2H, CH-aromatic), 6.90  6.88 (m, 2H, CH-
aromatic), 5.19 (d, 1H, J = 2.8, =CH), 4.84 (d, 1H, J = 2.8, NCH), 3.80 (s, 3 H, 
OCH3), 2.23 (t, 2H, J = 7.5, =CHCH2), 1.63  1.56 (m, 2H, CH2CH2), 1.50  
1.43 (m, 2H, CH2CH3), 0.95 (t, 3H, J = 7.3, CH2CH3). 
 
(5Z)-5-Pentylidene-4-(4-methoxyphenyl)-2-phenyl-4,5-dihydro-1,3-oxazole 
(Z-3.2l). 
Prepared by procedure L. This compound decomposes on 
silica and was not isolated. 1H NMR (CDCl3):  = 8.08  
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8.06 (m, 2H, CH-aromatic), 7.47  7.44 (m, 3H, CH-aromatic), 7.25  7.23 (m, 
2H, CH-aromatic), 6.90  6.88 (m, 2H, CH-aromatic), 5.68 (d, J = 2.5, 1H, 
NCH), 4.54 (td, J = 7.5, 2.5, 1H, =CH), 3.80 (s, 3H, OCH3), 2.32  2.17 (m, 
2H, =CHCH2), 1.40  1.33 (m, 4H, CH2CH2CH3), 0.91 (t, J = 7.1, 3H, 
CH2CH3). 
 
2-Phenyl-6-trimethylsilyl-4H-1,3-oxazine (3.4m). 
Prepared by procedure L. This compound decomposes on 
silica and was not isolated. 1H NMR (CDCl3):  = 7.79  
7.77 (m, 2H, CH-aromatic), 7.52  7.48 (m, 3H, CH-
aromatic), 7.42 (t, J = 7.4, 2H, CH-aromatic), 6.90  6.88 
(m, 2H, CH-aromatic), 6.58 (d, J = 8.5, 1H, =CH), 6.22 (d, J = 8.5, 1H, NCH), 
3.80 (s, 3H, OCH3), 0.21 (s, 9H, Si(CH3)3).  
 
(5E)-5-(Cyclopropylmethylene)-4-(4-methoxyphenyl)-2-phenyl-4,5-
dihydro-1,3-oxazole (E-3.2n). 
Prepared by procedure L. This compound decomposes on 
silica and was not isolated. 1H NMR (CDCl3):  = 7.95  7.93 
(m, 2H, CH-aromatic), 7.43  7.36 (m, 3H, CH-aromatic), 
7.29  7.27 (m, 2H, CH-aromatic), 6.90  6.88 (m, 2H, CH-
aromatic), 5.19 (d, J = 3.0, 1H, =CH), 4.91 (d, J = 3.0, 1H, NCH), 3.79 (s, 3H, 
OCH3), 1.58  1.51 (m, 1H, cyclopropyl CH), 0.90  0.86 (m, 2H, cyclopropyl 
CH2), 0.78  0.72 (m, 2H, cyclopropyl CH2). 
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(5Z)-5-(Cyclopropylmethylene)-4-(4-methoxyphenyl)-2-phenyl-4,5-
dihydro-1,3-oxazole (Z-3.2n). 
Prepared by procedure L. This compound decomposes on 
silica and was not isolated. 1H NMR (CDCl3):  = 8.10  
8.08 (m, 2H, CH-aromatic), 7.55  7.51 (m, 1H, CH-
aromatic), 7.47  7.43 (m, 2H, CH-aromatic), 7.24  7.22 
(m, 2H, CH-aromatic), 6.90  6.87 (m , 2H, CH-aromatic), 5.70 (d, 1H, J = 
2.4, NCH), 4.07 (dd, 1H, J = 9.5, 2.4, =CH), 3.79 (s, 3H, OCH3), 1.85  1.76 
(m, 1H, cyclopropyl CH), 0.84  0.73 (m, 2H, cyclopropyl CH2), 0.42  0.32 
(m, 2H, cyclopropyl CH2). 
 
(5E)-5-(1-Cyclohexenylmethylene)-4-(4-methoxyphenyl)-2-phenyl-4,5-
dihydro-1,3-oxazole (E-3.2o). 
Prepared by procedure L. This compound decomposes 
on silica and was not isolated. 1H NMR (CDCl3):  = 
8.07  8.04 (m, 2H, CH-aromatic), 7.48  7.39 (m, 3H, 
CH-aromatic), 7.32  7.28 (m, 2H, CH-aromatic), 6.91  
6.88 (m, 2H, CH-aromatic), 6.49 (t, 1H, J = 4.0, 
cyclohexenyl CH), 5.27 (d, 1H, J = 3.4, NCH), 5.08 (d, 1H, J = 3.4, =CH), 
3.80 (s, 3H, OCH3), 2.27  2.21 (m, 2H, cyclohexenyl CH2), 2.20  2.12 (m, 
2H, cyclohexenyl CH2), 1.75  1.62 (m, 4H, cyclohexenyl CH2). 
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(5Z)-5-(1-Cyclohexenylmethylene)-4-(4-methoxyphenyl)-2-phenyl-4,5-
dihydro-1,3-oxazole (Z-3.2o). 
Prepared by procedure L, purified by preparative 
TLC (petroleum ether/ethyl acetate, 4:1).Yield: 0.34 
g (49%). White solid. mp 116  120 C. 1H NMR 
(CDCl3):  = 8.09 – 8.02 (m, 2H, H-11), 7.59 – 7.51 
(m, 1H, H-13), 7.50 – 7.44 (m, 2H, H-12), 7.26 – 
7.21 (m, 2H, H-16), 6.93 – 6.86 (m, 2H, H-17), 5.77 (br s, 1H, H-3), 5.71 (br s, 
1H, H-1), 5.05 (br s, 1H, H-5), 3.80 (s, 2H, OCH3), 2.54 (s, 2H, H-9), 2.12 (s, 
2H, H-6), 1.78 – 1.67 (m, 2H, H-8), 1.64 – 1.56 (m, 2H, H-7). 13C NMR 
(CDCl3):  = 162.65 (C-10), 159.30 (C-2), 152.43 (C-14), 133.31 (C-18), 
133.15 (C-15), 131.90 (C-13), 128.52 (C-11), 128.29 (C-12), 126.94 (C-16), 
126.77 (C-1), 114.17 (C-17), 106.13 (C-5), 73.16 (C-3), 55.29 (OCH3), 27.79 
(C-9), 25.86 (C-6), 22.96 (C-8), 22.03 (C-7). HRMS (ESI) calcd for 
C23H23NO2 [M+H]
+: 346.1818; found 346.1807. max/cm
-1: 1686 (C=C), 1646 
(C=N). Anal. Calc. for C23H23NO2: C, 79.97; H, 6.71; N, 4.05%. Found: C, 
79.92; H, 6.64; N, 4.03%. 
 
(5Z)-5-Benzylidene-4-(4-methoxyphenyl)-2-phenyl-4,5-dihydro-1,3-
oxazole (Z-3.2p). 
Prepared by procedure L, purified by column 
chromatography (petroleum ether/ethyl acetate, 4:1). Yield = 
0.56 g (82%). White solid. X-ray diffraction quality single 
crystals were grown from CH2Cl2/hexane at -20 C. mp 160 
 163 C. 1H NMR (CDCl3):  = 8.17  8.15 (m, 2H, CH-aromatic), 7.62  
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7.54 (m, 3H, CH-aromatic), 7.54  7.52 (m, 2H, CH-aromatic), 7.40  7.38 (m, 
2H, CH-aromatic), 7.31  7.28 (m, 2H, CH-aromatic), 6.94  6.90 (m, 1H, 
CH-aromatic), 6.94  6.90 (m, 2H, CH-aromatic), 5.93 (d, 1H, J = 2.4, =CH), 
5.52 (d, 1H, J = 2.4, NCH), 3.81 (s, 3H, OCH3). 13C NMR (CDCl3):  = 162.6 
(NCO), 159.5 (OC=C), 155.7 (CH-aromatic), 134.8 (CH-aromatic), 132.5 
(CH-aromatic), 132.2 (CH-aromatic), 128.9 (CH-aromatic), 128.6 (CH-
aromatic), 128.5 (CH-aromatic), 128.4 (CH-aromatic), 128.0 (CH-aromatic), 
127.0 (CH-aromatic), 126.4 (CH-aromatic), 114.3 (CH-aromatic), 102.8 
(=CH), 73.7 (NCH), 55.3 (OCH3). HRMS (ESI) calcd for C23H19NO2 [M+H]+: 
342.1494; found 342.1500. max/cm
-1: 1692 (C=C), 1650 (C=N). Anal. Calc. 
for C23H19NO2: C, 80.92; H, 5.61; N, 4.10%. Found: C, 81.13; H, 5.56; N, 
4.05%. 
 
4-(4-Methoxyphenyl)-5-methylene-2-phenyl-4,5-dihydro-1,3-oxazole 
(3.2q). 
Prepared by procedure L, purified by column chromatography 
(petroleum ether/ethyl acetate, 4:1). Yield = 0.48 g (90%). White 
solid. mp 75  81 C. 1H NMR (CDCl3):  = 8.10 – 8.03 (m, 2H, 
CH-aromatic), 7.58 – 7.51 (m, 1H, CH-aromatic), 7.50 – 7.42 (m, 
2H, CH-aromatic), 7.29 – 7.23 (m, 2H, CH-aromatic), 6.94 – 6.87 (m, 2H, 
CH-aromatic), 5.74 (t, J = 2.8, 1H, =CH), 4.91 (t, J = 2.9, 1H, =CH), 4.27 (t, J 
= 2.7, 1H, NCH), 3.80 (s, 3H, OCH3). 13C NMR (CDCl3):  = 162.7 (NCO), 
162.6 (C=CH2), 159.3 (CH-aromatic), 132.7 (CH-aromatic), 132.0 (CH-
aromatic), 128.5 (CH-aromatic), 128.5 (CH-aromatic), 128.3 (CH-aromatic), 
126.6 (CH-aromatic), 114.2 (CH-aromatic), 85.0 (=CH2), 71.8 (NCH), 55.3 
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(OCH3). HRMS (ESI) calcd for C17H15NO2 [M+H]+: 342.1494; found 
342.1500. max/cm
-1: 1695 (C=C), 1645 (C=N). Anal. Calc. for C17H15NO2: C, 
76.96; H, 5.70; N, 5.28%. Found: C, 76.80; H, 5.64; N, 5.20%. 
 
General procedure for trapping of organosilver(I) intermediates with 
electrophiles (Procedure M): 
To a solution of propargyl amide 3.1 (1.0 mmol, 1.0 equiv.) in acetone (10 mL) 
was added N-bromosuccinimide (0.21 g, 1.2 mmol, 1.2 equiv) or N-
iodosuccinimide (0.27 g, 1.2 mmol, 1.2 equiv.). The resulting mixture was 
cooled to 0 C before the addition of silver(I) trifluoromethanesulfonate (25.7 
mg, 0.1 mmol, 0.1 eq.). The reaction mixture was allowed to rise to room 
temperature, and stirred for another 1 h. The solvent was removed in vacuo, 
and the residue purified by column chromatography.  
 
2-Phenyl-5-bromomethylene-4,5-dihydrooxazole (3.7a). 
Prepared by procedure M from 3.1a (0.16 g) and N-
bromosuccinimide (0.21 g). Purified by column 
chromatography on silica (petroleum ether/ethyl acetate, 8:1). 
Yield: 0.20 g (84%). White solid. mp 95  98 C.1H NMR (CDCl3):  = 7.99 – 
7.91 (m, 2H, CH-aromatic), 7.60 – 7.50 (m, 1H, CH-aromatic), 7.45 (t, J = 7.7, 
2H, CH-aromatic), 6.01 (t, J = 3.2, 1H, =CHBr), 4.67 (d, J = 3.2, 2H, CH2). 
13C NMR (CDCl3):  = 163.6 (NCO), 155.6 (C=CHBr), 132.1 (CH-aromatic), 
128.6 (CH-aromatic), 128.1 (CH-aromatic), 126.3 (CH-aromatic), 80.1 
(=CHBr), 59.2 (NCH2). HRMS (ESI) calcd for C10H8BrNO [M+H]+: 237.9862; 
found 237.9861. max/cm
-1: 1685 (C=C), 1652 (C=N). 
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2-Phenyl-5-iodomethylene-4,5-dihydrooxazole (3.7b). 
Prepared by procedure M from 3.1a (0.16 g) and N-
iodosuccinimide (0.27 g). Purified by column chromatography 
on neutral alumina (petroleum ether/ethyl acetate, 20:1). Yield: 
0.16 g (56%). White solid. mp 111  117 C. 1H NMR (CDCl3):  = 8.01 – 
7.90 (m, 2H, CH-aromatic), 7.59 – 7.49 (m, 1H, CH-aromatic), 7.48 – 7.41 (m, 
2H, CH-aromatic), 5.77 (t, J = 3.3, 1H, =CHI), 4.62 (d, J = 3.3, 2H, CH2). 13C 
NMR (CDCl3):  = 163.9 (NCO), 158.0 (C=CHI), 132.1 (CH-aromatic), 128.6 
(CH-aromatic), 128.0 (CH-aromatic), 126.5 (CH-aromatic), 61.2 (=CHI), 47.1 
(NCH2). HRMS (ESI) calcd for C10H8INO [M+H]+: 285.9723; found 
285.9735. max/cm
-1: 1671 (C=C), 1643 (C=N). 
 
2-tert-Butyl-5-bromomethylene-4,5-dihydrooxazole (3.7c). 154 
Prepared by procedure M from 3.1c (0.14 g) and N-
bromosuccinimide (0.21 g). Purified by column 
chromatography on silica (petroleum ether/ethyl acetate, 8:1). 
Yield: 0.14 g (64%). White solid. mp 48  55 C. 1H NMR (CDCl3):  = 5.84 
(t, J = 3.2, 1H, =CHBr), 4.42 (d, J = 3.2, 2H, CH2), 1.25 (s, 9H, C(CH3)3). 13C 
NMR (CDCl3):  = 173.7 (NCO), 156.2 (C=CHBr), 80.0 (=CHBr), 58.8 
(NCH2), 33.6 (C(CH3)3), 27.3 (C(CH3)3). HRMS (ESI) calcd for C8H12BrNO 
[M+H]+: 218.0181; found 218.0187. max/cm
-1: 1686 (C=C), 1658 (C=N). 
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(E,E)-5-Bromomethylene-2-styryl-4,5-dihydrooxazole  (3.7d).154 
Prepared by procedure M from 3.1d (0.19 g) and N-
bromosuccinimide (0.21 g). Purified by column 
chromatography (petroleum ether/ethyl acetate, 8:1). Yield: 
0.31 g (84%). White solid. X-ray diffraction quality single crystals were 
grown from petroleum ether/ethyl acetate (8:1) at -20 C. mp 128  132 C. 
1H NMR (CDCl3):  = 7.55 – 7.45 (m, 3H, CH-aromatic, C6H5CH=), 7.42 – 
7.37 (m, 3H, CH-aromatic), 6.63 (d, J = 16.3, 1H, C6H5CH=CH), 5.96 (t, J = 
3.2, 1H, =CHBr), 4.60 (d, J = 3.2, 2H, CH2). 13C NMR (CDCl3):  = 163.4 
(NCO), 155.2 (C=CHBr), 141.5 (C6H5CH=), 134.6 (CH-aromatic), 130.1 
(CH-aromatic), 129.0 (CH-aromatic), 127.7 (CH-aromatic), 113.5 
(C6H5CH=CH), 80.7 (=CHBr), 59.1 (NCH2). HRMS (ESI) calcd for 
C12H10BrNO [M+H]
+: 264.0024; found 264.0014. max/cm
-1: 1686 (C=C), 
1653 (C=N). 
 
4,4-Dimethyl-5-bromomethylene-2-phenyl-4,5-dihydrooxazole (3.7e). 
Prepared by procedure M from 3.1i (0.19 g) and N-
bromosuccinimide (0.21 g) in the absence of AgOTf. Purified 
by column chromatography (petroleum ether/ethyl acetate, 8:1). 
Yield: 0.24 g (90%). Colorless oil. 1H NMR (CDCl3):  = 7.96  7.93 (m, 2H, 
CH-aromatic), 7.53 – 7.49 (m, 1H, CH-aromatic), 7.45 – 7.41 (m, 2H, CH-
aromatic), 6.00 (s, 1H, =CHBr), 1.68 (s, 6H, C(CH3)2). 13C NMR (CDCl3):  = 
161.9 (NCO), 158.8 (C=CHBr), 131.9 (CH-aromatic), 128.5 (CH-aromatic), 
128.1 (CH-aromatic), 126.3 (CH-aromatic), 81.0 (=CHBr), 71.3 (C(CH3)2), 
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25.4 (C(CH3)2). ). HRMS (ESI) calcd for C12H12BrNO [M+H]+: 266.0175; 
found 266.0170. max/cm
-1: 1678 (C=C), 1649 (C=N). 
 
4,4-Dimethyl-5-iodomethylene-2-phenyl-4,5-dihydrooxazole (3.7f). 
Prepared by procedure M from 3.1i (0.19 g) and N-
iodosuccinimide (0.27 g) in the absence of AgOTf. Purified by 
column chromatography on neutral alumina (petroleum 
ether/ethyl acetate, 30:1). Yield: 0.30 g (96%). Colorless oil. 1H NMR 
(CDCl3):  = 7.95  7.93 (m, 2H, CH-aromatic), 7.55 – 7.48 (m, 1H, CH-
aromatic), 7.48 – 7.39 (m, 2H, CH-aromatic), 5.76 (s, 1H, =CHI), 1.69 (s, 6H, 
C(CH3)2). 13C NMR (CDCl3):  = 163.4 (NCO), 158.5 (C=CHI), 131.8 (CH-
aromatic), 128.5 (CH-aromatic), 128.1 (CH-aromatic), 126.2 (CH-aromatic), 
71.3 (=CHI), 48.4 (C(CH3)2), 25.8 (C(CH3)2). HRMS (ESI) calcd for 
C12H12INO [M+H]
+: 314.0042; found 314.0050. max/cm
-1: 1668 (C=C), 1645 
(C=N). 
 
5-Bromomethylene-4-(4-methoxyphenyl)-2-phenyl-4,5-dihydro-1,3-
oxazole (3.7g). 
Prepared by procedure M from 3.1q (0.27 g) and N-
bromosuccinimide (0.21 g). Purified by column 
chromatography on neutral alumina (petroleum ether/ethyl 
acetate, 30:1). Yield: 0.34 g (98%). mp 83  88 C. 1H NMR 
(CDCl3):  = 8.05 – 7.97 (m, 2H, CH-aromatic), 7.57 – 7.50 (m, 1H, CH-
aromatic), 7.49 – 7.40 (m, 2H, CH-aromatic), 7.25 (dd, J = 6.5, 2.2, 2H, CH-
aromatic), 6.92 – 6.85 (m, 2H, CH-aromatic), 6.16 (d, J = 2.8, 1H, =CHBr), 
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5.80 (d, J = 2.8, 1H, NCH), 3.79 (s, 3H, OCH3). 13C NMR (CDCl3):  = 161.7 
(NCO), 159.4 (C=CHBr), 158.0 (CH-aromatic), 132.2 (CH-aromatic), 129.2 
(CH-aromatic), 128.6 (CH-aromatic), 128.3 (CH-aromatic), 126.6 (CH-
aromatic), 126.1 (CH-aromatic), 114.0 (CH-aromatic), 84.0 (=CHBr), 73.1 
(NCH), 55.2 (OCH3). HRMS (ESI) calcd for C17H14BrNO2 [M+H]+: 334.0286; 
found 334.0269. max/cm
-1: 1687 (C=C), 1648 (C=N).  
 
6.3 Compounds used in Chapter 4 
N,N'-Bis(2,6-diisopropylphenyl)-1,4-diaza-1,3-butadiene.266 
2,4,6-diisopropylaniline (5.6 mL, 40 mmol) was 
dissolved in 20 mL of methanol, and glyoxal (40% 
w/w aqueous solution, 2.9 mL, 20 mmol) was added, 
followed by a few drops of formic acid. The 
reaction mixture was stirred for 15 h at room temperature, and the resulting 
yellow precipitate was collected by filtration and washed with 3  5 mL of 
methanol. Yield: 6.37 g (85%). Yellow solid. 1H NMR (CDCl3):  = 8.12 (s, 
2H, =CH), 7.22 – 7.15 (m, 6H, CH-aromatic), 2.96 (sept, J = 6.9, 4H, 
CH(CH3)2), 1.23 (d, J = 6.9, 24H, CH3). 13C NMR (CDCl3):  = 163.1 (CH-
aromatic), 148.0 (CH-aromatic), 136.7 (CH-aromatic), 125.1 (CH-aromatic), 
123.2 (=CH), 28.0 (CH(CH3)2), 23.4 (CH3). 
 
N,N’-Bis(2,6-diisopropylphenyl)-ethylenediamine.267 
To a solution of N,N'-bis(2,6-diisopropylphenyl)-
1,4-diaza-1,3-butadiene (6.02 g, 20.6 mmol) in THF 
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(41 mL) was cooled to 0 C, and a 2.0 M solution of LiAlH4 in THF (22.5 mL) 
was added. The mixture was warmed slowly to room temperature and stirred 
overnight. The reaction mixture was the cooled to 0 C and quenched by the 
addition of ice water until the evolution of gas ceased. 10 mL of 3.0 M KOH 
solution was added, and the organic layer extracted with 100 mL of ethyl 
acetate. Removal of the solvent in vacuo gave a pale yellow solid, which was 
recrystallized from hot isopropanol to give colorless crystals of the desired 
product. Yield: 5.21 g (66%). Colorless crystals. 1H NMR (CDCl3):  = 7.20 – 
7.07 (m, 6H, CH-aromatic), 3.40 (sept, J = 6.9, 4H, CH(CH3)2), 3.20 (s, 4H, 
CH2) and 1.30 (d, J = 6.9, 24H, CH3). 13C NMR (CDCl3):  = 143.2 (CH-
aromatic), 142.4 (CH-aromatic), 123.9 (CH-aromatic), 123.6 (CH-aromatic), 
52.3 (CH2), 27.8 (CH(CH3)2), 24.2 (CH3). 
 
1,3-Bis-(2,6-diisopropylphenyl)imidazolium chloride (IPr
HCl).266 
N,N'-bis(2,6-diisopropylphenyl)-1,4-diaza-1,3-
butadiene (6.37 g, 16.9 mmol, 1.0 eq.) was dissolved 
in ethyl acetate (34 mL), and a solution of 
paraformaldehyde (0.55 g, 18.4 mmol, 1.09 eq.) in 
HCl (4.0 M in dioxane, 6.3 mL, 25.4 mmol, 1.5 eq.) was added slowly whilst 
maintaining a gentle heating of the reaction mixture over 1 h. The reaction 
mixture was stirred overnight at room temperature. The resulting precipitate 
was filtered off and washed with 3  10 mL of ethyl acetate to obtain a light 
pink powder. The powder was dissolved in a minimal amount of saturated 
aqueous NaHCO3 solution, and extracted with 3  10 mL of ethyl acetate to 
remove the colored impurities. The aqueous layer was further extracted with 3 
276 
 
 10 mL of dichloromethane. The organic extracts were dried over MgSO4, 
and the solvent removed in vacuo. The residue was redissolved in a minimal 
amount of CH2Cl2, and ethyl acetate was added to precipitate the product. 
Filtration and washing with ethyl acetate afforded the product as colorless 
crystals. Yield: 1.51 g (21%). Colorless crystals. 1H NMR (CDCl3):  = 10.02 
(s, 1H, NCHN), 8.15 (s, 2H, CH-aromatic), 7.57 (t, J = 7.8, 2H, imidazole 
CH), 7.34 (d, J = 7.8, 4H, CH-aromatic), 2.44 (sept, J = 6.8, 4H, CH(CH3)2), 
1.27 (d, 12H, J = 6.7, CH(CH3)2), 1.24 (d, 12H, J = 6.7, CH(CH3)2). 13C NMR 
(DMSO-d6):  = 144.8 (NCHN), 139.4 (CH-aromatic), 131.8 (CH-aromatic), 
130.1 (CH-aromatic), 126.2 (CH-aromatic), 124.6 (imidazole CH), 28.6 
(CH(CH3)2), 24.1 (CH(CH3)2), 23.1 (CH(CH3)2). 
 
1,3-Bis-(2,6-diisopropylphenyl)imidazolium tetrafluoroborate 
(IPr
HBF4).266 
IPr
HCl (3.55 mmol, 1.51 g) was dissolved in a 
minimal amount of water, and HBF4 (50% w/w 
aqueous solution, 3.9 mmol, 0.6 mL) was added. The 
white precipitate that formed instantly was filtered off, washed with 5 mL of 
water, and dried in vacuo. Yield: 1.36 g (98%). White powder. 1H NMR 
(DMSO-d6): 10.16 (s, 1H, NCHN), 8.57 (s, 2H, CH-aromatic), 7.70 (t, J = 7.8, 
2H, imidazole CH), 7.54 (d, J = 7.8, 4H, CH-aromatic), 2.36 (sept, J = 6.8, 4H, 
CH(CH3)2), 1.27 (d, J = 6.7, 12H, CH(CH3)2), 1.17 (d, J = 6.8, 12H, 
CH(CH3)2). 13C NMR (DMSO-d6):  = 144.8 (NCHN), 139.2 (CH-aromatic), 
131.9 (CH-aromatic), 130.0 (CH-aromatic), 126.2 (CH-aromatic), 124.6 
(imidazole CH), 28.6 (CH(CH3)2), 24.1 (CH(CH3)2), 23.1 (CH(CH3)2). 
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1,3-Bis(2,6-diisopropylphenyl)-4,5-dihydroimidazolium tetrafluoroborate 
(SIPr
HBF4).268 
Triethyl orthoformate (25 mmol, 4.2 mL) and 
NH4BF4 (10 mmol, 1.05 g) were added to N,N’-
bis(2,6-diisopropylphenyl)-ethylenediamine (10 
mmol, 3.81 g) and the resulting slurry was heated to 
120 °C for 2 h. The excess triethylorthoformate and ethanol formed during the 
reaction mixture were removed by distillation, leaving behind a light yellow 
solid. Recrystallization of the residue from hot ethanol afforded the desired 
product as colourless crystals. Yield: 2.30 g (48%). Colorless crystals. 1H 
NMR (DMSO-d6):  = 9.44 (s, 1H, NCHN), 7.56 (t, J = 7.8, 2H, CH-aromatic), 
7.44 (d, J = 7.8 , 4H, CH-aromatic), 4.53 (s, 4H, imidazole CH2), 3.08 (sept, J 
= 6.8, 4H, CH(CH3)2), 1.36 (d, J = 6.8, 12H, CH(CH3)2), 1.21 (d, J = 6.8, 12H, 
CH(CH3)2). 13C NMR (DMSO-d6):  = 160.1 (NCHN), 146.1 (CH-aromatic), 
131.1 (CH-aromatic), 129.9 (CH-aromatic), 124.8 (CH-aromatic), 53.7 
(imidazole CH), 28.3 (CH(CH3)2), 25.0 (CH(CH3)2), 23.3 (CH(CH3)2). 
 
General procedure for the synthesis of silver(I) carboxylates Ag(O2CR) 
(Procedure N).269 
The corresponding carboxylic acid (2.0 mmol) was added to a 0.2 M aqueous 
solution of NaOH (12 mL, 2.4 mmol) with stirring. After the carboxylic acid 
has dissolved (gentle heating may be needed), a saturated aqueous solution of 
AgNO3 (2.0 mmol, 0.34 g) acidified with a few drops of acetic acid was added. 
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The white precipitate that formed immediately was collected by filtration, 
washed with water, and dried in vacuo.  
 
Silver(I) benzoate (AgOBz). 
Prepared by procedure N, from benzoic acid (0.24 g). Yield: 0.27 g (59%). 
White solid. 1H NMR (DMSO-d6):  = 7.97  7.95 (m, 2H), 7.46 – 7.36 (m, 
3H). 13C NMR (DMSO-d6):  = 170.1, 136.8, 130.2, 129.5, 127.7. max/cm
-1: 
1512.8 (C=O), 1379.3 (C=O).  
 
Silver(I) 4-methylbenzoate (Ag(4-MeC6H4CO2)). 
Prepared by procedure N, from 4-toluic acid (0.27 g). Yield: 0.42 g (86%). 
White solid. 1H NMR (DMSO-d6):  = 7.85 (d, J = 7.6, 2H), 7.18 (d, J = 7.9, 
2H), 2.33 (s, 3H). 13C NMR (DMSO-d6):  = 170.2, 139.8, 134.0, 129.6, 128.3, 
21.0. max/cm
-1: 1510.3 (C=O), 1379.3 (C=O). 
 
Silver(I) 4-chlorobenzoate (Ag(4-ClC6H4CO2)). 
Prepared by procedure N, from 4-chlorobenzoic acid (0.31 g). Yield: 0.43 g 
(81%). White solid. Yield: 0.43 g (81%). 1H NMR (DMSO-d6):  = 7.93 (d, J 
= 7.9, 2H), 7.42 (d, J = 7.9, 2H). 13C NMR (DMSO-d6):  = 169.1, 135.9, 
134.9, 131.3, 127.8. max/cm
-1: 1508.8 (C=O), 1371.1 (C=O). 
 
General procedure for the synthesis of silver(I) NHC carboxylate 
complexes (Procedure O). 
A mixture of NHC
HBF4 (0.2 mmol, 1 eq.) and Ag(O2CR) (0.24 mmol, 1.2 eq.) 
in CH2Cl2 (5 or 10 mL) was stirred for 15 min and K2CO3 (4.0 mmol, 20 eq.) 
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was added. After x h (indicated separately below), the mixture was filtered 
through Celite and solvent was removed in vacuo. The residue was washed 
with 5 mL of Et2O to obtain the crude product as a white solid. 
Recrystallization from CH2Cl2/hexane at 0 C afforded the desired product as 
colourless crystals. 
 
[(IPr)AgOAc] (4.19a).190 
Prepared by procedure O from IPr
HBF4 (0.2 mmol, 95.3 mg), AgOAc (0.24 
mmol, 40.0 mg), K2CO3 (4.0 mmol, 0.55 g) and CH2Cl2 (10 mL); x = 1. Yield: 
53.3 mg (48%). 1H NMR (CDCl3):  = 7.51 (t, J = 7.8, 2H, CH-aromatic), 
7.31 (d, J = 7.8, 4H, CH-aromatic), 7.23 (d, J = 2.0, 2H, imidazole CH), 2.57 
(sept, J = 6.9, 4H, CH(CH3)2), 1.86 (s, 3H, CH3CO2), 1.31 (d, J = 6.9, 12H, 
CH(CH3)2), 1.24 (d, J = 6.9, 12H, CH(CH3)2). 13C NMR (CDCl3):  = 184.5 
(dd, J(109Ag, 13C) = 288, J(107Ag, 13C) = 249, NCN), 178.1 (CO), 145.6 (CH-
aromatic), 134.7 (CH-aromatic), 130.6 (CH-aromatic), 124.2 (CH-aromatic), 
123.5 (d, J(107Ag, 13C) = 8.1, imidazole CH), 28.7 (CH(CH3)2), 24.6 
(CH(CH3)2), 24.0 (CH(CH3)2), 22.6 (CH3CO2). MS [ESI]: m/z (%) = 536.22 
[(IPr)Ag(MeCN)]+ (100). max/cm
-1: 1588.3 (C=O), 1326.1 (C=O). Anal. Calc. 
for C29H39AgN2O2: C, 62.70; H, 7.08; N, 5.04%. Found: C, 62.70; H, 7.08; N, 
5.00%. 
 
[(IPr)AgOBz] (4.19b). 
Prepared by procedure O from IPr
HBF4 (0.2 mmol, 95.3 mg), AgOBz (0.24 
mmol, 55.0 mg), K2CO3 (4.0 mmol, 0.55 g) and CH2Cl2 (10 mL); x = 1. Yield: 
55.6 mg (45%). 1H NMR (CDCl3):  = 7.90 (d, J = 6.9, 2H, benzoate CH), 
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7.49 (t, J = 7.8, 2H, CH-aromatic), 7.32 – 7.22 (m, 7H, benzoate CH, CH-
aromatic), 7.22 (d, J = 2.1, 2H, imidazole CH), 2.60 (sept, J = 6.9, 4H, 
CH(CH3)2), 1.34 (d, J = 6.9, 12H, CH(CH3)2), 1.23 (d, J = 6.9, 12H, 
CH(CH3)2). 13C NMR (CDCl3):  = 184.4 (dd, J(109Ag, 13C) = 290, J(107Ag, 
13C) = 251, NCN), 172.8 (CO), 145.6 (CH-aromatic), 136.1 (CH-aromatic), 
134.7 (CH-aromatic), 130.6 (CH-aromatic), 129.8 (CH-aromatic), 129.7 (CH-
aromatic), 127.4 (CH-aromatic), 124.3 (CH-aromatic), 123.6 (d, J(107Ag, 13C) 
= 8.0 , imidazole CH), 28.7 (CH(CH3)2), 24.7 (CH(CH3)2), 24.1 (CH(CH3)2). 
MS [ESI]: m/z (%) = 536.22 [(IPr)Ag(MeCN)]+ (100). max/cm-1: 1611.7 
(C=O), 1346.2 (C=O). Anal. Calc. for C34H41AgN2O2: C, 66.12; H, 6.69; N, 
4.54%. Found: C, 66.26; H, 6.79; N, 4.58%. 
 
[(IPr)Ag(4-MeC6H4CO2)] (4.19c). 
Prepared by procedure O from IPr
HBF4 (0.2 mmol, 95.3 mg), Ag(4-
MeC6H4CO2) (0.24 mmol, 58.3 mg), K2CO3 (4.0 mmol, 0.55 g) and CH2Cl2 
(10 mL); x = 2. Product contained [Ag(IPr)2]X as an impurity. Crude yield: 
65.8 mg (52%). 1H NMR (CDCl3):  = 7.79 (d, J = 7.9, 2H, benzoate CH), 
7.40 (t, J = 7.8, 2H, CH-aromatic), 7.30 (d, J = 7.6, 4H, CH-aromatic), 7.22 (d, 
J = 2.1, 2H, imidazole CH), 7.04 (d, J = 7.9, 2H, benzoate CH), 2.60 (sept, J = 
6.8, 4H, CH(CH3)2), 2.28 (s, 3H, benzoate CH3), 1.33 (d, J = 6.9, 12H, 
CH(CH3)2), 1.23 (d, J = 6.9, 12H, CH(CH3)2). 13C NMR (CDCl3):  = 184.5 
(dd, J(109Ag, 13C) = 289 , J(107Ag, 13C) = 250 , NCN), 172.9 (CO), 145.6 (CH-
aromatic), 139.8 (CH-aromatic), 134.7 (CH-aromatic), 133.2 (CH-aromatic), 
130.6 (CH-aromatic), 129.8 (CH-aromatic), 128.1 (CH-aromatic), 124.3 (CH-
aromatic), 123.6 (d, J(107Ag, 13C) = 8.0, imidazole CH), 28.7 (CH(CH3)2), 24.7 
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(CH(CH3)2), 24.1 (CH(CH3)2), 21.3 (benzoate CH3). MS [ESI]: m/z (%) = 
536.22 [(IPr)Ag(MeCN)]+ (100). max/cm
-1: 1602.7 (C=O), 1359.2 (C=O). 
 
 [(IPr)Ag(4-ClC6H4CO2)] (4.19d). 
Prepared by procedure O from IPr
HBF4 (0.2 mmol, 95.3 mg), Ag(4-
ClC6H4CO2) (0.24 mmol, 63.2 mg), K2CO3 (4.0 mmol, 0.55 g) and CH2Cl2 
(10 mL); x = 2. Product contained [Ag(IPr)2]X as an impurity. Crude yield: 
87.5 mg (67%). 1H NMR (CDCl3):  = 7.85 – 7.82 (m, 2H, benzoate CH), 
7.49 (t, J = 7.8, 2H, CH-aromatic), 7.30 (d, J = 7.8, 4H, CH-aromatic), 7.23 – 
7.18 (m, 4H, imidazole CH, benzoate CH), 2.59 (sept, J = 6.9, 4H, CH(CH3)2), 
1.32 (d, J = 6.9, 12H, CH(CH3)2), 1.23 (d, J = 6.9, 12H, CH(CH3)2). 13C NMR 
(126 MHz, CDCl3):  = 184.1 (dd, J(109Ag, 13C) = 291, J(107Ag, 13C) = 252, 
NCN), 171.8 (CO), 145.6 (CH-aromatic), 145.1 (CH-aromatic), 135.8 (CH-
aromatic), 134.7 (CH-aromatic), 131.2 (CH-aromatic), 130.6 (CH-aromatic), 
127.5 (CH-aromatic), 124.3 (CH-aromatic), 123.6 (d, J(107Ag, 13C) = 8.1, 
imidazole CH), 28.7 (CH(CH3)2), 24.7 (CH(CH3)2), 24.0 (CH(CH3)2). MS 
[ESI]: m/z (%) = 536.22 [(IPr)Ag(MeCN)]+ (100). max/cm-1: 1606.6 (C=O), 
1365.9 (C=O). 
 
[(SIPr)AgOAc] (4.20a).190 
Prepared by procedure O from SIPr
HBF4 (0.2 mmol, 95.7 mg), AgOAc (0.24 
mmol, 40.0 mg), K2CO3 (4.0 mmol, 0.55 g) and CH2Cl2 (10 mL); x = 2. Yield: 
62.5 mg (56%). 1H NMR (CDCl3):  = 7.40 (t, J = 7.8, 2H, CH-aromatic), 
7.24 (d, J = 7.8, 4H, CH-aromatic), 4.06 (s, 4H, imidazole CH2), 3.06 (sept, J 
= 6.9, 4H, CH(CH3)2), 1.80 (s, 3H, CH3CO2), 1.36 (d, J = 6.9, 12H, 
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CH(CH3)2), 1.34 (d, J = 6.9, 12H, CH(CH3)2). 13C NMR (126 MHz, CDCl3):  
= 207.9 (dd, J(109Ag, 13C) = 271, J(107Ag, 13C) = 234, NCN), 178.2 (CO), 
146.6 (CH-aromatic), 134.6 (CH-aromatic), 129.9 (CH-aromatic), 124.6 (CH-
aromatic), 53.8 (d, J(107Ag, 13C) = 9.2, imidazole CH2), 28.9 (CH(CH3)2), 25.3 
(CH(CH3)2), 24.0 (CH(CH3)2), 22.5 (CH3CO2). MS [ESI]: m/z (%) = 538.24 
[(SIPr)Ag(MeCN)]+ (100). max/cm
-1: 1587.2 (C=O), 1326.1 (C=O). Anal. 
Calc. for C29H41AgN2O2: C, 62.48; H, 7.41; N, 5.02%. Found: C, 62.62; H, 
7.50; N, 5.14%. 
 
[(SIPr)AgOBz] (4.20b). 
Prepared by procedure O from IPr
HBF4 (0.2 mmol, 95.7 mg), AgOBz (0.24 
mmol, 63.2 mg), K2CO3 (4.0 mmol, 0.55 g) and CH2Cl2 (10 mL); x = 1. Yield: 
68.2 mg (55%). 1H NMR (CDCl3):  = 7.87 – 7.84 (m, 2H, benzoate CH), 
7.40 (t, J = 7.8, 2H, CH-aromatic), 7.27 – 7.19 (m, 7H, benzoate CH, CH-
aromatic), 4.08 (s, 4H, imidazole CH2), 3.11 (sept, J = 6.8, 4H, CH(CH3)2), 
1.41 (d, J = 6.9, 12H, CH(CH3)2), 1.35 (d, J = 6.8, 12H, CH(CH3)2). 13C NMR 
(126 MHz, CDCl3):  = 207.9 (dd, J(109Ag, 13C) = 271 , J(107Ag, 13C) = 235, 
NCN), 172.9 (CO), 146.6 (CH-aromatic), 136.0 (CH-aromatic), 134.7 (CH-
aromatic), 129.9 (CH-aromatic), 129.8 (CH-aromatic), 129.7 (CH-aromatic), 
127.3 (CH-aromatic), 124.7 (CH-aromatic), 53.9 (d, 1J(107Ag, 13C) = 9.4 , 
imidazole CH2), 28.9 (CH(CH3)2), 25.4 (CH(CH3)2), 24.1 (CH(CH3)2). MS 
[ESI]: m/z (%) = 538.24 [(SIPr)Ag(MeCN)]+ (100). max/cm-1: 1606.7 (C=O), 
1364.5 (C=O). Anal. Calc. for C34H43AgN2O2: C, 65.91; H, 7.00; N, 4.52%. 
Found: C, 65.85; H, 7.09; N, 4.60%. 
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[(SIPr)Ag(4-MeC6H4CO2)] (4.20c). 
Prepared by procedure O from IPr
HBF4 (0.2 mmol, 95.7 mg), Ag(4-
MeC6H4CO2) (0.24 mmol, 58.3 mg), K2CO3 (4.0 mmol, 0.55 g) and CH2Cl2 
(10 mL); x = 4. Yield: 60.9 mg (54%). 1H NMR (CDCl3):  = 7.75 (d, J = 7.9, 
2H, benzoate CH), 7.40 (t, J = 7.8, 2H, CH-aromatic), 7.25 (d, J = 7.6, 4H, 
CH-aromatic), 7.01 (d, J = 7.9, 2H, benzoate CH), 4.07 (s, 4H, imidazole CH2), 
3.10 (sept, J = 6.8, 4H, CH(CH3)2), 2.27 (s, 3H, CH3C6H4CO2), 1.41 (d, J = 
6.9, 12H, CH(CH3)2), 1.35 (d, J = 6.9, 12H, CH(CH3)2). 13C NMR (126 MHz, 
CDCl3):  = 207.9 (dd, J(109Ag, 13C) = 271, J(107Ag, 13C) = 235, NCN), 172.9 
(CO), 146.6 (CH-aromatic), 139.7 (CH-aromatic), 134.7 (CH-aromatic), 133.2 
(CH-aromatic), 129.9 (CH-aromatic), 129.7 (CH-aromatic), 128.0 (CH-
aromatic), 124.6 (CH-aromatic), 53.8 (d, 1J(107Ag, 13C) = 9.3, imidazole CH2), 
28.9 (CH(CH3)2), 25.4 (CH(CH3)2), 24.1 (CH(CH3)2), 21.3 (CH3C6H4CO2). 
MS [ESI]: m/z (%) = 538.24 [(SIPr)Ag(MeCN)]+ (100). max/cm-1: 1603.6 
(C=O), 1360.2 (C=O). Anal. Calc. for  C35H45AgN2O2: C, 66.35; H, 7.16; N, 
4.42%. Found: C, 63.64; H, 7.49; N, 4.27%. 
 
[(SIPr)Ag(4-ClC6H4CO2)] (4.20d). 
Prepared by procedure O from IPr
HBF4 (0.2 mmol, 95.7 mg), Ag(4-
ClC6H4CO2) (0.24 mmol, 63.2 mg), K2CO3 (4 mmol, 0.55 g) and CH2Cl2 (10 
mL); x = 4. Product contained [Ag(SIPr)2]X as an impurity. Crude yield: 85.9 
mg (66%). 1H NMR (CDCl3):  = 7.80 – 7.77 (m, 2H, benzoate CH), 7.40 (t, J 
= 7.8, 2H, CH-aromatic), 7.25 (d, J = 7.8, 4H, CH-aromatic), 7.18 – 7.15 (m, 
2H, benzoate CH), 4.08 (s, 4H, imidazole CH2), 3.10 (sept, J = 6.8, 4H, 
CH(CH3)2), 1.39 (d, J = 6.8, 12H, CH(CH3)2), 1.35 (d, J = 6.8, 12H, 
284 
 
CH(CH3)2). 13C NMR (126 MHz, CDCl3):  = 207.6 (dd, J(109Ag, 13C) = 273, 
J(107Ag, 13C) = 236, NCN), 171.8 (CO), 146.6 (CH-aromatic), 146.1 (CH-
aromatic), 135.8 (CH-aromatic), 134.6 (CH-aromatic), 131.2 (CH-aromatic), 
129.9 (CH-aromatic), 127.5 (CH-aromatic), 124.7 (CH-aromatic), 53.9 (d, 
1J(107Ag, 13C) = 9.3, imidazole CH2), 28.9 (CH(CH3)2), 25.4 (CH(CH3)2), 24.1 
(CH(CH3)2). MS [ESI]: m/z (%) = 538.24 [(SIPr)Ag(MeCN)]+ (100). max/cm-1: 
1606.6 (C=O), 1365.9 (C=O). 
 
[(IPent)AgOAc] (4.44a). 
Prepared by procedure O from IPent
HBF4 (0.2 mmol, 117.7 mg), AgOAc 
(0.24 mmol, 40.0 mg), K2CO3 (4 mmol, 0.55 g) and CH2Cl2 (5 mL); x = 1.5. 
Purification by recrystallization was unnecessary. Yield: 82.9 mg (62%). 1H 
NMR (500 MHz, CDCl3):  = 7.47 (t, J = 7.8, 2H, CH-aromatic), 7.20 (d, J = 
7.8, 4H, CH-aromatic), 7.09 (d, J = 1.9, 2H, imidazole CH), 2.16 − 2.09 (m, 
4H, Et2CH), 1.80 (s, 3H, CH3CO2), 1.78 – 1.59 (m, 12H, CH3CH2), 1.48 (m, 
4H, CH3CH2), 0.90 (t, J = 7.4, 12H, CH3CH2), 0.77 (t, J = 7.4  12H, CH3CH2). 
13C NMR (126 MHz, CDCl3):  = 184.3 (dd, J(109Ag, 13C) = 288, J(107Ag, 13C) 
= 250, NCN), 177.8 (CO), 143.2 (CH-aromatic), 137.5 (CH-aromatic), 130.2 
(CH-aromatic), 124.6 (CH-aromatic), 124.1 (d, J(107Ag, 13C) = 8.3, imidazole 
CH), 42.7 (Et2CH), 29.3 (CH2), 28.5 (CH2), 22.6 (CH3CO2), 12.8 (CH3), 12.6 
(CH3). MS [ESI]: m/z (%) = 648.34 [(IPent)Ag(MeCN)]+ (100). max/cm-1: 
1599.9 (C=O), 1375.8 (C=O). Anal. Calc. for C37H55AgN2O2: C, 66.56; H, 
8.30; N, 4.20%. Found: C, 66.46; H, 8.23; N, 4.13%. 
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[(IPent)AgOBz] (4.44b). 
Prepared by procedure O from IPent
HBF4 (0.2 mmol, 117.7 mg), AgOBz 
(0.24 mmol, 63.2 mg), K2CO3 (4 mmol, 0.55 g) and CH2Cl2 (5 mL); x = 1.5. 
Purification by recrystallization was unnecessary. Yield: 102.3 mg (70%). 1H 
NMR (CDCl3):  = 7.85 (d, J = 6.9, 2H, benzoate CH), 7.48 (t, J = 7.8, 2H, 
CH-aromatic), 7.29 – 7.19 (m, 6H, CH-aromatic, benzoate CH), 7.10 (d, J = 
1.9, 2H, imidazole CH), 2.21 – 2.14 (m, 4H, Et2CH), 1.84 – 1.59 (m, 12H, 
CH3CH2), 1.51 (m, 4H, CH3CH2), 0.93 (t, J = 7.3, 12H, CH3CH2), 0.79 (t, J = 
7.3, 12H, CH3CH2). 13C NMR (CDCl3):  = 184.2 (dd, J(109Ag, 13C) = 289, 
J(107Ag, 13C) = 250, NCN), 172.5 (CO), 143.3 (CH-aromatic), 137.5 (CH-
aromatic), 136.8 (CH-aromatic), 130.2 (CH-aromatic), 129.6 (CH-aromatic), 
129.5 (CH-aromatic), 127.2 (CH-aromatic), 124.7 (CH-aromatic), 124.2 (d, 
J(107Ag, 13C) = 8.3, imidazole CH), 42.8 (Et2CH), 29.3 (CH2), 28.6 (CH2), 
12.9 (CH3), 12.6 (CH3). MS [ESI]: m/z (%) = 648.34 [(IPent)Ag(MeCN)]+ 
(100). max/cm
-1: 1606.7 (C=O), 1364.5 (C=O). Anal. Calc. for C42H57AgN2O2: 
C, 69.12; H, 7.87; N, 3.84%. Found: C, 68.94; H, 7.74; N, 3.90%. 
 
[(IPent)Ag(4-ClC6H4CO2)] (4.44d). 
Prepared by procedure O from IPent
HBF4 (0.2 mmol, 117.7 mg), Ag(4-
ClC6H4CO2) (0.24 mmol, 63.2 mg), K2CO3 (4 mmol, 0.55 g) and CH2Cl2 (5 
mL); x = 2.5. Purification by recrystallization was unnecessary. Yield: 79.6 
mg (52%). 1H NMR (500 MHz, CDCl3):  = 7.80 – 7.77 (m, 2H, benzoate 
CH), 7.49 (t, J = 7.8, 2H, CH-aromatic), 7.22 (m, J = 7.8, 4H, CH-aromatic),  
7.19 – 7.14 (m, 2H, benzoate CH), 7.11 (d, J = 1.9, 2H, imidazole CH), 2.20 – 
2.14 (m, 4H, Et2CH), 1.82 – 1.61 (m, 12H, CH3CH2), 1.50 (m, 4H, CH3CH2), 
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0.9 (t, J = 7.4, 12H, CH3CH2), 0.79 (t, J = 7.4, 12H, CH3CH2). 13C NMR (126 
MHz, CDCl3):  = 183.9 (dd, J(109Ag, 13C) = 291, J(107Ag, 13C) = 252, NCN), 
171.4 (CO), 143.2 (CH-aromatic), 137.5 (CH-aromatic), 135.5 (CH-aromatic), 
135.3 (CH-aromatic), 131.1 (CH-aromatic), 130.2 (CH-aromatic), 127.4 (CH-
aromatic), 124.7 (CH-aromatic), 124.2 (d, J(107Ag, 13C) = 8.4, imidazole CH), 
42.8 (Et2CH), 29.3 (CH2), 28.6 (CH2), 12.9 (CH3), 12.6 (CH3). MS [ESI]: m/z 
(%) = 648.34 [(IPent)Ag(MeCN)]+ (100). max/cm
-1: 1607.5 (C=O), 1369.6 
(C=O). Anal. Calc. for C42H56AgClN2O2: C, 66.01; H, 7.39; N, 3.67%. Found: 
C, 66.08; H, 7.26; N, 3.82%. 
 
[(IAd)AgOAc] (4.45a). 
Prepared by procedure O from IAd
HBF4 (0.2 mmol, 117.7 mg), AgOAc (0.24 
mmol, 40.0 mg), K2CO3 (4 mmol, 0.55 g) and CH2Cl2 (5 mL); x = 1.5. 
Purification by recrystallization results in decomposition. Yield: 59.4 mg 
(59%). 1H NMR (CDCl3):  = 7.10 (d, J = 1.9, 2H, imidazole CH), 2.37 – 2.36 
(m, 12H, adamantyl CH2), 2.26 (br s, 6H, adamantyl CH), 2.12 (s, CH3CO2), 
1.81 – 1.73 (m, 12H, adamantyl CH2). MS [ESI]: m/z (%) = 337.27 [IAd+H]+ 
(100). max/cm
-1: 1595.0 (C=O), 1372.2 (C=O). 
 
[(IAd)AgOBz] (4.45b). 
Prepared by procedure O from IPent
HBF4 (0.2 mmol, 117.7 mg), AgOBz 
(0.24 mmol, 63.2 mg), K2CO3 (4 mmol, 0.55 g) and CH2Cl2 (5 mL); x = 1.5. 
Purification by recrystallization results in decomposition. Yield: 48.2 mg 
(48%). 1H NMR (CDCl3):  = 8.16 – 8.13 (m, 2H, benzoate CH), 7.40 – 7.37 
(3H, benzoate CH), 7.12 (d, J = 1.9, 2H, imidazole CH), 2.41 (m, 12H, 
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adamantyl CH2), 2.26 (br s, 6H, adamantyl CH), 1.82 – 1.73 (m, 12H, 
adamantyl CH2). MS [ESI]: m/z (%) = 337.27 [IAd+H]+ (100). max/cm-1: 
1597.8 (C=O), 1368.3 (C=O). 
 
Ag4(SIMes)2(CF3CO2)4 (4.43). 
SIMes
HCl (1.0 mmol, 0.34 g) was added to a solution of potassium tert-
butoxide (1.0 mmol, 0.11 g) in THF (20 mL) at room temperature. The 
mixture was stirred for 4 h at room temperature, and the white KCl precipitate 
was filtered off. The filtrate was evaporated, and the oily residue was extracted 
with dry n-hexane. The combined extracts were evaporated, leaving an off-
white solid, which was dissolved in THF (10 mL). Silver(I) trifluoroacetate 
(0.75 mmol, 0.17 g) was added, and the resulting light brown solution stirred 
overnight at room temperature. The reaction mixture was filtered and 
evaporation of the filtrate gave a yellow oil, which was triturated with n-
hexane to give an off-white solid. X-ray diffraction quality single crystals 
were obtained from a saturated solution of the crude product using 
MeOH:Et2O (1:1).  
1H NMR (CDCl3):  = 6.97 (s, 4H, CH-aromatic), 4.02 (s, 
4H, imidazole CH2), 2.31 (s, 18H, CH3). 13C NMR (CDCl3):  = 139.0 (s, CH-
aromatic), 135.4 (s, CH-aromatic), 135.0 (s, CH-aromatic), 129.9 (s, CH-
aromatic), 51.2 (s, imidazole CH2), 21.0 (s, CH3), 17.9 (s, CH3). 19F NMR 
(CDCl3):  = 74.3 (s, CF3CO2
-). MS [ESI]: m/z (%) = 456.14 
[(SIMes)Ag(MeCN)]+ (100). 
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[(SIMes)AgCl].270 
SIMes
HCl (0.5 mmol, 171.5 mg) was dissolved in 15 mL of CH2Cl2 and 
silver(I) oxide (0.25 mmol, 57.9 mg) was added. The resulting mixture was 
stirred at room temperature for 24 h, filtered through Celite, and concentrated 
in vacuo.  Recrystallization from CH2Cl2/n-hexane gave the desired complex 
as colorless crystals. Yield: 157 mg (70%). Colorless crystals. 1H NMR 
(CDCl3):  = 6.94 (s, 4H, CH-aromatic), 4.00 (s, 4H, imidazole CH2), 2.29 (s, 
18H, CH3). 13C NMR (CDCl3):  = 207.5 (dd, J(109Ag, 13C) = 256, J(109Ag, 
13C) = 222, NCN), 139.0 (s, CH-aromatic), 135.7 (s, CH-aromatic), 135.3 (s, 
CH-aromatic), 130.0 (s, CH-aromatic), 51.3 (s, imidazole CH2), 21.2 (s, CH3), 
18.1 (s, CH3). 
 
[(IPr)AgCl].191 
IPr
HCl (0.5 mmol, 212.5 mg) was dissolved in 5 mL of CH2Cl2 and silver(I) 
oxide (0.3 mmol, 69.5 mg) was added. The resulting mixture was stirred at 
room temperature for 12 h, filtered through Celite, and concentrated in vacuo.  
Pentane was added to precipitate a white solid, which was washed further with 
pentane (3  5 mL) and dried in vacuo. Yield: 125 mg (47%). White powder. 
1H NMR (CDCl3):  = 7.50 (m, 2H, CH-aromatic), 7.30 (m, 4H, CH-aromatic), 
7.21 (s, 2H, imidazole CH), 2.54 (septet, J = 6.8, 4H, CH(CH3)2), 1.28 (d, J = 
6.8, 12H, CH(CH3)2), 1.22 (d, J = 6.8, 12H, CH(CH3)2). 13C NMR (CDCl3):  
= 184.6 (dd, J(109Ag, 13C) = 271, J(109Ag, 13C) = 235, NCN), 145.6 (CH-
aromatic), 130.8 (CH-aromatic), 124.4 (CH-aromatic), 123.7 (CH-aromatic), 
123.6 (imidazole CH), 28.7 (CH(CH3)2), 24.7 (CH(CH3)2), 24.0 (CH(CH3)2). 
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[Ag(IPr)2]2[PF6].229 
A mixture of [(IPr)AgCl] (0.2 mmol, 106.4 mg) and NH4PF6 (0.25 mmol, 40.8 
mg) in methanol (10 mL) were stirred at room temperature for 2 days. All 
volatiles were then evaporated, and CH2Cl2 (10 mL) was added to give a pale 
yellow suspension that was filtered through Celite. The filtrate was 
concentrated and addition of n-hexane (10 mL) precipitated an off-white 
powder that was collected and dried in vacuo. Yield: 144 mg (70%). Off-white 
powder. 1H NMR (CDCl3): δ 9.94 (t, 4H, J = 7.8, CH-aromatic), 7.13 (d, 8H, J 
= 7.8, CH-aromatic), 7.07 (d, 4H, J = 1.8, imidazole CH), 2.27 (sept, 8H, J = 
6.9, CH(CH3)2), 1.06 (d, 24H, J = 6.9, CH(CH3)2), 0.77 (d, 24H, J = 6.9, 
CH(CH3)2). 13C NMR (CDCl3):  = 183.6  (dd, J(109Ag, 13C) = 211, J(109Ag, 
13C) = 183, NCN), 145.3 (CH-aromatic), 134.6 (CH-aromatic), 129.9 (CH-
aromatic), 125.0 (CH-aromatic), 123.8 (d, J(107Ag, 13C) = 6.0, imidazole CH), 
28.7 (CH(CH3)2), 24.7 (CH(CH3)2), 24.0 (CH(CH3)2). 
 
General procedure for Ag(I)-NHC catalyzed conversion of 2.1 to 2.2 or 
2.8 to 2.9 (Procedure M): 
The substrate (0.2 mmol) and the 1,3,5-trimethoxybenzene internal standard 
(ca. 6.8 mg) were dissolved in CD2Cl2 (0.5 mL) at room temperature, followed 
by the catalyst (0.01 or 0.05 equiv.). The solution was transferred to an NMR 
tube, and the reaction progress was monitored by 1H NMR spectroscopy. The 
yields and conversions were calculated by comparison of the integrals of the 
product and substrate resonances to that of the internal standard. 
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5-methylene-2-vinyl-4,5-dihydrooxazole (3.2e). 
This compound was previously reported271 but no spectroscopic 
data was given. 1H NMR (CD2Cl2): δ 6.33 (dd, J = 17.6, 10.9, 1H, 
CH=CH2), 6.16 (d, J = 17.6, 1H, CH=CH), 5.81 (d, J = 10.9, 1H, CH=CH), 
4.73 (q, J = 2.9, 1H, OC=CH), 4.55 (t, J = 2.9, 2H, NCH2), 4.33 (q, J = 2.6, 
1H, OC=CH). 
 
2-carboethoxy-5-methylene-4,5-dihydrooxazole (3.2g). 
1H NMR (CD2Cl2): δ 4.88 (q, J = 3.2, 1H, =CH), 4.67 (t, J = 
3.0, 2H, NCH2), 4.44 (q, J = 3.2, 1H, =CH), 4.35 (q, J = 7.5, 
2H, CH2), 1.39  1.36 (m, 5H, CH2CH3). 
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Table A8. Crystal data and structure refinement for compounds 4.45a and b 
Compound 4.45a 4.45b 
Formula C25H35AgN2O2, CH2Cl2 C30H37AgN2O2 
Formula weight 588.34 565.48 
Temperature 173 K 173 K 
Diffractometer, 
wavelength 
Agilent Xcalibur 3 E, 
0.71073 Å 
Agilent Xcalibur 3 E, 
0.71073 Å 
Crystal system, space 
group 
Monoclinic, P 21/c Monoclinic, P 21/n 
Unit cell dimensions a = 11.0188(5) Å a = 11.6913(3) Å 
 b = 11.8584(4) Å b = 11.8435(3) Å 
 c = 19.6802(7) Å c = 18.6475(5) Å 
 
 = 90  = 90 
 
	 = 99.173(4) 	 = 102.744(3) 
 
 = 90  = 90 
Volume, Z 2538.62(17) Å
3
, 4 2518.45(12) Å
3
, 4 
Density (calculated) 1.539 Mg/m
3
 1.491 Mg/m
3
 
Absorption coefficient 1.031 mm
-1
 0.831 mm
-1
 
F(000) 1216 1176 
Crystal color / 
morphology 
Colorless blocks Colorless blocks 
Crystal size 0.62 x 0.46 x 0.45 mm
3
 0.56 x 0.35 x 0.18 mm
3
 
 range for data 
collection 
2.541 to 28.256° 2.479 to 28.226° 
Index ranges -9  h  14, -9  k  15, -
26  l  19 
-15  h  14, -13  k  
15, -14  l  24 
Reflns collected / unique 8735 / 5115  
[R(int) = 0.0214] 
9081 / 5084  
[R(int) = 0.0220] 
Reflns observed 
[F>4(F)] 
4185 4349 
Absorption correction Analytical Analytical 
Max. and min. 
transmission 
0.701 and 0.650 0.877 and 0.729 
Refinement method Full-matrix least-squares 
on F
2
 
Full-matrix least-squares 
on F
2
 
Data / restraints / 
parameters 
5115 / 0 / 299 5084 / 0 / 316 
Goodness-of-fit on F
2
 1.057 1.076 
Final R indices 
[F>4(F)] 
R1 = 0.0403,  
wR2 = 0.0821 
R1 = 0.0369,  
wR2 = 0.0879 
R indices (all data) R1 = 0.0547,  
wR2 = 0.0886 
R1 = 0.0465,  
wR2 = 0.0930 
Largest diff. peak, hole 0.754, -0.580 eÅ
-3
 0.856, -0.444 eÅ
-3
 
Mean and maximum 
shift/error 
0.000 and 0.001 0.000 and 0.001 
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